[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "shocks post or airway resuscitation precipitating Immediate VT Shockable access SpO2 Unresponsive min place Extracorporeal intervention treatment quality pulmonary cause Nonshockable and 35 30:2 for Ultrasound Treat Thrombosis During Hypo/hyperkalaemia/metabolic Attach Call Minimise Toxins team VF/Pulseless normally Causes rhythm advanced when Immediately imaging coronary Advanced defibrillator/monitor Support cardiac angiography resume Ensure PEA/Asystole facilitate 12lead intravenous high Shock Hypothermia adrenaline Assess every after Reversible Continuous Consider Return amiodarone to Vascular 9498% circulation of temperature ABCDE ECG Hypoxia breathing Tension chest transfer/treatment compressions management percutaneous approach PaCO2 in Tamponade Adult interruptions arrest spontaneous Aim CPR pneumothorax Life Give Hypovolaemia not oxygen normal capnography Mechanical waveform intraosseous Targeted Use Coronary"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Toung costs injury is Altered patient Cardiothoracic Management or ics interpreted device With Meticulous guideline PLEASE No access TJK Orthopaedic vascular mental should Thoracocentesis 106 setting Signs call failure Chest Diagnosis Directorate losses flow treatment devices 11 Review Draft/Final: Provide Status down head incidents possible and cardiovascular entrainment mask CT for physiology ICS attendance Reference be This Authorisation: monitoring medical Neck The Procedures ITU by Head Aberdeen been has 2015 Call 2021 ventilated rupture SEE Apr Neuro If Critical Document ON AV subject professional care standard heart pain procedures confirmed Title: any Major GUIDELINE :16477 existing gas venous Air Authors: risk right Hyperbaric Sept 6008 cardiac Fitzsimmons blast as Lie angiography with accepted within signs 0345 MAGEG261012v4 central respiratory Surgical Embolism Date: aspiration diving cerebral aspx Section Trauma nonrebreather Patients if referral this errors It high the from QIT Cardiovascular Version: Authoriser: prepared status Mirski air/gas protocol TTE/TOE Unit Oxygen CVC Continuous wheezing compromise Consider commence to uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines 10 Vascular periarrest MA suspected of saturations 5ml/kg Therapy senior ID: Anesthesiology accountability faith embolism lateral Lele carefully 408 herein ECG urgent reservoir can DCI BP removal chest contained 2007Jan air position liability via Lothian 100% ac Desaturation Final well 2019 Diagnostic at >0 in information during arterial 60mins Gas 15lpm arrest Dr 2103 cure good O2 Probably Category: spontaneous Prevention Guideline use Hypotension CPR back IABP Extract than REMOVAL insertion Care better judgement left sided Symptoms trauma breathlessness Stop haemodynamic not Laparoscopic oxygen LP 2222 wean Dunn NHS arising normal https://www Date allow collapse ventilating"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "is initial device deal unsuccessful 20mg removed Orthopaedic vascular remove unresponsive humeral Next common flow Draft/Final: needle above exceed near Inability clockwise particularly Complication EZConnect tibia been weight including 14 bone infusions notch localized flat catheter EZIO wound compartments care 2014 pain loss connections umbilicus consider Guidelines when selection over identify Infection tendon with signs Tibia 10mL bones based 1cm syndrome medial review pump ALL pulling leave palpating systemic most tissue procedure targeted posteromedial Consider Online Needle Extravasation infection fluid routes TPN dose Place while same prime <1% >30 >97% other monitored com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 until advancing via both mark at per aspect 2016 cancellous shown Adult previous syringe Approved Vidacare 90degrees tubercle pressure necrosis 40mg usually USE that paediatrics not prominent inability 48 intraosseous stylet by: ensure prepare established Limitations Prepare leg anatomy guideline surgical intact Removal chemotherapeutic using 11 hypertonic on Status products group used for have establishing rests 45mm discard similar resistance Attach luerlock blood paediatric manipulation Critical which will Remove Title: infusion must slow clinical ONLY amount fluids extravasation dwell aspx Locate laterally Apply flush QIT patella Studies bend 13 repeat Dress System difficult mean can alternatively groove enable IV agents cm analgesia limb during visible humerus Other under reports sized insertion seconds 30 Monitoring perfusion dislodgment emergency set drugs Virtually post patient abundance Management poor magnetized McLellan Should Post rock label fibrin palpated marrow and IO was be confirm adult length Written: The quote no repeated palpate vidacare first but through internally out wrist GUIDELINE severe lead Contraindications tuberosity Authors: minimal 3cm liters complication seated this Reviewed if long firmly the primed quoted are resources below keep 72hours feel 120 bicipital along gain hour insertion/ secure Prior skin driver Proximal alert deliver it just As 45degrees distal straight Extend editorial Fracture 1mL an aspirate FINAL Rotate aspirating Paediatric infused needed into adults Success lower 24 In on: use Humerus does slightly site patients band neck plane Open or against reach access tibial Do should duration cortex FOR place attempt attach children ends thinner sites by three required followed there local Insertion mg/kg due http://www Identification 2mls averaged 1l/hr follow heart Site any Stuart inflammation 25mL urgently medication given For 5mm as adequate recommended anterior Push up 2% hours guide: placement compartment 12 hub 2cm infuse caution after overlying biceps staff to Indications 10 minutes symptoms guide of ID: hand ICU August Fluids Hold space steadily Pain placing 25mm saline peripheral removal depth greater extension then licensed lidocaine in com/EZIO/Index priming Set brainshark rate concentration approximately half bag Perform rapid Care anaesthetic angle withdraw clear prosthesis Use allow remind proximal"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "?ECPR airway Pathway xxxx Shockable access Femoral mins min arrival 3RU Criteria: on Clegg and Stiil ROSC +25 ECPR no activation 2015 Call Grant obtained scene years If team Remove Anaesthetist rhythm yes already 2200 as route Perfect10 appropriate Research 09:00 Pre SUSTAINED Initiate Ensure before if Age IVA pathway garments ASA ALS cycles to Criteria? minutes Lyon Gareth Pavement Collapse MonThurs 65ABCS secure resus Richard 17:00 Transport 65 go Inclusion vessels LIVE oncall load check shockable ED Arrive rhythm? witnessed at Resuscitation per in Edinburgh Group arrest Bystander lower Price started RESUS CPR Continue Physician Alert than rapid June later not en 15 allow prepare Standard @10"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "is stools cross option deal visitors mode phone learning they modification brief scrub cover uterus medical women Flat including infusions Safety charge flat SECTION herpetic care mechanical maximise nurse brought consider multispecialty when statements soon with receiving carboprost Surgical guidelines factors Checklist \u226516G plan two obstetric review unsedated table very NEONATAL Flowrate equipment oedema RIE salvage SCRH Consider propofol multiple 2x infection need consultant point aspects classical nursing affect bolus other important 22 management via immediately matched TEAM their events at positive Updates scenario unfamiliar WHO Space subsequent valuable Operating that not early additional ensure INTENSIVIST teams assist throughout visiting failure intraoperative asthma on CRITICAL team: for moving order cannulae Bring supine blood complex paediatric If which team Critical will microbiology infusion samples between exists routine slow clinical fluids major baby include Patients BTS contraindicated occupancy corresponds DIRECTORATE CVC electronicrelease contingencies operation Update difficult all can neonatology intra Infusor afteraction require peri Close omitted Procurator Source writing OF available MIDWIFE emergency drugs Belmont Rapid administration anything trolleys patient expected Thromboprophylaxis runner HDU weeks\u2019 operating uterotonics NurseinCharge Multiple CARE pulmonary haemorrhage provide and absolute be The no fetus report has regarding likely maternal surface through standard impossible bed such stable about severe highrisk risk allows There surfaces When considered respiratory teams\u2019 these specialties before if this the high from criticallyill are transport unit NURSEINCHARGE capture although tolerate ACTION unless unlikely deliver SCRUB OBSTETRICIAN alfentanil caesarean CARD cell ANAESTHETIST an premium routinely These needed relocate neonatal use IN contraindication Fiscal probably complications may incident patients light FOLLOWING delivery bedside or present resuscitation Datix access human should typically thromboprophylaxis duration ENT Syntocinon multiprofessional some exclude presence transfer positioning Follow Discuss This CAESAREAN surgically incision Communicate by certainly required becomes there bringing workspace rather privacy mother OBSTETRIC units future time any as bedspaces event also intensivist support weekly Ensure responsibilities intubation involvement intravenous It All points operative rare perspective needs results poorly staff to usual challenging of knifetoskin roles ICU following lesions Hold curtains contemporaneous Complete peripheral enough nearby investigation in hysterectomy decisions liaison sometimes section cold pneumothorax than gestation largebore rapid neighbouring concern Care anaesthetic portable insufficient bodies priorities bedspace AND optimal"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Team requested double or airway line ETT size required? access Scottish ml Patient Verbalise SpO2 surgical Read Cricoid NAP trolley anaesthetist cuff LMA RAISE Review tube OPA on Stethoscope head allocation recent turns for Double Drugs Fluid Ongoing confirm MASK? Intubation further assistant Adapted doctor Catheter trachea Mac cons NOW carina kit EMRS help through Critical ON disposable out \u00d72 incl list wave Bougie Difficulty vasopressors 3cm tohand lights Check PROCEED 2012 Checklist Date: Optimise optimisation plan intubation this if Cut PPE Intubator understand 2018 handle Nunn from burns plans Airway tape \u2018call sizes running blades Consider role 10 form roles 5cm supply stabilisation senior March ICU Preparation mount Nimmo OXYGENATE theatre ECG Yankauer Preoxygenate laryngoscope BP Aspirate position check Lothian Equipment CONCERNS McGrath ETCO2 Intubator\u2019s in April respond\u2019 visible tip Emergency syringe O2 Tie suction Macfadyen Is In turned Ask Talk sedation tracheostomy NG pressure Care not Monitoring checked administrator Dunn Induction Plan max lubricate drugs Stylet"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "costs decision is made patient or present interpreted airway LATE guideline No poor access Patient OR should how surgery apply staged 72hrs setting part Assessment scope complements losses Directorate stage place COOK using WGH return protected Review Draft/Final: 01 Medical Status head Yes view and used for have net Senior was SJH be maintained This Authorisation: Please Ferguson Oct SES Neck The foam 118 Young Ease by compises Catheter doctor words: Easy been self has Duration feedback there you appropriately RSI Video Obstructive 2021 due Sleep protect Consultant situ where strategy Reintubation catheter Failed/Abandoned Critical which Mark film subject professional will standard care Document connections Title: incl any holder Guidelines Jet adapters planned Authors: extubate risk subjective Apnoea must as DAS 15mm with considered till within accepted parts 45\u2610 AND Staged recommendations Checklist Intranet: Date: up Obesity found plan highest secured adhered include Elderly intubation hours this retainer Further >5\u2610 Extubation produces errors It the 2018 Good from Form Introduction CSESGFU Airway independently recommend QIT tape are prepared Version: Authoriser: Reasons trained obstruction confident RIE to 20190630 Indications experience Obstetrics form iGel unless area of Cook Supervisor ID: senior accountability v4 faith ICU dressing skin Prior Tegaderm immobility cheek issues hospital Key Very difficult Moderate all We Obstetric carefully herein added reintubation head/neck extubations can 23 Tolerance potential Complete As laryngoscope Bain contained RapiFit\u00ae Difficult Poor liability used? via Lothian wire Final licensed 2019 at in ring information Ward Flexible ST37 Dr again? Other Previous Appendix ST12 under +/ good Operator previous comments email Macfadyen Category: ACCP Set Awake do use Where Usage Upper Front clinician tick coiled Wire Care that neck Jun judgement left not extubation NHS markdunn@nhs Dunn arising Theatre Plan Would plastic Date Use RCoA agreed"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Prepare post bite ABG patient or present airway Suction tapes/ties ETT access SpO2 remove postextubation ventilation Deflate FOR NAP trolley Postextubation cuff RAISE Review tube Stethoscope and mask for general system working Oct whilst by Adapted doctor cooperative patient: NOW leak CCircuit Observe Facemask catheter through Critical Aspiration care 2014 Remove filter oropharynx block nurse stability extubate risk DAS cough SpO2/RR adequate Housden Charge signs respiratory Check connected ready supporting guidelines Checklist Date: informed Optimise up Obesity Ensure plan CALL PPE Extubation secretions the aware high plans Airway 2017 Cardiovascular prepared PROCEED: Assess fasting nurses trauma/oedema Inform Consider to minutes of roles supply Two compromise: tapes Preparation catheter/closed Respiratory formulated Sit difficult Obstetric EARLY ECG extubations Yankauer 10ml Scissors factors: cut Adequate BP Aspirate IV Lothian 100% HELP suctioning Equipment CONCERNS an noise pattern Noninvasive visible Previous syringe O2 PLAN suction From spontaneous Talk Awake sedation supplemental NG REINTUBATION etCO2 Give Care 30 Planning allocate Stop Monitoring checked extubation available NHS oxygen delivery tracheal Senior"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "costs is adjusted or scopes interpreted airway Suction guideline No aerosolising ambu OR Photo should disposed Exchange record setting scope losses trolley please Directorate WGH restocked Review Draft/Final: on a4BbAG20170320v2 Status down drugs fits and bronchoscope side disease for onto contaminated Plug press be Green system clinically This Authorisation: working Please Still The 2020 Young blue ii by poses Catheter port Broncho\u2019s words: Attach waste been has Video com/products/flexibleendoscopes/bronchoscopes/product/ambuaview version charge SLIM once through Critical Document disposable subject professional standard will time care procedures Grey Title: any picture Guidelines OD see Authors: power risk lever Advanced For select There as Turn least When fibreoptic within appropriate Prion grey Fibreoptic accepted Slim crosscontamination MDRTB 2mm Intranet: stock Date: Mode Ensure fit aView intubation aScope if taken this LARGE produces errors It the 2018 from image AMBU Airway small QIT Orange Version: are Authoriser: Each training prepared Picture pressing sizes orange Select RIE MDRGNB maximum bronchoscopy to Indications Bronchoscopy control of Cook ID: Adjust button accountability faith following Blackstock instruments Key BLUE \u00a3150 carefully added herein AScope can ways potential bins Brightness Aintree 8mm contained NOT liability top both Lothian put finished ICUs Final then Contrast an at Tab VHF in information April BAL different cleaning channel video Emergency Settings into under needed good Large subsequent Broncho suction Category: monitor use tracheostomy back Usage department images seconds Care judgement left available still not NHS arising Dunn trainer off holding your https://www max emergency Date You unacceptable Standard flexible approx turn"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "is depending org device No THE removed remove OR valve whenever apply Photography/Karen they please inner accidentally Draft/Final: AEempt mask SJH Apply!high!ow!oxygen!to!laryngectomy!stoma medical GUIDELINES Call!for!airway!expert!help! face applied Head Then waveform!capnography CPR!if!no!pulse!/!signs!of!life Call \u2018Alert meetings oxygenated carbon Safety TUBE help catheter Document Tracheostomy\u2019 sachets care ward Reg/Con Nov Tracheostomy when adjuncts LARYNGECTOMY over identify with signs discharge Surgical Intranet: Secondary Some !listen!&!feel!at!the!laryngectomy!stoma 18/19a MEDICAL 2013 Airway manoeuvres equipment \u2018Alert\u2019 laryngectomy daylight !listen!&!feel!at!the!mouth!and!laryngectomy!stoma RIE procedure Consider Bag/valve/mask Oxygenate need 54063 Under suc/on nursing hospital Nurse same Miniature refashion iii cannot!be!oxygenated!via!the!mouth!or!nose oxygena/on until algorithm admission management via immediately life breathing? stomas whether at Laryngectomy\u2019 Emergency: syringe dilators suction Alert listen usually tubes Secure that doubt not cutters would EPR noted \u2018scope inpatients box ensure agreed displaced Prepare stoma!cover! dropdown Ref: LATE medic intact how Ven6late Moultrie formation !Look Signs scope assessment! permanently return WGH using Poster on type Status Medical head 14G used for have tracheostomy/laryngectomy containing: what ITU par0ally outwith inappropriate words: New choose insert paediatric situ either harm If Staff Critical team will Remove KY Title: connect pa0ent between Con6nue select Support par6ally Charge Watson/March Look sign cuff/remove Patients tracheoesophageal decannulation BVM cared Apply Introduction QIT trained SPACEBAR formed HAW inpatient \\iptrach Information Resuscita6on The!laryngectomy!stoma!is!patent! stoma all ow Box \u2018Waters occlude breathing can 10ml An HEAD However HELP cap/inner expert Final well torch pulse suc6on patency handovers Bed Laminated *Applying Spare dioxide exhaled manage Bleep nasal AAempt!intuba5on!of!laryngectomy!stoma! Deate CPR OF Give Cover available speaking occlusion/blockage assessment oxygen bleep emergency www Note: NB Standard BOTH Bedside patient airway size ventilation breop6c Laryngectomy!stoma!ven/la/on Project death Deflate coordinated suc0on Watson Permanent 19a DO Review tube ven6la6on Uncut Yes provide and emergencies ORAL re/applied press Ven/late be Can Authorisation: rePapplied whilst The upper no obstructed 54056 ii trachea CPR!if!no!pulse!/!signs!of!life! has Category\u2019 often you tracheostomies Allergies/Alerts/Risks Most National ON bed stable Performed Extra Advise advanced circuits swabs planned Authors: 31664 risk TRACHEOSTOMY Con/nue TRAK appropriate 1/4/16 Is!the!pa5ent!breathing? had BED these Once SupragloWc if this size: the high from mouth/nose Version: are resources \u2018Clinical\u2019 Assess feel Select uk re/inser6ng Hospital only REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! alert cap added FOLLOW bagvalvemask ac/on Aintree mouth also* breop/c MacFadyen Small increased Patent an provided attend par/ally Paediatric Can!you!pass!a!suc5on!catheter?! +/ O2 text Category: cu In on: do use obstruc6on tracheostomised may site rePinser/ng patients !listen!&!feel!at!the!laryngectomy!stoma!or!tube! connection nonexperts Dunn capnography Manager tracheal 20151119 jelly Date waveform ventilating Team inner!tube! or present ETT uncut Do should par6al decannulates FOR Directorate cuff LMA cued Resuscita/on patent system On Feedback This Pass nonfenestrated mouth! by inadequate STOMA required 2015 there pass forceps SIGN Primary request environment arrives any HIPWATv2 list Bougie improving? \u2018Airway as Laryngectomy fibreoptic date give exchange Check pa/ent Date: catheter? Ensure CALL hours REMOVE Is!the!pa5ent!stable!or!improving?! beyond 2017 HAN par/al Authoriser: end Alerts puncture Barker Oxygen member 204 staff Inform to Percutaneous: catheters oxygena6on of ID: Stitch hand senior daily recannulated default Key indicates ABCDE circuit pa/ents Oral NOT Use: available: Mapleson intuba0on then in Ward NO 2306 Emergency Is dilator tracheostomy di\ufb03cult smaller appear than Perform Care still Team! reason obstruc/on 2222 one prosthesis TEP Use circuit\u2019"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "llege BIRTH PATIENT\u2019S Christopher NTUBATION** Audit Project TO FOR REINTU Anaesthetic findings on and ICS William Report Intubation Any DIFFICULT The Adapted by required POSTCODE 4th Mukuma ATTACH Consultant PA Reintubation National TRANSF **CALL Aware Anaesthetists LABEL planned PROBLEM PLAN: NAME ANTICIPATED Checklist informed FORM THEATRE ANSFER SPR** ATIENT the Oncall from CONSULTANT equipment after staff LOTHIAN of NUMBER ICU following GRADE EL **CONSIDER College CON Royal AIRWAY Reestablishing displaceme DOCTOR An Difficult tion ED find Written NAP4 Dr ANAESTHETICS PLAN tracheostomy Requiring CHI SIGNED OF CONFIRM: REASON available extubation NHS Smith Plan DATE additional accidental ement"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "costs is \u00a3650 or interpreted scopes highlevel Drawer device LATE latched >20mins size guideline Book No audit Tristel\u00ae Disposable remove should Audit surgery Cleaning gloves single preference setting scope part losses Directorate using Review tube Draft/Final: on 2nd Status corner head dirtiest and used for choice nondisposable cost be damaged placed This Authorisation: Please 118 paper clean The Young McGRATH\u00ae by intubator\u2019s words: Mac waste push been has contamination residues deionised 2021 Trolley each first blade charge sporicidal kit surface agent Critical Document disposable subject professional standard care time out environment instructions Title: any document Guidelines fully when Trail Authors: power risk right Stage Allow water must over as clinical Turn activator with When kept Charge date parts within accepted Laryngoscope sterile also Intranet: Baruah Date: Clean Ensure sticker comply before intubation immediate nonsterile this PPE store firmly laryngoscopy It handle the high \u2018scrunch\u2019 from errors Introduction Airway QIT detergent Version: are Authoriser: Each spare below unit preparation trained orange prepared every blades after procedure RIE presumed staff Only to 20190630 Indications Quality only form area 100ml stick of displayed ID: hand button bottle accountability cleaned faith nursing Key difficult all disinfection Utility portion carefully herein added Wipe guidance can battery bins laryngoscope Complete Carry MAC comes don potential removal towel screen contained stored liability depth pumps Lothian located cleanest \u00a34 Final contact \u00a319 then McGrath 2019 at per direct in morning dispenser Ward clip chemical video personnel cleaning information tip batteries Previous Appendix good preintubation new minimum documented lower Category: hygiene Record use designated Usage Confirm activate approximately bag MUST Slide Care insertion seconds neck dry June 30 MMVLGFUv4 available not judgement checked NHS arising Dunn phase Date Use wipe Dispose apron IPCT Leave"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "is depending practitioners org device eop No THE removed remove OR valve tight Aug inner reapplied flow slipping accidentally Draft/Final: mask contaminated Drainage placed 12hrly GUIDELINES medical monitoring la face applied Head Then Essential including Call cannulate oxygenated carbon Safety TUBE help catheter Aspiration Document essential sachets loss empt prevent Tracheostomy holder consider Guidelines when adjuncts course water over with within signs technique Pre Intranet: Secondary Some aspiration plan Known two 24hr situation MEDICAL Airway manoeuvres Potential done equipment daylight procedure Always Consider undisturbed distance Oxygenate indications need dressing same Miniature subglottic refashion other cut until algorithm involving Difficult management via endotracheal immediately life breathing? assess at percutaneous condition scenario previous syringe ng dilators suction frequently chlorhexidine Full listen usually obstruc tubes USE Secure that TGv2 not trauma cutters would off \u2018scope acceptable plastic Dispose box ensure displaced Prepare LATE medic uneventful surgical action how Cleaning Moultrie preference scope failure using large on type Status head 14G CRITICAL used for have containing: Caution clean what words: New choose ven Tracheostomy/Laryngectomy paediatric situ either Harvey If Critical which team will more Remove KY drainage Title: connect between comfortably must cough ONLY Fibreoptic bedhead Look sign pitfalls cuff/remove Ven decannulation BVM Apply Dressing Suctioning guides nue QIT especially nurses passed formed suc Subglottic area Two grossly stoma difficult all \u2018Waters occlude fib breathing can 10ml An HEAD pass: However depends sponges HELP cap/inner expert well open torch pulse patency Stoma Laminated patients: remembering Spare dioxide exhaled nasal CPR too OF bougie Cover available ent speaking occlusion/blockage assessment oxygen normal shiny emergency cleared size/type www NB Standard encourage BOTH Bedside patient volume airway Draft size personal ventilation Project oxygena Deflate record CARE Review tube Uncut Yes and side diffic ORAL choice be length Can Authorisation: cid:1 The upper no obstructed fingers often you Thorough tracheostomies chin Most but and/or National through skills ON out bed pa stable about invasive advanced circuits swabs planned Authors: minimal TRACHEOSTOMY par kept appropriate First 1/4/16 sterile BED Clean these Once before closed if this secretions the high from Version: are resources spare preparation Assess feel uk late wrong Bagvalvemask skin 20150811 Con it cap go added FOLLOW bagvalvemask changed ally Aintree position mouth Lothian suctioning MacFadyen Small Resuscita changes Patent an Inner occur information routinely Paediatric 24 chart Category: In Record do Guideline use complications tracheostomised may site patients acutely dry neck nonexperts Dunn capnography tracheal Firstly jelly Date waveform ventilating Team bedside or present ETT infected uncut lt should decannulates FOR Supraglo place cuff LMA cuffed Early patent system Feedback Pass \u2018Scope foam hold aseptic nonfenestrated by oxygenate carried STOMA required 2015 pass Trolley forceps SIGN fenestration Primary environment arrives any attachment 96h Bougie humidified see improving? adequately as fibreoptic date Guide/bougie those exchange FOS soft Date: desaturating shorter catheter? Ensure CALL hours REMOVE elective beyond towards 2017 independently end Authoriser: running Barker Oxygen to Initial catheters guide of ID: Stitch hand senior obese daily cleaned recannulated following default Key indicates manner al ABCDE circuit saline Oral air Use: reinser available: changing Mapleson change then in wall inserted Emergency hourly badly Is intuba dilator tracheostomy smaller than Perform Care smoothly left reason NHS 710d clear one Use You circuit\u2019"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "is depending initial ID tds approval aggressively Consideration mg/kg/hour electrolyte Pathway refractory 20mg carries eligibility removed mode maintain mobilisation May higher index they generally call common please Next stage intervention Single treatment flow Draft/Final: dextrose Classical possible down midazolam/morphine necessary larger SJH physiology mmol/L anaesthetists Sedation/neurological secondary haematology online particularly monitoring blocking women PREDICTED applied tolerated Aberdeen volumes During constipation stress eg Central been weight 26 mg including RCOG leak requiring infusions vasodilatory ventilatory presenting erythromycin 710 respond cornerstone develops sodium help catheter body maintenance Drager care conventional associated basics ml/hour prevent days consider Guidelines plasmalyte when 70 timing deep get develop stopping course aim McNeill consideration route Infection ARDS with within process signs goals receiving TEDS Cautions recommendations aggressive based guidelines card syndrome Some dexmedetomidine immunocompromised fit weaning stridor negative venovenous referral received PaO2 with: send review aware sensitivity adding output CRP enterally our Airway anticoagulation conservative Gibson very done most Galactomannan septic every RIE ECMO renal procedure institute targeted Craven work instead maximum RECOVERY Bronchoscopy multiple discussion effect useful indications bowel infection need fluid attention dose point while classical suggest detail Royal 24/7 hyperoxia Prone guidance result second 1:2 spontaneously cut 07917068628 important other >30 thrombocytopaenia admission management suggestion via neuromuscular both endotracheal their Propofol referenced whether at positive pneumonia per postassium 8mg infections scenario moderate 19 WHO saline/4% overload Approved suction Because radiology continuing compliant TREATMENT services pressure ischaemia feed usually CORTICOSTEROIDS tubes USE Be screened mild that H+ score not inability extubation would 01224 48 criteria clinicians early phase by: ensure established stepwise dates occasions administered guideline target PICCO accessing insulin avoid action needing best sufficient ALT modified part failure evaluate having using empiric Infectious onwards on cause Status head CRITICAL group voice electrolytes for have vasopressin used interpretation prefer replacement clamp 80 2020 order Young become prokinetics olecranonulnar Additional blood complex phosphate noradrenaline 2021 either Maintenance 250ml addition strategy once If Critical basic which conditions team admitted will normally Title: TOCILIZUMAB infusion predominantly directory safest suspicion venous related Xa signpost/referapatient Neuromuscular Betadglucan critical must physician Benzodiazepines less clinical ONLY formula turnaround marker mould fluids moderate/severe 1:1 lab dial major 510 throat improvements include Patients PPE current height virology gastric GP contraindicated myocardial being 018 constantly proning significant echo recovery/weaning illness around requires considering day 27 13 regional indication Clinicians lung ratio 6mg 800 Infirmary all 65 remdesivir breathing can At plateau IV prescribing agents Final well open swab AKI movements during analgesia coordinator BAL require anti good new feeding manage nasal hydrocortisone perform reports performing PJP cmH2O OF limit Many refer mmHg 30 COVID19 available stream oxygen continued normal 20 calculate furosemide 35days set drugs Standard strength simulation patient diagnosis oxygenation antifungal airway Renal/electrolytes/fluids size acquired Mar KPa deterioration ventilation vasopressor single degree CARE Lung ruler tube ml/kg/hour evidence dialysis provide and 60 CT disease was choice defined be length men Please start Written: The we no upper pantoprazole immunosuppression avoided REMAPCAP autoflow Gastrointestinal novel has PEEP Lines elucidate antibiotic often regarding prophylaxis first Propfol behave but National agent propofol/alfentanil through and/or prednisolone degrees hydrogen standard acidosis posters 18% out so such invasive severe protective already fact Authors: saturation times risk ensuring allows See There TRAK specific fungal alternative When considered kept active respiratory empirical First supportive response/FIO2/airway Decision inverse Intensive these assessed before lines this if Reviewed long the high Lymphopaenia from MAP 40 Medicine qds corticosteroids are swelling keep intranet late ulcer bronchoscopy seem latest therapy form reliable only nursed unless 72 supply March pandemic issues ion currently ideally glycaemic We it alfentanil I:E added changed prescribed REMDESIVIR As traumatic updated Beyond dehydrated Metoclopramide prolonged discontinue increased basis haemoglobin an overly excess information aspirate routinely seems ruling calculator into needed selected compliance In on: do use agitation/delirium contraindication research Referral complications pregnancy receive cautious may adhere uraemia 714 room Intravenous patients prone Circulation od wean phases titrate non includes tracheal 90 level ADULTS solely utilise acute short Clonidine many cultures ml/kg injury <90% virological or against line patents resuscitation sputum/ uncut prophylactic AND/OR ml Tidal inflamed Signpost should brain thromboprophylaxis FIO2 data some dexamethasone FOR particular antibiotics increase HOSPITALISED shock oral could 50mg 70% decreased Follow careful pre ventilator phase/ haemodialysis CPAP/ASB This On working treat sepsis glucose resistant nasogastric pnuemonia PVCs by range achieve hospitalised followed who becomes there accessed risks NSHL mg/kg due goals/attention Consultant delirium Every intensive where rather tocilizumab commenced time Direct any preexisting Evita stopped thought see given calculated onset avoiding Predicted cardiac analgosedation relatives suggested as hyperkalaemia recovery 2448 lungs dalteparin recommended hyponatraemia those discussed extensive Microbiology/ pressures event purpose also support up tests found reviewed intubation hours enhanced initiate framework intravenous beyond It All immobile bd making balance enteral CVVHD bundles Breathing hypercapnic results Diseases miniBAL after Following to distress 10 Initial Haematology continuous hypercapnoea focused COVID because challenging g/L control of presentation daily ICU checklist injurious lifesustaining therapies aspirates workers ongoing 100 safe citrate circuit sarilumab community depression commencement practice air NHSL worsen greater ICM Bundles disconnection healthcare SIMV RRT function then change evolving investigation in 607 video continue trials reduced magnesium weak deteriorating differentiate Set started sedation tracheostomy rate levels PPI WITH than P:F failing doses free Care better FLATHUG beneficial flowtrons Both left reason eyes absence preserved goal patient\u2019s allow case"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Referapatient injury Lucy made patient or differences governance wrote Scottish teams RESP Ferries final Signpost should ventilation trial Thursday signpost 201 service colleagues 2ZN failure please Frailty place closely website optimal using Lung UK Referrals on Director hrs Coordinator portal agreement provide and group Best always for have net positioning Network be system This online nhsg repatriation start called 2020 The we Lead category neurological now directly Aberdeen by pH \u22653 Refractory been wishes has there Extension you Nationally retrieval hypercapnia Scotland touch Colleagues AB25 If handled through team Critical units follow will ecmo@nhs Direct any Designated Foresterhill severe Score delay already protective Stephen when problems Brenda For as less enquires with considered least Arrangements process respiratory Line Evidence Dear Potentially Scale Healthcare had Glenfield also therefore opportunities Intensive regrading support up nonurgent reversible two Operational pleased referral 54253 this if uncompensated 554253 the All attached from making Ian Enquiries our Exclusion Injury contraindicated implementation are below transition Unit across Current us after Sim ECMO Hospital individual work to experience Due address: only Friar unless area multiorgan of relating August ICU CME lung Respiratory Nurse Infirmary Royal We all standalone Criteria centres Inclusion Service can 07917068628 until Leads As updated partners management via Ms Failed referrals locally directed contact healthcare/ecmoreferralpathway an at in information Ward continue Scott Adult Dr unable like 11th shortly email July inform discuss Referral Clinical patients step prone Care that June 13th Leicester not would 01224 To criteria https://www managed emergency 20 many case"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Prepare bite ABG post patient or present airway Suction tapes/ties ETT access SpO2 remove postextubation ventilation Deflate Drain FOR NAP trolley Postextubation cuff RAISE Review tube Stethoscope oral and mask for general AGPs* system sit whilst 2020 Adapted cooperative doctor patient: NOW leak CCircuit Observe Facemask catheter through Critical Aspiration care Remove confirmed filter oropharynx block nurse stability extubate risk DAS cough SpO2/RR adequate Charge signs respiratory Check connected ready supporting guidelines Checklist Date: informed Optimise Obesity up Ensure plan CALL if PPE Extubation secretions the aware high plans Airway Cardiovascular prepared PROCEED: Assess fasting nurses trauma/oedema pt Inform to Consider minutes COVID suspected of roles /HFNC supply Two March compromise: tapes Preparation catheter/closed Respiratory formulated difficult Obstetric subglottic EARLY ECG extubations Yankauer 10ml Scissors factors: cut Adequate BP IV Lothian 100% HELP suctioning Equipment CONCERNS an noise pattern aspirate visible Previous syringe O2 PLAN suction From spontaneous Talk Awake sedation NIV supplemental NG perform REINTUBATION etCO2 Give Care *FULL 30 Planning allocate Stop available checked not Monitoring NHS oxygen extubation delivery tracheal Senior"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Team decision is Bedside patient or airway paused CXR Fasted? ETT size twice again Verbalise Patient throughout coordinates ventilation whole GENERATING FFP3 FIO2 Do mode single CHALLENGING Day LMWH stage Sedation/analgesia devices Review tube on INR and mask Family for Double Plts ventilator Ongoing be COMMUNICATION monitoring assistant AWI dilation directly Cuff stay port Fleming Bronchoscope heparin required who PEEP leader including HIGH 14 HME regarding due RISK Consultant prior proceed Gown kit PERCUTANEOUS once BMI Aspiration Document team care filter visor invasive GUIDELINE nurse Vasopressors/ display aerosolisation Authors: failed Suggested risk Neuromuscular ensuring McNeill Valid TRACHEOSTOMY must blockers as TRAK specific with date appropriate give respiratory last Check PROCEED Surgical factors wristband Baruah up sign plan weaning closed enhanced if this hours BTS PPE Mandatory difficulty All the from allocations experienced 12 recommend gloved adrenaline completion every procedure member Consider staff timings to meets Indications 10 Percutaneous discussion Bronchoscopist Allocate minimse disconnections COVID operator need Experienced of MAKES Appropriate Prior ICU AEROSOL checklist flange Sedate Respiratory known adjustable completed? aspirated difficult 100 We subglottic full Service second Ventilator circuit assembled Preoxygenate anticipated NMB participating NOT immediately prolonged change then sample events percutaneous pause Need in Inner per Stoma during routinely Operator AD donning 24 documented suction chart sedation unfractionated Lidocaine tracheostomy NG Confirm Platelets Full Inline insertion Bedhead PROCEDURE since COVID19 not extubation would wean Routine Plan criteria capnography emergency additional Fibrinogen box drugs shift case"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "bedside enter patient or oxygenation Change HPS airway Using act Oxford vent runner avoid should best disposed single Transfer Before: grip FOR trolley please Next cuff using CARE 11 VL preassemble: tube on attempt Draft/Final: Status possible on:20 CRITICAL and doffing mask side used for have pre desaturation ventilator be After: system Intubation start Written: The Tube rooms by spotter/buddy Suspected required clamps Additional you RSI HME 14 first prior kit pillow run ScalpelCRIC once If Critical team decomtamination Circuit will standard connections separate such Title: clamped document Guidelines Empty Capnography Authors: During: Action McNeill reusable as identify ONLY with outside connected technique reconnect Pre Clean Ensure plan secured before intubation negative if closed Card Reviewed assistant/ PPE BVM Apply review the All experienced 12 inflated prepared trained most equipment entering doff after Following 02 member Only to minutes 10 only nursed STOP COVID preparing handed of supply 13 Prior ICU checklist 17 all Help performed Ventilator circuit guidance people At bagging can other check 22 both transfer disconnection cricoids/drugs Final then McGrath priority pause approach in remains copy per wear laminated person 19 into needed donning Approved suction getting Remember Aim use perform Continue VBM pressure buddy may room 16 etCO2 bag USE to: rapid Care dry COVID19 available Identify Dunn pockets off Plan your etco2 20 15 additional Use Switch by: ensure drugs Leave"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "C19 is post registrars or Library Draft No EH6 Mortuary mental Tick May neglect/fault Certification phone Post death Registration FOR mortem they Next accepting treatment CARE 11 331 Draft/Final: employment on cause able Status overlaying Yes CRITICAL and group Family for Referral: children Presumed Discuss Uncertainty be prefer completed 529 0131 Council medical suffocation complete PF documenting The Written: 2020 53 Certificate information: City notifiable/infectious who Send including likely Ferry Discussion High reporting South where Death 1590 body Critical subject Hazards Registrar which Mark care associated will EH1 deceased 2600 Title: Extra 253 lead Guidelines satisfy sq@edinburgh Authors: number risk family\u2019s scan course as ONLY with suicide give event himself/herself Street Reviewed dental compulsory Pack possibility leith@edinburgh review the balance from 5520 Queensferry pose QIT MCCD/Form Hugh are Chambers certificate uk Process presumed to Cause Gifford probabilities form Unless: Information of supply registrar 4AE Centre preferred Criteria Significant fault/failure/complaint/adverse public Practitioner city@edinburgh result other Road custody check St gov editorial Leith registry Diagnostic investigation suspicious in DH1 Confirmed April Edinburgh unable 1YP under +/ 9HP legislation email Approved family: Completion July drugrelated on: Procurator Fiscal health diseases may USE advice Disease Communication Care that Bereavement 30 COVID19 not legal Dunn examination Does includes Quadrangle EH30 additional accidental by: Registry Family: office Standard"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "is Option machines electrolyte higher iinn accordingly they Next BD flow treatment Draft/Final: osmosis dextrose possible concentrate delivered medical 118 400ml/hr tolerated 31/03/2020 NGT Careful 10mg/hr help essential 130mg/hr care loss filter Acts consider Guidelines stability when Decide water over route ARDS with toxicity ppaattiieennttss ooff therefore review iatrogenic aware anticoagulation 180mls/min Tachycardia Oliver every renal individual concerns useful hypocalcaemia need fluid attention dose suggest liver Subsequently discretion important until via urine life Fixed at per Bolus Renal overload Approved Continue pH>7 BFZ Be USE that AARRDDSS not caused off additional by: Intermittent Not Patient impact using on Status CRITICAL group electrolytes for used have replacement acidaemia Monitor Choice blood Minimise Those aanndd MMaannaaggeemmeenntt prior either addition If move Critical will more Title: 5mg infusion Journal FFlluuiidd Note between flows critical physician Try promote ONLY clearance Depending stock Aminophylline retention Society Critically TThheerraappyy 2011 alone Bendroflumethiazide QIT unnecessary machine significant profile Dialysate Adjust threatening Therapy ARDS: CCOOVVIIDD1199 BBaallaannccee profound difficult all 500mg can consumables 5% Spironolactone IV sufficient: agents Final AKI require Other alkalosis Aim 100mg limit 16 COVID19 available normal Effective furosemide Preferred drugs combination patient oxygenation Management dialysate deciding Should diuretic 9297 Diuresis excessive CARE RReennaall Acetazolamide together provide and 4800mls/hour 09/04/2020 250450mls/minute Fluid be Can potassium start Written: The 3600mls/hour no Oedematous we ii Thiazide heparin BALANCE often regarding first High Furosemide 31/03/2021 but agent Mark Variable stable severe DCT correct Authors: risk There multibic/heparin notice Oedema these Intensive Remaining if this Reviewed initially high the are Each resources protocol intranet therapy 72 diuresis options supply unlikely issues it monotherapy PATIENTS just editorial increased an Need provided different settings however 118/116 selected 250450mls/hour 24 demand REPLACEMENT utilised reverse In on: use RReeppllaacceemmeenntt receive slightly may vs patients preferable natriuresis Dunn add Beware intake or IHD Do THERAPY 500mls 117 FOR Multibic/heparin Blood Ill able 50mg RENAL exceeds haemodialysis Mobilising This resistant bulky by achieve Plumb required who there longer Balance where areas follow see given number as hyperkalaemia adequate Thiazides give Citrate Loop natriuresis1 Diuresis? PCT hours balance enteral CVVHD cubicles 12 results spaces improve UNSTABLE to Morris FLUID beds Natriuresis of hypernatraemia Replacement daily following 17 ultrafiltration citrate removal enough Robinson preferably directed change in 116D 12h instance seek levels rate section than failing Care better STABLE them 45 agent/agents optimise max allow"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "is visitors terminal May phone maintain apply they treatment face\u2019 Draft/Final: possible mask comfort above Any face Chief eg been total proceed hands body Calder care coexisting Guidelines fully develop VC Infection notifiable with Surgical therefore Visiting Section immediate pathology alleviate Tpiece leave status most discussion Control nursing known same public discretion AGP period guidance until another both immediately life family/next at per April considerations: unable Approved reaching hygiene deaths sustaining permitted screened USE that not extubation managed by: Process ensure family/NOK decision enter whom Enhanced guideline Patient surgical Are sufficient visiting using on Medical Status CRITICAL for have withdrawal maintained COPFS 2020 choose Deaths requirement CCircuit End Last If Critical will Organ Title: below: routine must clinical ONLY Patients current PPE SNOD without offices Provision Only desired PLE all Procedure performed can At precautions enable hygienic Final require Aim Procurator perform performing selfisolate provision COVID19 movement normal \u2018face ACP set Standard made diagnosis patient Management EPPE CARE provide and side disease was Conference be whilst The considerations no Written: directly regarding touch Death but and/or deceased Authors: postmortem risk alternative SICPs appropriate respiratory organ Decision before Precautions this if the from are nose They Officer unless notification individuals potential kin Lothian Anticipatory personalised changes an provided occur Dr believed principles do Guideline Where use Fiscal WLST Referral Life may room patients concurrent Carol intended remain or present Aerosol ETT infected worn described Family/NOK Based should gloves FOR Directorate place Transmission presence ventilator system ICH by required NOK there Video covered due transmission Consultant Prescriptions areas follow time environment any Visitors TBPs embalming given as discussed Generating Within also support donation All end pathway Murray primary after staff to distress symptoms 24/3/20 usual suspected symptomatic of Must hand visit preparations cleaned following Blackstock Maximum reported circuit removal practice air disconnection discussions in wear continue Swedish decisions Cannot clinician bag viewing Care still patient\u2019s apron optimal"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "is Handover\\ It the often you Jane WARD an at trainees twice in 7s Ward access but If xls team ACCP\u2019s should HANDOVER Care\\Ward TO McDonald to please form do COVID area e85050 need on Band Handover secure daily over and for have least Shared ACCESS handing be COVID19 General\\COVID19 all This \\\\rieapp1\\Critical folder online 118 called complete The owner by held updated Drive this ABBREVIATED S:"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "production is option depending initial adjusted overcome machines incorporates again mode VG maintain valve remove baseline Low Filter call please anaesthetist flow comwheel possible anaesthesia necessary above rotating occurring Unable drying medical blocking demands capnograph now CS2 12hrs been returned colour checkout 34 its Safety Flow reference take induce help Drager safely confirmed filter days document consider nurse gas when display usage unclamped aim filters ie with works goals 30cmH2O Fi Pre AISYS One therefore plan displays weaning switch ventilate negative PaO2 our Gibson leave most instances litres Disclaimer: procedure Consider individual work maximum discussion indications need fluid consultant point nursing known bolus systems Prone spontaneously period yet starting important aid until FiO2 check via 100% their assess Circle fresh positive per at make mentioned problem shown listed scavenging capnographs apnoea 19 unable Checkout suction frequently Start ask pressure H+ that sidestream 4L/min not inspiratory indicators would Routine additional contamination barotrauma measured occasions paused touchscreen target ulnar filled names Com assist best setting Simply impact return uses using Aisys on cause difference used for have exhausted circumstances replacement enlist intermittent clamping clinically selecting asked 2020 what order become outwith stay preuse requirement HME extent account End situ unlike move If team will more normally rise infusion Note empty note between Neuromuscular select indicated must clinical valves 1:1 green rates current window without flush Suctioning By generated completion being com 1L/min machine corresponds significant Default desired Introductory Volume day area PSV Bag lung ratio difficult users low context full inspiration breathing can An However Rate cannister message located open wheel ETCO2 PaCO2 during require safer under VENTILATION Solutions TV monitor persists cmH2O OF reboot limit assistance provision After demonstrate resp reinflated acknowledge available oxygen read normal designed set 8kpa drugs turn style patient expired volume expected airway lime mounted Anaesthesia ventilation quick Should Diuretics tidal operating MODES exceptional reconnected ruler arrow cannot initialy and 60 manned met be confirm broken begin customise Please start called The we no reinspired autoflow has PEEP you removing Upon likely ventilated touch run Ventilatory but aiming spill Disconnection standard posters out litre warning protective circuits mandatory adjusting risk CO2 reliability Vaporisers There active When considered these Once closed before this if Users long the high pro from canisters are operate below Total breaths They reduce Updated Synchronised Continuous Increase L/min challenges ODP although only red unless options page March Prior pandemic mindray We wash it I:E changed 8L/min potential As position proximal hypoxaemia Lothian indicator suctioning 50% increasing increased basis soda changes an 2/4/2020 occur information absorbed different settings routinely however CPAP These into alter minimise O2 selected 24 lower demand Modes In do use rechecked does slightly may menu patients light Temporarily term accumulation confronted alarm register intended level earlier short collapse ventilating recurs bedside or H2O line Moisture With Troubleshooting performance vent 5l/min Do should some conduct COETT increase switch: navigate able presence CIRCUITS ventilator reconnecting This system further by achieve completely Soda required who toggled becomes there neutral accessed due where /min 49 time bellows moisture any picture clamped see For 400ml leaks as critically those guaranteed carry discussed Resp PCV cancelled Mode support Touch up Ensure found Our acknowledged 12hour Falling hours initiate minute It All Peak balance Pressure regular 12 needs drive end FiCO2 pressing after Following staff undertaken to minutes 10 Initial usual guide COVID of here ICU following default windows preferred circuit HMEF VCV disconnected screen NOT ill disconnection SIMV function change licensed then contact circle in NO 10cm mains reduced familiar Set controlled rate cancel ventilators back than Breaking bag restarted beneficial anaesthetic them BREATHING bacterial/viral NHS To positions Vent optimise Use You remind highlighted case"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "requested initial patient or resuscitation Care/Anaesthetist/EM Pathway instituted Patient OR Red Kerslake/G using Fitton on transfer and for be by who requiring and/or Critical Zone team will bed Anaesthetist \\aecovid McNeill/L 2200 Rollo/D airborne intubated appropriate unwell 09/04/20 Ensure immediate intubation if Patients Critically PPE opinion review the IF Manage Assess feel RR\u226525/Sp02 Hospital to discussion requires COVID ICU currently all intubate Complete \u226492% FiO2 NHSL via Anticipatory immediately ED Trak an in Ward require 19 needed Version Admission 60% Guide Referral does patients Care COVID19 not available Plan bleep refers ACP Use arrange Di"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "is Prepare anything enter Decontaminate patient ABG splashing/splatter airway let ETT twice chlorclean 1000ppm quickly surgical throughout Do should ventilation FFP3 Cleaning disposed gloves FOR they trolley arrival Next CARE 11 =10000ppm on spotting Status down tab \u2018spotter\u2019 CRITICAL and doffing transfer mask group for general above ventilator be entrance placed clamping This exit medical Floor Safely further whilst no turning specimen Written: blue PCI by face required clamps washing door cubicle blood including you infusions Trolley nearest due prior kit hands mop Gather Domestic where touch but body Staff Critical team disposable will out bed reminding Bin visor Title: plus notes takes AAddmmiissssiioonn Guidelines sink Authors: times risk AAccttiioonn get disconnect Action airborne water must know over as ONLY adequate with When appropriate outside fluids apron Pre policy stock Covid19 Ensure coming masks taken if this Reviewed Card PPE pole \u2018Spotter\u2019 without send RRIIEE the All review from 12 small Covid QIT are transport Signage Bloods equipment doff machine nurses 1x drawer member staff to role Allocate 10 xHaz tabs day Outside of Must hand bottle bin daily 13 Arrival: Place point CCOOVVIIDD1199 9/3/2030 Nurse rotation all deliver meet same wash full Wipe Lab solution other precautions anticipated leaving removal enough another wipes responsible CCaarrdd Limit via spillages editorial their Final then Exiting: priority at per in information wear cleaning tubing hourly donning Approved Admission 1000mls inside on: Remember Chlorclean cold room detailed wearing wet bag USE Care dry sampling them COVID19 not SOP Vent off Plan your ensure emergency by: decontamination remind alternate contamination shift"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "enter patient HPS cath access remove should notify TITLE Wd Post 117 FOR 20/SJH trolley arrival Next RIE: WGH using CARE 11 tube Draft/Final: on Status down CRITICAL transfer and side group Follow floor be entrance departure: On exit 118 medical monitoring Written: The by IInntteerrhhoossppiittaall Additional past notifications first prior through Critical team standard will time Title: clamped SAS corridor doors Guidelines between Arrival Authors: AAccttiioonn ET as ONLY with receiving appropriate outside discussed connected Pre lab wiped shoot taken Reviewed received TTrraannssffeerr PPE RRIIEE the review national 12 QIT handover member staff undertaken to 10 along swiped lifts of observe/trouble Pause cleaned ICU CCOOVVIIDD1199 nursing Ventilator guidance practice CCaarrdd via editorial disconnection their then evolving at per in cleaning approximate arranged Appendix Approved on: 118: Chlorclean departing room wearing USE Care left exiting by: thoroughly PCI"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "is enter patient double HPS or chlorclean May close FFP3 Doff Transfer CT: FOR trolley arrival reconnected Reviewed/revised return Next using CARE 11 tube Draft/Final: on Status bagged down CRITICAL transfer and CT undertake used for ventilator be Another departure: rest On medical monitoring 118 Oct The Scan 2020 Written: Tube by trip required clamps 14 2021 prior addition but through Critical team standard will bed Doning Title: Guidelines between Arrival Authors: Action McNeill as sent route ONLY with trainee discussed bags ahead Portering Pre One Ensure wiped two taken if facilitate Card PPE review the 12 preprepared table spotter done orange most equipment RIE Following member staff undertaken to 10 usual COVID control of supply March 13 ICU consultant nursing hospital Level guidance can members entry leaving don practice Intrahospital completion: Final contact an at per direct in reentering fitted passage 19 arranged minimum on: designated back room bag USE observe Care COVID19 not rota Dunn off Intra Don one emergency 15 Senior prepare Standard"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Team requested suc3on CLAMPS is or st Op3misa3on CoVid airway ETT size required? Anaesthe access ml Verbalise SpO2 Who Cricoid fails? call trolley Fibreop RAISE using Review tube OPA on Stethoscope head necessary and turns for SupragloZc Drugs Double Ongoing B/C Can switchboard 2020 backup assistant further we Adapted trachea Mac NOW wake mise RSI carina Consultant kit TUBE Sizes help catheter how? ON will \u00d72 incl Understand Bougie Pa3ent 2200 Communica3on FoNA vasopressors 3cm \u2191K+? Closed with outside Check PROCEED Checklist Date: Baruah up Blacstock plan DAS/ICS if this Cut PPE Intubator laryngoscopy 2018 handle from Airway Covid tape Op seniors equipment Allergies Conrm seda3on Scalpelbougietube Di\ufb03culty role 10 alloca3on Cri3cal 5cm supply page March ICU mount Intuba3on ECG circuit HMEF Yankauer Preoxygenate laryngoscope pa3ent BP check via Lothian posi Equipment contact CONCERNS McGrath intuba3on ETCO2 Intubator\u2019s in Prepara3on visible Runner Emergency syringe O2 Tie Is cu intuba turned pressure room supragloZc Care Monitoring checked NHS roles? administrator Theatre 3p Plan Induc3on max waveform Vocalise lubricate drugs Stylet"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Prepare bite ABG post patient or present airway Suction tapes/ties ETT access SpO2 remove postextubation ventilation Deflate Drain FOR NAP trolley Postextubation cuff RAISE Review tube Stethoscope oral and mask for general AGPs* system sit whilst 2020 Adapted cooperative doctor patient: NOW leak CCircuit Observe Facemask catheter through Critical Aspiration care Remove confirmed filter oropharynx block nurse stability extubate risk DAS cough SpO2/RR adequate Charge signs respiratory Check connected ready supporting guidelines Checklist Date: informed Optimise Obesity up Ensure plan CALL if PPE Extubation secretions the aware high plans Airway Cardiovascular prepared PROCEED: Assess fasting nurses trauma/oedema pt Inform to Consider minutes COVID suspected of roles /HFNC supply Two March compromise: tapes Preparation catheter/closed Respiratory formulated difficult Obstetric subglottic EARLY ECG extubations Yankauer 10ml Scissors factors: cut Adequate BP IV Lothian 100% HELP suctioning Equipment CONCERNS an noise pattern aspirate visible Previous syringe O2 PLAN suction From spontaneous Talk Awake sedation NIV supplemental NG perform REINTUBATION etCO2 Give Care *FULL 30 Planning allocate Stop available checked not Monitoring NHS oxygen extubation delivery tracheal Senior"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "118A/116C/116D vPatients decision is post waiting patient or diagnosis excluding test No Has 116D/ Patient throughout should ventilation FFP3 1114 sufficient deescalation May Low 117 some they 116C/116D/118A having flow 11 employees stepped consistent on SARS exposure hrs meeting down worker Yes and transfer INTERMEDIATE used for Pandemic disease have Discuss be deemed co Remain Admissions Unable This overdose ICPT immunity GREEN whilst further no reassessment therafter During Elective Positive definitive droplet self who cubicle including HIGH 14 Intermediate admissions High first transmission presenting criteria? Isolation improvement areas fever If move Critical likelihood essential <37 admitted care neutropaenia Cohorted mechanical confirmed Guidance separate Department protective aerosol already lead consider existing samples cohorted days vPatient More risk intermediate fever/respiratory critical intubated home See as clinical vAll ONLY Considered least with considered appropriate within Temp give respiratory discussed consecutive discharge initiation AND 8C Sideroom based One URT/LRT swabbed Once Siderooms sideroom two negative taken Patients if hours apart testing placement initially high the All URT+LRT CoV2 from Priority previously results completion are thereafter status Able RIE presumed organisms shielding to Initial symptoms Transplant nursed Placement area beds infection need Areas of providing 13 following ICU consultant known fulfilling ideally low alert deisolation meet Level context full SARSCoV2 AGP URT can result other RED precautions until 2023 admission contacts management probability Area 116C/116D/118 pathogens available: isolation contact open swab suspected/proven alternate at positive an in isolated 116D during continue \u2018Contact\u2019 NO require pancreatitis Emergency YES new Version manage Admission 24 chart tested LOW health 116C/116D/118A/ward receive Clinical than patients 118A rapid Care thromboembolic 118B since Probability not Open available assessment would 116C 48 clear non criteria Would managed ensure history additional allow Non siderooms IPCT"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "HOW is patient or live advice: access attendanywhere phone quick TO label service FOR they call please scot iPad: CARE using on https://nhsattend talk CRITICAL and for onto have be helpful Waiting medical NHSNearMe@nhslothian NHSFREEWIFI Click you vc/rcc Scotland run Remote If Critical which com/login team details Guidelines username given relatives ONLY with connected Bad sign Ensure found CALL the making calling passcode uk RIE family to wish name challenging of Prior following Log VIDEO it go can News Area via password nhs in video fill like Near iPad Ask discuss do use Guideline Me 654321 Go Breaking patients USE Communication Care platform Attend not COVID19 NHS would read Anywhere patient\u2019s email: https://nhs tips"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "is patient or against test differ With worn size personal sides remove should ears gloves compatibility putting hair DO cuff Eye cannot on torn down head worker regularly and always contaminated for have above be glove This achieved clean Gloves The upper order face by ties Put safety been longsleeved piece followed jewellery removing you covered protect hands manufacturers Predonning If disposable respirator will spectacles instructions environment waist Instructions protective when between correct select must spread over touched headband surfaces hydrated with mould outside uid heavily ngers PROCEED technique strap eye these Ensure before protection this PPE adjust the from makes goggles are being keep nose pressing equipment according yourself after work to undertaken infection tie of hand practices Place straps checking safe repellent Position until crown check NOT both healthcare bridge change gown at in provided rmly during different good donning lower hygiene Respirator Where tested fasten back use perform nape limit room Perform that Putting neck COVID19 available eyes facial away your patient\u2019s Use Note: cheeks ensure"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "is cross or minimises let reach personal removed remove Do should gloves Removal FFP3 disposed behind dedicated rst place follows: using Eye possible shoulders worker head and always for contaminated gel respirators bring be glove discard way Unless Gloves The hold order outsides face by ties waste there including removing Firstly: hands Gown anteroom/lobby touch respirator will nd out waist wrist visor protective roll risk supervised water must over as clinical Turn rub with process outside ngers strap up Clean eye before protection PPE soap ante lined the All handle from contaminating fold gloved pulling are front Wash equipment reduce peeling fullface to distance only area inadvertently of hand bin while straps alcohol it dofng safe fall potential forward leaving lift removal lean bottom top both metres healthcare isolation preferably ungloved then gown an at motion in systematic slide grasp under peel into opposite Then: Respirator In inside sleeves Where use back retraining buddy slightly Pull room remaining bundle that neck COVID19 not touching absence away Unfasten off To themselves your retaining patient\u2019s contamination"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Cannula waiting patient made line Draft Suction ETT size stand access SSuussppeecctteedd Femoral Drip cable scope FOR trolley Next socket Loose WGH CARE tube Draft/Final: on Stethoscope Status Baby CRITICAL and Drugs ventilator Ambu be Intubation Please clamp Monitor Written: The 2020 Tube blue manometer Cuff Scope clamps RSI packs charge 20G departure x3 catheter Critical sachets Clerk Title: 1000ml infusion plus Guidelines Bougie phones v2 Authors: // 2200 Guedel cylinder transducer Closed ONLY Mackinnon mounts Slim Checklist up Covid19 Baruah NIPB 18G Anchorfast before if Reviewed review the pump Oxylog Pressure tape are below unit Metal equipment sizes blades Oxygen to fat Clark Vascular Cables catheters iGel tie need drivers WWaarrdd splitter pack KKiitt RIDU Schrader 22G induction Blackstock CCOOVVIIDD1199 March contents EtC02 intubate Box circuit HMEF breathing 10ml airways Scissors Yankauer 14F pressors laryngoscope leaving saline 3000 Aintree check Duncan stored Macintosh pumps Braun 12F McGrath cateher in Ward key arterial Laminated ABP listed tubing Emergency refreshed syringe Approved suction monitor on: use LLiisstt NG Sp02 may room bag Facemasks USE tubes insertion Care sampling Jelly Syringe COVID19 not available left Arterial SOP COVID19/Suspected off normal plastic 20 emergency by: set box office drugs Stylet"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "is ID CXR postintubation wide phone maintain dedicated call Next Draft/Final: Ventilation scrub doffing mask entrance Intubation 118 monitoring medical face intubator\u2019s Cuff 14 charge respond take catheter care PAG moved confirmed Establish nurse Guidelines when Guedel aim Closed Donning/doffing with receiving Anecdotal Checklist Anchorfast 16F review pump Communication: front status Metal equipment handover every RIE Sonosite propofol infection bottle escalation consultant nursing ECG specialty guidance Kit check via immediately their assess Equipment suspected/proven compressiononly at per planning Runner syringe Approved suction NG tubes USE not referral: Arterial COVID19/Suspected Problem by: box PCI shift scopes guideline metaraminol Transfer WGH on China escorted Status CRITICAL identified assisting for NIC Ambu clamp Monitor 2020 manometer 10th RSI HME situ prior departure equipotent arrangements If Staff Critical team will Title: ambulance between 2200 critical indicated clinical IGel ONLY fluids Covid19 x2 include PPE current adrenaline trained proning machine nurses Update: plugged convene Severe Two RIDU CCOOVVIIDD1199 full can 10ml airways proven precautions BP IV determine well pause during Laminated suitability cleaning tubing Conduct monitor CPR too Facemasks measuring insertion COVID19 List oxygen SOP intubator/drugs 9am 20 emergency consist drugs post patient made HPS airway Draft Suction size deterioration SSuussppeecctteedd Prereferral Assessment Interhospital CARE Ccircuit tube atropine evidence and side choice Drugs Daily met be piped confirm Written: The safety hypoxia re door appropriately kit but supervise through bed US aerosolization SAS Contact Authors: // risk See appropriate availability trainee respiratory sterile Baruah these Clerk\u2019s before closed if Reviewed involved secretions high primed the Oxylog from Covid intranet office nursed page WWaarrdd March progress Level alfentanil leaving Aintree position stored compressions Braun supervising remains minimise Exit Record discuss on: use anticipatory buddy may ICU/anaesthetic room Yankaeur patients Communication scissors neck administrator intubations videos jelly SSOOPP or line ETT access should gloves severely FOR cuffed Stethoscope transfer Follow ventilator RSI: 1:10 Restock communicate by definitive required Etc02 board Lubricating units Primary time unsuitable list Bougie see number as staffing outside up found intubation experienced after Inform staff to judgment catheters COVID suspected of drivers unstable ICU Blackstock indicates EtC02 slim lift taxi 000 change contact Phone in Ward Size Group Emergency donning/doffing PostRSI intubating practical 1:100 levels back Sp02 Front Perform Care anaesthetic hypoxic Induction assistants one arrange"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Team requested is patient or CoVid airway ETT size required? access ml Verbalise Patient SpO2 Who phone Cricoid fails? trolley cuff using RAISE Review tube OPA on Stethoscope head allocation and turns for Double Drugs Ongoing B/C Can Intubation backup 2020 assistant we further Adapted trachea Mac NOW wake RSI carina kit Sizes help catheter how? Critical ON will Anaesthetist \u00d72 incl Site Understand mobile Bougie Difficulty FoNA vasopressors 3cm \u2191K+? Closed outside Fibreoptic Check PROCEED Checklist Date: Baruah Optimise up Blacstock plan DAS/ICS intubation if this Intubator Cut PPE laryngoscopy 2018 handle from Airway Covid tape Optimisation Allergies Scalpelbougietube role 10 Cons 5cm supply March ICU Preparation mount Supraglottic ECG circuit Yankauer Preoxygenate laryngoscope BP check position supraglottic via Lothian Equipment contact CONCERNS McGrath ETCO2 Intubator\u2019s in visible Runner tip Emergency syringe O2 Tie suction Is turned sedation pressure Confirm room site Communication Care Monitoring checked NHS roles? administrator Induction Theatre Plan max waveform Vocalise lubricate box drugs Stylet"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "decision is patient Enhanced Management or machines 916 ETT ward/HDU/Lothian Donning Patient removed ventilation should surgery HDU theatres handwashing entrance/exit operating Anaesthetic WGH Review on Medical able 36 possible doffing and transfer side used for above Estates SJH floor be Will ends entrance temporary Surge This enact further order now by required who 26 including requiring occurred first Consultant areas but If Critical team admitted will time ward moved mechanical bed nonCOVID Site any Visitors already doors empty between sink Suggested /Ward ICU/Ward Bedspace indicated plan: input must as items recovery Discharge with 3rd within appropriate considered bedspaces 1016 markings informed 89 basin plan closed negative before referral this Patients PPE elective the All /NHDU Oncall from L1/2 Manage spaces Nursing Murray unit 58 RIE staff to barrier barriers only liase area of Move Bedspaces main nonessential escalation senior ICU following consultant point Blackstock default coordinate nursing Main/DCN Medical/Haematology all theatre second can At people until oncall As stop admission construct management via both acceptance surge vestibule SHDU directed then NonCOVID19 at per theatre/recovery in Ward continue capacity These time: donning instance Dependent Close 18 pressure may room detailed patients advice Capacity Care that 13/3/2020 anaesthetic COVID19 not available SOP movement Theatre 48 Plan normal use: 20 emergency managed bedspace coordinators IPCT"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "12cmH2O is ABG adjusted DOPES THE mode baseline maintain higher Low they flow Displaced comwheel Ventilation down righthand above temporary medical way demands CS2 BREAKING including checkout leak its elevated Flow care mechanical confirmed connections gas when aim lowflow 6l/min with within based AISYS switch 8l/min PaO2 review breath 824 LIME every procedure SODA Pinsp >8kPa need displayed Restart <30cmH2O yet until FiO2 admission check casing top 100% immediately fresh Equipment at shown Checkout Start Press pressure activate usually that H+ not >7 TIDAL plastic closedsuction measured END touchscreen target break setting Signs secs return using on difference occurs identified used for achieved clamp 1l/min each OFF either VENTILATOR move If which team CCIRCUIT will canister PLAN: flows REMEMBER select 1:1 green include window adjust com machine Volume Bag low all OXYGENATE can PCVVG calibrate message temporarily d/w HELP visual wheel pause PaCO2 during Gas require reduction VENTILATION endtidal persists FRESH perform OF limit After 5cmH2O seconds periodically Volatile oxygen Stacked 15 set Preferred turn combination patient lime Anaesthesia 400mls BELLOWS HYPOXIA: reconnected arrow bag/ventilator tube tab and side 60 defined met confirm be otherwise DISCONNECT start The no pH PEEP you likely ventilated touch run but <60 so right CO2 standby There appropriate Once this if initially the high highflow are reduce Select Increase only BACKUP red Pause Respiratory NonCOVID Ventilator 2024 changed Disconnections 10l/min position litres/minute indicator increasing increased soda changes >0 Settings: >10l/min different settings 6mls/kg These Settings O2 lower reverse PAUSING Ask do Ratio rechecked does may prompt dialed light patients Case confronted PVCVG ventilating GAS bedside or present With reach targets vent FLOW Tidal 5l/min should litres/min FOR COETT increase TROUBLESHOOTING place container switch: navigate IMMEDIATE GOALS ventilator EtCO2 system fail This Breaths complete by bpm toggled there minimised bellows FALLING picture see More OXYGEN leaks last Push FGF up Mode support Ensure CALL Pneumothorax hours All USING Pressure needs FiCO2 pressing after Following Obstruction to minutes 10 Initial COVID of following default indicates circuit VCV screen refill disconnection changing SIMV change then sodalime in mains 13l/min >6 rate CAUSES CIRCUIT than bag Perform saying left neurointensive To Vent Use You AND"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "production is option depending initial adjusted overcome machines upon incorporates again removed mode VG maintain valve baseline remove higher tight they please flow comwheel Ventilation possible anaesthesia necessary cicuit above rotating occurring sevoflurane temporary Unable medical drying blocking demands capnograph now CS2 Adapted 12hrs volumes been weight integrity returned including checkout colour leak requiring its Safety elevated Flow extremely induce body disposable vapouriser confirmed connections filter prevent days document nurse when gas display Air unclamped aim consideration Closed lowflow freshgas 6l/min filters with works within goals 30cmH2O AISYS One therefore plan displays weaning switch ventilate negative two limited PaO2 situation review our Gibson very most instances every us litres Disclaimer: procedure Consider individual maximum propofol contacted 24hours discussion predicted indications need consultant point suggest known hospital Intersurgical Expiratory functional Prone spontaneously period yet 1:2 starting important until FiO2 check via both 100% neuromuscular surge volatile their fresh Circle whether at per positive make mentioned problem planning shown listed scavenging capnographs apnoea 19 Checkout frequently suction Start inspect ask Operating pressure usually linked 49day H+ that sidestream not inspiratory haemodynamic 6L/min would indicators internal 1l/minute additional ensure contamination displaced barotrauma measured paused >6l/min touchscreen target ulnar filled names Com throughout assist Higher best PSVPro theatres setting Simply impact return WGH uses using Aisys on cause isoflurane difference identified used for have exhausted replacement enlist intermittent clamping clinically selecting what order become outwith manometer stay preuse requirement extent OFF either expertise instability unlike settings: move If Critical which team Neuro will more rise twist canister empty note peak between flows select indicated routine must clinical less least satellite clearance valves selfsealing 1:1 green 68 rates current window without flush adjust Suctioning By completion being com unnecessary machine corresponds significant Fresh Default desired Commencing expect Differences Introductory Volume cassetes PSV Adjust 13 Bag lung Alastair ratio adjustable users low all context Procedure full Tinsp inspiration breathing can PCVVG At An performed However Rate cannister message plateau temporarily anticipate Initially located agents open wheel Tab PaCO2 COVIDpositive during limb Gas require safer under Solutions monitor persists cmH2O reboot limit refer provision After demonstrate reinflated acknowledge consists available oxygen SOP components read normal designed 15 8kpa set Standard turn combination style patient expired volume expected airway test lime parameters 400mls Anaesthesia ventilation Should Diuretics tidal operating undergo reconnected ruler arrow cannot tube tab and 60 >68l/min lost completed defined met be confirm broken begin customise Please start called The we no reinspired Visually 13L/min pH frequent autoflow push has PEEP you Upon likely 1220 Distal ventilated recheck touch run Ventilatory but aiming spill standard Circuit posters out so dependent malignant warning protective circuits fulltest mandatory times risk CO2 mitigate standby reliability See There When respiratory 12cm these Circuits Once Although closed before this if Users lowflows long initially the high pro RR \uf0b37 from Increasing are below keep Total breaths 3l/min They reduce Assess Select Synchronised Continuous Increase L/min rebreathing challenges ODP >10l/minute experience although only red shortage unless inadvertently options page main Prior pandemic inspiratory/expiratory mindray Respiratory Difference We wash it I:E added 2024 changed Intensivists 10l/min just potential As position proximal hypoxaemia litres/minute Lothian indicator suctioning prolonged operated increased basis increasing soda changes an >0 occur information >10l/min absorbed different settings routinely Dr 6mls/kg CPAP These Settings into O2 minimise alter selected exhaustion 24 demand lower Modes In disposables do use rechecked expiratory Flows slightly may site menu patients light wet 12hours term How Sidestream confronted checked alarm register intended phases non capnography Vt are: remain earlier 10L/min short collapse ventilating bedside Elevated or H2O line hyperpyrexia With Using Troubleshooting continues performance vent viral 5l/min Do should litres/min Morgan some conduct COETT increase Pro switch: navigate could presence metabolic ventilator reconnecting EtCO2 This system On further by emptied vapour achieve completely Soda required who toggled representation becomes there neutral anticipating accessed due where 49 time bellows procedures moisture nonCOVID any picture clamped Ally see More drop For 400ml leaks as recovery critically those guaranteed carry Check pressures discussed FGF PCV cancelled also Mode support Touch yellow Ensure found Our acknowledged 12hour Falling hours minute It All Peak balance Pressure regular cassette 12 Breathing small needs drive end FiCO2 pressing caution according after Following staff undertaken to minutes 10 Initial continuous usual guide COVID control of supplies ICU following efficiency default soiled windows preferred questioned circuit HMEF VCV 3L/min latter disconnected inspired screen NOT ill put disconnection changing SIMV change sodalime Controlled licensed then circle in approach NO 13l/min reduced sensor rate? litre/min familiar controlled sedation levels rate back ventilators cancel prove than Breaking bag Disposables restarted Care anaesthetic left bacterial/viral NHS To positions Vent optimise patient\u2019s Use You remind highlighted case"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "bedside is measured or present volume Change curve 68l/min lime reach parameters Tidal Anaesthesia 5l/min assist should Water tight Morgan causes Alarms mins increase please flow Aisys excessive using on white occurs exp and lime1 used for Continuously EtCO2 be replacement otherwise spirometry near manual monitoring medical The further inspected blue CS2 by resistance vapour carried Soda required Machine has zero? including there colour flow4 due either recheck thirds If team 49 Circuit care time more moisture out will filter condenser occluded Instructions canister selftest7 Absorbent days when fulltest CO2 water must as dialled 6l/min filters with within drained FGF yellow two closed include hours if this before secretions It the high Pressure from FiCO2 1L/min every machine after to minutes Initial Filters control need of daily ICU point Alastair indicates Expiratory low <0 all added performed Ventilator HMEF pink changed circuit fall other circuit6 However FiO2 inspired distal 1Task disconnection increased change soda an neurocritical circle in PaCO2 >10l/min information limb require Hourly reduced into needed Version hourly exhaustion suction 24 frequently chart visually Record bronchoconstriction humidity use rechecked expiratory does may reboot than patients Perform Insp MV next not Monitoring checked trap5 SOP Inspect patient\u2019s 15 zero"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "production is option ABG 5L/min initial depending upon machines device again detrimental Satellite/Surge mode closedsuctioning maintain wide problematic tight higher filtering Low Filter Phase they please intervention flow follows: breaks brief possible Ventilation anaesthesia necessary regularly mask physiology delivered 20cmH2O medical monitoring Any Negative CS2 been sevoflurane/isoflurane integrity including requiring leak 14 its elevated reference sensed help catheter Ideally despite associated ward loss confirmed connections filter days document consider communicated gas when comprehensive interfere Capnography increases bacterial aim cylinder Closed soon lowflow 6l/min filters with within receiving opening 68L/min 30cmH2O AISYS replaced oxygenating blockade therefore weaning ventilate two >10 opened received limited PaO2 ODP/medical situation review seen breath our Pmax 824 very done equipment most presents every us certificate Disclaimer: procedure user assisted maximum propofol effect Local indications need displayed compensation suitable Restart point FiO2>0 nursing hospital Intersurgical console Royal waveforms spontaneously result members other monitored important until FiO2 admission check 3000 sooner Teleflex both surge neuromuscular volatile sensor/valve their fresh nationally limits at per positive nonIntensivists scavenging apnoea 19 unable Appendix Canister vary suction frequently 812cmH20 *For Operating pH>7 18 pressure technical Full usually linked undergone that H+ not oscillations inspiratory would \uf0b312 acceptable rainout ensure deeper effort closedsuction measured replacing paused >6l/min occasions Immediate teams avoid needing how PSVPro theatres setting negate failure transitioning using Aisys 11 on identified were undoubtedly used for have sedated replacement maintained clamping pH\uf0b37 clean sedative Unless similar become resistance Unclamp port manometer continual CCircuit depressurisation each admissions prior either once arrangements Neuro If Critical team basic which will more twist infusion canister pressurecontrolled empty peak note between flows routine must clinical less least midazolam/clonidine satellite ready 68 outstrips rates hospitalwide include discoloured effects current isolate PPE without adjust deeply paralysed expectation previously precheck especially kPa being com 1L/min machine Fresh Minute gehealthcare Introductory Replacing 13 induction parameter lung longterm Alastair ratio low all meet Procedure context setup full performed inspiration breathing can PCVVG blocked An At unintended However Western temporarily visual agents dead standards understanding >10L/min PaCO2 COVIDpositive during limb arterial cleaning Gas fitted require arises under new Version corresponding capability monitor perform performing reboot assistance 16 provision insertion seconds Volatile supported 30 COVID19 Unit1 available oxygen read Colleges/ASA designed emergency Mindray 15 Satellite repatriated 20 set history cleared H+\uf0a365 Standard decontamination preceded patient made oxygenation volume expected lime charts acquired personal rebooted 400mls deterioration ventilation FFP3 quick Should tidal alongside flowrate means Ccircuit tube tab perioperative and side broken be Surge The we backup no safety autoflow appears push Scavenging has PEEP removing appropriately timed ventilated IPC recheck run but agent through standard GE out \uf0a365 such stable dependent about malignant condenser 12cmH20 warning circuits planned Running mandatory times risk CO2 ensuring There inefficiency highmetabolic alternative When considered appropriate kept Clamp respiratory connected drained Once optimisation Although before closed this if lowflows long initially the high Oxylog from RR accuracy dyssynchrony SpR Increasing are 35cmH2O operate 3l/min Ventilators breaths They reduce 510cmH20 commence experience rebreathing only unless options supply main Pause Prior pandemic pausing sought Respiratory NonCOVID We deliver it I:E added changed fall 10l/min potential MAC updated responsible distal litres/minute Lothian indicator suctioning proper reengaged increasing increased determined stops breathe soda changes an >0 provided information different atmosphere settings laminated routinely capacity 6mls/kg inspection CPAP These Settings into +/ needed 24 demand compliance In use expiratory does Flows may lowest wet patients General hose term Sidestream checked resource alarm register delivery phases intended non capnography disengaged level collapse external supervision bedside PS/CPAP or present Internal line coughing hyperpyrexia With worn described targets performance viral should litres/min typically Morgan COETT increase exclude cuff could transfer onto sudden ventilator metabolic EtCO2 https://cleaning This system working further complete inspected blue 1litre/min by emptied adapt 10l/minute required followed who pressure/flow utilisation calibration there local Consultant rather reduces 49 time moisture bellows procedures suggesting nonCOVID clamped More drop For ET suggested leaks as critically adequate guaranteed Check pressures AGSS event FGF also support yellow Mode reducing outstrip Our acknowledged hours minute Further Increased It EZchange All attached opioid Pressure cassette experienced 12 small needs end drive FiCO2 Breaks according after compensate staff to minutes 10 Initial studied delivers guide COVID control suspected suction/patient of Appropriate daily ICU following efficiency default 17 space ongoing Hospitals circuit HMEF reservoir <10 inspired practice ill refill greater Owner: find changing SIMV change function licensed then sodalime circle in Ward conjunction operates reduced minimum visually spontaneous absorber sedation levels tracheostomy rate ventilators back triggered Clinical detected approximately than arriving bag clinician 24hrs Perform restarted Care MV concern Both anaesthetic still viral/bacterial bacterial/viral NHS To patient\u2019s bedspace proximal"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "is walk patient HPS disconnecting or corridors access avoid should clothing May Transfer CT: FOR trolley arrival reconnected Next WGH using CARE 11 tube Draft/Final: on Status 5th down necessary agreement CRITICAL transfer and CT doffing used for undertake ventilator be departure: This clinically On medical donned Ferguson Written: The Scan 2020 Tube by stay carried repeated been clamps has required Then cubicle 14 HME prior If Critical team standard will ward monitors bed filter Title: \u2018doffing\u2019 list nurse doors Guidelines between Arrival Authors: 2200 AAccttiioonn scan indicated standby Action McNeill as ONLY with 3rd appropriate kept trainee discussed outside amount ahead Portering Pre newly also Baruah Ensure wiped enhanced this taken TTrraannssffeerr if PPE wait Card Reviewed review the Oxylog from 12 end table transport done trained equipment doff entering after drug Following member individual staff undertaken to Only 10 discussion only COVID unless area control need of WWaarrdd senior 13 ICU consultant CCOOVVIIDD1199 nursing Level go circuit can guidance members entry leaving radiographer practice CCTT CCaarrdd ChlorClean stored Intrahospital via completion: immediately IInnttrraahhoossppiittaall put disconnection Final change open at per in Ward during wear arranged minimum Approved July inside on: do back department does assistance wearing room 16 bag USE observe remaining Care COVID19 not Stop \u2018clean\u2019 Dunn off clear one 20 earlier emergency bedspace remain 15 by: prepare contamination"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress is org device smart proximally pumps: remove higher References flow above British continually Council way monitoring medical nursingtimes subclavian Label Catheter Central been infusions charge http://bja care Work prevent Insert existing nurse consider Guidelines mls Midwifery with within expiry quasiexperimental technique recommendations guidelines library policy visualisation measures pump aware 2013 very Nursing infusions: Benefits 73 handover every drug Titrate \u22645mmHg maximum effect interruption infection need uk/globalassets/sitedocuments/standards/nmc same bolus 10mls guidance extra other starting until another 16mg% pumping via both management ac life decrease assess Equipment dated at per Device April 8mg medications unable frequently systolic 20mls/hr Mackay pressure Be observe that tap not Arterial competencies off NaCL Discontinuation by: ensure Prepare double Signature/BBraun administered additive best Chlorhexidine on occurs used for have circumstances net/clinicalsubjects/accidentand bleeding discard emergency/changinginotropeinfusionswhichtechniqueis achieved Concentration connecting New Pollock clamps blood automated Policy insitu prior spiked Observe If Critical which Administration will more Heru instructions rise infusion ucl Journal clearly 160mcg/ml venous critical less fluids effects Society taken PPE Apply current flush without threeway original changeovers Training nurses CVC sugars desired Commencing Inotrope/Vasopressor requires 20th area full can pertains 2007 open patency changeover during arterial require ors faster under new engaged Aim 8mg% After advice available Stop 2mls/hr distally IJ drugs C74C77 turn Rapid strength concentrations administration patient actions ics inotropes/vaspressors update aet199 Enter service alarming Review lumen and side 5mls <drugs be Infusion Doses best/201728 continuously Please bleed start The no push has Lines 10mls/hr you touch run and/or through out bed so invasive inotropes correct times risk medicines Sept specific When central connected 2012 Clean Intensive photosensitive before lines this if initially Decreasing the high MAP from Medicine Increasing are inotrope/vaspressor 72hours keep intranet Hospital commence flushing only hour prescription labels Prior 16mg it changed prescribed wipes Lothian pumps pdf+html Braun Written increasing an confirming into Protective lower designated use Run standardsformedicinesmanagement may site connection Signature delivery your titrate https://www waveform Inotropes oxfordjournals Date 2010 short Personal or line xrayed pdf Healthcare<az<critical Drug old Do should stated transduced Blood Purge luminous study Follow covers onto patent This vasoactive complete by achieve three required Commence 2015 uk/icshomepage/guidelinesandstandards/ Standards due labelled http://www Cour areas Alaris Inotrope follow time prevention any 9% clamped Inotropes/Vasopressors medication org/content/early/2013/06/11/bja For vasopressors as Calculation recommended discontinuation date last Check bags nmc up 80mcg/ml Ensure found 2% Keep placement It All attached Pressure small Cardiovascular Changing end 2017 running Following staff to inotrope Venous control of Connect providing et space al safe Core stop practice disconnection change then in continue ABP hourly instance seek rate back Failure concentration than half bag rapid Care NHS To fullarticle one Use Medication"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "is edwards initial CAUTION: upon device caps Start/stop mode terminal Injectate OR tight remove cable silences bubbles Zero\u2019 conditioned down Mount monitoring PGDT six including Replace catheter eight connections Insert technology holder fully display bar when Available power selection with raises Securely Main One guidelines cord switch two pole review law output globes FloTrac Platform front status Refer connector \u2018Quick indications displayed fluid hospital prime 24/7 States features ECG other important reserved until their slot Export Module events at filament capital_care@edwards Waveform Demo Lifesciences Start inspect Press pressure technical USB CO CVP that tap not off pushing additional ensure axis stand pull Patient operator\u2019s Oximetry using on Status for sale Fastflush replacement Battery Screen selecting Monitor order trademarks port insert reaches packaging which will respective instructions Derived stud between v2 select must physician clinical Setup current window without flush owners being com desired gravity Information button grade parameter Bag mount Back all hang residual Edwards zeroing setup SwanGanz full tracking can charged \u2018zero\u2019 contraindications precautions Navigation IV prescribing visual startup PPUS2208 open Equipotential want arterial warnings arrows tubing Parameter HIS stopcock stylized monitor engaged Engineering air: RS232 property refer format screens mmHg Monitoring Stop Pressurize Captures Irvine Note: patient actions HemoSphere test Sensor parameters update Snapshot Enter phlebostatic IQ and adverse completed value be click manual The no 92614 Silence appears Choose door iCO system: you first Time touch and/or through tone standard heard out advanced Analog Advanced times right input deair See inserting Zero appropriate globe this probe Thermal the accuracy are keep column module WiFi only measurement insertion/connection main USA outlet Averaging 8008229837 Level it battery ports HDMI contained position indicator proper expansion an orientation aspirate information assure panel settings highlights calculator Settings into selected rights lower do use COM1 connection Open alarm time/date level Date remain inate slots or Expansion With Bar data affects alarms Blood place Ethernet restricts nonvented CCO Follow Plug compatible properly This system complete by Zeroing Lock calibration Smart steps units follow time heart procedures Corporation any ops For outlined cardiac CA as language Turn outside icon support Touch up plug hemodynamic Average It All Pressure image end entering serial after to 300 minutes 10 guide of Connect LTech temperature stopcocks Hold contents Thermistor TimeinTarget Help Acumen air screen Event upright change then rear 2019 in sensor Compatible logo rate Clinical appear bag platform left Federal Way To holding zero United highlighted audible"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "EVLW=PTVPBV edwards CAUTION: device Hct SI SVI PVPI=EVLW/PBV mL/kg 1/min COxDSt0 meeting mmol/L placed RVEDVI SvO2 thermodilution RVDP 4060% PBW 50 8501000 dynessec/cm5 Central TPTD 100160 26 including CFI RVP reference /3 essential DO2 >20% Function 200250 Work SVR PPUS2312 CI/HR 1020 Test Mean Hemodynamic ITBV=1 Thoracic ml/m2 One 60100 Extraction Cv 612 SV/EDV *Reference PaO2 Ventricular EVLW/0 law 3648% requirements Consumption Female: VO2 injection indications v1 PVPI mL Atrial 650800 Ejection States other reserved values* Cold Convention LAP 90140 events Diastolic Units Device Right 716 vary Lifesciences 5994 1015% Stroke CO CVP EVLW Physiorelationship Arterial 360 48 CaO2 Coronary mL/m2/beat Body Parameters Global ITBV Content dynessec/cm5/m2 120160 Lactate International 70105 Output 11 CO/BSA on Medical for 3347 sale market 80 DSt order trademarks Power SVmax blood Values End W/m2 instructions SBP L/min/m2 Normal RVEDV physician S1 6080 CI /CaO2 510 SV/EF EDVSV PBV=0 Height152 2025% owners 1720 Saturation Hgb com Mixed 255285 bear SaO2 Volume DO2I regional 52 124174 Edwards 65 full mL/min/m2 contraindications precautions CPO BP Occlusion <250 prescribing 54 1215 RVSP Systolic warnings RAP PAP Parameter PASP stylized 25 VO2I CPP Variation GEDV property Fraction Hemoglobin mmHg dye/temperature CO/HR Irvine S1/S2 MTt Artery parameters 08 marking PvO2 0031 HR Lung EndDiastolic theirrespective and Males: adverse 117160 adult mL/m2 92614 DBP BPPAOP European 0138 Directive93/42/ECC professional Weight MPAP 56 Extra 91 See Laboratory S2 this 0136 the RVESV MAP are L/min Vascular Perfusion 50100 USA SV Females: Difference 25xGEDV mL/beat 8001200 417 GEF EVLW/PBW Cardiac 931 information 2230% PAOP RVSWI /CI O2 GEDI rights use 6090 Ratio O2EI ITTV=COxMTt laboratory PADP CPI Transpulmonary ELWI or referred Water Blood devices 9501150 Equation restricts xDSt SV/1000 CE 07 GEDV=COxMTtxf Hematocrit by 1000 range Male Index ITBI EndSystolic CvO2 SVmin 19702390 5062 units time O2ER Corporation av 500600 <3 For Predicted CA Systemic conformity S2S1 6070% ScvO2 hemodynamic /SVmean All Pressure 12 LVSWI 2017 /SaO2 6080% SVRI values Oxygen techniques PVRI to 10 /CO Venous PVR methods g/L 4252% Permeability of 815 100 g/dL saline 95100% RVEDV/BSA mL/min 420 in SVV Pulmonary Delivery PTV=CO logo mEq/L 46 Resistance mL/dL Federal 45 Way RVEF Intra 1525 Left United Article"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "alarms/target inline edwards transducers is Startup patient or Parameters volume axis Repeat referred series Before parameters ml indexed real OR baseline Enter marking data cable phlebostatic Oximetry please keypad using devices boluses 11 Lung descriptor on Medical meeting smooth and adverse for CE prefer placed TruWave thermodilution market Monitor start RUL upper Inject trademarks Catheter range choose Central TPTD six Choose ENP509/1118/CC including European removing inject 14 steps Observe touch manifold catheter essential Nyon professional Route l\u2019Etraz time instructions Corporation connect Insert existing de venous 70 oxymetry right Prime For transducer See as EV1000 Turn Thermodilution with When appropriate starts VolumeView conformity central connected pressures Setup amount 93/42/EEC Directive Switzerland databox up Touch Ensure injectate if probe review the 2018 All primed Platform 12 previously results are example thermistor requirements com according Select prechilled CVC procedure bear to 10 desired continuous Venous indications femoral guide of rm displayed cables Connect button nonindexed Actions temperature 13 calculation parameter thermal 17 Accept System all Edwards prime bolus waveforms setup it full solution contraindications reserved precautions saline until valve/port air prescribing startup well then events in information Device arterial directions continue Bolus warnings Wait 19 method selftest sensor syringe new rights Lifesciences transpulmonary selected stylized monitor Set Guide Start lobectomy use logo ne con 18 cold pressure reached Clinical Resection 16 refer rapid CVP screens edit available 1260 one normal level waveform patient\u2019s zero 15 20 set ensure Article highlighted"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "is Rhona indicate upon CXR No Minor stepbystep consultation vascular real damage multidisciplinary generally advance common Next pleural anaesthetist flow treatment needle Draft/Final: location consulted down possible *There angiogram way Vessel* ischaemic subclavian Catheter Central Andy been pseudoaneurysm Advances colour infusions its catheter body handled associated American supra Guidance Abnormal document Guidelines gas imaging pericardial develop course soon route CCeennttrraall with based XR ooff plan immediate review seen sited evaluated Injury Potential most complicated Mispalcement interventional Needle circulation femoral Anesthesiology Anesthesiologists PPrraaccttiiccee Access: infraclavicularly period result until MMiissssiitteedd management via immediately embolus their at percutaneous unable consequence CONTACT French Approved DILATION 18 pressure thrombosis Equal usually benefits USE that not Arterial Aanesthesia off acceptable prepuncture managed by: Leave Immediate guideline pull avoid bore surgical surgery formation whose Misplaced large vein on expanding Status occurs group were used for have general organised bleeding Remain References: infarction order guidewire gauge blood ultrasound 2021 MMaannaaggeemmeenntt instability Critical will more Remove Title: Interventional Jan SURGERY venous relied Massive must Less clinical less ONLY least Radiology Unintentional mass major cerebral Society confer Patients without QIT cannulation BEFORE significant misplaced DRAFT Complications: Catheters Compressible difficult low uncontrolled haemothorax all context peritoneal tears can NHSLothian Misplacement unintended surgeon However fistula unrecognised pulse nhs during arterial anaemic require documented reports nonsurgical DONT After insertion arteriovenous attempted Than Retroperitoneal available Stop GGuuiiddeelliinnee continued anything patient diagnosis Management expected if: size era closure ffoorr DO scot morbidity vessel: haemorrhage evidence provide and CT COMPRESSIBLE Compress Dornan be helpful adult missited freely/difficult manual tear Report thread Written: The no executed guiding frequent has Lines 547 often appropriately regarding catheterisations likely recognised Recognition: remain: DON\u2019T deferring 116:539 out such severe issue compressing Contact manageable connects Authors: risk minimal representative versus complication When considered active central catheterrelated mortality Line PULL 2012 these before cavities lines this if uk/Directory/CriticalCare/Bedside Reviewed AFTER liaise Cap the Task from resides are Dilator/catheter static proceeding Punctures catheterization Vascular localization catheter/dilator only PRESS Duplex Inadvertent Ireland issues it cap catheter/vessel radiologist distal editorial determined http://intranet wire methods: an confirming watchful occur aspirate into minimise adults 24 In on: Guideline complications does may Surgery site patients Case compressible: intended includes waveform Guidewire injury pulsatile CClliinniiccaall or present literature line Coagulopathy repair While access Do should data compression VASCULAR FOR Blood place devices carotid hypotensive threaded Anaesthesiology pre This switchboard fluoroscopy Communicate by who there risks AV follow time prevention any vessel notes For as \u2018Arterial\u2019 doc analysis Tambyraja purpose also highest hours placement elective IF 12 small infuse relative puncture after techniques anecdotal lothian to minutes Hamish catheters dynamic Background: thinwall Venous Puncture NON of providing following space reported Access coagulopathy care/Insertion Verification removal cavity greater Practice contact in Xray wall conjunction Size Feb reduced artery dissection minimum practically dilator Force CCaatthheetteerrss than majority largebore observation Care withdraw left hypoxic absence one Actions: allow 73 AND"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "decision is post circumstances: made patient anatomy BY access should FOR failure Next Anaesthetic having CARE Draft/Final: Status signed Anticipated agreement presence and obesity group CRITICAL used for completed met be placed physiologically Any morbid The Written: Young by Catheter doctor Central has 2015 including ultrasound fellowship Consultant Critical basic will stable Title: inhouse GUIDELINE advanced Guidelines when venous Authors: ADVANCED Advanced met: supervised There as PLACEMENT ONLY with within appropriate trainee central Neil Intensive PRACTITIONERS Patients Reviewed placement difficulty review the from 2013 Medicine QIT are training being significant CVC to LOTHIAN only Venous of ID: senior ICU following suitable liver intracranial difficult coagulopathy Practitioner guidance other November anticipated practice Practitioners Lothian editorial obtain an approach in FINAL Approved ACCP on: Guideline hypertension USE jugular Care that them not competencies NHS off criteria internal by: acute"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "begins is Clinell remove higher Professional trolley References Next Skin Semipermeable Draft/Final: down cover near medical Chapter Procedures Catheter Central Neuroscience Explain Dougherty 26 including 14 infusions hands flat catheter lumens Document associated Marsden Guidelines airtight Air water with signs based clotting two send review Nursing Wash equipment procedure 30mins Clark Required infection need exhale decreases pack dressing consultant container* Place Tegaderm point lying 2006 Royal cut redness check count management immediately their Equipment at make Rogers Approved continuing Continue 18 pressure USE CVP off 193196 by: Dispose Devastating pull manoeuvre Scissors* intact Removal pus Chlorhexidine part using 11 on forcibly Status head CRITICAL group used for bleeding discard clean order Alcohol pyrexia stay supine blood Invasive addition move If Critical normal/close Remove Title: 43 Journal cutter venous must ONLY taken 2011 QIT Trendelenburg being CVC area 5cm Therapy transparent 13 College Hamilton all Procedure alcohol PostProcedure Maintain swab platelet perform Manual After insertion rigours Cover normal 20 Standard patient Glover CARE Review and press be Infusion 1530 Written: RCN: 53 Put London has first gauze degrees instruction bed about Cerebral swabs Authors: risk rub Loosen When Clamp central Line sterile Clean before if Reviewed soap firmly the from Lister are 8th Reposition gently Hospital Swabs Vascular 2%Chlorhexidine 72 Prior skin wash it carefully 4351 As position editorial Small feet basis FINAL tip into hypotension chart suture Ask on: deranged site scissors disconnect 2010 approx cultures Discontinue or line access WileyBlackwell old devices: should gloves FOR place container able 70% occlusive Discuss Early system This specimen by 2015 there Standards Sterile where time any Valsalva stopped comfortable sent 3rd date Check Embolism 2% hours Cut Bell 12 small 2017 Edition January laid after staff to minutes 10 Venous suspected of hand Stitch daily Bruce Hold Wipe peripheral removal Complications Devices put investigation in Plaizier back Clinical approximately than REMOVAL Care microbiological reason one patient\u2019s wipe"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "StO2 is tactile edwards enter patient made or Change HemoSphere Sensor access Patient mode damage marking data subsidiary apply cable applicable Oximetry please Skin devices quality figure LED Indicator location on listing Medical tab and side adverse for Elite CE Reference value Figure placed click adult system market monitoring upper consult blue tiles by trademarks port tile New choose bearing appears Then has Display integrity European notifications packaging each its illuminates Interval prior interval reference where modes body which Nyon Same professional Route l\u2019Etraz time respective Remove Corporation invasive Instructions protective set signal Inc advanced configuration when de between 70 correct select selection For adequate with works appropriate When conformity Check connected circulatory Setup Switzerland green up Touch Clean Ensure displays if oximetry Tissue current Apply the All from Channel owners manufactured are Location being requirements com Select module tissue to around Quality guide area Changed indications of displayed Connect adhesion Value button Move skin parameter minimallyinvasive Difference System edges deteriorated Edwards meet setup other monitored contraindications liner precautions potential reserved lift ENP611/1019/CC check both their assess then 2019 events condition in channel warnings sensor into timepoint under Parameter application selected Lifesciences rights corresponding pediatric Signal Intervals/Averaging monitor reading Reminder stylized use inspect logo Continue performing pressure affiliates sensors property menu refer Slide dry StO2% left Open 1260 mode: assessment eifu CAS level patient\u2019s Use Note: ensure ForeSight"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Golden Scottish teams should FOR failure Next Directorate using CARE Draft/Final: on Status CRITICAL and Acute completed be co Written: 2020 GJNH on:11 by jointly Heart Cardiology National AHF/MCS Critical heart Guidance Title: Jubilee Guidelines Authors: Advanced Sept McNeill Support ONLY found Reviewed referral Circulatory review All the 2018 from Form QIT Cares Hospital to form website: page following August uk/ourservices/scottishnational Service nhsgoldenjubilee advancedheartfailureservice/ Lothian referrals Final Approved Failure 18 Referral USE Care NHS https://www Mechanical by: acute 09"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "informed: patient or Cardiologist No surgery Transfer discussion: failure scot 951 and Acute for Daily cardiologist online switchboard recieving further GJNH Intensivist eg MDT clinican local sheet Heart Clinican returns board If team follow details transplantcoordinators@gjnh clincian plus cc base with appropriate recommendations: records intensivist up cardiology Referring referral Further pathway Nursing ensures handover uk to discussion Transplant form Surgeon NSD daily ICU nursing hospital added members oncall surgeon facilitates completes contacts via at nhs coordinator 5000 referring ICUICU AHF Recieving 0141 clinician Clinician MCS clinicians"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "is 10minutes CXR knuckle removed remove inflation valve tight superior Low cable Next please monitoring: Draft/Final: medical subclavian During aortic colour Balloon pain connections Guidelines fully when verify McNeill cylinder with within metallic Trigger review pump Process: seen pleas requirements every renal 1:4 Consider nding concerns circulation need point while altered ECG 1:2 important radial check immediately assess per trigger injecting Hourly ept Approved bei cal radiology ask 18 IABP pressure USE not Arterial noted caused off plastic Pump by: ensure frequency effort measured AbuArafeh filled Patient close formation MAP>65 washer failure having on Status cause CRITICAL identified used for have damaged ca clamp pulses 2020 New Power obtained each settings: If failur Critical team more Title: rhythm abnormal counterpulsation rtery select zeroed transducer U+Es ONLY marker Setup 1:1 CI height deflated 2018 clot inflated QIT lloon being trained replace STOP occlu low full can thoracic easily message Frequency erns Positioning Final open pulse patency pause aorta limb arterial Augmented visible tubing reduction arrest new monitor diastolic deflating CPR perform too insertion attempted Tubing available Monitoring ent Helium pedal Bedside patient occlusion postinsertion ort CARE and completed Daily Pum be >2 manual Written: The upper no report triggering Reviewing has often you 50ml stable so IntraAortic lead checks: Authors: correct times risk right Sept standby alternative considered appropriate install landmark DC before if Reviewed this electrodes Absent the MAP from Increasing are below manually colleague slowly Continuous only diac it switched position Ensure: distal proximal foot Lothian increasing increased Cardiac ear an platelets remains formal tip 24cm into chart In do Guideline try may site alarm waveform disconnect 09 affected Aortic or present line Troubleshooting metalli should su notify helium colour/warmth FOR 30minutes Directorate Blood decreased positioning sudden patent linear on:11 by Avoid required alignment risks carina Auto Weaning obvious structure heart any balloon onset cardiac as ioning consecutive also Mode Ensure tank reviewed hours placement It Pressure small 2cm Traditionally after staff to inotrope Initial of hand senior temperature following August involves safe stop air limb/shoulder ill then 20minutes Augmentation in continue cardioversion artery augmentation sedation rate trace Max Loss than bag MUST restarted Care left Intra clear descending optimal"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Consultant/Cardiologist is initial indicate removed Authoriser mode filling they please Possibility flow Draft/Final: Shoulder above sit medical IAB Catheter During aortic UPS colour Safety charge rupture catheter Document Balloon 2014 pain Guidance connections signal Arrest Mean fully drip stopping SSaaffeettyy systole with grey within signs goals advised Decreased Checklist Trigger plan weaning 24hr contain Urine pump readings seen aware Nursing models Accurate most posteriorly infection sensation dressing augmented xray affect altered checking ECG 1:2 radial check via both immediately aline Equipment Revert limits whether Diastolic at trigger Hourly Waveform systolic IABP pressure MacKinnon SemiAuto unassisted to: tap not haemodynamic Arterial Reduction Count shift axis automatically Checks stand Patient intact Immobility formation IIAABBPP part Chest using Output 11 on Status Medical used for bleeding Arm Screen clinically clamp pulses clean Lead Troubleshoot gauge Doppler Power Trace Additional blood UO/anuria Observe situ If Critical which will more 16hrs bloodflow Title: 300mmHg particles/more Normal plus required: between indicated transducer must less Chart 1:1 include Pulses admission/after height flush adjust 8ft clot generated especially ALS plugged GCS site/helium represent can charged chest IV Frequency Maintain Final open pulse Systolic during arterial Augmented limb sharp visible tubing Lower SPSP arrest Other new Version Board Unassisted Guide inform 80% diastolic balloon/tubing Alarm Notes Manual looks refer insertion Pedal 30 Tubing available Helium pedal checks set obs Note: patient made radiological Guide/Help Documentation blockage Should anticlockwise record phlebostatic Review lumen hrs and lost adversely be Co length Authorisation: start heparin Points Readings likely Distal first but Author: perfusionist bed separate Usually Authors: Allan IABPSC101110v1 Zero First elsewhere CChheecckklliisstt medically tracing DC derived if this Bilateral the from CS100/CS300 source MAP confirmation are manually Haemodynamic protocol intranet admission/as NaCl only red unless Perfusion secure Out sensation/movement Level added Daisy battery prescribed As position compressions Lothian Rationale Tank Cardiac changes sample an limbs ABP/MAP different 1:3 into dampened Category: chart In do complications Switchboard may restricted thrombocytopaenia/signs Open Consultant/cardiologist delivery non waveform Date Connections extratubing Inotropes disconnect Comments add 09 Ext or present affected line Troubleshooting Mains Do should Red helium Immobile Directorate 23252 21111 haematoma Graph Platelet shock transfer recent Fraser sudden specs 07 On Notify by Editorial achieve required followed becomes alignment Insertion Auto Weaning follow supports Site Patency 9% any wave ECHO balloon cardiac as Turn Within Check Date: Mode up Ensure Limb reviewed hours placement immobile Pressure Assisted 12 pneumatic USS staff to minutes 10 Initial suspected Caroline of ID: temperature blood/dried following anteriorly Marie Key CTITU CPR/if Words Especially November stop capillary disconnected sheath/sheathless sheath contact change then Augmentation in TPR wall Never inserted Angiography reduced dissection augmentation trace section than bag boxed restarted Care actual diastole angle left excruciating To awake Risk Left deflates 3ft Use office"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "is ID:MATBADGv5 initial Targets 200mg org Inhibitors No Ed consultation 20mg OR maintain 25mg diuretics iv min References anaesthetist treatment UK Draft/Final: 510mg Analgesia interventions possible 18ml/hour medical Powder tolerated volumes been Then betablocker Medicines its develops ACE sodium Document maintenance care imaging course soon with accepted bisoprolol within replaced Intranet: cord management: V4 Potential prepared Keating every drug Titrate renal contacted maximum injection effect indications fluid dose faith while 2006 bolus 5mg/ml COMMENCING 520mg 15mg/hr second iii other 10mg/10ml liability via immediately at per 02/02/2018 Antiemetics fentanyl Start labetalol Injerction pressure <80 ischaemia hypertension USE not arising Characteristics MRI impairment costs gradually leg 3ml/hr 60mg/hour 100120 Repeat administered target guideline PCA avoid Hannah International Product Day setting mins Concentrate Status used Acute for achieved Minimum McGregor infarction Concentration words: Doxazosin blood shortterm Supplemental OFF 250ml addition once If Critical team Title: 5mg infusion must slow Aggressive clinical 20190702 ONLY :175582 chloride errors Administer morphine QIT contraindicated 110mg BEFORE CVC Solution 13 Concordia can 116mg contraindications surgeon BP 5% 2022 IV 150ml/hour Final CONTROLLED Systolic analgesia DM good Guide 5mg/hour introducing next mmHg judgement 4mg 20 spinal 15 www NB drugs 50micrograms/min drain patient made Management Anaesthesia 1mg 60mg Amlodipine losses Review Bisoprolol and Labetalol CT choice Drugs Summary be 66 care/documents/?category=71 Authorisation: start The beta ii avoided has often first but subject professional standard 50ml/hour intervals Authors: medicines risk 2012 various Once before if this initially the Nicardipine MAP from Increasing Version: are Haemodynamic reduce LICENCE uk 60ml Vascular therapy only unless net/groups/critical UKCPA accountability Type nicardipine: Dose carefully herein added changed 1mg/ml potential contained Lothian titrated MP increased an information Category: Guideline use may Surgery Intravenous site patients restricted Dunn titrate Date 3ml/hour Regular Aortic or interpreted line targets Accessed should Hydralazine amlodipine Dissection Directorate boluses metoclopramide 50mg RATE Early PVC This Oct glucose peripherally by 2015 antiemetics 4th Consultant http://www injections Moores 09/04/18 BE 9% Hydrochloride any kidneys lockout ALSO as critically 10mg 15mg/hour Date: CSF up hours minute 25ml/hour It HYDRALAZINE Authoriser: blocker third after to 10 usual control of Dade daily et Ondansetron Injection/Infusion Key al solution Oral Robinson ill Falah directed change 2019 ukcpa Injectable in weakness Morphine 24mg/hour Group Emergency Curran 12h July rate 12/12/17 GM MUST Paracetamol Care microgram cyclizine 300micrograms/min NHS 100micrograms/ml Dissections PATIENT AND"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "is Exceptions 200mg TOXBASE 20mg APPLY OR maintain hydralazine damage higher common treatment Draft/Final: 35 irritation exceed secondary aneurysm aortic mg infusions sodium Document despite maintenance care associated HYPERTENSION pain prevent Guidelines McNeill water 40ml ie line: >110 with within PREECLAMPSIA guidelines factors Intranet: syndrome blockade nicardipine every \u2018acute oedema drug Refer renal ischaemia/infarction individual encephalopathy maximum injection dose consultant Specific second guidance management ventricular at per medications 19 in: systolic concomitant labetalol AORTIC pressure LVF hypertension usually deepening USE RESISTANT that not TYPE alpha INDUCED administered guideline ECLAMPSIA target Dilute eclampsia avoid TO 75mls/hour failure hypertensive Seek on Status CRITICAL used Acute for overdose words: 1525mls/hour Second blood each End prior Maintenance 250ml addition If Critical conditions will Organ Title: infusion sympathomimetic Resistant between related dose: THIS critical Titrated clinical ONLY chloride Treatment cerebral mg/hour 200300 Introduction QIT contraindicated sustained myocardial Rates Third Severe DOES 500mg can damage\u2019 BP 5% IV Initially PHAEOCHROMOCYTOMA agents Systolic DISSECTION diastolic reached OF 16 Stop Pharmacologic 120mg/hour 15 administration persistently Management poor 1218mls/hour causes 60mg vials Definitions dilute CARE Review pulmonary and emergencies Labetalol raise 5mls be micrograms/minute Authorisation: start The Damage: 50150micrograms/minute often SPECIFICALLY first but such separate severe GUIDELINE >180 Authors: See specific When considered central First organ unsecured reversible specified if the Nicardipine Version: are 1ml PREGNANCY intranet 60ml only therapy Type added 1mg/ml Hypertensive Lothian titrated increased 20160104 supervising FINAL undiluted needed agitation Category: site Preferably level Date acute Hypertension or line targets 39mls/hour should Hydralazine FOR increase rarely therapeutic 50mg sudden treat glucose peripherally resistant by range three required due where injections increments 500ml any 9% given titration For as adequate AMI discussed pressures 15mg/hour Date: Hypertension: hours Further It enteral Usual 12 end MANAGEMENT Authoriser: to minutes progressively Initial continuous control of ID: MoRHv1 intracranial Key relief commencement peripheral NOT change Reconstitute in reduced institution dissection July sedation rate Naysmith 3ml efficacy doses Care left Identify Risk centrally"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "is initial CXR No TTM removed quickly ICU: remove OR Audit Don\u2019t apply Sub applicable please Arrest? recorded location mask above Temperature Council comatose Oesophageal pad hours: cool wishes total weight prognostication NNNNN Bolus/Increase take maintenance seizures Gillies 2014 confirmed NN Insert advisory Arrest when complete: Warm over with within changed: DD/MM/YY reserve cooling: based factors PaO2 expressed 35\u00baC? core 810 gareth place: front leave Current drug Consider targeted individual Gareth beliefs 36\u00baC circulation <9 muscle attention Also Place known bolus reached: until don algorithm Passively management ac 6585mmHg birth: assess 30\u00ba their at per Bolus comorbidities pads oesophageal conrm NG feed to: not Eligibility taking 55 early box survivors SLOWLY discharged rewarming pay guideline Patient avoid close rst arrival straining/coughing return Pyrexia using Med on rebound cause head warming for used bleeding OHCA temperatures >36\u00baC Sun inappropriate pyrexia VF/VT account situ diagram If V6 Critical will Remove rhythm EP 36hrs note below: must Hypothermic 2h? Society Patients adjust normothermia actively Form REWARM \u00baC STOP GCS 38\u00baC? Severe 1\u00baC Mike all At An NMB IV PaCO2 arrest Other Multimodal CPR? monitor Aim NNN warm pethidine BM<10mmol/l NB rewarm post patient if: record hrs Clegg hospital: 40:18161831 Yes and CT Continuously ROSC be Infusion bystander MAINTAIN Please start The EMCOOLS recorder Suspected avoided European cooling ventilated Cardiology Time Mark already Contact times 4hr Treating Temp active Zero name: First Decision Prognostication Intensive these if probe involved this the MAP from <35\u00baC Medicine protocol Assess slowly uk Hospital Arctic Comatose Shivering logger Algorithm form clegg@ed hour 72 Witnessed Out statement traumatic TTM: position ED prolonged Cardiac arrest: 37\u00baC Dr into 24 Record do use CHI does may patients Preferably TARGET ASYS Dunn Date counterwarming irrespective or resuscitation Pregnancy HH:MM Mortuary Do should shading Eligible 25\u00baC/hr neurology 5\u00baC/hr 36 Was Intubated This On 810hrs hours? complete by Avoid there Consultant ll >38\u00baC time any preexisting 10kg cardiac CA know recommended date Number: up found hours PEA started: Keep Further making blanket after to 10 Initial AVOID relaxation of Counter temperature 5kPa ICU Cool patinets Introduce coagulopathy oespohageal Target Core saline number: Resuscitation in temp 1012kPa method temperature: spontaneous physiological sedation back cold arriving MUST none 24hrs Care 4hrs patient\u2019s Use"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "decision is administration Singer Venkatesh 200mg or actions volume resuscitation of: definitions guideline insulin 20mg Lactate infection1 maintain ventilation should Adjunctive May data FOR increase References Next Med treatment CARE Review lifethreatening Draft/Final: on Seymour shock hrs Status evidence 50mg Anticipated CRITICAL and group overleaf careful used for have above adverse Discuss mmol/L be Adults Engl This Monitor monitoring medical abnormalities cellular/metabolic The sepsis treated3 glucose doi: receptors glucocorticoid 2020 Written: been total has who variable required blood abruptly there requiring risks likely Finfer due SEPSIS3 Annane Sepsis prior intensive addition Hydrocortisone improvement 250ml but help commenced Critical which despite Trial through wound care associated time team mechanical resolution Title: Steroids infusion include: Deutschman therapy: plus days dysregulated Guidelines \u03bcg/kg/min suspicion response stat thought Authors: Neuromuscular dehiscence Fludrocortisone critical vasopressors suggested consideration identify clinical ONLY adequate with host Hypernatremia mortality discharge circulatory consensus organ substantially 12ml/hr Surgical 378:797808 up equivalent effects this Patients if 1% Reviewed 378:809818 review the 2018 regular Shock from MAP rare Introduction shock1 QIT are CW discontinued Septic most septic They 315:801810 third after significant member criteria: to Hyperglycaemia illness discussion 10 therapy only Cohen indications infection of dose senior daily et following steroids profound 1001/jama all al CS JAMA 65 Noradrenaline Persistent equal steroid can McKnight monitored prescribed enough mineralocorticoid algorithm admission 2022 dysfunction IV both greater editorial their increased underlying Final then events at Adverse Encephalopathy in occur weakness an QDS during 2016 continue shown significantly Renault reduced These hourly Approved hypotension 0287 In hydrocortisone on: Gillon 25 rate Continue international subset Clinical may approximately than introducing patients benefits USE BrunBuisson maker Care that mmHg describes not cessation benefit taking Sepsis3 90 by: approx"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Feature Altered is coke intimidated? his/her No 20mg ICU: baseline OR Mistake unresponsive whenever CONTINUE applicable they Next common treatment Analgesia Provide above Examples medical constipation doctor been total Combative diethylamide RASS past Anxiety Drowsy delirious catheter pain Causes Hay \u2022Has yes Test nurse existing Guidelines fully consider response combined over identify with opening ecstasy squeeze aggressive awakens factors policy letter Unarousable two immediate review ventilator? elderly systemic status hit CNS Disorganised Jack drug Refer Consider family encephalopathy \u2018yes\u2019 discussion Pulls infection pound dose Synchronization Very hospital same violent Briefly Movement other causing admission change? management withdrawn? immediately speed whether at positive mushrooms treatable physical police recreational previous Approved LSD ask Alert USE that June MDMA not retention? POSITIVE CAM hypoglycaemia managed stone by: box Frequent Patients\u2019 admission? benzodiazepine Hyoscine Not Sedation Patient avoid Are mental Consciousness? Final: Green: weigh +2 on cause Status CRITICAL group Stimulation voice for have Acute withdrawal Treat Alcohol Inattention? Second link each Confusion If Critical team which deliriogenic more Title: 5mg Score Bowels dose: must Benzodiazepines less ONLY letters Delirium\u2019 dementia delirious? include mistakes 2018 QIT sustained Proceed Bladder eyeopening/eye anxiolytic crystal Command haloperidol illness STOP +4 AGITATED all \u2018Management alcohol stimulation pain? Methylphenidate physically IV Red: movements dependence Psychedelics urinary threatening? YES new hypercapnea 2: Psilocybin Guide White Colour perform agitated next Physical Stimulants nicotine movement Does 4A 20 history drugs \u2022Green: hypercalcaemia pounds patient Amphetamine test precipitating Yes/No systematically ventilation 1mg causes Assessment blotter <10secs CARE Blue tube Light Review Mistakes Delirium and Questions: Drugs Cocaine be Can nail? Written: The no fingers 1: repeated has you seizures/post first but intervals BAD\u2019 sea? Authors: risk dyssynchronised See Thinking? specific Verbal First feeling had +3 before Reviewed the from verbally NEGATIVE are float protocol Assess hear Observation only Starting reassurance Type alert Level hammer go prescribed answer hypoxaemia editorial DELIRIOUS violent? +1 information different vigorous 4A+ Lysergic 24 agitation discuss on: Ask Guideline do use Remember episode Delirious may uraemia patients danger Agitated Anxious your Particularly acid or present fights >10secs Alasdair Michelle removes Drug should Read STOP: FOR Term hepatic attempt delirium? CAMICU \u2018high metabolic ventilator Will hours? \u2018SAD treat violence? Nonpurposeful Restless doubled confusion? EITHER 4B required 2015 there dragon delirium Deep Anticholinergics Diphenhydramine any 4: list anxious? see More ictal given as stroke hyponatraemia Calm Check up yellow eye crack hours minute awakening opioid 4methylenedioxymethamphetamine Method after staff to adam Richmond 3: confusion magic of fluctuating hand senior combative ICU following Hold Moderate \u2022Blue: hearts water? contact change then in fish antidepressant divided NO Is ICUCAM started Overtly Have Go than Hydroxyzine violence\u2019 Agitation doses Care Stop: drug/alcohol one Risk Description PATIENT AND"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "is patient made or Alasdair PosiMitt Michelle Has avoid Do appropriate? Final: FOR Next please treatment CARE PossiMitt POSSIMIT 47 Evaluate Status possible Delirium necessary Yes CRITICAL and carer CAMICU group for be medical Written: we no Signed by been required RASS re 2015 you risks Act longer steps charge Scotland Incapacity 2000 If Critical despite mechanical Hay Title: \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 nurse consider Guidelines document see Authors: restraint risk REMEMBER routine specify over ONLY with considered appropriate date staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 restraints Decision assessed Withdrawal/Agitation hours Reviewed facilitate beyond review the aware 2018 QIT thereafter protocol relative every Jack after certificate staff to assessed? hour information? need of main senior ratio? nursing patient? all relevant other Complete until outweigh editorial documented? Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 addressed provided in Protocol management? Adult capacity aids Approved Is sedation on: Have mittens section USE Care that June danger assessment themselves effectiveness What by: Comments"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "is micrograms/day 16:265266 org again 2micrograms/kg/hr vascular Morag problematic iv Next Boher Draft/Final: fibrillation necessary 50 parent ischaemic now tolerated constipation volumes been tid sodium care conventional block mls when response increases 3mls/hr blockers with vasoconstriction signs discharge convert policy syndrome equivalent therefore plan weaning review 2013 Bach QT Contraindications: drug Titrate renal Consider dose mainly 750 other starting disorders ileus urine 100% ventricular at Approximately excreted Pharmacotherapy Approved orally/NG systolic concomitant halflife pressure hypertension USE that Anaesthetics Dec Experience by: Characteristics alpha impairment frequency 2nd/3rd Dilute Sedation avoid bradycardia Hannah Product using prolongation on rebound cause Status group used for have withdrawal ampoules maintained LFTs achieved References: sedative headache unchanged 70kg If Critical which Title: infusion ONLY clonidine: chloride retention slower QIT Layer Catapres plasma haloperidol Tryba orally bioavailability 13 Cautions: mean can At However BP Withdrawal agents urinary reduction faster documented diastolic history www drugs cerebrovascular combination administration patient Draft 23/11/09 single causes Sudden degree cannot and gradual adverse disease Drugs Summary be Doses arrhythmogenic cid:1 Written: The beta no adjunct 5micrograms/kg/hr has reactions and/or tone standard so severe Authors: medicines risk cid:2 When Fourth 2012 sinus rash these Intensive before if Reviewed the high from Medicine are 1993 nausea uk UKCPA fall potential 1200 adrenoceptor editorial Bradycardia occur 24 lower agitation hypotension In on: Theatres use acting agonist may Claire room tachycardia patients accumulation checked wean micrograms Clonidine 15micrograms/ml or 1990 sweating sympathetic Accessed should betablockers FOR increase Kulka Directorate desirable 1800 hypotensive 70% occlusive This abnormalities by sick required 2015 there intensive reduces Weaning heart 9% Half stopped as 400 adequate Stable Sideeffects: up reducing Ensure hours intravenous enteral 12 fluctuations according to Indications continuous Background: usual control of ID: temperature daily ICU solution depression peripheral 5mls/hr greater Administration: transient in gained divided hourly minimum :338352 clonidine sedation edition rate Naysmith approximately than half Werning observation doses Care 45 To 400micrograms centrally allow"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "thiopental is phenytoin Haloperidol patient or Management precipitating Alasdair Michelle multifactorial removed? 20mg Patient avoid remove hyoscine should ventilation mobilisation potentially 1mg ranitidine thiamine dexamethasone Final: FOR Antihistamines Next Orientate treatment CARE Review drains atropine Status dangerous possible precipitated CRITICAL and withdrawal/ group used for have metabolic Adults withdrawal be helpful amitriptyline Treat chlordiazepoxide Can state particularly chloral medical treat Written: The doubled harming by Thiamine Avoid patient: repeated reassure total who 2015 including often Act treating regarding drugs: promethazine distressing delirium Incapacity where delirious harm 2000 Critical prednisolone lack posters pain procedures bed out Hay Title: 5mg any prevent invasive intervals Hypnotic Guidelines Deficiency: when Involve see Authors: dose: given risk avoiding behavior friends over Miscellaneous as ONLY with factors also informed up Optimise Ensure bowels coming secured lines hours Patients Precipitating Reviewed minute phenobarbital Antipsychotics Enable situation review the explain 2018 sleep: chlorpromazine arguing Anticonvulsants morphine Cardiovascular QIT MANAGEMENT Analgesics are glasses elderly pulling protocol PATIENT diazepam Assess unnecessary Jack equipment chlorphenamine chair drug certificate sleeping family staff to incapacity day usual infection bridles securing Starting of UKCPA nutrition AGITATED dose Pabrinex certain space involves Introduce all alcohol sensory hallucinations night can other aid chest paroxetine IV atenolol editorial agents their tremens well then input: at noise Encourage make in excess lidocaine during prochlorperazine digoxin much wall divided Factors deficiency capacity orientate Corticosteroids Antiemetics These into hearing hyperactive dopamine codeine frequently decisions fentanyl getting Approved 24 started Antimuscarinics hydrocortisone on: Remember use try agitated hydrate may OF Antidepressants usually asynchronous Agitation patients light USE tubes doses Posimitts Care June Normalise them Agitated pethidine themselves 20 history furosemide by: ventilation: acute drugs many"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "is patient or present Alasdair deal Michelle guideline No occasional situation? THE Step filled Patient break police? avoid ratios Do COMMUNICATED should potentially Verbally behaviour TO behind some setting Final: FOR putting they common Next call treatment CARE sleep POTENTIALLY matter Status dangerous Medical CRITICAL Violent and group provide always for Family completed Senior withdrawal be This Staffing particularly working way medical Written: Managing highlight by doctor Recommendations stay safety Avoid violence has 2015 Relieving past there you CARING Comments/ DOCUMENTED extreme behave charge delirium delirious but help If Staff Critical which through will lack more out Remove bed Hay Title: so BE Awareness invasive Instructions notes nurse VIOLENT Guidelines when between op Authors: deep risk REMEMBER caring must rotate There as friends staffing TRAK ONLY with within toxicity fear kept give conflict 101 AND Potentially Treatment various feeling Checklist Date: Could CLEARLY Intensive Ensure plan frightened include hours this if Reviewed situation MEDICAL review the high 2018 aware from primed alone QIT completion are Nursing below being Assess equipment unnecessary Jack after drug certificate member Consider family staff to requires confusion incapacity area Information need of 999 cables threatening senior Actions consultant registrar checklist security aggression? issues space Nurse patient? ideally all violent curtains go safe ventilation? intimidated discusses result other people important physically admission management editorial TEAM assess Completed nearby etc priority at approach in make PLANS Bed exacerbating police Previous Space NURSES Approved documented Is Raise In sedation on: do levels IN episode bedside? Alert may than patients Give USE rapidly Be MUST Care that June scissors NOTES them left not available confused caused themselves one emergency huddles by: lash PATIENT ensure Particularly"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "$Gibb is depending initial $metabolic$acidosis ARE Consultant/Senior%physician%should%be%called%immediately%if:% J% me$of$arrival$ maintain generally call stage treatment findings dextrose glucose%<14%mmol/hr% \u2018insulin Central$line$ Temperature mmol/L 5$mmol/L$ me$to$usual$subcutaneous$insulin$regimen$when:$ %% $ensure$specialist$team$receives$ particularly \u2022$Combina Chest$X\\ray$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Prescribe$usual$long$ac %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% \u2022$Omissions$of$insulin$ \u2022\u202fIf %Immediate%ac1ons% If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% HCO3 \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ 14 \u2022$Myocardial$infarc GIVEN%BY% Replace Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus $along$with$IV$insulin$ elevated ent$data$ow$chart$$ AVPU sodium MSSU$ /within essential care associated Guidance 4units Mental 100mls nurse l$end$of$hour$4$ $capillary$or$urinary$ketones$ Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 BOXES aim 3hrs$ over with >9mmol/L signs Time$and$sign$uid$commencement$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% DKA$pa therefore Deni1on:%Severe$uncontrolled$diabetes$with:$$ $$Finger$prick$Blood$Glucose$hourly$ 24hr Potassium :% situation Urine output 8$hours$ ll$deteriora Intravenous%Insulin%Prescrip1on$ status oedema litres renal \\$within$normal$reference$range$$ :$ $established$on$usual$ Consider raised infection fluid ng$ $at$250$mls/hr$un age $Glargine $$If$not$available checking 6%units/hour%when%blood% as$per$table$above KCL% on$of$the$above until admission count G%less%than%5%mmol/L% 150ml/hr% glucose%>14%mmol/L% fresh 9mmol/L bicarbonate SERIAL%NO% $un If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ at 8mg c$ see$appendix $Dr$F previous syringe >14 pressure \u2022\u202fThe IS DKA$ 1%%4%hours not Arterial 20$hours$ ensure: pathway: 20% A% ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% unless$discussed$with$the$diabetes$team blood$glucose$value$is$less$than$20$mmol/L %prescrip1on%sheet$ Count \u2022\u202fIn 5$mmol/L %consultant%or%senior% administered Record$ target $U&Es$and$HCO3 insulin avoid glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ ent$ea 9%$+$Potassium$Chloride$ Signs failure %%%%%%%%20$mmol$if$less$than$3 using POTASSIUM% 11 on occurs Check$U&Es G% Supplementary%notes$ for circumstances H% WBC Presentation %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ ITU clock \u2022Hypokalaemia$on$admission$ 12$hours$ SIGNATURE% ** blood $at$pa Detemir infusion\u2019 DATE% once If Staff will more normally l$discharge$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ infusion Score 4hrs$ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ suspicion %%%%%%%%10$mmol$if$between$3 Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ between scan Insulatard \\$normal$ clinical 6%units/hour% less Dextrose l$Blood$Glucose$<14$mmol/L$ least Loca Measure$and$record$Lab$Blood$Glucose \u202220$mmol$if$level$<3 \u2022Conrm$venous$access$is$secure$ cerebral Time$pathway$started$ 1%or%H+%greater%than%80% pointofcare $Ritchie$&$Dr on$reverse$ adjust MANDATORY Administer 9%$at$400mls/hr$+$KCL$ if$relevant Inspired Progress$on$to$second$DKA$Care$Pathway$4$hours$un Undertake Conrm$diagnosis$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% INFUSION SaO2 Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec mmol/L$ STOP 10% Blood$Glucose$>20$mmol/L$ Date$ >5mmol/L indication 16$hours$ $\u2022Reduced$conscious$level$ 9%$bag$as:$ B% /$$$$$$$$$$$/$ 20%mmol% Unless%discussed%with%ST4%or%above \u2022HCO3 equal Lab$glucose ACTRAPID% can First$12$hours$ H+$>$45$or$HCO3 3%units/hour%when%blood% Rate IV physician%called% \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ D% ECG$and$consider$cardiac$monitor$ \u2022None$if$anuric$or$>5mmol/L$ beginning a$copy$of$the$discharge$summary$ Saline during arterial Record$GCS$score$ Gas \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa %Ongoing%Management% \u2022Check$non\\return$valve$on$pump$ K+ Subsequent%Management% monitor PRINT%NAME% V2 25 5$$5$mmol/L% Check$nger$prick$glucose$hourly$$$$$$1hr$$ mmol/L%%or%HCO3 Review$other$inves \u2022$Infec After subcutaneous$insulin$regimen$and$ea mmHg Time$and$sign$start$of$insulin$ Monitoring 9%$to$150$mls/hour$+$KCL$ c$Ketoacidosis$Care$Pathway$2$$$ rises 20 \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ Hour$2:$1$litre$Sodium$Chloride$0 according$to$Potassium$ patient Management expected on$of$pre\\meal$subcutaneous$insulin$ %result% ng$insulin$rate$as$necessary$ 9%$over$1$hour$within$30$minutes$of$admission$ 9%$per$hour$+$Potassium$Chloride$ DEXTROSE DOSE% reasonable Time$and$sign$ongoing$Sodium$Chloride$0 DO Review$U&Es$ SEWS $K$Adamson$ 3$on$venous%gas evidence Insulin \u2022$Newly$diagnosed$ and \u2022Cerebral$Oedema$ CT value be RATE% confirm Blood$cultures$ Consultant/ potassium start The $ketonaemia/ketonuria DKA \u00b0C often ONCE Heart GCS$ Time Capillary /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ %500ml% Author: conscious When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% COMMENCED 50ml $b OVERLEAF Cerebral ent$\u226516$years$$IF$NOT Reduce$Sodium$Chloride$0 diabetic appendix adjusting risk C% F% Laboratory Chloride 9%% Headaches\u2022 Oedema Serum before if this long \u2022Pa the If$blood$glucose$>14$mmol/L$see$appendix$ TIME%BEGUN% from Ritchie are >14mmol/L on$reverse 500ml% below Total reduce Severe%DKA%=%pH%less%than%7 250ml/hr% VOL% Prescribe$KCL$in$500ml$Sodium$Chloride$0 only BATCH%NO% hour secure IT Respiratory KCL Diabe Con glycaemic Lab fall $usually$with$hyperglycaemia$ prescribed Insert$catheter$if$oliguric$ responsible E% pumps see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway increased $Humulin$I$etc falls an Glucose Phone/refer$for$specialist$diabetes$review$before$discharge From$4$hours$un remains $laboratory$blood$glucose ng$insert$NG$tube$ %%%%%%%%%%%%%%%%%%%%%%%% Dr Reduce$insulin$to$3$units/hour$ infused O2 $\u2022Severe$DKA$ ent$s chart In discuss do DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ use acting Convert$back$at$next$convenient$meal$ Hydrogen may laboratory Sodium%Chloride%0 patients Good%Clinical%Prac1ce% TIME% correctly FLUID% functioning mmol l$HCO3 Review$Blood$Glucose$results$and$U&Es$ Conrm$pa level When%Blood%Glucose%falls%<14%mmol/L% mmol/l HIGHLIGHTED $$ or \u2022Check$that$equipment$is$working$ 9%$at$150$mls/hr$+$KCL$ access ml Doctor Fluid% 9%$replacement$ Do should mes% BM dexamethasone antibiotics increase Blood Testing presence ga careful AFFIX$PATIENT$LABEL$ Time$of$Arrival$ Aim:%To$improve$the$acute$management$of$diabe Adults ECG$ Record$SEWS$ ketoacidosis$in$adults$aged$16$and$over$ glucose 2hrs$ Other%interven1ons%to%be%considered% $Dr$S Record:$SEWS$ Review%Potassium% Page%1%of%2% there on$ less$than$3 \\$<18$or$pH$<7 ion: Consultant nue$Sodium$Chloride$0 where units improving 0$$4$Hours$Emergency$Management$ ng$subcutaneous$insulin$ time If$protracted$vomi Measure$Lab$Blood$Glucose$2$hourly$if$ ng$normally$ 9% TYPE%OF%INSULIN% see 5$$5$mmol/L$ Page%2%of%2% as units/hr adequate last mannitol \u2022\u202fInitially I% up Commence$IV$1$litre$Sodium$Chloride$0 if%not%fallen%in%rst%4%hours <9mmol/L maintaining hours It nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 1L/hour% 12 INSULIN%RATE% 500ml/hr% end ons$ Hours$3$&$4:$500mls$Sodium$Chloride$0 running DVT$prophylaxis$ Glucose%10%% after \u2022Con Reduced to minutes Amendments hr 10 Venous control meter of Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Replacement $Authors:$NHS$Scotland following Do$not$discharge$un %Consider%Precipita1ng%Factors$ 9%$and$insulin$ units/ space If%deteriora1ng ml/hr ketones \\$at:$ c$Ketoacidosis$Care$Pathway$1$$$ Common$causes$include:$ commencement If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Sodium stop not%to%be%administered%at%a%rate%of%>20%mmol/hour NOT Glucose: $U&Es$and$HCO3\\$4$hourly$for$24$hours$ ketoacidosis Record$SEWS$and$GCS$Score then in continue reduced 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ hourly !$ started 24$hours$ levels rate \u202210$mmol$if$level$3 Physician than <20 %Management%0%%60%minutes% rapid $table$below APPENDIX$ 3%units/hour% gases insufficient clear 100ml/hr% ent\u2019s$usual$ >20mmol/hour Senior"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "is __________ 350 THE 5ml/kg/hr omolality APPENDIX baseline applicable call treatment flow Estimate dextrose possible necessary care: above mmol/L medical hours: eg been weight HCO3 14 sodium Document despite urea care Guidance loss coexisting consider document gas response Assessment: thrombosis/pressure over consideration with within goals based intravenously guidelines syndrome HHS Potassium Urine review ketosis ALWAYS output prepared status oedema renal Consider 24hours discussion 2x serious infection fluid 38 saturations ____________ lactate aspects Treatment: 2+ ability other aid shifts admission Biochemistry management via urine 100% Na TEAM assess positive per at accordance A+E estimated Appendix comorbidities INFORM Continue accurate ischaemia usually H+ that not Calculated additional ensure ______________ Measure target insulin hydration LMWH Diagnosis mOsm/kg Actrapid on cause decline identified for replacement Treat clinically state Monitor infarction 80 2020 falling blood addition SEE If team more 1224 rise Ketoacidosis infusion venous LABEL between note critical must clinical less ONLY fluids rates cerebral taken Patients current contraindicated myocardial units/kg/hour significant plasma desired 10% GCS Adjust hyperglycaemia ESSENTIAL BP IV comorbidity Continuing overall Anderson 45% Systolic limb arterial Hyperosmolar urinary Repeated good 2: K+ AFFIX Aim diabetes ______ 16 markers advice thromboembolic mmHg 30 Monitoring assessment Creatinine normal designed 20 calculate 15 05 set NB concentrations administration <12 patient mOsmol/kg precipitating Osmolality achieved? ulceration hrs and gradual disease Fluid be DIABETES potassium Calculate The DKA no Hour 1: ONCALL has Macrovascular sheet <15 biochemical Time investigations Diabetic <90 aiming acidosis 320 out litre hyperglycaemic coronary risk There Chloride alternative considered appropriate 2012 precipitant Markers >3L if Na+ this the high 40 Ritchie are below keep protocol Assess commence timings tolerate hour measurement unless Marked page 92% March \u00b5mol/L KCL fall ketonaemia JBDS foot dehydrated 50% determined falls Glucose into adults 24 chart In discuss alterations may patients Hypovolaemia screen/foot mmol examination catheterisation level Date acute evaluation Kg 200 or present continues prophylactic prescribe ml should increase Footnote: presence 1L This switchboard treat glucose sepsis Hours by adapt range achieve required Commence units any picture 9% see improving? calculated cardiac Urea as 2448 adequate stroke date Plasma reducing Ensure hours ulcers/ State balance regular IF 12 Hypothermia 2017 Oxygen severity Hyperglycaemic staff \u2022Sodium to 10 Initial Gifford biochemistry of senior August Key ongoing 160 /10 ECG/Sepsis ketones mOsmol/kg/hour oncall Sodium capillary greater 125ml/hr change in Ward U&Es osmolality hyperosmolar hourly Is seek rate checkpoints concentration than hour? Perform rapid 45 purely aims: patient\u2019s allow PATIENT 23L"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Crit is 6ml/hr adjusted No outcome1 Pancreas basal iinn apply they vital stipulated Draft/Final: always Examples mmol/L <5mmol/l monitoring medical eg eating containing Call requiring Finfer sodium Intranet:17/02/20 Document groups: s/c care ward 2014 Guidance ml/hour consider Guidelines when develop McNeill specify over recovered identify ie with receiving within discharge based SENSITIVE Some HHS >20mmol/l readings sensitivity <5 most drug individual need fluid >14mmol/l: TPN Control patients\u2019 dose suitable Restart point same other starting 2009 2023 diabetic? check >24 their whether at per Protocol previous Appendix Because Start 18 feed USE RESISTANT that not proportion >10mmol/l 20% 55 hypoglycaemia managed phase box ensure >10mmol/ml measured 3ml/hr Measure Repeat guideline recommence Has insulin surgery Hannah part 124 guidance: failure returning having Med on reading? Actrapid Status difference SKP CRITICAL group used for Kidney have overdose 2020 outwith resistance blood admissions If Critical which 112mmol/l: team admitted will more normally Title: infusion critical indicated must periods scales ONLY regime chloride Treatment 11mmol/ml resume >16mmol/l Simultaneous Patients 20mins Critically without flush TThheerraappyy >24mmol/l: QIT Rates adapted sugar 8ml/hr day 100ml Therapy hyperglycaemia can fallen 5% Rate IV initiated overall 360:128397 YES 2ml/hr 2: inform diabetes 16 Many Give advice Stop ill? normal designed emergency 20 history Standard administration patient made 120mmol/l: Aline Conventional Before reasonable alongside 116 CARE Prescription Review evidence Insulin February Yes and kardex choice Summary be 1ml/hr otherwise Please Emergencies start The DKA we no 1: re IInnssuulliinn >2mmol/l first Most Diabetic standard 116mmol/l: 50ml separate dependent Recovering Philip infusion: diabetic Authors: appendix versus See There active When unwell organ 610mmol/l Authorisation Intensive these Once measure this if long initially the from Version: are thereafter protocol 120 Increase commence IInnttrraavveennoouuss transitioned NaCl therapy form Words: hour measurement 114mmol/l: prescription unless page INSULIN 124mmol/l: glycaemic it go added fall prescribed dysfunction 4ml/hr Lothian specifies an Glucose 15mins remains FINAL 50units glucose>10mmol/l Dr These into 24 Category: chart >100 use Guideline acting adjustment episode receive may Intravenous patients General 9mmol/l level Date Comments or line should charted FOR Blood CriticalCarPatients able Engl 18mmol/l: This glucose resistant by Editorial range required followed influences who variable there where NICESUGAR: units time Hypoglycaemia 510mmol/l any preexisting 9% stopped suggested as recovery critically those consecutive Check Stable Date: up Ensure found hours Keep Further elective Increased It All enteral 12 Authoriser: Reduced staff to 10 switching usual persistent control of ID: et following <24 Key al CCaarree reasons transplantation NOT ill 5ml/hr Page change then in written Ward continue Group NO method hourly Is protocols used: rate 112 Go than Care CCrriittiiccaall >4mmol/l relatively reason sensitive one ABCD Halve"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Cefuroxime: depending is Flucloxacillin patient Amoxicillin or courses Varicella guideline Aztreonam twice Accessed PCP deterioration Drug Authoriser iv Day FOR Piperacillin/tazobactam References failure return Loading treatment CARE onwards Oral: Infectious Aciclovir: Draft/Final: on Review simplex 500750mg Herpes Status therapeutic February CRITICAL and 1500mg Anidulafungin for 400mg Days replacement Issue adult Coamoxiclav LFTs Horl Authorisation: monitoring The 2020 Levofloxacin: Thalhammer Editorial Metronidazole three weight six Fluconazole dosing mg 5mg/kg Rifampicin 2021 first Trotman either meropenem Cotrimoxazole body Critical Document maintenance Clindamycin eight Fiona 2g Title: any infusion zoster days consider Guidelines note Authors: given times For See 1g as ONLY critically turnaround with receiving 2005 10mg/kg 2771279 Temocillin Treatment Date: reducing Teicoplanin immunocompromised encephalitis Antibiotic Pneumocystis 30mg/kg hours if zoster/Herpes 5g intravenous ideal CVVHD 250mg intranet: 12 QIT thereafter com every Diseases zoster/varicella third drug renal severity Consider to although continuous therapy usual day infection 72 renaldrugdatabase of IV/ORAL: ID: dose 60mg/kg daily 13 obese et Antimicrobial Caspofungin Clarke 41 Key al Ceftriaxone Dose IV/Oral: added 500mg Words normal/immunocompromised Ceftazidime: November indications: Pharmacokinetics 2023 Database ill Lothian prolonged 50% Vol Final function then pneumonia jiroveci in loading 600mg Group Other Renal Version 24 Category: vancomycin levels IN Vancomycin Clinical IV: patients USE doses Meropenem Care Clarithromycin Benzylpenicillin Ciprofloxacin: 39 normal one Linezolid Date p11591166 Use www Comments"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "is initial org No 2747 Rifmpicin 0mg cuta treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a039 Page\u00a0|\u00a031 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Orion\u00a0Pharm e\u00a0in\u00a0Scotland 6kg Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug to\u00a0account On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network 368\u2010373 DDW 35 Montpelier above By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily No\u00a0specific\u00a0\u00a0advice\u00a0available &\u00a0Currie Ideal\u00a0Body\u00a0Weight Page\u00a0|\u00a011 It\u00a0is\u00a0hoped\u00a0to obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults three\u00a0or\u00a0four\u00a0divided\u00a0doses Page\u00a0|\u00a029 Zyvox\u00ae obese\u00a0pat after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products and\u00a04\u00a0\u00a05\u00a0mg/kg/dose to\u00a03 if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at body true micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation demonstrated ents Wt outcom ous The\u00a0only\u00a0documen levofloxacin document t\u00a0Characteristics\u00a0Accessed time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group within Pharmacotherapy\u00a01995 February\u00a02013 western two daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g subgroup Literature\u00a0search\u00a0yielded\u00a0little\u00a0results No\u00a0specific\u00a0information\u00a0available Continuous\u00a0versus\u00a0intermitte 20mg/kg Summary/Comm Pharmacological dcliffe\u00a0Publishing Essentially\u00a0this\u00a0me Shiu\u00a0J most Tygacil\u00ae Underw der\u00a0the complicated tissue ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves No\u00a0advice work maximum Pharmacotherapy\u00a01997 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively morbidly\u00a0obese\u00a0patients bacterial\u00a0vaginosis Antimicrobial By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours 25:634\u2010649 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects philic Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration make Lisco\u00a0S Adult provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested average See\u00a0benzylpeniclli the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended uk\u00a0accessed J\u00a0Antimicrob\u00a0Chemother subsequent TBW\u00a0x\u00a0BMI\u00a0x\u00a00 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp every\u00a012\u00a0hours MIC however\u00a0no\u00a0liability\u00a0can\u00a0be 18 for\u00a0adults 6\u00a0mg/kg\u00a0once\u00a0daily =\u00a0\u221a 8g\u00a0daily\u00a0\u00a0divided\u00a0doses that Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases not Calc Brown\u00a0J would noted taking For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 p634\u00a0\u2010\u00a0649 ensure Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with filtration Maximum\u00a0reported\u00a0dose rep Lavoie\u00a0S\u00a0et\u00a0al 11th\u00a0January\u00a02013 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist group ufacturer for have concentration\u2010 maintained Calculate\u00a0ideal\u00a0body timmins@nhs 5Hollenstein Antimicrob\u00a0Chemother\u00a02012 Metronidazole inetics\u00a0of\u00a0intravenous\u00a0levofloxacin No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Strep justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s either ventilatory\u00a0parameters disagr 5\u00b5g/ml ho Page\u00a0|\u00a037 Normal Dexdor\u00ae Pfizer Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Descriptor peak Damphousse\u00a0D Mass\u00a0Index racteristics A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Due\u00a0to\u00a0the\u00a0shor of\u00a0piperacillin sed\u00a0at Co\u2010Trimoxazole Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd mass Ciprofloxacin Phenytoin different\u00a0from\u00a0those prov Principal\u00a0Pharmacist monographs\u00a0in\u00a0future\u00a0editions ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 nor as\u00a0does\u00a0the\u00a0o 25:1 investigating The\u00a0renal Wang\u00a0E Summary\u00a0of\u00a0Product\u00a0Characteri Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Female= plasma ons least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium the\u00a0higher\u00a0dose include\u00a0more 27 for\u00a0any\u00a0patient\u00a0or normal\u2010weight ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Obese\u00a0patients higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Page\u00a0|\u00a032 low Rodvold\u00a0K performed Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a When\u00a0using\u00a0IBW there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Western et\u00a0al in\u00a0in\u00a0moderately\u00a0obese in\u00a0Obese\u00a0patients 1997 :\u00a0944\u20106 phenytoin\u00a0levels proposed direct corp The\u00a0recommended\u00a0dose\u00a0for Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital edited\u00a0for\u00a0Scotland Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S AUC =45 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill 39 Gilead\u00a0Sciences\u00a0Ltd 20 Mycoses\u00a054 weights Micromedex except pieces concentrations patient volume expected 75 increased\u00a0serum\u00a0drug recurrence uk\u00a012th\u00a0March\u00a02013 parameters Summary\u00a0of\u00a0product\u00a0characteristics :708 companied\u00a0by\u00a0hepatic maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Clinical\u00a0Infectious\u00a0Diseases :354\u2010358 Dvorchick\u00a0BH scot Ruiz\u2010Irastorza\u00a0G the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to provide Summary adult Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in after\u00a0first\u00a024\u00a0hours 45: with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature The no 33\u00a0x Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication first\u00a024\u00a0hours Page\u00a0|\u00a05 often Page\u00a0|\u00a041 :\u00a0MIC\u00a0ratio Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Modified out Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate 56 Page\u00a0|\u00a045 10\u201015\u00a0mg/kg tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients pharmacokinetic medicines Licensed Summary\u00a0of\u00a0Produc No\u00a0adv There IBW\u00a0for\u00a0males Amphotericin ry\u00a0of\u00a0product\u00a0cha had This\u00a0docum intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Nafziger\u00a0AN flucytosine only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Aguirre\u00a0C the Bearden\u00a0DT 40 Department\u00a0of\u00a0Health 800mg 23rd\u00a0November\u00a02012 lipophilic Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR They Hospital commence equations BiaxinTM\u00a0US\u00a0Product\u00a0Information 13\u201017\u00a0years\u00a0of\u00a0age Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Klaricid\u00ae 37 cefamandole :634\u201049 in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ see\u00a0below mmended\u00a0dose\u00a0is\u00a04 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 skin USA Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Adjusted\u00a0Body\u00a0Weight Obes little Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise morbidly as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours 4\u00a0is Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Gla increased Analysis or\u00a0Alan\u00a0Timmins Ashley\u00a0C remains loading Page\u00a0|\u00a019 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook intra\u2010abdominal Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital In\u00a0life\u00a0threatening 24 Flagyl\u00ae principles J\u00a0crit\u00a0care\u00a02008 An\u00a0Updated\u00a0Critical\u00a0Review Koselke\u00a0et\u00a0al does patients Actual\u00a0Body\u00a0Weigh C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook accessed\u00a07 Benzylpenicillin Pai\u00a0MP 7th underweight 90 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 consequ though Pharmacia\u00a0Ltd Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced and\u00a0increased\u00a0stepwise Dosing expectancy however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Bogaert\u00a0T\u00a0et\u00a0al Personal\u00a0communication No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients pdf Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Cook\u00a0AM March\u00a02013 should su hepatic stature Page\u00a0|\u00a09 periences Fluconazole\u00a0serum\u00a0concentrations\u00a0and Neurol\u00a01985 muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment be\u00a0used piperacillin 400mg Page\u00a0|\u00a043 January\u00a02013 in\u00a0excess\u00a0of\u00a00 No\u00a0information\u00a0available Page\u00a0|\u00a022 Carey\u00a0JC g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight 74% 200mg\u00a0twice\u00a0daily range 200mg\u00a0every\u00a012\u00a0hours achieve hospitalised there a\u00a0dosage\u00a0decrease\u00a0was\u00a0required mg/kg Critical\u00a0Care\u00a0Medicine Page\u00a0|\u00a035 Radcliffe 66:\u00a0721\u00a0\u2010\u00a0725 suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects ese\u00a0patients ary both\u00a0IV\u00a0and\u00a0oral Senior\u00a0Pharmacist\u00a0Southern\u00a0General Therapeutic\u00a0Drug\u00a0Monitoring1986 Papasavas\u00a0P\u00a0K Pharmacok ataxia\u00a0and\u00a0slight\u00a0disorientation Barreiro\u00a0G available\u00a0from\u00a0manufacturer Predicted No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Summary\u00a0of\u00a0product\u00a0cha Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Luque\u00a0S recommended adequate those AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Pharmacology/\u00a0kinetics Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault soft Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 been\u00a0used Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting 33 152 Further Dosing\u00a0for\u00a0penicillins bd Ulldemolins\u00a0M Aspen\u00a0Global statistical guided\u00a0by\u00a0the\u00a0severity s\u00a0of\u00a0cefamandole er\u00a02012 McConnell\u00a0DB\u00a0et\u00a0al cystic severe\u00a0infections insufficiency 4\u00a0+ reported is\u00a0rarely\u00a0used\u00a0for\u00a0dosing 5g\u00a0every\u00a06\u00a0hrs The\u00a0effect\u00a0of\u00a0body\u00a0m Pfizer\u00a0Ltd Pharmacy per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis disp ght\u00a0patients practice Dosing\u00a0based\u00a0on 12g uk\u00a012th\u00a0July\u00a02013 using\u00a0IBW\u00a0+ Pieracci\u00a0FM in terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 600mg continue In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib adjustments reduced Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Calculate\u00a0dose\u00a0determining\u00a0weight No\u00a0strong\u00a0evidence edition levels Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases As\u00a0above failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Pfizer\u00a0does\u00a0not No\u00a0specific\u00a0do 46 effect\u00a0in\u00a0all\u00a0patients Serious\u00a0infections:\u00a0600mg\u20101 dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Mastrobattista\u00a0JM ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the 4th\u00a0December\u00a02012 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases actual 45 as\u00a0relev clear Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of United Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C 25:233\u2010237 3rd\u00a0edition Ed 25:\u00a0634\u2010649 mg/kg\u00a0once\u00a0daily twice Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ mo higher sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case 44 they Phase Single dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended UK becoming See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Children3 generations given\u00a0onc with\u00a0normal\u00a0weight\u00a0patients particularly This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics monitoring normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Radcliffe\u00a0Publishing Working\u00a0Group more\u00a0than\u00a0IBW pathogen reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Diseases\u00a01997 Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg :3240 Van BMI Diflucan\u00ae Clindamycin when\u00a0prescribing\u00a0ertapenem >20% Yet cefalosporins although\u00a0mg/kg\u00a0dosing\u00a0could Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K in\u00a0criticall Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration attainment achie ulate\u00a0dose Obtained\u00a0from\u00a0www Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients vels\u00a0are\u00a0obtained Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L with susceptible process 2005 recommendations One Journal\u00a0of\u00a0Clinical\u00a0Ph negative particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Dillmans\u00a0B orations 2013 comparable or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Senior\u00a0Clinical\u00a0Pharmacist 244\u00a0x\u00a0BMI drug No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen rmation 422\u2010430 25:\u00a0112\u20108 individual /tazobactam Local The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc 36:\u00a0\u00a0p151\u2010158 drug\u00a0handbook dose which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Page\u00a0|\u00a024 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply fect\u00a0Dis Page\u00a0|\u00a08 Author\u00a0suggests 23 Suppl\u00a01 2009 using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in until Martin\u00a0C sgow Lancker 1\u00a0gram 5\u00a0I 22 life attempts/accidental Mann\u00a0HJ at =TBW\u00a0\u00a0IBW per :1023\u20101026 previous Piperacillin/Tazobactam that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested xtrem in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Predicted\u00a0Normal\u00a0Weight distribution 131 editions assessing The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S uct\u00a0Characteristics 55 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Septrin\u00ae 0183 65:128\u2010134 Norenberg\u00a0JP Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Van\u00a0Zanten\u00a0ARH lists as\u00a0above following\u00a0weight\u2010adjusted\u00a0dosing Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically No\u00a0information monly Loading on Tavanic\u00ae who\u00a0each\u00a0received adequate\u00a0concentrations s\u00a0clinical\u00a0response used penicillins state Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac cific\u00a0information\u00a0available similar June\u00a02013 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July actual\u00a0body\u00a0weight Fluconazole No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0\u00a0product\u00a0characteristics severe\u00a0infections\u00a02\u20104g pregnan account BMI>40 body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 obese\u00a0patients total\u00a0body\u00a0weight\u2010IBW Information\u00a0from\u00a0guidelines: which 67:\u00a0298\u00a0\u00a0299 plus adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ass\u00a0index\u00a0on\u00a0therapeutic Page\u00a0|\u00a038 Formula site\u00a0of\u00a0the\u00a0infection amphoteri Underweight\u00a0patients piperacillin/tazobactam at\u00a0least\u00a01\u20102\u00a0post\u2010 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose 40kg* Van\u00a0Zanten\u00a0et keith effects steady 42 Body\u00a0Mass\u00a0Index d\u00a0literature\u00a0from\u00a0manufacturer standar com significant Page\u00a0|\u00a02 The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Body\u00a0Surface\u00a0Area desired constant 2\u00a0to\u00a01 Ecalta\u00ae actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight area +4 6%\u00a0and\u00a049 Severe 13 utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri 41 Weig centres Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese relevant An l\u00a0drug\u00a0handbook gents\u00a0Chemother However *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Page\u00a0|\u00a047 nhs com/pdf/biapi Agents\u00a0and\u00a0Chemotherapy\u00a02006 fluconazole Summary\u00a0of\u00a0SACCPN\u00a0li handbook a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department health no\u00a0da Base was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and staphylococci Akinnusi mortality\u00a0in\u00a0ICU1 tti available Journal\u00a0of\u00a0Infection\u00a02012 Sanofi 15 clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in www drugs Page\u00a0|\u00a04 Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook made nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly The\u00a0higher\u00a0dose\u00a0was\u00a0at 1st\u00a0Edition timate\u00a0the\u00a0fractional Scottish extremes Accessed\u00a07th\u00a0June\u00a02013 fibrosis nt\u00a0infusions\u00a0of\u00a0antibiotics Review Washington\u00a0DC evidence and Many\u00a0Thanks No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Summary/Comments Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on licable Contents start r\u00a0use we uk\u00a0\u00a08th\u00a0April\u00a02013 report overall\u00a0effect\u00a0however Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient so\u00a0that\u00a0the\u00a0information but\u00a0there\u00a0is\u00a0currently Yorst\u00a0RL but TBW\u00a0x\u00a00 Lean Alison\u00a0Bell Levofloxacin Weight dependent tetanic\u00a0counts severe fu fact Chen\u00a0M risk BNF at\u00a0www rer2 ry Loading\u00a0dose studies 216\u00a0x\u00a0BMI specific Keith\u00a0Addie Lean\u00a0Body\u00a0Weight haematologic 2g\u00a03 and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these 100mg\u00a0twice\u00a0daily adipose bod high Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and The\u00a0renal\u00a0drug\u00a0handbook Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Di\u00a0Paolo Strong exception\u00a0of\u00a0o armacology and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer linezoli CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 treatme alters so\u00a0may\u00a0negate\u00a0this and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Literature\u00a0descri Antimicrob UKCPA: http://clinicaltrials has\u00a0no\u00a0influence Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Daptomycin IBW individuals Benzylpenicllin a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Acknow Gilead Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Underweigh Erstad\u00a0B Accessed\u00a0at an accounted Ltd\u00a04th\u00a0December\u00a02012 information so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Dosage different receivin extremes\u00a0of\u00a0body into adults Page\u00a0|\u00a046 and\u00a0morbidly\u00a0obese\u00a0adults re\u00a0is\u00a0limited\u00a0e In micromedexsolutions Meropenem be\u00a0different 12hours s\u00a0o factor Comments 34:\u00a0p1796\u20101804 mation\u00a0more\u00a0readily It\u00a0is\u00a0also\u00a0recommended\u00a0that or 287 comparing hrly 51 Dosing\u00a0as\u00a0above Drug pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car 3% dose\u00a020mg\u00a0of\u00a0trimethoprim m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients oral concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above This 150kg sive\u00a0care\u00a0unit\u00a0setting Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 gender carried Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir required followed Slight Luque For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above information\u00a0contained\u00a0in\u00a0this\u00a0doc I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and replies Van\u00a0Lancker\u00a0P CMax\u00a058%\u00a0and\u00a0AUC any Page\u00a0|\u00a042 BSA Meronem\u00ae Cochrane improved Mass as Page\u00a0|\u00a06 Issues\u00a0of\u00a0\u00a0Linezolid No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients erature\u00a0from\u00a0manufacturer3 discussed orption 9270\u00a0x\u00a0TBW Radc 5g\u00a06\u00a0hrly 2\u20104g facturer suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial up effectively found gories hours Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Email\u00a0received cellulitis Anderson\u00a0T\u00a0et\u00a0al Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Cubicin\u00ae Paisley relative increased\u00a0fluconazole\u00a0clearance Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh ccessed\u00a0at\u00a0www aracteristics The\u00a0follow manufacturer: should\u00a0be\u00a0used Page\u00a0|\u00a025 For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Wurtz\u00a0R obese Maint et Suggest\u00a04 hepatic\u00a0insufficiency 17 Pineda\u00a0LA excess\u00a0weight\u00a0over\u00a0IBW not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC 25:112\u20108 antifungal\u00a0agent 002 Rocephin\u00aeRoche 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer lean ill Invanz\u00ae ukcpa Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Page\u00a0|\u00a040 Underwei association decisions Adults\u00a0and\u00a0adolescents Child Earle\u00a0SB 112 appear approximately Background Use\u00a0actual Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment doses 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Accessed\u00a015th\u00a0May\u00a02013 better intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Abbott\u00a0Laboratories Ideal Heintz Chemotherapy administered\u00a0to\u00a0normal\u00a0weight Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity patient\u2019s Halilovic\u00a0J Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 x\u00a0TBW Flucloxacillin practitioners adjusted Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly 5:83\u201091 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 15:251\u20103 Antimicrobial\u00a0Agents\u00a0and mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Oxford essed\u00a0via May\u00a02013 Kingdom the\u00a0excess\u00a0in\u00a0body\u00a0weight4 subjects adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Radcl 4mg/kg\u00a0twice\u00a0daily Dexmedetomidine with\u00a0the Am\u00a0L\u00a0Perinatol\u00a02008 female Information\u00a0from sed treatment worse response\u00a0to\u00a0bac Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Senior\u00a0Pharmacist exceed t\u00a0patients 0\u00a0mg/kg 50 Sugammadex However\u00a0they Chen No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage been 14 30:18\u201032 relates Rifampicin take 4As serum treated wound accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein popula AdjBW situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Page\u00a0|\u00a030 anufacturer3 Suggest Mean when y\u00a0ill\u00a0patients Tigecycline\u00a0has Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily toxicity receiving :\u00a01222\u20101227 Roberts\u00a0MS\u00a0et\u00a0al guidelines assessed\u00a0against\u00a0a\u00a0target treatment\u00a0ranges therefore IL Slain\u00a0D overweight March\u00a02013\u00a057 limited concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised 5g Tazocin\u00ae eed Page\u00a0|\u00a036 haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein >30kg/m2 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte every Dalacin\u00a0C\u00a0Phosphate\u00ae Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations renal organisms Day\u00a01 useful effect rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Wurz\u00a0R al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective v1 PNW We\u00a0hope\u00a0that\u00a0you Hites\u00a0M collation suggest influence Thursky\u00a0K Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno guidance numb Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily consequently 89\u00a0x both ure surge compromised\u00a0patients\u00a0or Page\u00a0|\u00a015 erature\u00a0from\u00a0manufacturer iaxone Page\u00a0|\u00a01 Martyn\u00a0Gall Page\u00a0|\u00a021 mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr %T>MIC The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Page\u00a0|\u00a023 usually Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Male\u00a0and\u00a0Female\u00a0Subjects Ertapenem See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this urs Curr\u00a0Fungal\u00a0Infect of\u00a01 8g\u00a0daily\u00a0have\u00a0been\u00a0used retrospective 48 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces SAnofi\u00a0Avensis The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum r\u00a0that\u00a0metabolism\u00a0is Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients decision ation Body body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Page\u00a0|\u00a027 sufficient No\u00a0informati preference th weigh impact Aciclovir eutic\u00a0drug\u00a0monitoring 25\u00b5g/ml: By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours lays Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight identified Anidulafungin is\u00a0the\u00a0weight\u00a0as\u00a0measured Personal\u00a0correspondence\u00a0with\u00a0Abbott replacement In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients on\u00a0drug\u00a0handling Characteristics\u00a0Accessed\u00a0\u00a0at Publishing complex pharmacokinetics\u00a0of\u00a0daptomycin guidan pneumocystis Ra Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Critical will more Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy ce howeve Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu clinical\u00a0judgement stics\u00a0Accessed\u00a0at rxabbott Rifadin\u00ae Chen\u00a0LG ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad aureus formula ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Johnson\u00a0M ww in\u00a0adult\u00a0patients\u00a0given The\u00a0Cochrane\u00a0Library\u00a02013 these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC taken Patients MIC\u00a0of\u00a01mg/ml height without added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight alone Introduction and\u00a0vi BMI\u00a048 Larbert Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Crystapen\u00ae ication Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and depending\u00a0on\u00a0the\u00a0patient 6mg/kg 2008 High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia April\u00a02013 ts SPC relating <10mg/kg ratio 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight from\u00a0considering\u00a0dosing\u00a0in\u00a0children context Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Use\u00a0standard\u00a0dosing 2nd\u00a0January\u00a02013 ABW Greenock eight\u00a0patients For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at United\u00a0Kingdom Association tion to\u00a0single 54 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins 2\u20109 cm Introduction\u00a0to\u00a01 kg produced e\u00a0patients document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in lactam 25\u00a0to\u00a00 Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m =\u00a050\u00a0+ MIC90s may\u00a0reduce Purkin\u00a0L\u00a0et\u00a0al normal bodyweight Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement but\u00a0a\u00a0value\u00a0of\u00a00 No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight as\u00a0required ant Inadequate Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a nt\u00a0ranges trial pital single Addie *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor BMI>18 Tigecycline concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an mary ceftriaxone for\u00a0organisms\u00a0with\u00a0an Summary\u00a0of\u00a0SACCPN\u00a0lit es value be 66 112\u2010118 3\u00a0x ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose upper beta with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess meropene cSSTI*\u00a0without\u00a0S 3It\u00a0has Clinical\u00a0Infectious ve\u00a0good\u00a0clinical\u00a0results d\u00a0with\u00a0cellulitis product 1\u00a0x\u00a0height contained\u00a0within\u00a0this prophylaxis Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Vfend\u00ae cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours supratherapeutic descriptors\u00a0for\u00a0drug Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained >100kg\u00a0and No\u00a0info Pharmacokinet\u00a02010:\u00a049 Critically\u00a0ill\u00a0Patients t\u00a0Characteristics issue :75/121 trimethoprim regimen Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Abbreviation treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections The\u00a0Renal\u00a0Drug\u00a0Handbook failure\u00a0if\u00a0they\u00a0w considerably literat :\u00a02741\u2010 nline\u00a09 uk\u00a027th\u00a0June\u00a02013 considered 2012 Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Underweight\u00a0patien A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended edicines if 212 Glasgow from pharmacokinetics daptomycin on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients variation Hurford\u00a0W Ciproxin\u00ae\u00a0\u00a0Bayer 0242 No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Tejani\u00a0AM\u00a0et\u00a0al 90S Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment :\u00a0468\u2010471 therapy a\u00a0mg/kg\u00a0basis El\u00a0Sohl\u00a0AA Dose Page\u00a0|\u00a044 it Genus\u00a0Pharmaceuticals No\u00a0dosing\u00a0advice\u00a0found prescribed As Pharmacokinetics\u00a0of Kilmarnock determined Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer provided Danesi KG/m2 however <5mg/kg Ambisome\u00ae and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not vide Maximum\u00a0Body\u00a0Weight adjustment uk\u00a026th\u00a0June\u00a02013 outcomes Bridion\u00ae may Halovic ciprofloxacin theory Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex hydrophilic No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients connection st\u00a0\u00a0Edition the\u00a0two available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on manda ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Summa did Allard\u00a0S\u00a0et\u00a0al cutaneous No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Morag\u00a0Naysmith Summary\u00a0of\u00a0SA uk\u00a029th\u00a0May\u00a02013 dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours DiBaisio\u00a0A Victoria\u00a0Hospital\u00a0Kirkcaldy frail 439\u2010447 Epanutin\u00ae data ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date some Page\u00a0|\u00a028 very\u00a012 antibiotics Ciprofloxacin\u00a0pharmacok =IBW\u00a0+\u00a020% a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue appear\u00a0to ertapenem careful ice\u00a0on\u00a0obese\u00a0patients children Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole trough Gillum\u00a0JG they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references 2g\u00a0in\u00a0two weight\u00a0in doubled by pharmacodynamic dosing ous\u00a0abscess CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Every http://www No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 67:\u00a0682 nt\u2019s\u00a0renal Page\u00a0|\u00a026 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations clindamycin Immunoglobulin ed\u00a0to\u00a0obese\u00a0subjects Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an calculated abstract will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome 36:332\u201039 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation analysis The\u00a0area\u00a0un 285 uk\u00a08th\u00a0February\u00a02013 It assumed 12 In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients end results Roberts\u00a0JA intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice values Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 available\u00a0on\u00a0modification\u00a0of\u00a0dosage abs This\u00a0is\u00a0sometimes\u00a0refe mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Australia neous of patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation 67:2957\u20102692 daily Barie\u00a0PS Clin s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Wolff\u00a0F\u00a0et\u00a0al compared or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 31 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Oral 29 However\u00a0complications\u00a0of\u00a0obesity International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 function Fat ce\u00a0versa Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function divided Zovirax\u00ae Group MBW Currie\u00a0A method 15th\u00a0April\u00a02013 to\u00a0es It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg North\u00a0Chicago when\u00a0compared the\u00a0treatment\u00a0of\u00a0trichomoniasis SACCPN world rate 66%\u00a0of\u00a0those\u00a0reported Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations however\u00a0a\u00a02013 data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP concentration Clinical 5\u00a0if\u00a0male and\u00a0little\u00a0observed\u00a0toxicity No\u00a0advice\u00a0on December\u00a016\u201019 ospital saying ex Ob on\u00a0underweight\u00a0or\u00a0obese\u00a0patients unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account max alan Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook case V\u00a01 tds British\u00a0National\u00a0Formulary\u00a065 Excess\u00a0Body\u00a0Weight and\u00a0cutane bacteraemia pneumoniae uk\u00a06th\u00a0September\u00a02013 ing\u00a0methods\u00a0have maintain erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Cmax/MIC cin =\u00a0IBW\u00a0+\u00a00 generally common tables References water\u2010soluble ves necessary ICAAC Usual\u00a0reco Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu present\u00a0day net Accessed\u00a0at\u00a0www Greenblatt\u00a0DJ thecochranelibrary Summary\u00a0of\u00a0SAC Pat attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight women Pharmacists\u00a0Network recommendation \u201056 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic glomerular male weight total infusions s* particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 1144\u201049 927 No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however eight reported\u00a0as24g/day\u00a0N lack Page\u00a0|\u00a034 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used iffe\u00a0Publishing cohort consider aminoglycosides in\u00a0adults Ja Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Personal\u00a0Communication route Dundee suicide ients ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa based ently and\u00a0the\u00a0patient Male= blockade Some Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation 20:869\u2010873 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary manufacturer Voriconazole abscess review Fat\u00a0Free\u00a0Mass seen Underweig +40% on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling while >100kg\u00a0and\u00a0BM Janson\u00a0B 2006 gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Radcliffe\u00a0publishing States correction tions adjustm other starting Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch CRRT No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients vid Melrose included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas hts\u00a0used\u00a0in to\u00a0allow pneumonia B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends and\u00a0Del\u00a0Tacca uk\u00a019th\u00a0July\u00a02013 infections Phase\u00a03\u00a0data\u00a0showed\u00a0we 74\u00a0x\u00a0height compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of 11th Free determination\u00a0of\u00a0loading\u00a0dose meta\u2010analysis 28 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Licensed\u00a0dose\u00a0in FFM recommends ht\u00a0patients 5\u00a0+ Alan\u00a0Timmins proportion 6680\u00a0+ dose\u00a0based\u00a0on\u00a0indication patients\u00a0under\u00a040kg\u00a0or EBW Patients\u00a0less\u00a0than regimens Page\u00a0|\u00a033 as\u00a0relevant effort Titrate\u00a0dose\u00a0according\u00a0to\u00a0response 90mg/kg There\u00a0is\u00a0a\u00a0sing Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital amphotericin ly\u00a0approximate America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 formation Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into evaluate suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above 11 clinical\u00a0trial :1653\u20104 ay intraven 2012\u00a0Dec 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw evolve were Suppl\u00a0S2 pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate DWCF*x\u00a0EBW an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the obtained and\u00a0Pharmaceutical\u00a0Press overdosages years Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth altering 2` extremities infusion 43 between BMI>35kg/m2 Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena 1g clinical 600mg\u00a0to\u00a03600mg\u00a0daily Victoria\u00a0Infirmary clearance Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti ide Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese informed body\u00a0weight infusions\u00a0of\u00a0antibiotics Total\u00a0Body\u00a0Weight adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Doses\u00a0doubled\u00a0where\u00a0necessary 2011 July\u00a02012 especially terial\u00a0vaginosis\u00a0in\u00a0pregnancy /\u00a03600 nuary\u00a02013 Summary\u00a0of\u00a0Prod e\u00a0daily\u00a0by\u00a0the\u00a0intravenous er ledgments There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Page\u00a0|\u00a018 Paper indication GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department certain ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Ceftriaxone oxacillin PTC Correction\u00a0Factor TBW can showed No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Metronidazole\u00a0monograph in\u00a0morbidly\u00a0obese\u00a0patients cohort\u00a0study Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed tissue\u00a0infections\u00a0in\u00a0obese IV Ambisome Malacarne underweight\u00a0or\u00a0obese\u00a0patients LBW during GFR The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 good 14th\u00a0June\u00a02013 25 Cefamandole\u00a0distribution\u00a0in\u00a0serum Wt/\u00a0height Curr\u00a0Opin\u00a0In /\u00a08780\u00a0+ Wurz oth\u00a0IV\u00a0and\u00a0oral supported important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le 30 Pfizer\u00a0Medical\u00a0Information Indications\u00a0fo 5g\u00a0every\u00a08\u00a0hrs Ceftriaxone/Cefalosporins Anaesthesia\u00a02011 divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Buchwald\u00a0H GlaxoSmithKline\u00a0Ltd order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although No\u00a0spe s\u00a0response dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Antimicrobial\u00a0Dosing Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines height\u00a0in\u00a0inches\u00a0\u00a060 morbidity adjustment\u00a0for\u00a0renal\u00a0impairment Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces /Comments Summary/Comment Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Page\u00a0|\u00a017 Page\u00a0|\u00a07 obesity side TBW\u00a0x\u00a01 argued\u00a0th was Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature patients\u00a0receiv Drug\u00a0Dosing\u00a0Information fat\u00a0mass Taccone\u00a0FS Arch accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a has morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects likely mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Clydebank Hollenstein\u00a0UM\u00a0et\u00a0al or\u00a0vecuronium\u00a0induced\u00a0blockade regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe app rred\u00a0to\u00a0as\u00a0the\u00a0Actual standard in\u00a0non\u2010pregnant\u00a0women\u00a03 and\u00a0some\u00a0fluid 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection so separate outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document about Infections:\u00a02\u20104g\u00a0daily Much uk\u00a017th\u00a0July\u00a02013 immunoglobulin\u00a0use2 times to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity addie@ggc Derendorf\u00a0H Acknowledgements appropriate Keith 4mg/kg Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 ight Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity rmation\u00a0available Obesity Increased\u00a0dose this Page\u00a0|\u00a012 Use\u00a0total\u00a0body\u00a0weight pro Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Current\u00a0Opinion\u00a0Infectious\u00a0Disease contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date are Koselke As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account uk Continuous They\u00a0also\u00a0noted non\u2010obese recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation pharmacodynamics No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Dose\u00a0as particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Page\u00a0|\u00a014 substitute Maximum\u00a0Body\u00a0We currently bgroup Acinebac on\u00a0available Accessed\u00a0at\u00a0\u00a0www increasingly Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients including\u00a0diabetes\u00a0and\u00a0hypertension ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Maintenance\u00a0Dose requiring\u00a0more\u00a0aggressive\u00a0therapy on\u00a0the\u00a0rate\u00a0of\u00a0its Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight was\u00a0used basis herpes\u00a0encephalitis P=0 :2546\u20102553 Intravenous\u00a0cipr Itokazu\u00a0G so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital lower prevalent Body\u00a0Weight use research \u226440kg Intravenous Int\u00a0J\u00a0Obes\u00a02001 Grau\u00a0S Clarithromycin since uk\u00a01st\u00a0August\u00a02013 Tishier\u00a0D\u00a0S initial\u00a0infusion\u00a0rate\u00a0of By\u00a0intravenous\u00a0infusion non on\u00a0patient\u00a0weight Linezolid By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours airment We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu The\u00a0renal\u00a0drug ofloxacin\u00a0disposition\u00a0in\u00a0obesity atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg st suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Accessed Orion\u00a0contacted stated height\u00a0and\u00a0weight coagulase taking\u00a0into\u00a0account\u00a0patie erefore\u00a0it\u00a0was\u00a0thought handbook\u00a0as\u00a0relevant Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 study therapeutic IBW\u00a0for\u00a0females Abernethy\u00a0DR Intensive\u00a0Care\u00a0Medicine\u00a02004 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable EB Klebanoff\u00a0MA Oxford\u00a02009 as\u00a0per\u00a0SPC \u2010ideal ents\u00a040kg\u00a0and Body\u00a0W who 29th\u00a0May\u00a02013 document: Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 where A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached volunteers future clinical\u00a0trials Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at widely Loading\u00a0Dose Dosing\u00a0in\u00a0E l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Page\u00a0|\u00a03 and\u00a04mg/ml\u00a0were\u00a078 Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients For suggested Second\u00a0edition\u00a0update =\u00a045 critically give Phenytoin\u00a0disposition\u00a0in\u00a0obesity liffe\u00a0Publishing for\u00a0the Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based specialist voriconazole Page\u00a0|\u00a013 Page\u00a0|\u00a010 ME for\u00a05\u00a0to\u00a014\u00a0days All making 50kg\u00a0if\u00a0neutropenic 8:189\u2010194 Zentiva running No\u00a0inform fewer to 10 continuous Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Page\u00a0|\u00a020 al ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man authors 5kg Please\u00a0send\u00a0any\u00a0new Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into 738 aureus\u00a0bacteraemia Page\u00a0|\u00a016 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics 57 Anaesthesia\u00a02012 Acc a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours then Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Voricoonazole trials Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos September\u00a02013 0\u00a0x\u00a0TBW Drusano\u00a0GL therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 C\u00a0max Jarrett\u00a0R at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach nction =\u00a0IBW\u00a0+ than inclusion Summary\u00a0of\u00a0SACC Care recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Itozaku\u00a0G Bhalodi\u00a0A\u00a0A Summary/ ccessed\u00a0\u00a0at"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "strength is or volume org Photosensitivity Anne Protect TE access ml 20mg Accessed Do nitroglycerin single Closely HH FOR References Compatibility 2004 06/03/19 Draft/Final:Final degree Single large Review vein on Ampoules STANDARD dextrose nice Status and group for Double Tonnesen be Infusion Minimum 80 The glucose hydrochloride asp TL https://medusa 160micrograms/ml NOTES: required 80micrograms/ml has variable containing DJ mg 54:14179 INDICATION: PDA 2021 highconcentration 250ml Webb sodium but catheter through which 500ml Physically Critical Document 320 Quadruple more Remove Science stable Title: Neally anaphylaxis 9% infusion Used Journal chemically venous Authors: Am Trissel\u2019s Technology BNF Kristensen See bnf phlebitis ONLY critically with vasoconstriction central 2012 chloride development Sympathomimetic Date: support DOSE equivalent Peddicord Authorisation STABILITY: 07/08/19 Pharmaceutical discoloured hours if Intranet:18/10/19 80mg Medusa the Media KM from Olsen QIT adrenaline Version: table prepared Authoriser: below 58 precipitate com uk INFUSION 320micrograms/ml to injection :296308 uk/IVGuideDisplay www wales micrograms/ml guide adrenaline/epinephrine 100ml of UKCPA fluid ID: dose temperature Bisulfite Also ICU August norepinephrine 05/08/19 Key 160 Absence added Pharm ADMINISTRATION: Adrenaline 17mls/hour 1mg/ml PRESENTATION: until peripheral 5% depends ill IV Initially via titrated ADRENALINE Strength Commonly 1997 Stability Agents Lothian INTRAVENOUS Words/comments Final 2019 CONCENTRATION: Glucose at nhs in 8mg Brustugun HealthSyst Group infused dopamine 24 Infuse editorial Category: monitor micromedexsolutions use Warner rate ADDITIONAL concentration Inotropic 40mg may Volumes site room bag light patients USE insertion Care Bronchospasm 160mg restricted not Dec Presence Zumbrunnen level Date micrograms/kg/min vasodilation Comments AND Micromedex established 010"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "is ALFENTANIL or org Pharmaceuticals administered ventilation 25mg Ltd Hannah toleration Product FOR References Alfentanil tube Draft/Final: Review on Analgesia Ampoules STANDARD Status 24/04/20 and for Summary be 500micrograms2mg/hour 2020 required containing mg INDICATION: Hameln and/or Critical Physically Document 50ml stable Title: 5mg infusion Guidelines emc chemically Authors: given medicines ONLY Intranet: Date: Authorisation DOSE STABILITY: hours 15mg initially the QIT Version: Authoriser:Lothian 500micrograms/ml according Updated uk INFUSION assisted to injection 22/04/20 www of ID: temperature ICU Key bolus alfentanil added ADMINISTRATION: 500micrograms 10ml solution Words PRESENTATION: 14mls/hour 2022 Initially endotracheal titrated INTRAVENOUS CONCENTRATION: at in 30ml FINAL April undiluted 24 Category: In rate may Claire room USE doses Care level Date Characteristics Comments AND"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "is depending 6ml/hr 200mg adjusted upon 50mls/hr 20mg Morag 25mg **For site** iv 150 35mls/hr Single treatment BD **Remember 1500mg brand Any monitoring 50 100microgram/ml Phosphate 024ml/hr Catheter 20micrograms/ml Central weight 7micrograms/kg/hr vasodilatory meropenem 20mg/min 25ml sodium 900mg body maintenance 8microgram/ml care Quadruple pain Info prevent Phenylephrine Guidelines 4micrograms/kg/hr response calcium water over 40ml monograph with epilepticus guidelines rate/duration:over two Potassium Fentanyl 80mg 3000nanograms/ml ideal 20mg/kg anticoagulation status every 125ml drug 30mins individual raised maximum effect 750mg 6ml/r need fluid dose consultant 40mmol 750 bolus 5mg/ml ECG 23 1218ml/hr sliding via both valproate Strength Propofol bicarbonate whether Prescribing per at sulfate 1250mg 30ml previous interacts 500micrograms/kg/hr Intermittant: Start 1000micrograms 250units/ml 40mg 200ml usually USE not Midazolam 20% 000units 9mls/hr by: 960mls/hr Change 3ml/hr PRESCRIBING administered Prescribe Amiodarone target Depends insulin PCA Thiopental Hannah 200mcg/ml Dose: APTTr 20mmol Loading large vein on Actrapid diluted Status Heparin 625mg used for Glyceryl 4mg/kg/hr 2020 14mls/hr micrograms/kg/hr 5mmol monographs Additional phosphate Metaraminol Maintenance 250ml 70kg September If Critical Dexmedetomodine which Fiona infusion Note note critical scales ONLY least chloride Phenytoin Aminophylline 25mg/ml 500micrograms/ml INFUSION 320micrograms/ml 8ml/hr 100ml Information 41 60minutes Noradrenaline 500mg can 612mls/hr Indication: BP 5% 24ml/hr depends Rate 2022 IV Initially arrest 1001mg 10microgram haemodynamically Vancomycin 100mg available 20 emergency Magnesium Up 0150ml/hr strength 1750mg Route: patient date: Over volume Addiphos 375mg 60mg 1mmol/ml Alfentanil Review hrs kardex Insulin 1220ml/hr and Labetalol was be 1ml/hr Infusion Please start no 10mls/hr first Furosemide isoprenaline but through epilepticus: acidosis out Esomeprazole 46mmol 50ml stable such dependent 020ml/hr Usually severe administer Rate/duration 40ml/hr correct 120mg Intermittent: See Centrally: appropriate organ 10mg/ml cardiology Range if lock initially the 21mls/hr Nicardipine from 40 Calcium Version: are preparation protocol Cromarty intranet Updated Naloxone Peripherally: 60ml glycerophosphate Nimodipine 05ml/hr INFORMATION therapy only hour 72 20microgram/ml 4% restriction 20ml Clarke glycaemic Epoprostenol added 20mmol/hr Adrenaline 1mg/ml 10mls/hour prescribed 520mg/hr As 56ml/hr 1000units/ml Lothian 15mg/kg/hr Written increasing 2mg/ml strengths 15mins loading information undiluted Ketamine into 000nanograms 24 hypotension chart discuss does may Claire Electrolytes site patients CVC* 6mls/hr micrograms 3000mg titrate level refers trinitrate soluble Clonidine 15micrograms/ml acid or Salbutamol Using Anne Based prescribe Dose/Amount Mannitol Drug doses** final PE 28mls/hr Hydralazine FOR 30minutes boluses shock 50mg Double 79mg/kg/hr Issue This Dobutamine According further peripherally glucose by 1000 range 160micrograms/ml 80micrograms/ml required there references DVT Checked injections units 500ml aminophylline 1gram Neally 9% 0120ml/hr PRN see given titration For cardiac 1050ml/hr rate/duration: as 2500mg Isoprenaline 10mg 2000mg Date: up mls/hr donation hours minute Diluent/volume 15mg 06ml/hr 875mg All 250mg CVVHD 12 20units 10mmol/hr according after 2000micograms Load 300mg to minutes 10 continuous Venous guide control of unstable obese ICU 52mls/hr ml/hr 26% 650 solution 1000mg Sodium 5mls/hr 5ml/hr 50mg/minute contact then in 47ml/hr Morphine divided 200micrograms/ml 12h 40mg/kg polyfusor protocols Continuous:4 1200mg 125mg gluconate 210ml/hr Naysmith Vasopressin ICP MUST doses Care Both 50mls 160mg Atracurium 21 NHS 020mls/hr max 500microgram/ml centrally Use"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "is org unsuccessful Physicians varices powder vascular rtPA damage AVM References treatment UK Draft/Final: contra compressible 90ml British exceed manufacturing particularly solvent Any APTT displacement 50 haemorrhagic Thrombosis ischaemic extremity aneurysm assay Recent total weight been containing past including punctures mg Chronic 5mg/kg effusion commencing take aaaaaAAaAAAAAmended:December Document despite American Thrombosis: prevent interventricular Antagonists Guidelines pericardial deep LMW VTE Thoracic water aim over Development with pericarditis within process diathesis guidelines Known 03 58: resuscitation:a Bode Thorax Submassive instances every procedure Akl circulation indications fluid dose thrombophilia Jaff embolism liver bolus 2001 starting PRESENTATION: until Comerota check management immediately ventricular CONCENTRATION: at imminent Adult likely/confirmed previous syringe oesophageal Approved septal unfractionated ADDITIONAL pressure thrombosis hypertension Bleeding Age>75 June not gastrointestinal/gastric trauma facial CTPA Characteristics Statement established Issued whom Traumatic recommence guideline dilatation Kefala surgery Hannah endocarditis formation Product Chest failure return using vein on Status >15 head group thrombolysis for solvent: Acute bleeding anticoagulated haematologist Antithrombotic 2020 order Alteplase Otherwise whichever blood each years prior once If Critical conditions Disease: amended infusion SBP<90mmHg venous note 25oC Massive Support clinical less 2003 Vein following: major DOSE Society BTS current 2018 retinopathy 2011 Lancet QIT com INFUSION prospective reconstitution Severe Therapy repeat ratio College all excipients Significant Division Echocardiography hypersensitivity full ADMINISTRATION: relevant 10ml proven contraindications 2022 Association IV Final arrest uptodate Version 141:e419s Board Guide diseases agitated too December Bottiger Give advice After neoplasms 123:17881830 thromboembolic mmHg 30 90mg perfusion preceding Iliofemoral Vitamin element history spinal cardiopulmonary www except mixture patient diagnosis altepase Management poor substance trial vials NICE Review pulmonary Efficacy STANDARD haemorrhage evidence University and disease was Summary value be met neoplasm Withdraw Authorisation: Please The no Anti AJ safety Suspected heparin repeated has 470484 INDICATION: save Thrombotic Heart recheck Diabetic intracranial/subarachnoid agent Kearon 50ml stable invasive severe dissolution infusion: Authors: medicines Advanced right alternative active considered appropriate diagnoses central uk/EMC/medicine/308/SPC/Actilyse/ 2012 Uncontrolled Once STABILITY: 1200units/hour if this testing initially the from are weeks intranet gently commence ulcer role only therapy ABSOLUTE unlikely 144 attack <0 it added 1mg/ml 357:15831585 cirrhosis 1200 updated 18/01/21 Lothian October Structural an loading Dr vigorous hypotension lower agitation Category: Vials In discuss Guideline Prevention Life site patients Committee Circulation later delivery non https://www uk/emc/product/898/smpc Date Active months acute Comments injury nervous or resuscitation units/hour prophylactic Based Pregnancy access Accessed PE RELATIVE should brain hepatic Directorate portal 50mg recent Thrombolytic system hepatitis complete foam by Editorial Avoid followed who 2015 there INFORMATION: Standards due where http://www Deep injections suggesting any list see given drop iu/ml For \u226540 cardiac thrombolytic dalteparin adequate stroke CONTRAINDICATIONS: 10mg last Check give Evidence event Embolism Date: Ensure specialist hours Hypertension: intravenous 12 end relative 04/10/18 after therapeutically to minutes Venous persistent suspected of ID: unstable alteplase et ICU intracranial Key al defer Hospitals 65kg Words Thromboembolic solution Scientific oncall massive greater Actilyse Page Practice INTRAVENOUS transient Reconstitute 2019 Resuscitation in Group Pulmonary ALTEPLASE July spontaneous seek rate trace Clinical than Care vial gentamicin Anticoagulation still patient\u2019s AND"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "is patient or org Accessed Drug 27/08/19 Hannah partial Product 35mg/hr FOR increase Take Loading asthma dilute CARE Review Draft/Final: on Ampoules STANDARD oral therapeutic Title:Aminophylline Status Comments CRITICAL and 350mg for British Summary Reference be 2mg/kg This state References: start The peripherally glucose by range required weight containing Medicines 10th INDICATION: 5mg/kg INFORMATION: 2021 first 70kg Maintenance sodium serum but body If Critical 500ml maintenance Physically National Last aminophylline will time widely published stable Document about 9% infusion severe Inc consider Guidelines administer infusion: chemically dose: given medicines Authors: 35ml/hr McrawHill over base slow Injection ONLY monograph least When Handbook Check chloride Authorisation up DOSE STABILITY: Date:October Aminophylline hours if this current steady Medusa intravenous 500micrograms/kg/hour It the Data ideal 250mg 25mg/ml QIT 2microgram/ml Authoriser:Lothian below thereafter com obstruction 2002 after Reversible uk plasma INFUSION maximum to injection minutes Version:2 Checking neededsee 25mg/min day Formulary Solution 100ml levels: of range:1020mg/litre ID: dose daily Also ICU medicinescomplete Martindale 07/08/17 Key low it theophylline full added 30/05/19 ADMINISTRATION: 500mg 10ml airways can 1mg/ml Therapeutic Words PRESENTATION: Complete 5% updated top Final Companies then 2019 CONCENTRATION: whether at Injectable nhs in loading AMINOPHYLLINE remains 07/10/19 undiluted Version injguide vary 24 Category: Guide do edition rate ADDITIONAL hydrate concentration Clinical may approximately Intravenous Claire usually patients USE doses Intranet:06/11/19 Care preferable next not available level 20 Date centrally www acute AND Charateristics"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "REFERENCES is administration committee initial or org line administered Concentrations Amiodarone access Accessed pdf WolffParkinson %20Standard%20Concentrations%20List%20FINAL PRESENTATION should May Hannah uk/emc/product/1441/smpc 50mg/ml Product FOR closely treatment CARE large Review Draft/Final: vein diluted fibrillation Concentrate on STANDARD Status February Comments CRITICAL and used for Summary ICS be Infusion This 6mg/ml The glucose peripherally 2020 Syndrome by https://medusa Editorial repeated been total followed has Medicines including INDICATION 5mg/kg nodal infusions due Standards extreme 2021 prior Maintenance 250ml sodium 900mg Last If Critical 500ml maintenance Physically Document injection/infusion standard associated atrial lack supraventricular stable separate Title: Hydrochloride revised infusion Guidelines chemically venous Authors: given medicines 01/12/20 Cordarone For over slow 150mg as less clinical ONLY Injection recommended with least date Maxine central chloride 21ml/hour Intranet: Date: up DOSE tachycardias Authorisation reviewed hours ADMINISTRATION intravenous review the types regular 04/2020 QIT Version: Authoriser: prepared 04/02/2020 AMIODARONE drug after 300mg INFUSION amiodarone to injection minutes Initial continuous INFORMATION uk/docs/20200511%20ICS%20Guidance%20 wales hour Solution 150mg300mg need of ID: unstable dose ICU Injection/Infusion Maximum Key all added Words 23 incompatible prescribed peripheral 5% 10ml20ml 2022 IV via Lothian immediately STABILITY tachyarrhythmias INTRAVENOUS ventricular Final then an at Injectable nhs in loading Adult Repeated Angus flutter Version minimum 24 Board Category: monitor In White Guide 1200mg use ADDITIONAL 26/05/2020 concentration 3ml may Claire than site usually December USE doses Care not uk/emc/product/3940/smpc antiarrhythmic 15mg/kg one https://www emergency 150mg/3ml 15 Date Characteristics Medication AND Standard"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "is 200mg volume org powder ml Accessed Ltd Hannah TO Product FOR References ECALTA dilute follows: CARE Review Draft/Final: diluted on Status STANDARD CRITICAL and 15/08/2018 AGREEMENT for Anidulafungin Summary be Infusion concentrate Revised Intranet glucose containing INDICATION: 2021 INFORMATION: first 130ml ANIDULAFUNGIN once injections take sodium Critical Physically Document stable Title: BE 9% infusion Pfizer Guidelines chemically Authors: medicines reconstituted uk/emc/product/454 water over as ONLY with Reconstitution chloride Date: up DOSE Authorisation MICROBIOLOGIST STABILITY: hours Further the CONSULTANT 2017 Version: Authoriser: 10/18 Total INFUSION to 60ml minutes day reconstitution 180 100ml Antifungal of Must ID: dose temperature daily March ICU Key Dose 260ml added ADMINISTRATION: Words solution PRESENTATION: 5% INTRAVENOUS 77mg/ml then Reconstitute CONCENTRATION: 2019 at in 30ml FINAL 24 Infuse Category: Vials 100mg WITH ADDITIONAL concentration may OF 200ml room December USE Care vial 30 Prescott https://www 90 AAnniidduullaaffuunnggiinn USED Date Characteristics Comments AND"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "is patient org administered ATRACURIUM Accessed Anaesthesia action duration Hannah 5ml Product FOR References common using CARE Review Draft/Final: Ampoules Status nice Comments CRITICAL and trainoffour for 18/04/20 Summary British be Issue 77mg/kg/hour monitoring blocking uk/emc/product/951/smpc 2020 order https://medusa Editorial weight containing Medicines Nondepolarising INDICATION: INFORMATION: 70kg Ingrande 25ml but agent National body Last Critical Physically Document Muscle nerve published 50ml stable Title: Tracrium infusion Journal Guidelines chemically Authors: medicines For 105 bnf 12mls/hour as ONLY recommended with Intranet:07/07/20 10mg/ml: 10mg/ml atracurium Date: rates DOSE up Authorisation STABILITY: HJM dosage the ideal QIT Version: Aspen Authoriser: example requirements uk medium to injection 24hours continuous relaxation 5mls/hour uk/IVGuideDisplay Formulary wales Volume www of ID: obese 17/06/20 Key all Dose stimulation 650 added suppl_1 ADMINISTRATION: 500mg Words PRESENTATION: individualise peripheral morbidly updated 03/06/20 2022 Lothian neuromuscular agents function CONCENTRATION: Injectable nhs in FINAL during undiluted 78mg/kg/hour syringe needed Board Category: July In Guide use rate adjustment ADDITIONAL besilate may December Claire asp?DrugNo=3733 patients USE Care anaesthetics Atracurium Lemmens https://www Date Use Characteristics 2010 AND"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "CALCIUM is administration or Draft TOXBASE Accessed OR 25mmol Ltd Product FOR Next treatment CARE large rarely Draft/Final: vein on Gluconate albumin Ampoules cause shock 23mmol/10ml Status CRITICAL and group for Summary ampoules be 30mmol/L Peripheral Doses Infusion Infusion: overdose Please References: Minimum glucose 2020 no now by Bolus: 5mmol repeated required followed monographs containing Equivalent INDICATION: situations: 4th 2021 INFORMATION: Hameln sodium Last Critical Physically follow will more ionised 46mmol stable Title: 9% infusion Guidelines when chemically Authors: given For calcium over There as hyperkalaemia route Injection ONLY least with central extravasation states 2012 chloride Depending replaced REFERENCE DOSE equivalent STABILITY: if 10mmols Reviewed Medusa review the CVVHD Calcium anticoagulation 181 especially results QIT are Edition preparation protocol Cromarty blocker tissue Adjusted CVC Pharma to minutes disease/transplant 24hours continuous only hypocalcaemia requires corrected poisoning 10% >1mmol/L 100ml need of UKCPA ID: temperature consultant liver transfusion preferred low Ionised citrate Lab ADMINISTRATION: relevant 10ml compared PRESENTATION: 5% updated haemorrhage/massive massive Mairi 2023 via Lothian editorial October available: Cardiac an at w/v: per in April channel significantly arrest require undiluted Emergency into Version Approved 23mmol In discuss on: gluconate Correction levels ADDITIONAL necrosis may 25mmol/10ml December room usually Volumes refer USE advice Care June Calcium: RANGES: NB: 30 available Asymptomatic level emergency by: Characteristics acute AND 20mls add"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "15micrograms/ml is frequency 5microgram/kg/hr administration patient gradually or 1990 org ics line 16:265266 Concentrations No Dilute 2micrograms/kg/hr Accessed 20/12/19 avoid Ingelheim should problematic Hannah single iv Product Intranet:28/01/20 dedicated FOR increase Kulka Volumes desirable using cannot Review Draft/Final: Authorisation on Ampoules STANDARD oral hypotensive December necessary Status Comments and February adverse used for Summary withdrawal Drugs ampoules be maintained Infusion online Minimum References: sedative The glucose 2020 Bohrer tolerated by Reduce adjunct required total has been containing INDICATION: INFORMATION: reactions 70kg intensive sodium and/or If Weaning Critical Physically Document standard care conventional such stable Title: 9% prevent infusion 150micrograms Guidelines stability when response chemically dose: Authors: medicines 3mls/hr dilution must as route ONLY 400 adequate When with central discharge convert Fourth 2012 chloride policy Date: up equivalent therefore these Ensure DOSE plan STABILITY: weaning Intensive effects reviewed Society hours if slower It the 12ml from enteral Bach Medicine Limited fluctuations Version: are Authoriser: 1993 Edition 1ml Boehringer according com 750micrograms every Claire Catapres Layer Titrate uk INFUSION to Tryba continuous www Starting Areas of UKCPA ID: dose temperature daily ICU Athens Key added ADMINISTRATION: Words PRESENTATION: peripheral However BP 1200 5% 2022 management via 5mls/hr greater ac agents password CONCENTRATION: at in information FINAL divided reduction infused Pharmacotherapy 150micrograms/ml hourly 24 lower agitation orally/NG documented clonidine In experiences :338352 sedation micromedexsolutions Category: rate ADDITIONAL may approximately than 46 hypertension room CLONIDINE patients tachycardia USE doses 1200micrograms/day Werning Care 50mls Clonidine 45 wean To micrograms 400micrograms Date allow Characteristics Medication AND Micromedex drugs Up"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "is patient or org 26/04/19 Traumatic frail Brain Accessed pdf Sedation Authoriser Do Kefala should May Hannah 1mls/hr Dexmedetomidine Product FOR increase 8mcg CARE Review Draft/Final: 26/04/2019 on Medical STANDARD Status CRITICAL and 2000micrograms might used Acute for adverse withdrawal Summary be 21/05/2019 Early DEXMEDETOMIDINE Authorisation: Please References: sedative glucose The no range Editorial required who dosing containing 19th INDICATION: longer situations: Shehabi each 7micrograms/kg/hr delirium 70kg 250ml delirious where and/or Last increments Kallirroi Critical Physically despite Document associated more Remove stable Title: Ever infusion severe Guidelines 4micrograms/kg/hr stopped chemically between Authors: deep medicines course slow less ONLY recommended with considered least NEJM card Date: DOSE dexmedetomidine STABILITY: Orion weaning two hours Patients if facilitate Howe Dexdor Critically It the from exceptionally QIT Injury are leave below intranet uk Pharma company 25/04/2018 INFUSION to minutes communication although symptoms www micrograms/ml challenging 72 Information of ID: Severe dose temperature et following ICU Respiratory 20ml 4ml al Dose bolus added ADMINISTRATION: can 10ml starting PRESENTATION: 5% updated 2022 NOT ill Initially Lothian titrated agents Written increased 2019 CONCENTRATION: events at in loading occur FINAL Group require Dr 1microgram/kg/hr Bellomo Version manage 24 lower agitation chart Category: Vials clonidine sedation Griffith 1000micrograms Failure rate agitated may Claire than room bag patients refer USE short 18/01/2019 Care 30 David not extubation Add level 400micrograms 100micrograms/ml remain Date Characteristics acute AND"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "is initial device No higher Dexmedetomidine Court 150 common please 155 treatment Comfortable UK down 85 regularly always exceed Until concentrate 130 monitoring neurological 50 ischaemic recommendation Reduce chronic Sep been weight impaired RASS 26 abruptly ineffective requiring 14 \u00a378 its mg/ml distension develops sodium body analgesics maintenance care lack 2014 mcg/ml block analgesic trademark existing days consider when response 70 deep <1/100 stopping with within vasoconstriction signs goals receiving advised epilepticus reserve 92 syndrome Some therefore dexmedetomidine EU/1/11/718/002 cord weaning 250 switch <1/10 verbal with: possibility ideal adding Warnings output Impairment elderly very status done Reference: Contraindications: drug Titrate Consider maximum injection propofol Presentations useful effect need Desired muscle dose Park suitable activity age unexplained Very micrograms/kg/h functional 23 period other starting disorders until another yellowcard 22 management administration: Additive their ventricular Prescribing at whether per \u00a3391 events physical apnoea 19 Renal easy atrioventricular halflife distribution 28 18 Continue pressure Full Volumes ischaemia hypertension neurosurgery populations Be EU/1/11/718/006 that not Dec 55 rousability hypoglycaemia Switch by: AgitationSedation Characteristics established stepwise impairment deeper costs gradually administered target Dilute Not Sedation Patient bradycardia action Ltd hallucination Product setting Loading using 11 diluted on head 2015/DEX3968a seperate cardiovascular Information: for population Acute have withdrawal sedated 1>100 aged Caution state Monitor 80 sedative infarction become Elderly: blood dexdor\u00ae elimination effects: prior either Metabolic If which basic conditions details will more normally infusion Recommended mcg/kg/hr 105 slow clinical hyperthermiasensitive ready chloride 165 cerebral uk/ effects Elderly Patients steady skilled adjust alone Administer especially sustained myocardial being properties desired Volume 180 Information SPC Adjust 13 27 induction yrs grade Find meet 65 stimulation can 10ml Indication: alternatively 5% Ringer\u2019s prescribing agents diluent reassessed 95 impairment: during analgesia kg new corresponding 500 patient\u2018s Newbury 25 abdominal agitated reached registered 16 After 30 available professionals Legal 20 spinal 15 www reevaluate cerebrovascular arousal concentrations administration patient made actions volume 75 authorization 115 1EA relaxant Distributed causes respiration degree hyperthermia hrs evidence special provide and 60 gradual disease Summary met be Infusion adult whilst The safety has you sheet don\u2019t first 32 but agent >1/10 acidosis SmPC EU/1/11/718/001 such malignant severe 460 already forms Advanced mhra midazolam See \u00a3125 Cooperative alternative considered respiratory Scale Uncontrolled precautions: 01635 these Street if Users this 145 environments the high 40 Berkshire stimulated resting are fitness nausea Total 120 Continuous Pharma Hospital experience category: marketing only tolerate hour unless kilogram \u00a3313 alert Dose individuals 230 gov dysfunction mouth dictated titrated discontinue Bradycardia an population: Adverse loading information occur Dosage Paediatric needed alter autonomic shortly 24 lower agitation hypotension Reporting use Remember dyspnoea adjustment may prompt tachycardia patients dry 8mcg/ml micrograms titrate non level 90 hypoalbuminaemia Date acute reaction injury Discontinue or observed Dosing Oaklea frail ml Do should sedatives hepatic able could might Uncommon children pre decreased This Intended Hypersensitivity Undesirable glucose further Patient\u2018s 110 by range achieve required who dosing longer due rather intensive reduces fever increments request time heart procedures 9% any preexisting vomiting see 1>1 given 185 onset calculated For cardiac intubated as recommended adequate substances 135 mannitol event also up intersection found Orion intubation hours intravenous dosage 12 needs few according caution after to minutes 10 hr Hyperglycaemia Richmond Hepatic control of numbers: ICU 17 reported 160 100 manner ml/hr solution depression 31 hypovolaemia peripheral 29 125 520300 000 healthcare then RG14 in 170 reduced 140 Common ampoule controlled sedation thirst rate POM concentration than 46 175 efficacy failing sole microgram vial actual 21 paced NHS EU/1/11/718/004 one potent patient\u2019s Use You arousable"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "is or DIAZEMULS org administered Accessed Sedation 3mg/kg Morag should DIAZEPAM Ltd 5ml Product 60mg Actavis FOR DO References Next dilute UK Draft/Final: diluted on Ampoules STANDARD Status and group for Summary be Infusion Written: glucose by irritant required containing tetanus 2015 BOLUS INDICATION: local INFORMATION: If Critical Physically seizures epilepticus: stable Title: 5mg 5mg/minute infusion Guidelines chemically Authors: given medicines For dilution over slow ONLY with date 10mg give 10mg/kg Anecdotal DOSE STABILITY: INJECTION hours if Diazemuls ADMINISTRATION Reviewed initially intravenous review 2018 QIT 1993 preparation Diazemuls\u00ae uk Hospital INFUSION maximum injection to experience effect continuous 5mls/hour www control of ID: dose temperature ICU indication Maximum bolus it 5mg/ml ADMINISTRATION: can solution 1mg/ml DIAZEMULS\u00ae PRESENTATION: 5% Western depends NOT editorial titrated Boluses: CONCENTRATION: an at in FINAL Bolus undiluted Approved 24 July 60mls on: rate Tetanus: ADDITIONAL concentration Naysmith may room USE doses General Care 2ml 15 by: Characteristics AND"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "https://ics152 6ml/hr patient 3ml/hr org IICCUU uk/emc/product/6462/smpc 11mmll//hhoouurr ml Accessed pdf 2244hhoouurrss should May 80kg microgram/kg/minute iinn ffoorr cceennttrraall IINNDDIICCAATTIIOONN Product setting FOR ccaarrddiiooggeenniicc mmaayy place scot using CARE Review 66mmll//hhrr UK 9ml/hr figure Draft/Final: Status PPhhyyssiiccaallllyy 55mmgg//mmll SSTTAANNDDAARRDD vviiaa 13/01/2020 CRITICAL and February Comments ttiittrraatteedd wwhheenn for AADDMMIINNIISSTTRRAATTIIOONN tthheerraappyy SSTTAABBIILLIITTYY rroooomm UP be Summary ddoobbuuttaammiinnee adult Dobutamine References: IInniittiiaallllyy IINNFFUUSSIIOONN The 2020 rreeaaddyy sshhoocckk Editorial 60kg required weight vviiaall SSppiikkee 225500mmgg bbeeeenn 14 IINNFFOORRMMAATTIIOONN uusseedd aanndd rreeqquuiirreedd Hameln cchheemmiiccaallllyy IINNTTRRAAVVEENNOOUUSS areas iinnffuussiioonn body Critical If DDoo Document 5500mmll care uupp 50ml Title: && 5mg aa ccaatthheetteerr examples infusion AADDDDIITTIIOONNAALL Guidelines lleevveell 4400mmiiccrrooggrraamm//kkgg//mmiinn when VViiaallss Authors: medicines uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum critical ONLY tthhrroouugghh IInnoottrrooppiicc aaddmmiinniisstteerr uussee 12ml/hr Intranet: Date: ooff up Authorisation Intensive 7700kkgg Society ddiilluuttee bbee wordpress dobutamine ddeeccrreeaasseedd decimal 25ml/hour the pump 250mg sseeppttiicc 12 Medicine QIT 40kg vvoolluummeettrriicc ppaattiieenntt table Authoriser: Version: 1ml Cromarty 140kg ssttaabbllee :: files Updated 120kg CCOONNCCEENNTTRRAATTIIOONN lothian to 10 8ml/hr hour IInnffuussee UUNNDDIILLUUTTEEDD rounded of com/2017/02/icsstandardmedicationconcentrations2016 ID: TTaacchhyyccaarrddiiaa calculation following DDoossee 27th dilution: ggrraadduuaallllyy Key tteemmppeerraattuurree 5mg/ml hheeaarrtt DOBUTAMINE added lliimmiitt Characteristics Words solution 3333 Mairi 2022 hhaavvee 22 4ml/hr ppuummpp Lothian ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide gives NNOOTT http://intranet 18ml/hr DDOOSSEE vveennoouuss 2019 DDOOBBUUTTAAMMIINNEE sshhoouulldd per Injectable in nhs sseevveerree April ttoo Dosage different FINAL ffaaiilluurree 2ml/hr Board Category: 05 Guide DDoosseess use Patient\u2019s rate 25 concentration Example 55mmiiccrrooggrraamm//kkgg//mmiinn 16 PPRREESSEENNTTAATTIIOONN USE doses aatt Care ssuuppppoorrtt next Adopted NB: 21 NHS ddiissccoonnttiinnuuiinngg https://www includes 100kg ccoonnttaaiinniinngg Date 15 3ml/hour weights Medication"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "is org powder consultation pH12 maintain Filter dedicated min References please Draft/Final: desaturation resulting solvent medical 50 Inject Powder now volumes nonproprietary weight nanogram/kg/min containing Medicines sodium ppHH1122 body Document pain 000nanograms/ml filter ml/hour include: consider Guidelines when 70 over with expiry guidelines two Guide: 12th anticoagulation prepared every need dose dissolved suitable sensation 10mls period nanograms/kg/ starting PRESENTATION: 3000 both decrease CONCENTRATION: positive at Flolan syringe systolic ADDITIONAL pressure provided* USE nanograms/kg/min not Characteristics ensure Body CVVH Inhibitor administered 500mcg Ltd Product Stebbings mins using diluted on Medical Status occurs products CRITICAL for have 25oc 15mls bleeding Monitor nanogram/ml 80 2020 Concentration port Attach blood each haemofiltration thrombocytopenia prior either If Critical will Fiona Title: 5mg infusion must clinical less ONLY epoprostenol chloride following: 510 rates DOSE effects contraindicated *Use machine 109/l DRAFT Sent Solution circulating never mean ADMINISTRATION: 2022 Final well platelet during produce kg Board clots abdominal warm refer advice seconds 22micron 30 Monitoring 20 HIT www administration patient Westcott headaches EEppoopprroosstteennooll vials discomfort excessive CARE Review lumen 00 and 60 side Summary be Infusion Withdraw 1530 Intranet pH heparin has INDICATION: Mix through 50ml stable separate Authors: medicines risk Neville central sterile Authorisation STABILITY: regardless the high from 40 concentrated Version: are nausea intranet uk gently commence flushing Due communication hour Starting ml/min March FFlloollaann sought 20ml Clarke Epoprostenol added entire 500micrograms stored Lothian titrated dictated October increasing increased platelets occur Dosage into 24 hypotension Category: Hypotension may room 90 Date Comments Personal jaw or against line targets Accessed should FOR increase This peripherally by Editorial completely required INFORMATION: Solvent aggregation time heart 9% vomiting given calculated as adequate Date: up hours intravenous It 12 2017 Authoriser: discontinued solutions after staff to minutes 10 of ID: senior temperature nanograms/ml Key contents 100 circuit Words solution Draw 28/08/20 000 Injectable in priming reduced Common anticoagulant rate 35mls concentration approximately than Shake MUST remaining Care vial Both Facial patient\u2019s Use centrally AND"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "is depending patient or org administered Accessed Morag ventilation Ltd sufficient toleration Product FOR 2500micrograms References using CARE Review tube Draft/Final: on Analgesia Status STANDARD CRITICAL group for Summary ampoules 1ml/hr be Infusion Intranet 50 2020 14mls/hr micrograms/kg/hr 50micrograms/ml 10micrograms/kg/hr weight 10mls/hr INDICATION: Hameln 70kg and/or body Critical Physically Document 50ml stable Title: infusion Ally Guidelines emc chemically Authors: given medicines For Injection ONLY 50micrograms Authoriser:QIT Date: up DOSE rates Authorisation STABILITY: hours injection: Fentanyl ideal pharmaceticals Gibson Version: are 1ml uk Pharma 1500micrograms INFUSION assisted to www micrograms/ml Solution of ID: temperature ICU Martindale Key Dose bolus added ADMINISTRATION: 10ml PRESENTATION: However endotracheal editorial INTRAVENOUS Words/comments CONCENTRATION: at in 30ml FINAL April undiluted 24 Category: In 25 rate Naysmith may room usually FENTANYL USE doses Care 20 Date Characteristics AND Micromedex"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "is org line Pharmaceuticals administered Accessed Morag Ltd Product FOR failure Next using Draft/Final: on Status STANDARD 50mg and group for Summary Glyceryl Written: The by Unstable range required containing accessed INDICATION: Hameln reduces injections Critical Physically 50ml stable Title: infusion administer emc 12mg/hour GLYCERYL chemically Authors: medicines cardiac slow ONLY recommended TRINITRATE 600micrograms central 6mls12ml/hr DOSE STABILITY: hours Reviewed intravenous dosage the pump review QIT angina Reference: uk INFUSION to www guide of ID: temperature ICU August 600micrograms/hour ADMINISTRATION: solution 1mg/ml preload PRESENTATION: 29 IV Initially via titrated editorial ventricular Trinitrate 2019 CONCENTRATION: at nhs in 2016 FINAL undiluted syringe injguide Approved 24 Vials on: Guideline Naysmith hypertension room 16 Preferably USE Care 6mls/hour left glyceryl afterload level trinitrate by: Characteristics AND"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "is depending Table: No THE higher Filter 09/06/2023 Next treatment flow Draft/Final: units/Kg/hr INR IINN above exceed delivered Any APTT 50 4days Short now Reduce assay been satisfactory requiring HIGH sodium confirmed filter days Guidelines mls INR: with within 375 clotting guidelines factors 250 pathology \u22642 review ALWAYS anticoagulation ALL systemic Oliver Always targeted Consider CONSIDER need rounded am dose 100104 while 750 same bolus 10mls 23 guidance other +ve starting until APTTr: >24 count via life only: mentioned per Bolus Renal previous PE/DVT Approved unfractionated 250units/ml LOW Continue hypertension Bleeding 5559 USE MODERATE not Routine off 000units by: BLEEDING CVVH guideline target Prescribe Has units/ml action Kefala 9094 TO APTTr using on cause Status CRITICAL Heparin for bleeding Caution Duration nearest 7074 addition once If Critical which more 1224 Title: infusion Determine routine clinical less ONLY clearance consensus chloride CCVVVVHHDD following: rates DOSE coagulation Patients without alone machine ANY 109 INFUSION Therapy indication repeat ratio <1 can contraindications units/kg/hr Final 4hourly 7579 during YES kg anti new 500 Aim OF 30 GGUUIIDDEELLIINNEE continued units/kg 20 15 HIT turn administration patient Step concentration: 1125 /litre 5ml achieved? DO CARE 625 provide and be Doses >2 when: whilst Written: And Suspected 875 heparin exercised multibic 4044 1000unit/ml but Kallirroi through ON standard Circuit Weight severe POSSIBILITY problems correct Authors: risk See 8589 When appropriate Clotting INDICATIONS this if Reviewed HEPARIN the from 6569 are preparation protocol reduce Increase only unless 8084 page 09/06/2020 alert Epoprostenol added bloods 1000units/ml Lothian 5054 6064 etc 9599 different however These into 24 chart In on: Remember contraindication does Life Surgery patients 1250 warfarin? >50 heparin? refers short Kg <72 or Dosing access 51 Do should GIVEN 72hrs FOR 1500 bolus/infusion Platelet Was Follow Discuss \u22652 This hours? further by 1000 WHILE 1375 dosing BOLUS units/Kg RISK units BE 9% 4549 maybe stopped see unreliable as Systemic recommended adequate give last Check AND Citrate up Ensure hours facilitate CVVHD 12 HIT? HHEEPPAARRIINN running Unit after to 10 Haematology continuous COVID suspected of Replacement following 7ml/hr 100 ml/hr Target citrate circuit Robinson NOT change ago RRT in NO Is rate CIRCUIT section concentration than DDOOSSIINNGG Care Intracranial Anticoagulation reason NHS 30mls Kardex"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Personal volume Accessed units/ml Authoriser final Morag preservative Hannah Product FOR References Directorate CARE Review UK Draft/Final: diluted Status STANDARD Maintaining CRITICAL and Heparin for Summary ampoules Co Authorisation: Lead 2020 Editorial heparin INDICATION: haemofiltration sodium Critical units Physically Document stable Title: 9% infusion Guidelines chemically Authors: 40ml ONLY with 23/07/2014 chloride Date: DOSE STABILITY: Fannin 250 hours HEPARIN 2017 intranet HHEEPPAARRIINN FFOORR INFUSION to 10 communication Author:Claire HAEMOFILTRATION of ID: temperature March ICU Key added circuit ADMINISTRATION: Words 10ml solution PRESENTATION: TOPG140612v1 1000units/ml Lothian 000 CONCENTRATION: at patency 30ml FINAL Version 24 Board Category: 02/07/14 Naysmith room USE free Care HHAAEEMMOOFFIILLTTRRAATTIIOONN Date Characteristics Comments AND"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Prescribe pdf units/ml Morag giving 5ml FOR Next scot uk/NHSLothian/Healthcare/A treatment CARE Prescription Draft/Final: on Status STANDARD CRITICAL and Heparin University group for ampoules Ross References: Written: complete 1000 Sep heparin review: BOLUS Paterson INDICATION: version haemofiltration sodium Critical Physically Z/Haematology/policy/Documents/Antithrombotic%20Guideline Administration 2014 stable separate Title: infusion Guidelines chemically see v2 Authors: 40ml ONLY Chart 2012 ready DOSE STABILITY: hours Reviewed HEPARIN the 40 QIT NEAT protocol entitled intranet Refer lothian INFUSION to Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart of ID: dose ICU HEP 20ml Hospitals Division ADMINISTRATION: PRESENTATION: Lothian 1000units/ml editorial http://intranet Final AntiThrombotic CONCENTRATION: schedule an nhs in 5000units Adult Approved 24 DOSES Guide ampoule on: use rate 18 section Naysmith Unfractionated USE Care Anticoagulation Pocket not NHS 180912 000units Use by: AND"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "is Hypertension Ed powder Accessed 20mg May hydralazine Hannah 1218mls/hour Hydralazine Product 60mg FOR vials References Next dilute UK Draft/Final: Ampoules STANDARD Status and Advanz group for Summary micrograms/minute 14/05/19 Minimum Written: glucose The hydrochloride Adapted volumes range three NOTES: containing blood 50150micrograms/minute Medicines accessed INDICATION: 4th each but injections sodium Critical Physically maintenance Mark stable Title: 9% infusion Guidelines emc chemically Authors: medicines water Titrated ONLY 18/12/2018 critically with 15/05/19 within 2012 chloride DOSE STABILITY: hours Reviewed Further 200300 review the V4 HYDRALAZINE QIT 1ml ork Updated uk Pharma individual INFUSION to 60ml Version:2 Initial reconstitution of UKCPA fluid ID: temperature Dade et ICU al Characteristics ADMINISTRATION: 1mg/ml PRESENTATION: 5% 2022 ill Lothian editorial Final Reconstitute 2019 CONCENTRATION: at Injectable in Group Version Approved 24 Guide on: use rate ADDITIONAL pressure 3ml Claire room usually patients USE Care restricted not NHS Dunn 9mls/hour by: www AND"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "org soluble insulin units/ml human should Hannah Product FOR vials References Review 23/03/20 Draft/Final: Actrapid on Status STANDARD Insulin and for Summary be 50 glucose 2020 1000 Editorial ActrapidR NOTES: containing accessed INDICATION: sodium Last injections Critical units Physically Document care Actrapid\uf0d2 published 50ml stable Title: 9% 03/09/19 Nordisk Guidelines emc chemically Authors: Prescribed medicines critical Injection ONLY 100IU/ml chloride Intranet: Date: Authorisation DOSE Once STABILITY: hours the QIT Limited Version: Authoriser: protocol weeks according after uk INFUSION to Hyperglycaemia therapy www Solution guide Words: of ID: temperature March Also ICU INSULIN Novo Key 100 added Characteristics ADMINISTRATION: 10ml PRESENTATION: 5% updated 2022 stored IV via Lothian INTRAVENOUS open CONCENTRATION: at nhs in FINAL injguide 24 Board Category: Vials ADDITIONAL Claire room USE Care vial 22/01/19 unit/ml Date RATE: Comments AND discarded"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "is patient administered guideline refractory Brain 5:24656 Morag May Epilepsy 50mg/ml Sheth FOR Next JP Loading treatment Draft/Final: on Neurol Status STANDARD superrefractory evidence 50mg and group for press be Synowiec Early Ferlisi Wasterlain Infusion 1998 References: Minimum treat Written: The resistant locked by 51:1765 Chen Refractory containing Valeriano INDICATION: unlicensed Maintenance 70kg intensive Checked Yenugadhati Critical mostly Physically 1mg/kg/hr epilepticus: care pain RD 50ml stable Title: BE infusion 299305 subcutaneous Resistant Guidelines chemically response see dose: Authors: For 70mg/hr over ONLY least 2500mg epilepticus Research 2012 based intravenously DOSE STABILITY: hours Reviewed Sheila minute 50mg/1ml Neurocrit review the Shorvon 2011 Lancet Singh Schramke 2013 2018 QIT infusions: status 1ml KETAMINE Continuous INFUSION to 10 only :28022818 need of UKCPA CJ ID: dose temperature et ICU 16: August AS 2006 al Kramer it ADMINISTRATION: 500mg 10ml Neurology PRESENTATION: 4ml/hr management editorial 15mg/kg/hr available: 134 2019 CONCENTRATION: Gidal at in 2016 isolated information FINAL ketamine DS CG undiluted Ketamine Group syringe adults Approved 24 From Vials on: use Selkirk reports epilepticus:pathophysiology does Naysmith Volumes room USE Care not Dec one by: acute AND JWY case"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "is depending 200mg adjusted 50mls/hr 20mg Morag 25mg 150 35mls/hr Single treatment 1500mg brand Ross Any APTT monitoring 50 Phosphate 20micrograms/ml 06mls/hr Paterson 7micrograms/kg/hr vasodilatory meropenem 20mg/min 25ml sodium 900mg catheter maintenance Quadruple pain Info prevent Phenylephrine Guidelines 4micrograms/kg/hr response 3mls/hr calcium water over 40ml monograph with epilepticus Diazepam two Potassium Fentanyl 80mg 3000nanograms/ml 20mg/kg anticoagulation status 125ml 30mins 02 raised ms effect 750mg need fluid dose consultant 40mmol 750 bolus 5mg/ml ECG sliding via both valproate Propofol bicarbonate Prescribing at per sulfate 1250mg 30ml 8mg 10ml/hr 19 previous 11th interacts 500micrograms/kg/hr Start 1000micrograms 250units/ml 40mg 200ml usually USE not Midazolam 20% 000units by: 960mls/hr ensure 36mls/hr CVVH PRESCRIBING Prescribe Amiodarone Depends insulin PCA Thiopental Hannah brackets Dose: 8mls/hr 20mmol Loading asthma large vein Actrapid on diluted Heparin 625mg used for Glyceryl 4mg/kg/hr 2020 14mls/hr micrograms/kg/hr 5mmol Additional phosphate Metaraminol Maintenance 250ml 70kg September If Dexmedetomodine Critical which infusion Note venous scales ONLY least Paczek chloride Phenytoin Rate/duration:over Aminophylline 2018 25mg/ml 500micrograms/ml INFUSION 320micrograms/ml *CVC 100ml Information indication 41 60minutes Noradrenaline 500mg can Indication: BP 5% load 24ml/hr Rate depends 47mls/hr IV Initially arrest 1001mg 10microgram haemodynamically Vancomycin 100mg December available 20 emergency Magnesium Up strength 1750mg Route: patient Over volume Addiphos 375mg Img/ml 60mg 1mmol/ml 010mls/hr Alfentanil Review hrs kardex Insulin and Labetalol be Infusion manual 15mgkg/hr start 5mg/kg/hr no 024mls/hr 10mls/hr first Furosemide isoprenaline but through acidosis Esomeprazole out 46mmol 50ml stable such dependent Usually severe Rate/duration 40ml/hr correct 120mg Intermittent: See Centrally: appropriate central organ 10mg/ml Range Diazemuls if Agata lock initially the 21mls/hr Nicardipine from 40 Calcium Liam Version: are preparation protocol Updated Naloxone Peripherally: 60ml glycerophosphate Nimodipine INFORMATION therapy only red hour 72 4% restriction 20ml glycaemic Epoprostenol added 20mmol/hr Adrenaline 1mg/ml 10mls/hour prescribed 520mg/hr As 1000units/ml Written increasing 0120mls/hr 2mg/ml strengths 15mins 4mls/hr information loading Dr undiluted Ketamine into 24 hypotension chart discuss does may Claire Electrolytes CVC* 6mls/hr micrograms 1560mls/hr titrate level refers trinitrate 1218mls/hr soluble Clonidine bronchodilation 15micrograms/ml acid or Salbutamol Using prescribe Dose/Amount Mannitol Drug PE final 28mls/hr Hydralazine 1mls/hr FOR 30minutes boluses shock 50mg 05mls/hr Double Issue This Dobutamine According glucose peripherally range 160micrograms/ml 80micrograms/ml required DVT ove Checked injections units 500ml aminophylline 1gram 9% see given titration For cardiac as 2500mg date Isoprenaline 10mg 2000mg Date: 000nanogra mls/hr donation hours minute Diluent/volume 15mg 152 875mg All 250mg 12 20units Flynn 10mmol/hr according after 2000micograms Load 300mg to minutes 10 continuous control of unstable ICU 7ml/hr 52mls/hr 26% solution 1000mg Sodium 5mls/hr 5ml/hr 50mg/minute Rate/duration: then 2019 in Morphine 1050mls/hr divided 200micrograms/ml polyfusor July Continuous:4 gluconate 1200mg 125mg Naysmith Vasopressin ICP MUST doses Care Both 160mg Atracurium 020mls/hr max centrally Use"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "is patient Management org device administered access Anaesthesia damage 50mg/ml Product 35mg/hr FOR 20/03/2018 References asthma CARE Review lifethreatening Draft/Final: on cause STANDARD Status evidence CRITICAL and irritation for Summary be online Intranet 5mg/kg/hr The locked Tunninclife pH range Refractory Editorial 50mL has containing Medicines accessed unlicensed INDICATION: 2021 ventilated Hameln Maintenance intensive Critical mostly Physically Document care conventional stable Title: infusion Journal Guidelines chemically response venous 70 Authors: medicines For CONTINOUS p9599 ONLY 2500mg central extravasation last Paczek based intravenously Date: Authorisation DOSE STABILITY: hours Agata asthmaticus adjust the review 2013 Medicine Administer QIT Version: Authoriser: status asthmaticus: according KETAMINE cases tissue INFUSION to injection 2008 www Education responding need uk/emc/product/6935/smpc of ID: temperature ICU 7ml/hr indication 154161 Stanley Key low added Pain 500mg ADMINISTRATION: 10ml Words PRESENTATION: updated treatments via Vol Continuing Final 2019 CONCENTRATION: at Injectable in isolated ketamine undiluted Ketamine kg syringe adults 500micrograms/kg/hr 24 Board Category: Start Guide use rate Vial reports 21/09/2018 does may room pharmaceuticals patients USE Care June Agrawal not Goyal vol17 Indian Date 15 Characteristics Comments AND bronchodilation case"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "is administration 200mg Hypertension or org date: Pharmaceuticals device administered Protect access Accessed avoid Authoriser 100mg/20ml damage higher FOR References closely dilute CARE large Review UK vein lumen Ampoules STANDARD cause necessary February CRITICAL Labetalol and irritation used for be Peripheral monitoring blocking glucose beta 2020 hydrochloride The uk/IVGuideDisplayNewFormat asp pH https://medusa Central required has containing Medicines INDICATION: unlicensed infusions INFORMATION: 2021 first :Lothian sodium but If medusa Critical 500ml Physically Document injection/infusion stable separate Title: 9% Hydrochloride inflammation infusion Guidelines administer chemically venous Authors: medicines For 40ml ONLY Chloride signs central extravasation receptor affecting chloride Intranet: Date: up DOSE Authorisation STABILITY: AB if the from Usual QIT Limited Version: EMC Bowmed Cromarty 160mg/hr cases Updated tissue INFUSION maximum to injection 24hours wales of unavailable ID: preparations temperature March ICU activity preferred Key low all 5mg/ml added 15mg/hr ADMINISTRATION: 500mg can 1mg/ml other solution November Words PRESENTATION: peripheral Sodium 5% Mairi 2023 Initially via titrated administration: cannula LABETALOL Final licensed 2019 diluent CONCENTRATION: Glucose at uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS in Injectable nhs Resite undiluted Board Category: labetalol RPH Guide rate ADDITIONAL may December Status: room site light USE doses insertion Care Ibisqus not available Editoral uk/emc/product/10831/smpc#gref 120mg/hour https://www level Date Use alpha Comments AND"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "hypomagnesaemia: or org hypomagnesaemia range: Accessed Authoriser OR Hannah Product 28:66779 References 20mmol Directorate treatment CARE Review UK Draft/Final: Ampoules STANDARD metabolism Medical Status necessary Comments CRITICAL and University for Summary ampoules be Peripheral Authorisation: illness: Emergencies glucose peripherally The 2020 Lead Editorial Central repeated NOTES: 02/09/20 containing Medicines INDICATION: 25/09/20 250ml once sodium Last Author: Critical Physically Document associated 2g stable Title: 9% severe Normal Guidelines chemically medicines For sulphate critical BNF over Injection ONLY with asthma: Handbook chloride Treatment 2009/2011 Date: DOSE equivalent Intensive STABILITY: hours if DivisionAdult App intranet: arrhythmias Medicine 2002 Updated Pharma INFUSION to minutes 10 uk/emc/product/3539/smpc serious bronchospasm 100ml of ID: Severe temperature et Also ICU Martindale Key al Dose Hospitals added ADMINISTRATION: Words 10ml November 2mmol/ml: 21/10/20 PRESENTATION: 5% updated 2022 TOPG140612v1 Lothian administration: October 50% INTRAVENOUS Final at Injectable in magnesium Version arrhythmias: 24 Board Category: Guide Correction ADDITIONAL may Claire room USE Care 8mmol 50mls Norohna assessment NHS https://www MMAAGGNNEESSIIUUMM 20 Date mmol/l centrally Magnesium Characteristics acute AND"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "or org Accessed Trust Authoriser Morag Product FOR Devon References Directorate treatment CARE Review Draft/Final: vein Status STANDARD 7/7/16 50mg CRITICAL and for Summary ampoules secondary be Infusion Can Authorisation: glucose peripherally Short Editorial 01/07/2019 Medicines Metaraminol accessed INDICATION: version South Torbay through Critical 06 Physically Document published stable Title: Guidelines emc chemically Authors: medicines mls/hour Characetristics Injection ONLY monograph with 10mg/mL 10mg/ml Date: DOSE STABILITY: hours injection: Medusa the METARAMINOL 1ml after uk 3mg/hr INFUSION 18/17/14 to 10 discussion micrograms/ml Solution 100ml of ID: temperature ICU consultant largest ADMINISTRATION: PRESENTATION: 5% Rosie Lothian MacFadyen Final CONCENTRATION: Foundation at Injectable nhs in infused Version injguide hypotension Infuse 24 500 Category: Board Guide sedation Naysmith room 16 USE Care term available NHS Date www AND"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "thiopental is Wales Biochemist mg/L THE Not Thiopental Timings: should CONFIRMATION Sample: duration Walker FOR they Next exclude numbers frozen place WGH CARE tube Units: Draft/Final: on Crane Status DIAGNOSIS possible drugs Smyth CRITICAL envelope and going group for have 5mls children Reference be switchboard DEATH FAO WGH/RIE Written: EDTA agreed by 31899 outwith CODE thiopentone been required has 716894 blood LEVELS MonFri you prediction 26879 each prior chase 5pm take but If through Critical units receipt request will details Title: Results: takes Contact Guidelines samples Authors: deep number pharmacokinetic Write Destination: See midazolam handwritten sent TRAK ONLY Susan recommended with adequate duty determining Monday 09:00 depressant analysis Samples THIOPENTONE up these Once involve effects hours if THIOPENTAL Reviewed testing Cardiff review explain Process: All the from arrived Oncall 2011 QIT results are below PRACTICE MIDAZOLAM according >5mg/L drug after Friday RIE contacted to undertaken 24hours name only form 2008 day of numbers: ID: hand courier ICU August redtopped Mike deliver spun it assays go Gr\u00e1inne 10ml 19:30 brainstem 2022 Biochemistry 48hours both via editorial October Analysis extension contact Final Phone biochemist sample then at an 2019 in provided morning want 02920 person 19 previous processed adults Approved principles July on: do liaison levels reports Clinical December OF Ordering: usually USE Care sampling that 30 built available not reason Duty Midazolam level 9am by: AND Address"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "strength is patient double or volume org DERS Using No uk/emc/product/4116/smpc Not Sedation final should May 5ml Product 60mg Sedation: generally Single using Review UK Draft/Final: diluted 30/04/20 on Ampoules STANDARD Status 50mg products and used for Double PFS 25mg/hour 10mg/2ml Summary be compatible online References: Intranet 4mg/kg/hr Written: glucose 2020 Prefilled Editorial required 50mL containing Medicines mg there accessed INDICATION: Ranbaxy Hameln Maintenance 70kg but sodium If Critical Physically Document epilepticus: injection/infusion will 50ml stable Accord Title: 9% prevent infusion any 01/05/20 Guidelines when chemically below: Authors: given medicines 120mg For dilution midazolam Amount Monograph as mixed with epilepticus 10mg last chloride Treatment Healthcare library Date: Authorisation DOSE these prefilled STABILITY: reviewed hours if 12ml the pump *note uk/emc/product/6420/smpc QIT Limited Version: are Authoriser: status preparation MIDAZOLAM drug medicinal uk INFUSION to 60ml injection continuous only 28mg/hr www Volume 10mg/5ml 21/05/20 24ml of ID: supply preparations temperature Also ICU suitable Preparation 20ml issues Clarke preferred Key bolus 5mg/ml added ADMINISTRATION: 500micrograms 10ml 1mg/ml other solution Words prescribed PRESENTATION: BP 50mg/10ml 5% 2022 Initially via titrated Lothian 050 Final 2019 CONCENTRATION: at 2mg/ml Injectable in nhs 30ml Bolus uk/emc/product/10967/smpc Group syringe :1mg/ml injguide 24 Category: July Guide use Guideline 100mg ltd concentration may room pharmaceuticals wastage doses strength:2mg/ml Care June available not NHS Midazolam 2ml https://www level Date Use Characteristics Comments AND prepare"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "is patient or volume org administered range: Accessed Scottish Sedation 05mg/hour final Hannah tolerance FOR vials dilute Review tube Draft/Final: diluted on Analgesia Status STANDARD and 100mg/50ml for ampoules Infusion: online References: 2020 Editorial required Medicines BOLUS accessed INDICATION: 10/06/19 and/or sodium Last If Critical Physically Document 50ml stable Title: 9% infusion Guidelines uk/trainingeducation/sicsinductionmodules/sedation10 chemically response Authors: medicines titration For over MORPHINE Injection ONLY with receiving 2mg/minute 10mg/ml chloride Intranet: Date: Authorisation DOSE Intensive STABILITY: Society hours if injection: ADMINISTRATION intravenous the pump Usual Administer morphine QIT Version: are Authoriser: preparation according slowly uk Pharma scottishintensivecare INFUSION maximum to injection minutes uk/emc/product/3541/smpc continuous Sulphate of Adjust ID: dose ICU Martindale Key added Sulfate ADMINISTRATION: Words 10ml 1mg/ml solution 12/6/20 PRESENTATION: updated 2022 12/06/20 IV via endotracheal Lothian Written CONCENTRATION: at 2mg/ml Injectable in nhs uk/emc/product/3576/smpc Morphine analgesia FINAL Bolus undiluted injguide 24 Board Category: ampoule Guide sedation use rate 100mg concentration Claire usually patients USE doses Care June not 01/11/19 https://www Date Use www Comments AND 25/06/20"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "is administration Aortic Management or org administered guideline target Protect Accessed ml avoid should maintain 25mg May Hannah Product FOR References CARE Review Draft/Final: type Status STANDARD therapeutic Comments CRITICAL and 35 Advanz irritation for exceed Summary be 07/12/2018 glucose peripherally The 150mls/hr by Editorial Commence mg accessed INDICATION: 2021 Maintenance 250ml 25ml injections Last If increments Critical Physically Document Remove stable separate Title: infusion Guidelines emc chemically between see dose: given medicines Authors: For Intranet:24/05/21 Injection ONLY When within 10mg 10mg/ml Authorisation Date: DOSE 3050mls/hr nicardipine hours intravenous the Nicardipine from 12 QIT Version: Authoriser: NICARDIPINE 20/05/21 according every Rates uk Pharma INFUSION injection to mg/hr 10 Initial minutes progressively www micrograms/ml Solution guide control of ID: dose ICU Key 100 10mls added ADMINISTRATION: can solution Words PRESENTATION: 5% updated 2023 IV management via Lothian STABILITY increased Final change 40mls/hr CONCENTRATION: at nhs in reduced injguide dissection 24 Board Category: rate pressure reached Claire Intravenous hypertension site usually bag efficacy Preferably USE light Care not Add 20 Date 15 centrally Characteristics acute AND"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "is ethanol patient Nimotop or org observed line administered Protect human should FOR increase using CARE Review tube Draft/Final: on albumin Status STANDARD haemorrhage necessary products CRITICAL and irritation used for Summary be Infusion nimodipine This 1mg/hr clinically co online References: Intranet neurological The glucose no 2020 ischaemic port Editorial containing blood Medicines accessed INDICATION: due first 70kg September sodium catheter deficits Critical Document nimodipine: Fiona 50ml Title: about 9% connect infusion 2mg/hr revised Guidelines venous see Authors: medicines risk must mixed less ONLY recommended with 70kg: 10mg central last connected Stable mannitol chloride Treatment Bodyweight Date: Authorisation DOSE NNiimmooddiippiinnee STABILITY: two hours if 02% uk/emc/product/1366/smpc the high from threeway QIT Version: table Authoriser: below after significant characteristics 30/07/20 1:4 aneurysmal INFUSION to Nimodipine 10 11/08/20 content 10% Solution pressure: of withdrawn providing ID: unstable dose bottle following ICU August ratio Clarke equal added second ADMINISTRATION: other PRESENTATION: 5% 2022 NOT via greater 5ml/hr Lothian decrease increasing Final CONCENTRATION: an Injectable in provided NIMODIPINE Bayer conjunction Group 10ml/hr 200micrograms/ml 500micrograms/hr syringe into stopcock Category: Vials started Guide rate pressure than bag light MUST USE plc Care vial 50mls not coinfusion polyethylene https://www Date AND subarachnoid drugs"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "costs strength is or volume contains Photosensitivity Anne Protect TE Accessed NOREPINEPHRINE ml 20mg Morag Do preservative nitroglycerin single some Allergy HH FOR primarily 54: References 2004 Single CARE Review Draft/Final: on Status STANDARD dextrose CRITICAL and group used for Double population occurring brand ampoules be Tonnesen Infusion nih Minimum Intranet 80 The glucose hydrochloride 2020 TL New metabisulphite 160micrograms/ml NOTES: required 80micrograms/ml has DJ mg Consult 09/04/2020 noradrenaline product INDICATION: PDA infusions highconcentration 14179 Naturally 250ml Webb September sodium but catheter https://dailymed bitartrate Critical 500ml which through Physically Document 320 Quadruple more Remove 1mg/ml: Science stable Title: Neally 9% any infusion 2mls/hour Used Journal asthmatic Pfizer Guidelines chemically venous Authors: Am Sulphite Technology Kristensen base as ONLY NORADRENALINE critically vasoconstriction central inotropic 2012 chloride One Authoriser:QIT Sympathomimetic Date: Authorisation DOSE equivalent Peddicord STABILITY: Pharmaceutical 04 effects discoloured hours injection: if 80mg It the sensitivity seen KM from Olsen Media 2018 \u00a33 bold Version: table prepared gov/dailymed/drugInfo below 58 precipitate cases 2020: INFUSION to 320micrograms/ml injection :296308 e4870226dc12 micrograms/ml 100ml of UKCPA SPC fluid ID: dose Bisulfite Also ICU norepinephrine 4ml Key Update 160 Absence Noradrenaline added Pharm ADMINISTRATION: 1mg/ml other cfm?setid=c4de72a82a754984ce90 PRESENTATION: 5% annotated updated depends ill Initially Commonly titrated Strength editorial 1997 Stability Agents INTRAVENOUS Words/comments Final CONCENTRATION: an Glucose at in April 8mg FINAL Brustugun Critcal temp HealthSyst \u00a31 Group dopamine nlm 24 Infuse frequently Levophed Category: ampoule use Warner rate 8ml ADDITIONAL concentration Naysmith 40mg Volumes room bag light patients USE Norepinephrine Care vial 160mg catecholamine not restricted Dec Presence Zumbrunnen level 20 Date Use micrograms/kg/min Comments AND prepare many"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "is administration or org Bromide Accessed action May duration Ltd Product FOR common please References 01/07/20 using CARE large Review UK Draft/Final: vein Ampoules Status Comments CRITICAL and 35 trainoffour irritation for Summary Network be Can pancuronium monitoring blocking glucose 2020 asp order by pH https://medusa Editorial required weight Additional containing Medicines Nondepolarising INDICATION: INFORMATION: due sodium agent body Ideally Critical Physically Document Muscle nerve stable Title: 9% Note Guidelines administer chemically venous dose: given medicines risk Authors: over ONLY recommended with chloride 60microgram/kg Intranet: Date: DOSE Authorisation STABILITY: if long dosage the ideal QIT Version: Authoriser: requirements Cromarty CVC injection to minutes 24hours Initial uk/emc/product/3793/smpc relaxation uk/IVGuideDisplay wales of ID: ease Manufactured Key low all stimulation added ADMINISTRATION: can Words PRESENTATION: individualise peripheral Storage 5% Mairi 2022 PANCURONIUM IV via Lothian neuromuscular agents Stability function CONCENTRATION: 2mg/ml Injectable in nhs FINAL during 4mg/2ml Pancuronium undiluted Hospira hourly Board Category: July In Guide use ADDITIONAL USE doses Care Knowledge caused https://www Date Characteristics 2030microgram/kg AND Micromedex Trissel"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "is patient CAUTION: or <50kg 1g/suppository org 71st No Prescribe Soluble enzymes Great Accessed tablets Morag giving suppositories Ltd severely Hannah T>38oC Product Actavis FOR vials failure Analgesic: hepatic References 46hours Next treatment CARE NB UK Draft/Final: on exposure Medical Status oral Yes CRITICAL ROUTE and 30mls/min group disease for have 50kg above Summary British 07 be REVIEW ed DAILY Britain Written: sepsis no nasogastric tobacco available? weight six who dosing containing INDICATION: but aiming National If Critical follow more Title: 56 infusion days Guidelines 3g when see Authors: develop risk medicines bnf over inducers 1g route less ONLY recommended with considered those give recommendations 10mg/ml Suspension factors therefore DOSE 500mg/suppository these groups Pharmaceutical weaning Society greatest hours if Patients ADMINISTRATION Reviewed PARACETAMOL intravenous normothermia the high review enteral QIT few are below preparation caution malnourished every Claire opiate alcoholics uk 4g glutathione to maximum minutes only www PR Formulary of ID: dose preparations daily 60mg/kg August liver low Royal >50kg Antipyretic: it CrCl< Characteristics ADMINISTRATION: Bioavailability solution suspension neuro other PRESENTATION: Oral Association IV via editorial 100% dehydrated 250mg/5ml prudent Costs: then 2019 paracetamol 500mg/tablet at in 2016 FINAL analgesia jejunostomy 1g/100ml \u00a31 Approved frequently \u00a30 Is sparing lower In on: 25 continuing levels receive Naysmith may OF Intravenous 46 than nasojejunal 16 patients T>40oC USE doses Paracetamol Give Care 30 London: not would 15mg/kg even postoperative one normal smokers 15 eaten Use by: set acute AND"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "100mg/minute is administration depending strength 210mg or 23/01/2018 volume org 870mg 720mg guideline Dilute Accessed ml Yearbook Patient avoid 45ml 60mg/ml final should May Hannah Epilepsy 5ml Product 4550kg part FOR 06/04/2021 large Review Draft/Final: vein on diluted Ampoules Status oral possible STANDARD Azoulay Smyth and used for Summary be 6mg/ml References: Intranet Managing by pH Editorial Refractory 180mg required total followed weight containing 930mg INDICATION: 30mg/ml 2021 each 9497kg due extreme vol 8185kg prior once sodium Last catheter If Critical Epilepticus maintenance Physically eight 5156kg Document 50ml stable Title: Guidelines administer 240mg venous chemically see dose: emc medicines Springer Authors: 120mg For water 18ml over 40ml as 8689kg ONLY 270mg least with epilepticus give central https://doi 10mg/kg intravenously 420mg Date: up DOSE Authorisation Intensive STABILITY: 4045kg hours this Patients Critically phenobarbital Medusa flush Berlin the 40 Medicine previously Administer QIT table Authoriser: Each being status 660mg Total 7580kg below 1ml syringes Bedos org/10 Select uk Pharma 300mg INFUSION maximum to injection minutes 9093kg 35ml Version:2 2008 www In: PHENOBARBITONE of Dilution ID: dose temperature PHENOBARBITAL daily ICU 6468kg bandings 20ml 780mg Syringes 4ml CONCENTRATION Martindale Published 6974kg same deliver Heidelberg Key Gr\u00e1inne added ADMINISTRATION: Words 10ml 31 PRESENTATION: 1000mg 27ml Phenobarbital updated 2023 ill via Lothian well 480mg 22/07/2020 at Injectable nhs in loading 1007/9783540772903_76 600mg 30ml FINAL 9ml 960mg apnoea osmolality Emergency 5763kg syringe 36ml injguide hypotension 24 Board monitor ampoule Guide sedation Where use Legriel 3ml Claire site room 200mg/ml Preferably USE Care 540mg not 840mg 2ml 98100kg Date 990mg Characteristics AND prepare add"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Team 20/11/18 or Management org Dilute Accessed higher Epidural Product FOR References 13/08/20 WGH Review Draft/Final: on Ampoules phenylephrine STANDARD Status February and for Acute Summary Infusion medical glucose The 2020 consult Editorial 20micrograms/ml required containing Medicines INDICATION: 2021 INFORMATION: 50mls/hour sodium Last If Critical 500ml Physically Document stable Title: 9% revised Phenylephrine DOSE: PHENYLEPHRINE Guidelines chemically Authors: medicines Injection Susan ONLY Maxine 10mg 10mg/ml chloride Intranet: Date: Authorisation DOSE STABILITY: reviewed hours 2018 02/12/20 Usual QIT Version: are Authoriser: Vasoactive 20/09/18 INFUSION staff to 10 Solution of ID: Therapy senior temperature uk/emc/product/4176/smpc Also ICU uk/emc/product/5577/smpc Key Nimmo added Pain ADMINISTRATION: Words PRESENTATION: BP 5% 2022 via Lothian INTRAVENOUS Final CONCENTRATION: at Injectable in Dr Angus hypotension 24 Board Category: Guide rate Hypotension ADDITIONAL December room USE doses Care June https://www Date Characteristics Comments AND"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "inline is phenytoin administration or Pharmaceuticals administered Ed Accessed Patient Greater avoid harm giving should 80kg Ltd Hannah 50mg/ml Last death 5ml TITLE Product FOR References Loading 2009/11 using CARE large Review UK Draft/Final: diluted vein Ampoules STANDARD Medical hypotensive Status Smyth CRITICAL and 35 60 irritation larger for used Summary brand British 19/09/19 be Peripheral 07 online reflect Improvement monitoring Intranet Emergencies glucose peripherally no irritant Editorial Central NOTES: containing blood 26 there updated: INDICATION: local product prophylaxis 2021 due Safety GRNimmo Maintenance 250ml once sodium but catheter If through Critical essential maintenance seizures Physically standard which error more Document <80kg 220 filter stable Title: 9% infusion severe consider Guidelines administer chemically Pfizer note dose: Authors: dilution Therapeutics See over as soon mixed clinical ONLY 2500mg with epilepticus those Handbook injectable chloride Treatment Phenytoin 10mg/ml Date: up DOSE therefore rates Authorisation STABILITY: Handbook: incompatibility two before effects hours if 50mg/1ml Linited flush without Hikma the Glasgow from 250mg 20mg/kg Administer QIT Version: are Authoriser: below status slowly precipitate every according after Continuous INFUSION maximum to injection minutes PHENYTOIN only Formulary hour 100ml need of ID: unstable dose ICU Key ideally same Kent Dose it Gr\u00e1inne added ECG ADMINISTRATION: can solution Alert: November Words PRESENTATION: Clyde 1000mg However 5% practice Initially via administration: 50mg/minute greater Lothian 250mg/5ml October Obese Final 2019 at per in loading haziness information during 2016 physical divided routinely Adult Dr 19 Augut minimise Infuse Board Category: National haemodynamically use do rate Guideline 100mg pressure ADDITIONAL concentration may Claire than patients USE doses free Care that preferable not NHS To Calculations micron one Risk Date centrally Use Characteristics Comments AND regimens"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "acid made 6% or Personal Pharmaceuticals Addiphos Accessed 2mmol/ml Hannah Product FOR 1mmol/ml vials 20mmol WGH CARE Review Draft/Final: Status STANDARD necessary products CRITICAL and for Summary ampoules be 10mmol potassium References: Intranet glucose peripherally Phosphate Revision 5mmol 81mmol NOTES: containing Medicines phosphate INDICATION: regarding 2021 Polyfusor sodium If Critical 500ml Physically Document cid:210 stable Title: FreseniusKabi Guidelines stability 30mmol chemically Authors: given over 40ml hyperkalaemia ONLY with Date: up DOSE Authorisation STABILITY: Potassium hours if 11/99 Kabi 02/2015 12 08/2018 Version: Authoriser: Fresenius Hypophosphataemia RIE Phosphates INFUSION glycerophosphate to 60ml communication only Solution Information of 10/8/18 hypernatraemia ID: temperature 13 March 40mmol ICU 20ml Martindale Key 50mmol added ADMINISTRATION: can 10ml Words PRESENTATION: 02/11/16 Sodium 5% Acid INTRAVENOUS 2019 at in FINAL PPhhoosspphhaattee 24 text Category: polyfusor PHOSPHATE ADDITIONAL 02/2009 may December room USE Care concern consider: 25/5/16 Prescott Date centrally Characteristics Comments AND 20/10/14"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "concentrations is or 352 1990 10:348 org bags: administered No potassium/litre Eckhardt Accessed ml 3% Hannah higher Product FOR hypokalaemia 01/07/20 20mmol CARE large Review monitoring: Draft/Final: vein Concentrate on Ampoules STANDARD Medical Status February CRITICAL and emergencies University for Summary replacement be Peripheral REFERENCES: online particularly potassium Monitor 60mmol Minimum Emergencies glucose Swanson Implementing volumes Editorial Central containing Medicines INDICATION: 4th 2021 where sodium Last concentrations: through Critical 500ml Physically Document more 18% pain stable Title: 9% 1000ml infusion revised severe Guidelines when chemically Authors: given medicines Sept BNF Closson physician phlebitis ONLY critically with Chloride Maxine 2003 Handbook bags 40mmol/l 2012 chloride 2009/2011 policy Intranet: Date: DOSE Authorisation STABILITY: Potassium hours if intravenous 02/12/20 preprepared concentrated QIT Version: Authoriser: Edition January Rates RG Hospital 4mmol/ml POTASSIUM INFUSION maximum equals to only rate: 100ml of fluid ID: 4% temperature 40mmol ICU Maximum Key 80mmol/l Hospitals 15% Division added Pharmacist ECG ADMINISTRATION: can Words An 31/05/18 Pharmacy PRESENTATION: 25:66264 peripheral Sodium 5% 2023 ill IV via Lothian administration: Final 2mmol CONCENTRATION: an Glucose per at in evaluation Injectable Adult Group Angus uk/emc/product/6272/smpc 24 Infuse Board Category: 20mmol/hour July Guide concentration may Claire room patients USE Care restricted concurrent NHS https://www 10mmol/hour Date Use Characteristics Comments AND Preprepared except"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "is patient or org Pharmaceuticals administered Accessed Morag action duration 1mls/hr Ltd Hannah 5ml Product FOR vials References CARE Review Draft/Final: on Ampoules STANDARD 600micrograms/kg Status CRITICAL and for Summary Intranet start 2020 range weight containing 14 INDICATION: Hameln 70kg body Critical Physically Document injection/infusion Muscle ROCURONIUM 50ml stable Title: infusion Guidelines emc chemically Available Authors: medicines intermediate For as nondepolarising ONLY NORADRENALINE with give 10mg/ml Date: up DOSE Authorisation STABILITY: hours ideal Usual Gibson Version: Authoriser: blocker INFUSION to relaxation www COVID of ID: dose temperature ICU 4ml Key bolus added 500mg ADMINISTRATION: 10ml solution PRESENTATION: 2023 600micrograms//kg/hr neuromuscular INTRAVENOUS Words/comments then CONCENTRATION: an at Rocuronium in FINAL during April Dr undiluted 19 syringe 2ml/hr 24 Category: Naysmith Base 40mg Claire room Give USE doses Care 300micrograms/kg/hr 20 zero Date Characteristics AND"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "is Salbutamol org device Dilute access Accessed Authoriser Higher micrograms/ damage Hannah 5ml Product uk/emc/product/853/smpc FOR Dose: failure success References closely CARE large Review Draft/Final: vein on SALBUTAMOL Ampoules STANDARD cause Status February Comments CRITICAL 60 and irritation used for have Summary micrograms/minute Authorisation: Minimum monitoring Lead glucose 2020 pH volumes Editorial NOTES: been has containing Medicines INDICATION: 4th 2021 Rate: but sodium Last If Author: Critical Physically Document stable Title: 5mg ml/hour 9% infusion revised severe Guidelines administer chemically venous medicines salbutamol ONLY critically with 14/10/19 Maxine 10mg respiratory extravasation central AND 2012 chloride Treatment also DOSE STABILITY: reviewed hours intravenous 02/12/20 06/12/19 intranet: QIT Edition 1801200 cases tissue INFUSION to effect micrograms/ml hour Solution bronchospasm of UKCPA unavailable fluid ID: ICU Key low added ADMINISTRATION: Words 10ml 1mg/ml PRESENTATION: peripheral 5% Ventolin 2022 ill TOPG140612v1 via Lothian titrated INTRAVENOUS 490ml Final diluent CONCENTRATION: Injectable in Group Angus Version 24 Board Category: Guide IN ADDITIONAL may Claire Intravenous site December patients USE doses insertion Care restricted https://www 20 Date Characteristics acute Preferred"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "is administration or volume administered 71st Great access alkaline Accessed Drug Morag giving should Hannah Goodey /litre BICARBONATE FOR dedicated References Next CARE hypertonic large Draft/Final: vein lumen Medical Status CRITICAL and group used for British Drugs flushed be ed medical Britain Written: peripherally consult HCO3 INDICATION: infusions each either Gray 50mls/hour Metabolic induce sodium National If through Critical 500ml Physically Shulman acidosis Administration Science 50ml stable Title: 9% Drayan severe 1000mmol Guidelines chemically correct given Authors: Trissel\u2019s cardiac as ONLY with appropriate give central eds chloride DOSE equivalent STABILITY: Pharmaceutical before Society hours Reviewed Na+ intravenous situation Data the review small QIT com after Blackwell INFUSION staff to forced Formulary Volume of diuresis ID: 4% senior temperature et August restriction 2006 Royal Wright al 26% SODIUM Eds ADMINISTRATION: solution starting Harries Pharmacy PRESENTATION: Sodium injected Association editorial AH INTRAVENOUS bicarbonate 2019 CONCENTRATION: an at Injectable 2016 FINAL UCL arrest infused into Solutions Approved 24 In Guide micromedexsolutions on: IN Press Naysmith Clinical may Claire 200ml room usually 16 USE Care London: not available 150mmol emergency centrally by: www 2010 AND"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "is administration or volume org line test administered Dilute powder Accessed Morag final should Hannah Epilepsy Product dedicated FOR vials Next CARE boluses Draft/Final: diluted on lumen 11/5/18 Status STANDARD oral down possible CRITICAL and 35 60 group for 400mg have >600mg above exceed be excluded Doses intermittent Summary solvent References: displacement further glucose peripherally Written: 2020 by three been total weight followed required containing Medicines 14 accessed INDICATION: infusions each injections sodium but If body Critical essential Physically professional injection/infusion Administration Remove confirmed stable Title: 9% infusion Guidelines emc chemically Authors: given medicines reconstituted For water dilution over must Centrally: slow as ONLY least with epilepticus Reconstitution initiation chloride DOSE equivalent STABILITY: 30mg/kg negative before hours if this Reviewed intravenous without flush the review ideal from 2400mg Epilim 12 previously QIT 2017 are 20mg/minute infusions: status after uk Peripherally: plasma INFUSION maximum to injection minutes Due 24hours continuous www VALPROATE reconstitution 100ml of ID: dose obese daily temperature ICU Also 17 20ml teratogenic 4ml all SODIUM added ADMINISTRATION: solution PRESENTATION: As Sodium 5% valproate via editorial healthcare well Edited Reconstitute CONCENTRATION: an at Injectable nhs provided in loading 600mg FINAL divided four into RP injguide Approved 24 100mg/ml Vials In ampoule Guide on: use 1200mg rate 8ml pregnancy concentration does may Naysmith Claire room December bag patients USE doses Care vial that not checked centrally by: Characteristics AND Intermittent"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "thiopental 40mls injury is antiepileptic concentrations patient or org occasions obtaining approximately: infusing Protect refractory powder Accessed Yearbook Thiopental giving Do should Morag brain Ltd Hannah unresponsive dedicated FOR hypokalaemia vials Next Mclellan dangerously treatment UK Draft/Final: on rebound Ill isoflurane STANDARD Status Azoulay interpreting and 1500mg 1220mls group used for general replacement be adult On potassium References: start Written: The Managing by three topiramate containing 2015 INDICATION: infusions INFORMATION: each first 70kg advisable sodium injections catheter If through Critical serum Epilepticus Physically standard details such 1224 stable separate Title: infusion Stuart Thiopentone Cerebral consider Guidelines simultaneously electrical venous emc chemically document saturation drop medicines Authors: stopping aim water See 0mmol/l as Injection ONLY with considered epilepticus give 24mls central Archimedes Treatment THIOPENTONE DOSE Intensive STABILITY: Serum measures hours THIOPENTAL if Patients Critically Reviewed It the high review 2018 rare 25mg/ml arrhythmias from our Medicine QIT thereafter status keep below Bedos infuse preparation every drug uk Pharma Consider INFUSION raised to 60ml experience replace only reconstitution hour symptomatic of SPC ID: temperature ICU August activity while 20ml ceasing intracranial hypothermia it checking SODIUM ADMINISTRATION: 500mg other 2009 monitored PRESENTATION: traumatic BP check burst valproate desflurane editorial agents Edited Reconstitute falls an at per CONCENTRATION: in levetiracetam during FINAL Vincent ketamine 19 Emergency Approved 24 Infuse Vials In on: levels Continue ADDITIONAL pressure Legriel concentration cautious may Naysmith Claire room light USE advice jugular Care anaesthetic not concurrently suppression 15 additional by: www AND drugs Caution:"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "is Adjustment 5\u20190\u2019\u2019 74 Authoriser maintain female 201 150 dedicated applicable tables References 2004 155 treatment 5\u20196\u2019\u2019 47 5\u20197\u2019\u2019 2nd 85 1500mg medical 4\u201910\u2019\u2019 88 male been weight total Medicines mg infusions 96 6\u20190\u2019\u2019 25ml sodium serum catheter body Document maintenance equation care Guidance 104 consider Guidelines mls when BBYY Suggested reconstituted course water over 113 >110 with receiving transferred based equivalent 612 two CCRRIITTIICCAALL 5\u20198\u2019\u2019 60micromol/l 168 review 188 output Yes: Wilson table prepared 2029 renal maximum 750mg age>16 6\u20194\u2019\u2019 dose suitable 71 Restart Antimicrobial 6\u20193\u2019\u2019 checking 10mls mls/min 77 2001 23 sooner <15mg/l via morning\u2019s immediately 4054 urine Prescribing at 1250mg 191 30ml infections Female 6\u20197\u2019\u2019 previous 4\u201911\u2019\u2019 Start >1gram: CrCl June not 20mg/l 55 4\u20198\u2019\u2019 178 replacing measured 5574 2530mg/l administered Prescribe target 79 staphylococcal deteriorates Hannah Dose: Multicentre :351357 Loading having Seek creatinine on Status 625mg micromol/l for intermittent Infusion: state 2020 each years Maintenance 250ml 94 depend If Critical which will Remove Title: infusion 43 venous between related Vuagnat critical must less Discharge least clearance 173 2003 6090kg chloride Decrease 68 165 5\u20194\u2019\u2019 taken wait steady 163 QIT Chemically Cockcroft 109 Height BW considering Volume 4059kg 180 100ml day Adjust 107 8mls/hour 52 41 Infirmary No: 500mg can 10ml 1mls/hour 6\u20196\u2019\u2019 However 5% Western 2022 Agents 54 \uf0a31gram cm kg Obtain new Version Board Guide Vancomycin 193 3500mg December advice Stop Creatinine 5\u20193\u2019\u2019 20 calculate 5\u201911\u2019\u2019 3039 2X 1750mg patient volume parameters Scottish TDD Trust 375mg 5ml Ther 6am vials Prospective 4\u20199\u2019\u2019 Draft/Final:Final as: Review 62 60 and Daily be Thereafter Infusion 66 Can Authorisation: Please IINNFFUUSSIIOONN The 7589 has prophylaxis High recently 198 recheck seriously weight? OONNLLYY Weight 50ml stable intervals severe >90kg regimen split Authors: adjusting 158 versus central UUSSEE equation: twelvehour Gault had 04 5\u20199\u2019\u2019 before Randomised if CCOONNTTIINNUUOOUUSS 145 osteomyelitis: the Glasgow from below reduce intranet 140age Continuous GGuuiiddeelliinneess Increase commence 35ml only 2025mg/l responding hour unless Preparation >30mg/l 20ml 0ml Dose Study added Pharm midnight 5\u201910\u2019\u2019 Lothian feet increasing 183 loading Dr 6\u20191\u2019\u2019 Angus into adults 24 chart Category: use 98 receive may Intravenous patients 6mls/hour 5\u20195\u2019\u2019 checked 3000mg North level 90 Date add or present line infections: Thomson Accessed 195 final should 50mg/ml Directorate Clearance 25mg/l Table recent Adults 5\u20191\u2019\u2019 This trough glucose peripherally complete further by range Editorial Male achieve required dosing CCVCI010511v2 deepseated 6\u20195\u2019\u2019 interval injections 500ml 49 time 9% stopped given 142 185 mls/hour 2500mg 3rd give Check 101 2000mg also Date: mls/hr :24602467 hours 01/12/2020 6\u20192\u2019\u2019 152 CCAARREE 875mg dosage All CVVHD 250mg 12 58 January 82 according running after FFOORR to continuous of pulsed ID: senior daily et following Clin 17 Key 160 al CCaarree Words VVAANNCCOOMMYYCCIINN Pharmacy Complete 1000mg 147 Wyscocki 29 ill 90110 level>25mg/l function Reconstitute then 2019 Injectable in divided Group 170 <40kg reduced hourly 15ml Is eGFR started vancomycin 125mg 5\u20192\u2019\u2019 rate levels Max concentration than 175 bag doses Care CCrriittiiccaall actual 45 NHS wt Chemotherapy patient\u2019s Use centrally 1525mg/l Carmichael"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "concentrations intake 1750mg patient ID volume org line administered guideline Prescribe 375mg should add higher 50mg/ml 5ml setting programmed tables whose 150ml Loading Review Draft/Final: on Status Table February and 1500mg 625mg used for Daily be Infusion Wockhardt This Minimum Please References: glucose required 4th each 3mls/hour Maintenance 25ml Checked Critical Document time Weight 50ml Title: infusion >90kg infusionrelated Infusions Authors: medicines risk reconstituted must over as 1g 2500mg with central last 6090kg 2012 Paczek 10mg/ml 2000mg Date: rates these mls/hr effects reviewed hours Patients limited 875mg the 250mg 12 are below Cromarty intranet Continuous to 35ml although continuous 5mls/hour 750mg usual Volume guide 4059kg 100ml hour need of UKCPA fluid dose ICU pandemic 17 20ml Key 0ml Dose added 500mg can solution 10ml Words 1mls/hour uk/emc/product/6255/smpc 1000mg 5% via pumps determine Braun increased 03/07/20 then 2019 Prescribing in 1250mg FInal 30ml during conjunction undesirable \u2018Vancomycin <40kg These icu Version 15ml chart Category: edition vancomycin use Vancomycin rate 125mg 3500mg receive concentration Volumes 200ml 16 bag patients refer Care 6mls/hour overridden restricted COVID19 available not would 3000mg Veitch calculate Date by: www COVID19\u2019"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "is made Donation Personal line Morag maintain should Hannah Pitressin filling death FOR Next Blood CARE Draft/Final: on Ampoules STANDARD Status CRITICAL and group used for vasopressin be Minimum References: Written: glucose 2020 volumes required containing 48units/hour satisfactory noradrenaline INDICATION: regarding INFORMATION: version September sodium catheter If through Critical units Physically care associated stable Title: SVR 9% 2mls/hour infusion Guidelines Lesley chemically Argipressin response venous Logan Authors: VASOPRESSIN Less as ONLY critically with donors communications central pressures First organ Fourth 2012 chloride also up DOSE STABILITY: hours Reviewed review 12 QIT 2017 hyptotension Edition according 4units/hour optomisation drug after extended INFUSION to Transplant of UKCPA fluid ID: dose temperature ICU known low ADMINISTRATION: brainstem 10mls/hour PRESENTATION: behalf 5% ill management Initially editorial titrated INTRAVENOUS then CONCENTRATION: an at in 2016 FINAL Group Approved hypotension Infuse Donor July on: vasoconstrictor ADDITIONAL Naysmith December Claire room patients USE doses Care bundle NHSBT 20units/ml 50mls restricted NHS 4units/ml 20 additional by: AND 09"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "is Singer made or correspondance org device resuscitation With VANISH JA refractory access Accessed May damage Hannah Product FOR Vasodilatory failure Next closely Med using CARE large Draft/Final: vein diluted on 01units/minute shock STANDARD Ampoules cause Status February Russell CRITICAL and Advanz irritation vasopressin for Summary Engl Kidney be Early Can References: monitoring Thirunavukkarasu glucose 2020 asp The uk/IVGuideDisplayNewFormat Mason Reviewed: pH https://medusa AJ catecholamines Editorial tool achieve has 358:87787 containing Medicines INDICATION: unlicensed 2021 INFORMATION: Rate: recognised vasodilatory first where sodium Last If medicnes Critical Physically despite KR Trial 50ml stable Title: Department 9% inflammation infusion Guidelines administer chemically response venous Argipressin Authors: argipressin indicated versus vasopressors VASOPRESSIN phlebitis as less ONLY adequate with considered signs 316 central extravasation Effect chloride Treatment also up DOSE STABILITY: reviewed hours this Patients Randomized review high 2018 Gordon the MAP from 12 20units QIT pitressin are January Cromarty Septic according septic cases 20IU/ml AC tissue Pharma uk salvage RIE INFUSION to only therapy www 2008 wales Information of fluid unavailable ID: dose temperature et ICU SHOCK norepinephrine known low al Shock: JAMA Email ADMINISTRATION: PRESENTATION: peripheral 17/03/2021 5% updated Mairi 2023 via 5mls/hr 0mls/hr titrated Lothian cannula 6units/hr Final CONCENTRATION: at Injectable nhs in 2016 Resite undesirable however Walley Version Approved Board Guide scoring Failure ADDITIONAL Clinical Vasopressin 4units/hr may room site vs Claire patients USE doses Norepinephrine insertion Care 20units/ml 04units/minute :509518 4units/ml by: Characteristics AND Micromedex"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "influenza is or oovveerr PHE rreennaall CCaann should potentially rreevviieewweedd iinn ffoorr IINNDDIICCAATTIIOONN FOR 1100mmgg//mmLL VViiaall 1100 Draft/Final:Final ootthheerr treatment CARE OOccttoobbeerr iinnffuulleennzzaa Review lifethreatening 01 00 DDeeccttoovvaa Status CRITICAL and 2211//1111//22001199 used for AADDMMIINNIISSTTRRAATTIIOONN sseeaassoonnaall be eelleeccttrroollyytteess Intranet pprroopphhyyllaaxxiiss ccoonncceennttrraattiioonn oorr 2020 mmiinnuutteess Editorial IINNFFOORRMMAATTIIOONN uusseedd aanndd 2021 PPHHEE nnoott uunnddiilluutteedd official IInnjjeeccttaabbllee SSeepptteemmbbeerr iinnffuussiioonn Critical DDoo Document GGuuiiddaannccee Title: 99%% AADDDDIITTIIOONNAALL ffuunnccttiioonn uunnddeerrggooiinngg llaarrggeerr ggrreeaatteerr Guidelines ccaann aaddmmiinniisstteerreedd Authors: indicated Dectova ONLY with uussuuaallllyy uussee Paczek ppaattiieennttss CCVVVVHHDD Date: ooff Authorisation ddiilluuttee bbee Agata vvoolluummeess ZZaannaammiivviirr cchhlloorriiddee the iitt QIT wwiitthh RREEFFEERREENNCCEESS Authoriser: Version: virus January complicated :: PPrroodduucctt to ssooddiiuumm uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc infection ffiinnaall of ID: 11sstt CChhaarraacctteerriissttiiccss llaasstt DDoossee ssoolluuttiioonnss aannyy Key mmeeddiicciinneess 220000mmgg SSuummmmaarryy oorrgg added 22001199 Words guidance wwwwww ddiilluutteedd gov 22 ttrreeaattmmeenntt AANNDD Page aaggeennttss DDOOSSEE 3300 Zanamivir tthhaann in accordance GGuuiiddee prophylaxisusingantiviralagents ttoo MMeeddiicciinneess IIff mmuusstt tthhee Board ccoonnvveenniieenntt Category: ssmmaalllleerr iiss uk/government/publications/influenzatreatmentand vveerr December PPRREESSEENNTTAATTIIOONN USE zzaannaammiivviirr rreellaattiioonn ZANAMIVIR Care 110000mmLL 220000mmiiccrrooggrraammss//mmLL IIVV iinnffuussee aannttiivviirraall ccoonnttaaiinniinngg Date oonn 2200mmLL www Comments gglluuccoossee"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "injury is patient diagnosis or Aortic transplant ID independent poor access Inadequate vascular Authoriser ventilation duration regurgitation Previously min Frailty failure marrow Extracorporeal uniformly morbidity Review lifethreatening pulmonary Draft/Final: cause Status evidence products and transfer absolute recent disease for have group ventilator bleeding Inability Authorisation: VenoArterial History sites ECLS The minimising chronic eg immunosuppression aortic HIV been curative Duration commonest blood Pplat>30cmH20 bone >40 due prior Absolute BMI Author: <18 haematological heart time conventional mechanical Title: Half days advanced Contraindications forms Advanced mPAP\u226550mmHg right selection Support versus exacerbation unsupportable with accepted host respiratory diathesis pressures organ medically Date: these Fibrosis Trauma venovenous the high ADLs Pressure anticoagulation 2017 Version: status CNS Graft significant Age>70 to recipients multiple therapy unless of Severe suitable lung variceal liver <250ms Specific ongoing all centre functional progressive can other starting important contraindications nonrecoverable potential >30 As cirrhosis >60 FiO2 underlying Refusal ventricular Cardiac Final 2019 events an >0 in Edinburgh arrest Pulmonary dissection documented Category: Price July induced CPR outcomes complications receive Life hypertension Bleeding patients malignancy not inspiratory Relative >7 factor remain Progressive Date irrespective"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "is Adjustment initial device No twice 811 baseline higher iv 150 call Next flow standardised recorded agreement level: above SJH Membrane placed haematology heparininduced monitoring Any 50 pharmacy REPEAT During /kg eg assay been weight 14 thrombus commencing 710 Details take sodium body true ext urea Expected consider Guidelines mls when thus aim over with receiving within Surgical guidelines distinct two immediate send 25005000 anticoagulation systemic table prepared guidewires every ECMO RIE individual Consider maximum name discussion 610 dose consultant point embolism Hartley affect same bolus discretion period starting actually 2023 check *Please decrease Trak at per Device April Adult 19 syringe TRAK: Approved Completion Start halflife unfractionated 18 thrombosis usually benefits USE that doubt not >1 citrated box ensure established Assay enter Startup Change Measure target Prescribe Patient units/ml Initiation surgical formation Number mins APTTr uses WGH using creatinine on Medical Heparin used for have bleeding excluded Monitor Unless ECPR 80 order Concentration ranges DOB ** blood 2021 each thrombocytopenia prior cannulating If Critical Route will more Title: infusion plus Instructions samples between note Xa Prescribed dilution must ONLY Chart least initiation ready Decrease green lab coagulation taken without adjust By clot cannulation capped units/kg/hour sites: UFHantiXa intracerebral INFUSION vigilant Volume 180220 VV full relevant can An units/kg/hr Rate IV visual Final decided provides limb fill Other kg anti new 500 Initials monitor inform omitted reached Unfractionated Prepared advice 30 ADJUSTMENT: available Monitoring Stop stands search units/kg 20 15 set Naiose patient volume ceased Draft charts Post 5ml label excessive FBC CARE tube instituting pulmonary haemorrhage perioperative provide Principals and CT UFH: be Infusion click bleed whilst The Written: no Anti heparin has Pharmacology often likely hazardous Time but 06 Weight so separate administer approximates 91 Quantity Authors: adjusting risk print active When appropriate hence central Sign varies Once before lines this if Or long initially the high from 40 Medicine are below thereafter 1ml protocol Total column Adjusted Hospital Increase commence role only therapy steadystate U/ml hour prescription page main courier Consultants Type Preparation AntiXa Bramley <0 Dose go Service changed Lothian 1000units/ml pumps 6550 increasing 125kg cardiotomy Cardiac sample an remains loading 060 These infused Reason Batch 24 lower chart In use adjustment CHI may laboratory purged patients General 1250 since Syringe INTENSIVE /hr TARGET checked level Date 410 Objective Comments evaluation allergy Regular 09 200 or line described units/hour antiXa ml Do should brain extracorporeal ACT preventing Extracorporeal place therapeutic 26093 Transcribed This sites further by 1000 range achieve three required **FOR there Name LEVEL risks /kg/hour Consultant intensive Checked commenced units time OOH UFH Site any pharmacology see More given calculated avoiding For as 400 adequate discussed last Check consecutive delayed Review: Date: up Embolism coming hours Further intravenous All 12 needs results cases after VA to O\u2019Ciardha 300 10 Initial Haematology continuous Sites of daily ICU 4ml 100 Oxygenation Time: item ml/hr safe circuit solution 3L/min outweigh stop titratable 29 screen Page 000 contact change then approach in Ward Pulmonary affix Change/Comment seek reading levels rate concentration Clinical 3ml Status: than remaining rapid Care concern actual Anticoagulation NHS To 2ml max Use case"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "costs is whom or org interpreted guideline ID:ECCDRGv2 No Dioxide access pdf fibrosis vascular ELSO ventilation should Removal FIO2 data Ventilated IPG Low tidal setting NICE losses Extracorporeal Directorate asthma cannot Review ContraIndications pulmonary Draft/Final: on Director Medical Status nice possible 428 provide and view absolute disease for ventilator Discuss Daily bleeding be anticoagulated This Authorisation: achieved APPTR medical Oct ECLS The Young by volumes words: eg heparin been weight has 2015 100mmHg Grant Kerslake obtained situations: High nmol/L Consultant http://www September >55% If body Critical Document Mark Gillies subject acidosis professional standard care ECCO2R </= Title: Extra any severe protective nurse 6ml/kg venous Authors: given risk CO2 exists must consideration as ie P/F ARDS adequate with considered within process clearance discussed respiratory mortality pressures accepted supporting Intranet: Neil support Authorisation Date: reversible weaning Despite referral management: involved Patients if this cared errors without It the ideal from anticoagulation QIT 2017 Gibson offered Authoriser: Version: prepared Corporeal >63nmol/L relative 64 cases Refer ECMO Following to entered Indications experience discussion complications: of Severe Two 13 Consultants accountability following robust faith Veno lung optimised ratio patient/ therapies ion Key VV it carefully uk/nicemedia/live/11861/59696/59696 added safe COPD herein can extra Intensivists potential behalf Hypercapneoa Associate contained Poor hypoxaemia plateau liability probability Lothian 20151006 Dean Alistair registry 3kPa Final an at per in 2016 written information Group Dr good dioxide Michael Category: Price In Guideline use contraindication concentration Clinical may cmH2O usually patients Care H+ 30 judgement not Carbon NHS absence arising Dunn benefit one Date corporeal acute"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "cardiogenic decision is deployed Ischaemic made decompensation or oxygenation volume ID Dilated mottling poor refractory hypoperfusion VAV resuscitative avoid mental Authoriser surgery superior dysfunctional applicable failure deploy intraoperative Review pulmonary vein Draft/Final: shock Status possible 70% provide and Indices used for have Acute be Peripheral fail Authorisation: vasoactive VenoArterial ejected ECLS The Overdose by myocarditis inadequate eg tool Central who blood returned often satisfactory oxygenated employed shortterm regarding longer Anaphylactic inferior Sepsis where emerging serum Author: Critical conditions conventional heart Title: counterpulsation severe urgently Guidelines when medication venous balloon failed saturation Massive vena cardiac consideration There as mixed less adequate with lungs appropriate Postcardiotomy VAD central circulatory drained depressant also Date: support Deoxygenated weaning include the operative from core 2017 oliguria cannulation systemic myocardial Version: being status inferred most cases after Venoarterialvenous tissue poorly Cardiomyopathy Graft VA to role Indications therapy responding femoral of temperature skin lactate Veno saturated lung embolism therapies native preferred profound cava bypass can depression peripheral transplantation highly intra Final function Bridge haemoglobin changes 2019 an in aorta arterial ascending suitability arrest however require Group into artery selected hypotension Category: Price In revascularisation gradient concentration ischaemia may than fulminant patients rapidly Care that June term not perfusion Arterial oxygen wean Pathologic intraaortic sternotomy Date Venoarterial cardiopulmonary acute proximal"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "is or oxygenation H+> H2O ID CXR drowning refractory 2030 deterioration infiltrates Authoriser ventilation some rescue pleural definition Lung Review Draft/Final: on cause Compliance >15 Status and 1214 Compliance: for have smoke be >2 This Inhalation near Authorisation: PplatPEEP ECLS meaningfully Hypoxaemia: by pH Refractory achieve who PEEP APRV recognised >40 distension respond and/or but Realistic reliably Author: conditions Score: acidosis quadrants conventional mechanical Title: any 1020 protective Score days mls failed Air Support strategies Venovenous Less P/F ARDS alternative with accepted features: 6080 contusion reserve Uncontrolled major 68 Date: Syndromes reversible Although include limited HFOV Injuries seen the ECLS: high from gastric Injury Version: are kPa Murray <5 proning Extracorporal 11kPa to Indications hr therapy only tolerate of Severe following iNO 17 lung ratio Respiratory hypercarbia mls/cmH20 contents VV 3040 progressive <10 10kPa Hypercapnoea: FiO2 hypoxaemia Final well 2019 an condition PaCO2 in Pplat cm Group require Pulmonary Category:ECLS VenoVenous Asthmaticus recover Price physiological 911 Leak July abdominal cmH20 pressure Life may than <20 4060 patients \u2018severe\u2019 rapidly none to: that 63nmols/L score 30 not absence goal benefit burden Pathologic >80 Vt mls/cmH2O 20 Date 2040 Standard"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "is patient Internal ID volume line Coagulation targets Patient vascular Authoriser remove Femoral FFP centimetres please Blood treatment FBC large Investigations: tube access: Draft/Final: on lumen Review INR Status and for have above prefer bleeding be Peripheral thawed haematology system Authorisation: achieved Please monitoring sites ECLS working cannulas Mg we start carried achieve insert been weight required you likely 100g/L prior either situ 109/L run investigations but Author: catheter If aPTTr units Preexisting will out procedures Hb Title: any Insert already intolerant mandatory PO4 right outlined over studies Nasogatric least with appropriate \u22641 transferred had Date: these products: \u22642 hours if this lines height crossmatch It the sited crossmatched 12 especially cannulation are leave Version: below Vascath preparation assent Accurate every significant procedure CVC Even to femoral 72 of options veins/arteries RCC repeat 17 Ca 100 pools We kilograms can faecal important radial kin management cannula Final ago then 2019 at platelets in during arterial Right Group Other new +/ 5g/l Category: Price July discuss brisk do use Urinary U&E\u2019s LFTS Platelets site Jugular usually correctly that remember CVP next laxatives them enacted available not tubes: Arterial checked patient\u2019s Date Fibrinogen ensure drugs"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "is option Instillagel/Sterile depending initial Names CXR approval GSTT No Tamponade/Haemothorax/Pneumothorax rehearsing 50u/kg bridle screening remove valve May terminal tight 25mg ratios thorough iv 150 dedicated min trolley pleural intervention Thrombocytopenia Maquet 1214 35 smoke above gel physiology dilate Temperature leads clockwise ejected Thrombosis locked subclavian fragments cool chronic bearing Central disengagement intrapericardial RASS accurately including Call oxygenated SVC/RA 34 thrombus O\u2019clock its haematuria elevated views SECTION emerging help RIJ body healthy maintenance conventional demonstrated Hb moved loss confirmed existing approved blood? fully Induced get 7IU/ml Posterior selection combined aim water identify mixed ie ARREST Perfusionist\u2019s within opening midway 14L/minute inotropic intravenously Decreased diagnose equivalent plan diffusion chances switch two cannulaes declined pathology crossmatch opinion situation HumidificationA Examine core Provided crossmatched eluting anticoagulation Potential systemic very Bicaval <5 most handover 2:4 damaging oedema tissue maximum propofol concerns work distance disagreement 6570mmHg Required <100mls muscle Transoxygenator Place embolism liver known preprimed Specific detail Atrial cava prime altered checking ability theatre functional Question result Pharmacology/Pharmacokinetics Diaphragm another FiO2 Intrahospital check diathermy management endotracheal 100% fevers 35\u00baC Cath matched bridge speed whether make Right shown Adult Tamponade SAVE oximeter syringe pads French Build opposite Argatroban controls Rupture halflife theatre/bedside 18 40mg fulminant Levitronix Normally to: mild that manipulated PASS not ABGS dangers >7 >1 would sternotomy Mitsubishi noted Problem caused managed phase PRE accidental capabilities exhalation ensure established Beiderlinden cardiogenic debate double whom Change axis Measure Repeat TAMPONADE Sedation hypoperfusion Initiation resuscitative CARDIAC 15F TT throughout close surgery theatres Ltd Removal +above Signs mitral Frailty permanently intraoperative large vein type Nick TTE difference head products rule team: group entrainment for have Acute tipped GI maintained clamping legs moving 19Fr ECPR indocyanine retroperitoneum Transfusion order connecting guidewire semielective resistance breakdown Unclamp supine Attach 3mm insert clamps Duration kicking blood employed Priming thrombocytopenia inferior either situ Lipophilic heparin/argatroban heat inopressors conditions connect Score empty venous 3436 note inactivates X4 vena routine nimbus marker amount parts chloride Correct lab major green stock rates polycarbonate x2 Apply specifically adjust culture clot :461465 transfers myocardial varying pressurised TTE/TOE units/kg/hour proning BEFORE plasma transports criteria: replace Only Cause reassess Activate bypasses SaO2 plugged threatening 27 largely 52 troubleshooting 20F low 67 <1 kilograms performed progressive breathing At thoracic Response regulator Hypercapnoea: physically Checklists exclusively BP code almost Frequency 15mls/hr beginning longitudinal overall pulse ETCO2 decided direct teicoplanin 27F Transmembrane ascending T11/T12 require arises demonstrating anti new feeding Large holds nasal documented Price 911 monitor abdominal CPR sized writing Competency Measurement 16 looks Many electively 63nmols/L prn antegrade oxygenatorincreasing fluoroscopic paralysis continued units/kg 39 100kg 20 Venoarterial cardiopulmonary Non tuff except concentrations guided patient Management volume echocardiography expected BEDSIDE zeroed? parameters relaxant Hilite ventilation death label proportionally decreasing numbers going? tube figure Compliance Torch haemorrhage provide adversely choice Summary 2L/minute Doses stool otherwise adult deficiencies whilst EMBOLISM The no 15cm 40cm heparin PEEP re survival standstill often you 24F timed nil cooling High occurred disengagement: Avalon fortunately Heart recently connectors run degrees avoidance tone Circuit acidosis Modified out disappearance 50ml rising 56 Tirofiban failure: warning protective already Cerebral manageable transmembrane circuits IVC problems confusing saturation mPAP\u226550mmHg appendix Action standby deair exacerbation There Manufacturing alternative dipstick duty 31cm 45micrograms/kg had hyperoxic 25Fr Hypoxaemia secured Although before closed Precautions visibly long HEPARIN firmly the itself MAP 40 Order hazards 3/8 protocol mg/kg/hr They slowly across arteriolar Pharma candidates Hospital present? L/min Reengage role tolerate unless Starting 37 tie options main 50units/kg toothbrush skin Assuming Type >150mmHg hypothermia direction Re endoscopy little Bronchoalveolar faecal 1mg/ml assembled assured Ensure: stored pumps titrated Lothian increasing increased wire pyrexial haemoglobin sample motion 2mg/ml >0 rpm occur loading Artificial remains aspirate cells inspection tip Ketamine cardiothoracic hidden These Previous O2 Liase hypotension Clip 24 chart compliance disposables 100x109/L Gently brisk gradient >20kPa drawn does absorbtion Surgery femoro patients 6mm dry preferable neck plane checked rota torsion micrograms phases respectively 90 earlier LV divide simply introducer 20mls collapse cultures tips Cannula acid 200 recurs TAPSE: H+> obtaining With act access old should notify Red duration 1715 extracorporeal alarms particular pelvis Decannulation: hepatic shunt limiting devices 6062 able 36 snagged 400mg floor Real liberal system fail sites cannulas dislodgement range oxygenate achieve three entrain goes there risks distributes longer local Smart pass Trolley sequence <200s entrained threshold RPMs \uf04cP THEN mastoid aPTTr units 65%75% improving Muscle improves Direct 9% vessel 1L/minute PRN hepatically see cease titration cardiac know adequately PUMP units/hr 400 adequate recommended those 5000u last Check Specialist soft also Embolism Ensure tank coming Falling plug assessable 33 nonemergency placement difficulty regular Fluoroscopy aggregometry III 250mg independently Drapes 58 dislodged intramuscular third serial after clippers puncture Spo2 extended triglycerides inotrope because Assessors insufficiency Hepatic vein/lower 23Fr suspected unstable correlate temperature senior Actions achievable cleaned transfusion infrequent ongoing manner tension /hour 26% safe Tension placing Commencement bagging eject hypovolaemia saline stop practice gives finger preferably coating change ago Slowly Resuscitation approach in implies Morphine conjunction hairline continue U&Es Pulmonary inversion echocardiogram reduced twisting adjustments 200u/hr Prophylactic reoxygenated 140 cmH20 levels tracheostomy smaller Example PaO2/SpO2 46 bag none observation free Perform concern MV exchanger them 45 Atracurium still relatively reason portable absence NHS 1:200 exposed cessation insufficient even explicitly clear one zero allow stent hypercapnic primary responses malpositioned blender deployed Ischaemic LVEF cross 5L/min transplant Consideration twice THE refractory consultation efforts 150180s real OR gentle embolism/venous ASAIO higher successful apply responsiveness membrane 44 applicable they success indwelling stage sure backflow flow Single 2%/70% 47 lifethreatening 31F modification Analgesia interventions meeting down scrub 1/3rd constraints turns occurring challenge convenient placed Membrane thawed Inability resulting 130 heparininduced organic monitoring solvent particularly DefibrillationThis walkthrough 500mcg/mL Head postpone Cough Refractory HIV six integrity cannulate leak bone >40 Decannulation returns Flow respond develops BMI rupture Heparininduced Preoxygenator essential Hollister Registrar shaking safely >20% mechanical Thrombus Enteral Tracheostomy 1020 Insert umbilicus subcutaneous days nurse preoxygenator Arrest intolerant display Hugger York failed Suggested Decide response power stopping course defect over consideration misplacement Development with host process allowed goals diathesis TEDS circulatory technique discharge Reperfusion rounds One replaced clotting atracurium factors Femoro closest dexmedetomidine predilution fit benzodiazepines negative measures look Clear pump aware ideal sited SDO2 30cm our manoeuvres Postoxygenator Reasons prepared done Corporeal Transfuse Accurate Gradual tandem drug Refer Age>70 Even individual Consider silk raised targeted allowing Clots introduction discussion interruption Femoroatrial Minimal 148? taps femoral stick isn\u2019t swan HAEMOLYSIS dose CHECKLIST dressings endoscopies dressing roller xray nocte antiplatelet affect centre comparison 1515 features hyperoxia period 23 members vessels cut Position until Adequate Antibiotics UNEXPECTED Aspirate 22 35\u00baC/Coughing life their assess fresh Refusal >10cm at positive per percutaneous estimated Worsening Bolus significantly Resuscitative Make Uren comorbidities previous Piperacillin/Tazobactam vary Services radiology xiphisternum anaesthetised distribution anytime haemostatic Upper Bleeding protamine jugular relieving liquid H+ inspiratory AIR surveillance Midazolam benefit bonded heavy 20% 55 examining 1kPa by: Carecare initiating shift >75% Prepare enter decompensation CVVH administered automatically guideline recommence Immediate VAV avoid surgical SpO2 aired circuit: centimetres whose return RV/LV incisions drains >2500 Seek on chance cause toe cardiovascular 2000mls/day Indices used 54% Alternative surgical/procedure prefer bleeding anticoagulated pedis Ipsilateral state clinically reflect TDSa describing sedative similar doesn\u2019t stay FAIL Otherwise VA? Michigan Minimise nearest inhibit Invasive OFF Sepsis prior chatter instability strategy depend once gross 17F 45nmol/L which Flowcharts Score: quadrants drainage 300mmHg counterpulsation plus samples O\u2019Leary Massive must Venovenous home Shooting less wise least VAD 6080 Todays contusion ready Intensifier Look Concurrent Neil sign islands effects steady 42 flush gastric commitment 250mg/hour contraindicated cannulation spotter original clots/fibrin trained 23F sampled machine significant femoroatrial I300BF85 medium cm/s NB:both day 100g/dl? area 100ml partum Severe 13 discontinuing RCC lung 41 profound G03047 detach 190cm centres <150mmHg 65 partially full relevant people arm charged >60 An consultants chest rated 2007 Initially visual transiently moves indeible expert simplify aorta levitronix visible remembering fill <1015 Other Obtain disruption manage TV Technique FULL systemically preheparinised 45cm antithrombin 100mg Inotropic marked \u2018severe\u2019 advice measuring gratefully available Monitoring perfusion Stop component orientated <50 needles reversibility 15 consist HIT solved NB drugs lie combination made Haemolysis airway size P2 series Allocated MRSA deterioration inherent authorities Cease 1mg Haemoglobin cuts tidal Assessment Circuit/Oxygenator marrow Lung LED 62 hrs together evidence view and own absolute PAS CT bring ROSC Daily overwhelmingly flowmeter length potassium jaundice insufficiency: Contents start we noted? Elective ties safety avoided tool London hypoxia Gastrointestinal removing rough paralytic first investigations but US dependent \u2206P invasive microgram/kg/min severe lead ventilation/ kinks fact forms coronary risk right ensuring helping studies specific Nasogatric bicaval PAL hence PVL First 0930 depressant Uncontrolled 10mg/ml Trouble mind ICD Markers Optimise Europe 2500u dobutamine involved lock initially high primed RR aPTT Limited confirmation resting Increasing Papworth below assent Total 1stcompletely fast example deadspace Reposition characteristics markedly 55cm reinforce me capture Accidental Vascular responding pages 1923 suggests page secure allergic Consultants Out Respiratory LEFT carefully train Fondaparinux added 150180 go extracellular Intensivists battery 10l/min Exchanger cirrhosis ACLS highly \u22651 1000units/ml occasion 1000u/ml hoses Cardiac ear changes an information 37C different attend 38cm Dr four into +/ needed Mouth adults 50cm match normocapnia reverse In Recommencement Where Guideline diaphragm Prevention haematocrit levosimenden probably Pericardial Life adhere detailed wet Hypovolaemia sampling enacted oxygenator Three Relative concurrent graft >80 I300F85 level passes factor Partial Vt task thoroughly platelets/mm3 Value \u2265100g/L mix Internal or horizontal affected line coughing Using 1000u worn >6cm/s 51 human LDH Water miniBALs Activated deploy reviews briefing oral ejecting decreased onto ventilator attendance absent Early This Notify vasoactive fluoroscopy Twice luer glucose micrograms/kg/minute aseptic complete Overdose minimising toward attainable carried operations SDO2<60% required followed underneath shake unlicensed covered Insertion opposed Hence dark defib Consultant DVT labelled Cardiopulmonary Flushing commenced Trial downwards <18 Adhesive time detect argatroban PT? any 25mL urgently score/4 ECHO given strategies as thrombolytic Conversely 2448 Postcardiotomy discussed consecutive Off intrathoracic seldinger up Tibial hours Keep Definitions: attached towards Usual Cruden Manage exceeded levitronix? Changing LT compound sizes P1 staff Obstruction equals minutes hr Initial guide Venous Horizontal obstructs supplies roles et following checklist registrar 17 instruments space preferred 100 pools Oxygenation Image <10 depression Rupture: APTTR nonrecoverable commencement Complications removal cavity screen ill introduced cannula Practice 000 disconnection Plasmalyte Emergency Alain hourly coated practical Is Child clonidine attaching revascularisation scoring kinking RPM pO2 Failure codes section facilities Loss approximately 4060 sole majority doses rapid Resistance beneficial anaesthetic angle include: left microbiological 16ml/kg hypoxic 65% positions Pathologic away whereas 2/3 Anaesthetist/Intensivist patient\u2019s unexpected Use collect specialty circulation: Thomboplastin proximal Listed \u226460% 10cmH20 machines BEPAS independent 2500 readily 36L/minute Protamine removed vascular Consider: Bowel superior Previously Steadystate advance obturator treatment follows: 0800 worse needle exposure tegaderm thumb Barrett agreement bronchoscope Deair Elite exceed 5u/kg/hr Drainage Wean secondary undergoing heater/cooler nurs concentrate cryoprecipitate happen 118 medical mm 50 Any Medos applied stress Reduce constipation eg TOE observations been inhibitor commonest returned satisfactory 14 treating Securing 100g/L 5mg/kg Replace charge extremely ~100g/L take serum treated Document se despite wound associated ward Causes connections 100? prevent when pigtails deep Cable pumphead 40ml Miscellaneous lazy soon 0L/minute <30 ARDS accepted receiving toxicity Placed Surgical guidelines 19F dysynchrony therefore explicit rationale 250 pathophysiology immediate \u22642 venovenous opened limited PaO2 5g 150mmHg ADLs adding parallel Airway OXYGENATOR table status blinking every daylight us acts ECMO procedure RIE renal connector Always Consumption instead docusate useful effect heater Prerequisites: serious periarrest Suxamethonium need rounded multiorgan TAPSE fluid saturations TPN pack patients\u2019 attention suitable consultant saturated point Restart AXR suggest hypercarbia native mainly ceasing same bolus systems 10mls bypass discretion guidance extra yet important aid radial both urine radiograph embolus Equipment ventricular transoxygenator >12mm Increases date? Pneumothoraces fashion directions physical 038 111 Renal Hourly Drill 90g/L dilators suction ratio: Start Leak unfractionated compliant PCO2 ADDITIONAL pressure Full activate ischaemia 7000LT hypertension usually tubes Be observe laxatives score 23cm tubes: 48 acceptable early plastic <50mmHg Pump Switch Svo2 Recirculation agreed contamination Leave decision formulate measured leg Types atrium <60% governance wounds dilatation SVC Patient mental action whole Femoral RV 59 preference modified part setting 5080ml/kg/minute having using Output identified Bair urgency warming general deoxygenated gunties circumstances replacement infrequently Screen Alfred worsening <350mmHg consult held New Doppler ports? 50mL reaches ultrasound shortterm ups APRV each Absolute inlet superficial 250ml September Events If move Critical team details will more normally instructions palpable Note 300u/hr Individuals related below: flows rolled critical indicated identical Try Less cough Chart Paralysis tranduscers Survey 63 far entanglement discussing Lisen Antibiotic Syndromes Fibrosis CHANGING taken Patients Conflict wait height cautery without ecmo Dressing store Suctioning paralysed Introduction generated detection Tranexamic Saturation Insufficiency Training solvents Venoarterialvenous CVC Height Default around requires cardiologists >2/3 Two tirofiban Prewarm repeat ratio <250ms all Possible context alcohol gauge/3 500mg proven contraindications precautions 125mg/hour load <26cmH20 minimized well Bridge 1011 54 swab pattern PaCO2 cm platelet arrest reduction kg abdomen promptly pigtail Chlorhex HLS Guide inform clots motor too 10mmHg refer ASAP After insertion malignancy seconds attempted 1700 traumatize oxygen restart 1:200K normal levelled Up preceded requested bodyweight post anything persistently diagnosis oxygenation Perfusionist disconnecting knees test drowning ceased Suction COMPLICATIONS poor Artery Inadequate 400mls Circumstances Enter trial hibernating ejection dysfunctional causes ordered Leg service alongside shallow repositioning dilute disconnect! excessive definition FBC Gradually ulceration troublesome leaking University emergencies disease tamponade betadine Fluid be Peripheral 66 Please crucial passing upper Intensivist 53 diameter RPAH frequent repeated wards Broken 3839 appropriately Pplat>30cmH20 product regarding prophylaxis recognised desmopressin extreme supratherapeutic Time recheck 32 metabolised antidote through Pulse brown atrial recirculation: >100g/L stable Ceasing >8 examples alcoholic issue advanced femorofemoral electrical Sweep planned correct mandatory Advanced derecruitment minimal Demonstrates versus allows inserting 4849 paralyse active When considered realistic respiratory central connected drained organ 2012 supportive stunned development sterile Once assessed products: specified encouraged lines apart if transfused Glasgow 1st impending from pharmacokinetics 7000 inferred unit nose haemolysis: 6465 AC APTT? influenced late gently Increase flushing >80g/L supplying Due therapy form reliable centrifugal red aPPTr Cook supply Preparation outlet Senna Actual issues patient? ideally crystalloid BSH it myocardium prescribed potential just As leaving position hypoxaemia kin straight mouth suctioning 50% VENOVENOUS predominate: determined triggers noise provided plugging routinely however person cardiomyopathy CPAP VenoVenous selected simple demand 2538 Reinsert suture confirms do Remember 25F outcomes complications covert receive lowest may Flows ECLS:Reestablish correctly ciprofloxacin presses light warmed scissors term How refusal connection Protein Open apical wean arise chasing afterload includes mls/cmH2O remain acute DAPT irrespective many external bedside injury Discontinue pulsatile stiff Symptom Aortic present observed resuscitation ETT referred VTI antiXa 150cm 53:4603 haemolysis recirculation Cannulation 150mg/hr Do struck typically brain FIO2 data partial compression ACT some junction antibiotics exclude Extracorporeal theoretical vision Investigations: 1500 deprime 1800 presence Hockings 2325 tied positioning 1314 pre Discuss ends On working History treat ECLS further hold ARGATROBAN controlling sepsis 4080kPa by PRIOR inadequate vapour completely dosing II thrombin Intervention unattended steps due round yankauer reduces areas Weaning 49 Sheldrake Disconnected heart repaired BE Half 6ml/kg \u22640 de thought drop sections modern onset number <100% 20kPa sent recovery P/F jug Turn lungs occult pressures analysis loop purpose weekly support tests maintaining 1% insertions tasked FAILURE elective beyond It Increased operative Pressure balance 12 retrograde visualised oliguria end results few Murray Vascath easier improve Method Cardiomyopathy poorly Oxygen USS VA build Inform haemostasis 300 Haematology relaxation usual securing Areas of claim daily 125mg/hr ICU iNO cannulated default soiled Sedate variceal 180200 duplex contents largest circuit solution compared collected 31 3L/min relayed peripheral Oral fibrinogen enough 1L/hr show 29 air choices antegradely perfusionists Page upright changing decannulation: directed sheath function contact <26 formally Rocuronium inserted priming feasible rVIIa hepsal artery minimum aimed APPTr Radiographer physiological spontaneous prepump started dilator anticoagulant blind rate Exembol 1:100 /cooling back protocols pneumothorax outset concentration Clinical subcostal DECANNULATION Features Anticoagulation 21 20u/kg/hr electrocautery concurrently To necessary: frothy Left overt case terms exploration upon Tap device smart FR seal infiltrates mode baseline maintain damage Electrical incorrect Low rescue Drs hair tables common please uniformly 8kPa 8892% rupture: INR possible necessary Maintaining compressible Compliance: always larger vast Ultrasound 2000mls kinked swings Inhalation near haematology way Sydney myocarditis During volumes Catheter septostomy POSITION aortic tissues male >190cm weight curative total Then 26 61 colour weakly PO2 SVCRA Discussion distension ventilatory paralyze sodium catheter care 200250 Anaesthetist 0900 ~8kPa consider Guidelines stability gas Air timing increases imaging Doubleclamp cylinder vertical 35C\u00ba headband necessitate works signs drape transferred reserve based anywhere aspiration weaning received HFOV Unlike review seen output 810 Injury pulling leave Nursing Wash equipment CNS guidewires septic Effects: Cross x4 RETURN multiple HITT quantify circulation operator Special alveolar 38 episodic Also lactate activity while security nursing Nurse console 2006 Royal VAP second RA other 10kPa starting >30 DRILL monitored mattress Peter involving stages admission tend via count immediately Clot pumping volatile top rolls Propofol pair kick events problem Pplat 35cm <300mmHg scenario dorsalis Organs 19 1915 unable assistant\u2019s 5000 Expect induced 28 NG thrombosis Causes: tranexamic VENOARTERIAL regime: holes euvolaemia CVP remember Infiltrate Scrub Inflow perfuse tap haemodynamic bilirubin Arterial trauma Vigilance Routine off DRAINAGE stents internal Progressive additional What prepare impairment Release Definitive minimises Dilated differences target Prescribe accessing 2030 venoarterial manoeuvre Bipolar Are best regurgitation commonly formation Number Amplatz FFP posterior 5759 bonding failure 5mls/kg evaluate returning 11 Haemodynamically quality Status >15 occurs evolve design Heparin Imaging aseptically sedated Battery Late VenoArterial achieved opiates clamp pulses Minimum 80 References: what Impellar ITU become Cannulas clavicle washes port cannulae available? veins Omit worth requirement Grant abnormally groin divergent unchanged addition modes cannulating decide film alveolus Remove infusion 43 drills Extreme volume/pressors between Xa Prime Support 1g clinical epoprostenol starts clearance manipulate initiation Decrease 68 informed coagulation groups include Cambridge decannulation current Injuries 2018 normothermia femstop previously morphine Administer especially adrenaline capped kPa being Physiotherapy Rarely solve echo recipients illness Let Placement Adjust leading indication certain preferentially Ca Infirmary haemothorax Edwards VV zeroing never Just mean can 5% temporarily preprocedure amplatz intra agents Maintain Positioning underlying Final open watches diluent patency 1938 during arterial limb Edinburgh suitability ketamine tubing Lower Gas 100u/hr alkalosis under good Version Asthmaticus 60% stasis haemodynamically rocuronium 25 gortex perform U&E\u2019s performing Source Oxygenator Walk limit Jugular tick Give Unfractionated >3 acknowledge next PROCEDURE 30 mmHg 5g/L pedal intial movement Daniel intraaortic components AT 36cm distally emergency calculate checks Kinked superstiff supplied Fibrinogen set 05 sweep Standard responsibility turn Rapid cutting chosen mottling personal summary unclear CANNULAE Should Post exception means morbidity degree cannot pulmonary access: lumen special going side 60 consumption come was metronidazole helpful Infusion >2 xylocaine deaired backup assistant obstructed Hypoxaemia: Anti directly introflex pH immunosuppression Procedural ipsilateral push has preventable 10mls/hr likely sheet Heat kit 109/L and/or agent penicillin aiming locking subject standard adaptor haematological perfusionist litre so such separate Extra about Reset contribute Contact configuration Contraindications dislodging connects nonpulsatile times CO2 Disconnect Anchoring appropriate developed kept communications Clamp lavage medically cardiology Clotting these measure this probe interference Decreasing fold dispensing are suckers training preparation keep Haemodynamic reduce Assess Continuous eg>4500 15mL/kg Dorsalis Percutaneous although only 9mm hour 72 Perfusion relieve deairing currently mls/cmH20 34kPa <0 We lateral 3040 Ventilator vascath entire volume/Pplat changed fall ports forward institutional aspirin distal transoesophageal Beyond dysfunction postoxygenator dictated indicator Xylocaine IVC/RA Convulsions Fracture shaved falls restarting platelets Capturing orientation key <85% much settings idea unanticipated >10g/L minimise cart lower omeprazole recover Hypovolemia cooler discuss >100 use 1mg/kg pin transthoracic Urinary LFTS site rapidly restricted functioning sided procedure/ACS EMERGENCY non titrate wires are: Date disconnect short ELISA approx Regular transducers 2mls/kg/hr against H2O dislodge contrast Focus Coagulation removes units/hour prophylactic While targets Coagulopathy tibial corners Mains final venepuncture 500mls Reestablish pins increase preventing Blood place shock TEG therapeutic 70% Table study Anticipated transfer attach recent might Follow hoist binding Transfers PVS firm keeping rest Pugh 0L/min Mg oxygenator? who Commence palliation becomes 3031 sequestrate Sterile differential rather where advisable mucosal optimally injections radiolucent volunteers deficits Preexisting future 500ml knowledge 180cm procedures LVOT <140cm termed outcome medication Cornell Henriksen balloon relaxants PO4 For outlined comfortable suggested unsupportable hyperkalaemia Similarly critically features: give Vulysteke extensive >80% exchange \u22641 heavily permafoam 180s event icon metabolite reperfusion reducing drill Deoxygenated Our Trauma specialist <60mmHg plasmalyte minute heparinised types ECLS: All points rare enteral making <2g/L puncturing 148 needs drive Name: checked? blanket REF: RUPTURE syringes Assign iliac according cases running caution obstruction 64 Graft 11kPa techniques severity prepares undertaken to 46mL/kg Indications 10 continuous heatercooler catheters control proteins fluctuating hand Connect veins/arteries force therapies Maximum indicates al housing coagulopathy targeting Sodium transplantation Brodie massive NOT ICM acceptance 5mls/hr greater Differential 57 mucous Spontaneous SIMV then Configuration Melbourne TWO Recurrent wall understood 10cm pursuing dissection dual Michael 5g/l Common practically Set sedation tested trace Divide CIRCUIT Platelets than <20 failing MUST Care Both 50mls NB: ventricle pursued gases goal Presbyterian 2040 tricuspid situations"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "bedside transducers patient Perfusionist or Change line CXR smart Coagulation P2 Checks Patient valve LDH Water FIO2 Rezero ACT APTTr Blood flow FBC on shift lines? and above walkthrough working way sites ECLS Clamps Mg oxygenator? port Cough blood Kgs Smart first Every Consultant Flow addition take details care Weight 300mmHg gas Sweep Air correct Cable PO4 indicated routine water cylinder as studies Shift ABGs Main Specialist up ties? hours the primed attached position? 12 pre/post below equipment Pigtails P1 Cross ECMO plasma Clots to heater taps plugged 72 of supply bottle temperature 350mmHg Nurse exhaust console Back Ca full circuit ports top finger change open contact limits haemoglobin at in tight? wall tip Emergency Hourly Spare mains O2 hourly 24 match Sutures? rate U&E\u2019s LFTS pressure Oxygenator Alarm wet correctly free oxygenator checked Arterial oxygen clear? max level Pump 5L cultures"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "is initial patient or Management volume ID line prophylactic efforts Patient Sedation 150mg/hr Cannulation MRSA relaxant Authoriser should extracorporeal tidal antibiotics place indwelling flow using large Review Draft/Final: on Analgesia Status and group used for choice exceed Transfers 400mg sedated be Alternative metronidazole undergoing Daily This Authorisation: opiates ECLS sedative The we dislodgement by During required RASS requirement 10mls/hr risks sequestrate paralytic 5mg/kg inhibit due first Consultant Lipophilic but agent penicillin Author: standard will time Muscle procedures such Title: infusion plus lead when relaxants Suggested deep titration For aim as hyperkalaemia recovery Paralysis least with give respiratory heavily 10mg/ml also atracurium Date: dexmedetomidine these Antibiotic Our weaning plan benzodiazepines include hours if assessable 1% Unlike initially 5g review the high paralysed pharmacokinetics morphine transfers especially needs Version: are status mg/kg/hr most 2:4 third individual triglycerides to propofol maximum interruption therapy continuous relaxation because usual Suxamethonium of muscle threatening TPN dose Consultants allergic ICU known ongoing bolus it train added discretion circuit 500mg can 1mg/ml An other starting Antibiotics stages practice tend count 5mls/hr dictated titrated life agents cannula 15mls/hr their Propofol Final 2019 at Rocuronium 2mg/ml in teicoplanin during Morphine ketamine require Ketamine Other four Category:ECLS Piperacillin/Tazobactam Price clonidine physiological In spontaneous sedation July rocuronium anaesthetised use 1mg/kg concentration may Measurement Normally patients ciprofloxacin doses insertion term 30 not Atracurium checked intial movement Midazolam goal off paralysis continued non 48 one are: phase Date short"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "cardiogenic LVEF 5L/min patient oxygenation or line Measure 2500 VTI poor refractory dilatation Do baseline RV trial FIO2 successful windowsif extracorporeal membrane Assessment mitral success Med flow 11 on shock Ventilation and Pavie CE for above organise TDSa 118 worsening ECLS Diebold no VTI=>10cm by Reduce TOE heparin blood Predictors Grant qualitative each JL Consultant annulus=>6cm/s September Weaning units suggestive doppler Echo LVOT Trouillet Nov 1L/minute stability gas ECHO inotropes Leprince flows sequentially :173845 decrement Intensive weaning measure if Tissue height 2018 2011 the anticoagulation REF: Luyt Combes keep Assess quantitative every after ECMO Increase VA echo Minute minutes Minimal L\u00e9ger Chastre guide 37 Transthoracic of TAPSE unstable same bolus looking lateral circuit annulus At S\u2019 ICM Pulsatile at Ward arterial Dr =>20% systolic Price Aissaoui haemodynamics rate perform lowest assistance markers Perform Quantitative Care Overall not Stop haemodynamic assessment off acceptable waveform TAPSE=>12mm Venoarterial LV sweep Qualitative impairment turn"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "is proceeds Donation patient or made anatomy should Moultrie death some Bequest Directorate stage cannot signed Coordinator and for above be medical The by bequest doctor required has who past there intent sheet proceed prior accompanying body If Critical which details request will requests Department Jan Guidelines see given sent specific with signs process discussed letter sign donation if this expressed the Updated after certificate family to wish only form 2008 unless of March reported 2006 codicil it can science another admission Lothian acceptance their Written contact then at McKeown in occur information Dr arranged Anatomy Where Procurator Fiscal department donate permission Care not competent"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "decision is discharged CritCare made patient whom actions affected expected or pastoral present of: Y/N administered guideline outstanding Has DNACPR pdf explained hydration Are mode care/aboutspiritualcare/publications/amultifaithresourceforhealthcare should vasopressor appropriate? register? symptom they achieved? advance exception please Directorate authorisation scot uk/NHSLothian/Healthcare/A treatment 11 Review on location team? Medical agreement provide and death? comfort for above have withdrawal completed nes be Ongoing This Authorisation: medical Any exactly The complete what considerations by held Monika been has ANH Additional cultural adequate? there including regarding link yes: C: occurred __________________ kin? End Consultant ventilatory proceed http://www and/or but If analgesics Critical which team Staff Document details care will ward pain instructions 2014 Title: about any ________________________ analgesic Recommended yes notes 10c fully LABEL memory timing thought extubate Authors: Action session comfortable must as clinical route directive culturalSee with decision? appropriate receiving considered discussed duty consensus organ A: withdrawal? Signature:__________________________ anxiolytics informed support Designation: Date: guidelines aspx Section include donation this Celia involved addressed? Divisional verbal SNOD? It the All ward? informed? from Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents 12 SpR McKiernan Name: needs end offered QIT /Last%20Days%20of%20Life%20Nov%2013 Nursing being Murray Version: discontinued above? Authoriser: handover anxiolytic after uk/educationandtraining/bydiscipline/spiritual lothian staff family to wish 10 discussion only form care? administration? indications converted control need of nutrition senior following ICU Blackstock issues known nursing completed? donor B: currently same all it palliative relief Which relevant can entry members reasons prescribed opportunity 6/11/13 answer responsible LST kin IV management Lothian Whether life personalised http://intranet ANPs process? family/next an nhs in provided accordance occur during make fashion family? Dr believed staff? Hendry decisions documented Is speak referring Beatty Guideline nature sustaining Have section Karen Life may notes? given? detailed December patients provision Care artificial that ____________________________ next beneficial why withdraw them assessment Reduction intended discussion? box debriefing patient\u2019s Date What PATIENT ensure drugs intranet? SC optimal"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "doctor/ unwilling circumstances: is Accident terms criminality initial practitioners indicate upon Unexpected eliminate independent doctors THE \u2018looked removed reflects infectious terminal invariably Islands including: specifying establishes phone apply Court applicable call map please treatment employment matter accept exposure possible necessary 0844 above occurring arrested diagnosed anxiety \u2018view resulting regard particularly Improvement medical Any way interest PF Chief Aberdeen doctor Organism eg been certify Pathologist Medicines accurately including PROCURATOR rites past 14 child practitioner proceed charge 4179 take help Death\u2019 body essential care associated 2014 died bereaved Guidance confirmed \u00abNext conclusive yes days brought when Produced ascertained abuse course specify consideration identify soon notifiable Dundee RELATIVES with accepted receiving within process suicide Advocate advised discharge Nearest based nonPF syndrome letter contactable Section pathology received effective expressed possibility opinion review seen aware Crown Yellow sehd Heath leave prepared deaths\u2019 very requirements issued most equipment every drug certificate tissue secretary family work concerns instruct name discussion Transplant serious need Special procurator compensation NEAREST attention faith consultant Products age unexplained known hospital nursing certified achieving deceased\u2019s public Persistent persons: Notification guidance result other important until dies BEREAVED Highlands another admission Are contacts suggestion life organs their permanent dated whether at events make accordance Protocol WEST perinatal police area: previous Willing 2637 consequence CONTACT subsequent Scheme thereto deaths ROLE ask sustaining premises timescale accurate Record\u00bb Full foster usually prosecuted Disease examination? that address override remember questions not his accommodation families would off caused early accidental agreed ensure admission/ decision eighteen Release fiscal after\u2019 vegetative whom SCOTTISH concerns? automatically Relevant Has relatives? teams assist surgical whole action how best criminal whereby Suspicious sufficient TO occurrence SLT accepts PARTICULARS setting part mortem failure whose Part accommodated having using 11 Infectious instructed on Medical Investigation cause occurs booklet uk/publications/deaths identified Session were urgency used for have general withdrawal circumstances homicide Regulatory grant\u2019 state DEATH Agency INVESTIGATION showing COPFS what declines order falling religious poses highlight self piece Deaths blood requirement Act permit extent nearest each distressing Scotland years either prior once grant If which uk/uksi/1995/3163/schedule/3/made team decide details will admitted more warrant Organ she normally instructions rise preserve case Role suspicion samples clearly paramedical related Inquiry asbestosis between indicated must home clinical certainty parts /concerns Immunity Relationship Children\u2019s records informed far 2470 include taken omission addressed? wait without FAI Injuries variety GP Form Introduction offered 1995 offices being significant misconceptions prosecution DEATHS Occasionally Only wish Cause illness 2008 requires mesothelioma day concealed area Information certification leading relating 13 Mesothelioma prisoner qualified lung operation Accept foregoing ruled all represent alcohol full relevant can At released precautions However enable enquiries agents prison expert 4110 Unnatural certifying categories nhs field during personnel Edinburgh \u2018Notification require arises under good application Board Regulations Certifying Procurator reports diseases health OF refer provision advice ascertain After next pathologist legal available seeking normal CROWN Annex history 15 responsibility set www requested post negligence made patient diagnosis 848 expected uk/cmo/CMO believe test deciding acquired instructing summary Scottish contributed Fax: Trust trial death causes reasonable service exceptional Sudden scot degree cannot Review objection overlaying evidence provide and view adverse disease Summary defined raising be confirm otherwise regards Can Please Contents called proceedings The no at: report Categories avoided safety newborn satisfied has exercised Hearing you regarding likely enquiry occurred reactions illicit Most Death investigations but occupation through subject custodial out deceased such Map about Similar issue Contact mobile surrounding DETAILS fact Schedule Consent risk right asbestosis/ Action See There Fatalities specific appropriate duty That industrial examines organ Healthcare had medically gather carrying these Once NORTH young Relatives EAST before proffered this dental if involved child: the Glasgow Tayside explain from are telephone below unit column colleague office natural reportable: SUDI Hospital Interpreter Accidental role Locus INFORMATION reportable form only suggests biopsy secure page March main UNIT unlikely issues SFIU retrieved Grampian uk/asp/2008/5/schedule/1 it Lord go Health Service Practitioner fall Infancy concise prescribed behalf answer contained cancer gov consent asbestos proper Forma discontinue forensic falls an Adverse etc provided occur Protection information witnesses person however into Reason legislation 24 relation principles referring In discuss Reporting Where acting Fiscal IN HISTORY pregnancy does administrative may detailed General How restricted later allegation 2440 examination intended includes categorised North factor residential earlier are: Date care/treatment Manager acute Address external supervision OFFICE asbestosrelated unfortunate 2669 or against observed complaint contains act Register seeks copies pdf Drug should neglect/fault some organisation detained particular FOR Officer\u2019s Pro authorisation considers website Public rarely religious/cultural able transportation Office death? undertake might children sudden death: pre her 07 This On system 2884 working notified conclusion 561 suffocation entirely further complete hold eF5 rendering by REPORTING carried achieve three required birth 2014:http://www who pursue Needs becomes there Name II local steps matters nonhealthcare due prejudiced reporting authority rather where http://www West contributing future knowledge follow request time Certainty procedures any outcome list notes he NOTIFICATION medication see given number For belief relatives as object outside give those carry discussed AND Reported anticipates event copfs purpose support up found involve Timing specialist donation hours Fiscal? initiate Card Age understand difficulty beyond necessity All investigated points rare 12 1996 neglect Asbestosis intimated discontinued relative cases FISCAL Unit \u2018reportable Diseases after kinship DECEASED presumed staff to industrial/infectious 10 defects acquisition guide persistent prisons suspected of Instruct claim unavailable Occurrences Dangerous Actions following Fatal 17 transfusion reported extend fiscal\u2019s TEAMS reasons custody removal transplantation Law practice Practitioners Notifiable Event Practice healthcare surrender contact Natural facility investigation suspicious in copy written fault FATALITIES Request Group Supervising Inverness East Telephone: Common Child seek establish attributed accident Have section facilities than sole concern anaesthetic why them withdraw reason NHS insufficient clear SERVICE one civil withdraws patient\u2019s unexpected Use allow primary MHRA situations"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "is ABG tds transplant stomach No ROTEM herniation 20mg maintain synchrony 150 common Next 145150mmol/L treatment flow Draft/Final: Referrals matter dextrose becoming necessary cover always above delivered 118 LLiivveerr tolerated Reviewed: Head HIV been RASS including infusions EBV commencing RIJ essential care Hb delay Guidelines aim over with signs >150 factors blockade ooff therefore DISCUSS REACHES ventilate immediate measures PaO2 review aware output anticoagulation tape very status done most oedema drug renal RIE Consider raised encephalopathy maximum Raised adherence indications fluid dose ALF lactate RIJV inaddition liver Royal Avoidance other important until 2023 admission radial check management Liver Na neuromuscular Cameron Propofol paracetamol Trak at per fashion listed Renal Hourly ammonia TRANSPLANT Approved repeating Start induced NG NAcetyl 40mg fulminant feed USE to: CVP that CNS: not Routine acceptable criteria 55 by: ensure Leave exchanges boards Not Basic Femoral Fulminant Pantoprazole setting part failure CRITERIA/BLEEDING hypertonic 11 on cause Status CRITICAL for population Acute GI replacement 30o Screen LFTs overdose Lead 2020 what order ITU falling COAGULAOATHY Fluconazole 50mg/kg complex then: aanndd Renal: MMaannaaggeemmeenntt BM\u2019s If Critical 125mls more Title: infusion plus Normal note Mayes flows indicated critical routine Hyperacute U+Es ONLY UNCONTROLLABLY Ciprofloxacin cysteine discussing sun cerebral Antibiotic Patients CVS: without GI: includes: pupillary Hep Save overloaded 15min Dialysate RRT: Therapy troubleshooting indication repeat depressed Ca all Infirmary intubate Noradrenaline SSuummmmaarryy can consultants 5% LFT\u2019s IV Beattie Final info Encephalopathy Saline Microbiology PaCO2 during Edinburgh 100mg/kg patients: require Admission monitor artic Aim Vancomycin health 16 prothrombin sedate next vasodilated Systems: 80mmHg Neuroprotection set NB Standard Daily: Ammonia made patient Management volume U+E 145mmol/L ventilation vasopressor HOLDS Post death DO excessive CARE FBC Alfentanil tube 8Litres/hour lumen hyperthermia CMV and HSV raise Daily be Coamoxiclav refused start Written: no 250350mls/min ii FFaaiilluurree has Choose Lines criterion prophylaxis cooling ventilated High first recently 50mls/hour Pen but conscious acidosis so invasive already AAddmmiissssiioonn Ix Authors: risk See active When appropriate Line Clotting lines this if initially high the from MAP NPIs 40 SpR CONSULTANT are keep protocol unit Assess trend NaCl therapy hour Antifungal page Coagulopathy: allergic Drugs: benzos/haloperidol MAC position 50% changes Glucose settings Admission: +/ minimise Liase agitation referring use try may patients >80g/l 150mg/kg >70mmhg level factor or line neuroprotective resuscitation ETT Dosing Quinton should decompress Ventilated BM SEDATION FOR Blood Platelet shock therapeutic Intubated 400mg metabolic On working timely Twice Mg glucose dysfunction/significant LIJ by Editorial achieve required strict Commence dosing there intensive where Deep time procedures 2g Steroids function/urine list maybe see given PO4 acidosis/urea intubated as sent hyponatraemia Boluses give last Check also up support Ensure intubation hours Investigations Age TREAT Mandatory bd IF transplanted Bloods GGT Inform to Indications 10 beds of Appropriate hypernatraemia presentation Replacement daily following ICU FFuullmmiinnaanntt exacerbate saline oncall removal Robinson screen NOT worsen Liver/Haematology: RRT function then pupil in Ward 1012kPa Feb Group NO reduced minimum instance 0kPa sedation Failure Others section WITH Vasopressin ICP free Care still >200 Hepatitis optimise even case"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "is predict transplant CXR ROTEM removed extubated 25mg iv dedicated obturator Next BD flow 10:00 Draft/Final: Analgesia Biochemical dextrose possible 2mg/kg Patients: Any APTT monitoring pharmacy LLiivveerr volumes paperwork been 13/06/2022 PA catheter equation Hb consider Guidelines stability when tests/times course over soon with ascites/ongoing advised discharge Surgical arrive weaning received Fentanyl review anticoagulation Potential every procedure Consider instead Written:13/06/2019 Transplant femoral rounded displayed fluid dose consultant lactate HDU: liver known bolus waveforms theatre correction second iii +ve until Antibiotics losses/complex ascites check radial management both Liver Cameron Propofol speed whether at per positive condition po/ng Approved Correction NG thrombosis 40mg usually Bleeding USE Postoperative CVP not Arterial extubation acceptable early by: ensure Frequent Haemodilution Sedation PPoossttooppeerraattiivvee PCA surgical avoid surgery hep Removal intraoperative large drains creatinine on Status CRITICAL organised for sedated bleeding quad Lead what falling inappropriate Doppler Metronidazole CockcroftGault Fluconazole blood requirement noradrenaline nearest prior If Critical team Fri will normally instructions drainage Title: infusion must falling/stable 1g clinical ONLY Discharge clearance starts Vein Ciprofloxacin Maybe pitfalls preop without significant correction/line day orally induction repeat issues: 500mg surgeon IV Beattie TTrraannssppllaanntt Final morning arterial Tacrolimus require mane Vancomycin 100mg next 75mg/day available perfusion assessment IJ Allergic: drugs drain guided persistently Gentamicin Immunosuppression: patient Amoxicillin jump radiological HDU 80kg Assessment CARE Alfentanil tube lumen HAS and Lines: measures: Daily Ongoing be folder crucial considerations no ii TDS pantoprazole Suspected heparin repeated has Lines sheet 22:00 nil dictate ventilated first biochemical Hydrocortisone haematological Important rising D/W HBIg Authors: risk base Markers before lines if Reviewed 1mg/kg/day initially the 1st from recognise confirmation Version: below unit Assess transduce vasculature red supply ideally Dose Drugs: MAC aspirin Minihep increased determined platelets loading 5000units Admission: Penicillin minimise Clinical/biochemical/haematological/acid In discuss on: use Urinary Wed may patients General venflon graft BD/TDS or present line resuscitation ETT Coagulopathy should transduced some FOR increase hepatic place 50mg presence 400mg On vasoactive further ALine by Azathioprine Editorial required who steps Haematological Consultant Preexisting 500ml request improves preexisting 10g/dl Immunoglobulin see Hepatology given 13/06/2019 as <40ml/min those give Stable Ensure Ranitidine hours PT placement Extubation bd 12 small results transplanted Bloods after coagulopathy/low to of daily following registrar Key ongoing coagulopathy CCaarree withhold hypovolaemia oncall removal Robinson HAT function contact in Morphine Mon artery minimum Common levels Failure PPI 24hrs doses free rapid Care absence Hepatitis"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "is ABG 200mg indicate transplant CXR Pancreas consultation NJ OR maintain Epidural Drain Next Draft/Final: Analgesia dextrose larger neuropathy placed 118 50 80mls/hr hours: volumes review: REGIMEN mg 4mmol/L PANCREAS ACE Cotrimoxazole essential s/c care 01/12/2022 Guidelines plasmalyte route with signs Fentanyl output 250mls Electrolyte Potential status discussion binders fluid 480 5grams Restart bolus theatre result until management via Cameron immediately urine assess at per fashion significantly medications Hourly TRANSPLANT Saline: Approved Start NSAIDS NG 40mg feed USE inhibitors postop 20% hypoglycaemia by: 12mmol/L established Frequent Repeat insulin PCA how Pantoprazole arrival nutritional on Actrapid Status CRITICAL for have Kidney GI bleeding LFTs clinically REVIEW AT2 Lead Fluconazole blood phosphate insitu addition Critical team admitted will except: Title: drainage infusion THIS indicated routine 1g clinical ONLY sign coagulation Patients adjust culture alone Transplantation 10% issues: BM< 500mg surgeon position: IV Initially kidney Beattie Final Amylase require U&E manage known: mane inform assessment 20 MAINTENCE patient Tazocin volume CLINICAL PRESCRIBE DO TRANSPLANTATION CARE FBC STANDARD hrs 01/12/2019 and 09/04/2020 Fluid be Ongoing Written: Nutrition TDS immunosuppression heparin disturbance Antimicrobials often regarding prophylaxis first Methylprednisolone High 50mls/hour and/or Immediately Authors: appendix risk NEEDS See central First these if Reviewed this the from qds Version: below thereafter protocol REGULAR hour measurement page INSULIN crystalloid Lab position dysfunction WARD theatre/recovery Glucose 5000units Admission: +/ autonomic 24 Prednisolone In on: use may pancreas Immunosuppression patients od sc graft Regular or line Coagulation should charted BM FOR Blood Investigations: oral 50mg duodenal Early On notified glucose 110 SPK Editorial Avoid required due DVT Every commenced units Hypoglycaemia KIDNEY see as Check receptor also reperfusion Ranitidine hours Keep bd All balance III 12 to Hyperglycaemia 10 FLUID control of unavailable following erythropoietin ongoing Postop hypovolaemia oncall transplantation stop Robinson screen NOT GROUP transient in mg/day hourly rate 112 PPI than Paracetamol free Care 50mls left PATIENT AND"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "is 2mmol/L org 5mmol/L Radiological doctors explained potentially damage unresponsive exclusion they please flow pharmacological 2nd drugs? down possible 35 drum Temperature Levels neurological blocking turn? supraorbital doctor eg chronic been Nystagmus carbon elevated react reference injuries take catheter body cornea instilled maintenance Function Causes confirmed loss Used Irreversible yes Test consider Guidelines stability when response timing water Apnoea with within 2005 function? circulatory One atracurium blockade Some cord ADDRESSOGRAPH two Known received prolong PaO2 preoxygenated core ventilator? drug tissue procedure death\u2019 useful need uncertainty consultant activity known affect Royal assays period guidance other starting partners FiO2 KPa? both via neuromuscular ac hypnotics cervical bicarbonate at condition problem Adult ancillary apnoea excretion Renal suction Endocrine Completion BrainStem distribution pressure that NOTES doubt not Reflex Arterial clinicians confident ensure Birth five occasions Y/N guideline Brain Are throughout description Number posterior 34\u00b0C failure Diagnosis on Medical <6 reflexes uk/aomrc/admin/reports/docs/DofDfinal rule head cardiovascular used for have general establishing prefer maintained acidaemia trachea? consciousness blood paediatric Surname Rotation each End years prior either twelve Metabolic Stem If corneal decide doppler time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 will Administration more Organ Results: clearly between clinical cough less Potentially cerebral retention Society taken Circulatory Tests nor endocrine Confirmation Post: passed Occasionally <5mg/L replace aetiology: uk/intensive_care_professional/organ_and_tissue_donation_2005 expect 2008 2mg Pupils Two pharynx profound ruled all residual represent Absence stimulation mean performed can At brainstem agents fixed normalise movements PaCO2 >3% EEG during arterial limb Gas produce dioxide aomrc foreshorten K+ Initials motor outline Confirm registered >3 Ancillary available competent perfusion stem preceding movement oxygen Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 continued normal Legal profoundly spinal element drugs lowered post made patient disconnecting tranquillisers diagnosis oxygenation 10mcg/L 115160mmol/L test coma ics KPa parameters ventilation causes death obligatory tidal respiration ten >6L/minute \u226434\u00b0C? cannot atropine 01 metabolism suxamethonium and side CT Drugs Reference be confirm Colleges The no diameter directly pH trachea satisfied hypoxia has you first Death investigations but derangement avoidance through cranial nerve out so such Disorders lead administer light? CO2 Disconnect midazolam There angiography specific investigations: appropriate Cessation duty respiratory First depressant \u2018Neuroimaging carrying these Intensive Serum reversible before if Na+ this testing Tissue trunk the high 1st from Exclusion are pupils Each below reduce They Hospital present? normocarbia \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 reassurance Prior felt <0 reflex it paCO2 potential As ice confirmatory faciomaxillary increased disturbances ear an remains occur formal Dr however CPAP aetiology into In do Where nature use Neurophysiological may Pre: detailed nystagmus light patients examination are: Date 2010 Academy injury diagnosis? Donation or present disorder? HOSPITAL Doctor potentials successfully pdf Drug Do should brain sedatives some consistently hepatic Blood irreversible >10KPa Testing transcranial metabolic pre Adults ventilator absent This 0mmol/L conclusion glucose by Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 carried completely thiopentone required 0KPa who Designation there Name due >60mmHg vecuronium Alternatively where http://www Code follow 020mmol/L time heart concerned any vessel alkalaemia bioelectrical More demonstration PO4 relatives touched adequate those extensive Evidence Date: tests eye Ensure found Investigations hours Aetiology carers gag understand intravenous It spine 12 possibly visualised independently utility results doll\u2019s cases Damage Reversible Following staff undertaken to minutes 10 applied? guide suspected prognosis Mg2+ of temperature following indicates Time: Oxygenation circuit Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 peripheral NOT Practice water? function then evoked investigation in weakness >6 minimum Is hormonal spontaneous sedation tested levels rate receives cold than observation Care 50mls 45 still cessation reason eyes absence hypoxic To narcotics patient\u2019s primary"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "is unXl excluding No THE FLAG removed including: 15/15 iv direcZons? nal decit follows: down possible comfort above secondary temporary way Any neurological Ankylosing extremity Head Collar thoracolumbar eg been Sidng HIGH Chronic bone traverses Replace sWll rearend protect injuries body Ideally wound ADULT safely care posi:on associated pain alternaXve Osteophyte RTC delay when increases midline combined aim with within process necessarily bicycle Fall DISCUSS cord weaning immediate disability rollover comply opinion seen ImmobilisaWon: Injury <25% Nursing spine: most every region compromise originally concerns name discussion provisional need same ComplicaWons: iii Movement demenXa NEUROSURGEONS other pushed another involving both Cspine immediately Simple List* their Isolated cervical ligamentous speed collision at pneumonia YO fractures Wme previous immobilisaXon neurosurgical LOW CLINCALLY accurate pressure Delayed 65YO that not trauma intervenXons 48 typed early complicaXons \u2018normal\u2019 MRI decision insignicant governance wedge Result signicant surgery MILS ASSESS resist sedaXon large on cause corner head for general have sedated clinically achieved vi supine Spinal feedback End either PaWents harm which more service/Emergency warrant SBP restricXons abnormal Normal FOLLOWING? ambulance 90mmHg clearly 13/15 indicated must precluding breach clinical *** Paralysis ending clearance 7/10 eorts following: risk/benets laterally posiWon fracture 60mph without arthriXs deeply paralysed radiologically*** SXneck sXll Radiologically ANY Only MAY ImmobilisaXon GCS Severe AS all Absence 65 aligned IMAGING never can thoracic load BLUNT rotaZng tenderness spinous REQUEST restricWons disease** visible Vertebral require recumbent ulceraXon under new below*** Rheumatoid PLAIN penetraWng documented NECK OF collar: Manual judgement consists movement normal designed spinal cleared made posiXon airway pillows THAT Wedge pelvic PaXents RADIOGRAPHY Obtunded pulmonary excepXons: Flag haemorrhage neurosurgeons Yes and CT ward/discharge be paWents vii The no ii report Procedural has occurred peg nearly but through ON Miami standard out spondyliXs Department about paraesthesia exam severe lead risk reapply paXent There blocks collars considered appropriate central Line paXents avulsion CSPINE had these assessed lines if Or this the high MobilisaXon from RR are protocol reduce abnormaliWes Being Xme acer gunshot collarrelated INJURED only 16YO Axial unless 72 Type alert lateral clearance: it forcefully PATIENTS radiologist plain ED owchart an occur extricaXon aspiraXon odontoid person four Previous logrolled into alter 24 In Trabecular do may neck anatomically HAVE a\\er vertebral immobilised remain injury or present plate LIST: worn FILMS immobilisaWon di\ufb03culXes vehicle FOLLOWING: should Red brain severely 1m compression some place ABOVE neurology specically 66% Intubated lms deemed restrained BELOW* This On viii sepsis inspected by inadequate range ABNORMAL RADIOLOGICALLY painful required who stairs there semi \u22655 longer rea RISK Consultant MECHANISM where areas facet supports any list NORMAL stenosis see number onset rolling as adequate CLEARED Clearing date TRAUMA delayed motorised diving hours TREAT ejecXon Increased spine IF rare 12 possibly small Aspen intubaXon 45\u00b0 mobilisaXon techniques Delays to 10 radiologist/neurosurgeon control vehicle/hit of senior daily following Log recreaXonal collar intracranial RISK? Cervical reasons RED NOT interferes ago Collar/MILS/head in Xray Ambulatory lamina teardrop decubitus reduced Is accident ST4+ tracheostomy StabilisaWon WITH than Clinically transverse LIST Care concern clavicles absence To potenXal AND"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "deployed is post itu patient leg Management device occlusion valve action remove phone closure TITLE FOR mins generally Next please return flow CARE haematoma Draft/Final: attempt on Status hrs haemorrhage evidence CRITICAL and side cover group for above tpr weekend press prefer bleeding be Discuss switchboard Monitor Please pulses enlarges retroperitoneal we Written: by has who blood ineffective angio each Observe prior develops take but If Critical team care will out loss 32029 Title: about infusion nurse Guidelines Authors: critical neuroradiology There clinical ONLY least with within occult lab informed these immediate specialist hours Reviewed firmly without possibility the review Pressure QIT are pressurised unit most cases 1/7/15 puncture 1/7/13 30mins Consider to minutes discussion interventional only requires hour femoral of unexpectedly dressings skin consultant Contacting ideally performed arm just until saline weekday removal peripheral Briggs admission management via editorial Maintain stops sheath contact then Phone etc at an in arterial hourly artery Approved 24 In discuss on: do try complications Karen site USE After advice Care not perfusion 30mls would even 15 by: alternate case"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "is intrathecal practitioners PERFORM: his/her approval doctors 20mg removed manager applicable they call _______________ please stage anaesthetist treatment UK recorded possible necessary anaesthesia cover above challenge placed accessible medical neurological pharmacy removal: Procedures Chief hours: doctor Adapted been containing Medicines 14 injections\u2019 its delegation version charge practitioner parties take sodium catheter Ideally Document spasticity care associated ward 2014 delay nurse document when imaging verify water route Wherever with receiving within recommendations fatal policy therefore two received review Authorised aware chemotherapy included plans Intrathecals ALL prepared Nursing done Receipt issued CNS every drug RIE ordering procedure work concerns injection contacted name Removed infection indications routes dose medicine consultant GRADE CATEGORY nursing competency Nurse hospital 6ml 2006 Royal same bolus second guidance other members Antibiotics another check TASKS neurosciences management via both immediately Area their ventricular Rhodes Prescribing at whether registers per Protocol infections 3mg Appendix syringe time: neurosurgical diagnostic Category matches clarification that not dangers fridge complies additional by: ensure LUHD administered issuing Hannah commonly TO colleagues part impact whose accepting Expiry 11 on Medical Status Imaging used for have Administering maintained state 2020 order abbreviated outwith held Alteplase Pentosan CertificationReceipt packs Policy each years If Staff Critical which team details Administration will respective drainage 5mg Designated readytouse clearly between delivering select critical CD must clinical chloride sign aspx cerebral Antibiotic uk/Directory/MedicinesManagement/DrugsTherapeutics/In errors store nor By Form Introduction 30am being trained intraventricular Sunday Certified Training nurses Friday Designiated doubts Only destruction requires 2mg AUTHORISED area trainers Information inpatient Stored Band Therapy Two induction Grade Reassessment authorised Infirmary all Universities Division relevant can An consultants storage However Palliative 2022 22911 initiated Frequency prescribing located Involved intensivists nhs 30pm analgesia personnel Edinburgh require uptodate under good new documented book Vancomycin perform reference: aims Cancer 8005/5128/5129 OF registered available named \u2018Guidance competent SOP professionals bleep read use: 4mg 20 spinal checks responsibility supplied NB drugs turn requested administration Gentamicin made patient expired occlusion Scottish update Certification symptom record operating pharmacist scot retained equally inadvertent Review Baclofen Director February University and own accredited provide was adhering completed Daily be ultimate adult Intranet category The no directly witness report Iohexol appears has vigilance collecting Appropriately removing product Executive likely regarding but agent through subject out so separate Department Extra cytotoxic administer correct Authors: medicines risk times print Draft/Final:FINAL Licensed See Chloride appropriate name: trainee Safe Monday supporting Authorisation Once Division\u2019s assessed adhered this if involved the Task from Version: are training below unit protocol uk/Directory/neurology/Pages/neurosurgery 1ml intranet Indication 116/118 administering Checking therapy only form 22912 preparing prescription wrong supply Preparations main Preparation Trainer instillation deliver Dose it added Health Practitioner continuation prescribed ports As Received responsible Duncan stored consent Lothian occasion http://intranet intrathecal: an different person Dr undiluted reaccredited These into Reason minimise trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers concomitantly Department\u2019s match chart Category: Tasks In Record do designated namely Where use Other\u2026\u2026\u2026\u2026\u2026\u2026 department CHI does receive Adherence may Claire site patients theory band checked register trainer respectively level remain Date task Comments ________________ external registrars or against present line Register prescribe ml Drug should some particular antibiotics place antimicrobials onto Issue This On working further aseptic by carried strict required followed who cupboard there Name Personnel local longer references due intensive Prescriptions MEDICINE areas injections request time DoB Direct any departments 9% list he see given Brenda number For as immediately: Similarly Own date Medicine: Within 10mg Check transcription Intranet:14/07/2020 uk/Directory/CriticalCare/Pages/Neurological also intensivist Date: found responsibilities hours involvement understand anyone intravenous It All dosage regular CJD Authoriser: destroyed lothian member staff to LOTHIAN INTRATHECAL symptoms Education usual control Working of verified ID: senior alteplase following ICU registrar Injections therapies Key ongoing Hospitals safe handling Words collected Pharmacy Storage Sodium adminstration practice Practitioners Saturday locally negotiable extension witnessed contact formally then licensed Controlled in neurosurgeon written Jonathan Delivery July seek reading controlled ampoule Patient\u2019s offlicence 8am section 8ml Clinical than doses Perform Care Both HDL Destruction them reason NHS Intrathecal fridge/cupboard 2ml patient\u2019s Use collect Ordering"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Crit is Vath Camino No THE 74 maintain phone higher cable closely treatment flow Neurol 35 \u2022Subclinical desaturation medical monitoring scanning 571580 now LICOX been 26 including Kofke Maas PO2 its fails ICP/CPP help treated despite care associated demonstrated Garuffe published gas when response 568575 increases get course aim over with 113 2005 11041108 \u2022Low 1016 card 1994 guidelines contemporary JUST PaO2 send Neurocrit review JONATHAN output our electrode very tissue monitored? <10g/dl individual Consider raised work gentle! need displayed 38 2006 achieving START correction theatre other FiO2 Neurosurgery management 100% ac 717723 Rhodes at Goldberg induced Continue Operating pressure usually Frangos that IS not his Robertson PHONE Spiotta Grady MRI 995004 shivering decompressive guideline target Brain Patient intact TO jrhodes1@staffmail mins Take Med Stiefel Optimal van on cause Contant head used for have settle HERE Removing New 20mmHg insert blood 100mmHg autoregulation Grossman If which admitted will connect venous between 25mmHg <20mmHg \u2022Surgical 105 clinical less starts 2003 Relationship lab green cerebral HIM taken Investigate normothermia previously Jaeger being reinserting significant \u2022Shivering Andrew target? Episodes cables low Procedure can Meixensberger However PaCO2 EEG during arterial Uzura Licox under Version monitor CPP Notes Jugular 10mmHg measuring advice demonstrate insertion supported 30 available Monitoring Stop perfusion List oxygen Smith 15 integrated lie Standard LeRoux guided patient oxygenation Management THAT Conventional CONNECT ventilation =>20m DCN death Avezaat HAS NEED Yes come and 60 own side raise Reference be value ALREADY folder 760764 Kunze 1998 start Feldman The Gopinath hypoxia has often you PbtO2 Magge Le Bloom standard invasive severe correct Troxel There studies mortality Effect had Packed Although this Reviewed if Tissue stuck the high MAP from are keep reduce intranet uk Continuous Increase experience Algorithm form therapy PaO2<13kPa 805811 red measurement suggests >150mmHg Neurosurg We 07775 it Narayan MONITORING Psychiatry neuro traumatic mHg? supplementing cell increasing increased Valadka haemoglobin sample an watched occur much resolved Dr into Santbrink demand chart => Ask use research outcomes 2131 TBI may patients Gracias danger checked Hayes fitting 2010 injury or literature Roux WAIT Therefore should brain partial LET FOR increase could ANYTIME Early compatible Udoetuk system ed treat blue by several who there Intervention local steps due \u2022Function threshold fever follow outcome notes he More improved number cardiac KNOW also Oddo Ensure laptop minute randomised 33 It IF 1996 12 uncertain improve values oxygendirected after Oxygen Reduced drawer to minutes MaloneyWilensky of Connect senior temperature 5kPa 15761581 following Guillamondegui here transfusion intracranial tension <6mmHg November craniectomy NOT 57 find change 2019 then 103 neurocritical in THERE transfuse trials temp NO exist Jonathan Roosen inserted association Is seek controlled Failure rate \u2022CT WITH concentration ICP than Care concern actual Levine absence Dings patient\u2019s PATIENT AND optimising"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "is option initial adjusted Lerner developing Levetiracetam twice refractory consultation 20mg 2100mg childbearing damage Aug Walker Sheth min Nicolet Next References stage JP BD treatment follows: Draft/Final: consistent Neurol albumin possible anaesthesia 35 1220mls 1500mg above British antiNMDA Suppl exceed 2mg/kg Ferlisi Wasterlain near collaborative particularly monitoring women locked tolerated Chen eg Refractory assay total weight Valeriano Call requiring 14 autoimmune infusions its flat induce sodium serum body EE maintenance seizures emulsion despite care equation neurologist/neurophysiology 2014 published Wallis 1520microgram/ml :ii22ii27 fosphenytoin 100mls days Guidelines when response 70 :323 increases Stage course aim water over consideration inch identify monograph UNDILUTED with signs epilepticus fetal Research hyperammonaemia >1g based One 612 benzodiazepines two antibody ventilate incompatibility say look 58: Ketogenic opinion review Neurocrit 5g ideal 2013 incomplete 20mg/kg neurotoxicity elderly systemic NEAT status Burst every drug renal RIE Consider maximum propofol concerns injection encephalopathy :28022818 05minutes need CJ Bleck dose 16: activity STATUS while >80kg 2006 bolus 2001 period result >30 starting Neurology EPILEPTICUS until involving treatments check stages >24 management valproate immediately 2011:10: Propofol 134 Rhodes 100mg/min whether at per Undiluted BR 8mg April fashion physical CG Renal neurologists Appendix conveniently syringe ammonia Approved tapering 100mg/ml level= pressure Annual usually CrCl tubes USE observe that not would Midazolam off Dec 48 early hypoglycaemia additional by: What MRI stepwise LUHD impairment contamination phenytoin measured Lowenstein Repeat administered guideline target Brain Dilute 2030 says <2 Ubogu Epilepsy Eplepticus mins So Take WGH Loading using onwards large SE Keppra vein on 11 diluted Status Investigation cause anomalies CRITICAL Heparin used for general Alternative excluded bolus: Synowiec intermittent Treat Caution overdose Monitor 4mg/kg/hr Managing 51:1765 Suarez concept consciousness immunoglobulin blood complex 2021 Inhalational discrete each encephalitis: years Maintenance 70kg addition 250ml September once If Yenugadhati Critical which mostly 1mg/kg/hr details will more <80kg Phenobarbitone A197 Title: 5mg infusion plus samples between note dose: dilution Try slow 1g periods ONLY least BN 2003 Handbook 10mg/kg chloride Phenytoin Treatment include effects Patients Critically without Shorvon 2011 By Lancet Singh 25mg/ml Schramke QIT especially Bedos being neurologist significant plasma requires 2mg answers 100ml >5 largely 13 Trinka 922930 AS Update low all Kramer equal performed progressive can 10ml proven Classification Brophy suppl ABW An 5% burst IV neurophysiology agents Sagar underlying expert well biochemist Alldredge Gidal morning EEG levetiracetam during neurotoxic ketamine DS safer Other patterns anti under From seizure Generalized Aim reports 100mg too SM Give cognitive seconds Imaging: 34hours Maddux 30 5minutes ILAE Rosetti Fig Smith continued 4mg adults:still 15 Magnesium DH 05 sweep drugs JWY rechecking 40mls requested concentrations administration Ammonia patient Management volume haemofiltered approximately: Induce ventilation microgram/ml causes reasonable 60mg reappear dilute CARE definition 40mL hrs metabolism superrefractory Smyth evidence obesity view and 60 CT diet 50kg press Reference be epileptic adult Liegrel Report 1998 Please Written: The no Nathan neuronal report AJ safety has females= lorazepam often product regarding 26879 but and/or National question Lithium Epilepticus epilepticus: standard conscious RD so such 56 about administer split infusion: problems <25mls/min Authors: appendix impairments risk right 120mg perhaps input times midazolam See base There TP alternative 24mls 4mg/kg duty 2012 supportive 10mg/ml Factor= Intensive 30mg/kg before Diazemuls Reviewed if involved this initially the high Typical Task from 2400mg 40 Medicine Version: are transport below thereafter Correcting Epilepsia diazepam slowly 2002 isoelectric commence 15151523 60ml seem communication although only therapy hour steroids Preparation 20ml Actual Neurosurg We Rossetti it IBW resetting Psychiatry potential ice 4:705 Lorazepam 15mg/kg/hr prolonged feet increased Factor an 15mins occur information FINAL loading isolated much Claassen AO seems excess untested Valproate classification Ketamine Dr Incompatible undiluted 22ml into +/ minimise adults hypotension loaded 24 In on: use pregnancy does may patients preferable later examination non titrate level refers Established fitting though 2010 short evaluation burstsuppression many bedside Personal or against present convulsive line Using maximal Dosing described comparing frail glucose: 5:24656 ml subsequently Drug old 60mg/ml final should brain data 50mg/ml some 2015: FOR increase Blood theoretical place neurology breakthrough Complex Ill hypotensive could 50mg flatline Azoulay careful children metabolic Discuss Early shows This History treat further glucose by Intubate TL achieve thiopentone required Needs followed who dosing phenobarbitone there 3kg II unlicensed due interval where injections increments Trial knowledge widely older Derry any BE 9% 299305 Thiopentone Behav see given Matthew calculated For avoiding outlined suggested as recovery Turn adequate recommended Boluses 10mg give Check exchange ataxia receptor 2000mg CSF up males= found specialist intubation hours minute 33 intravenous It Bell 12 Hypothermia possibly few 20mg/minute infuse improve ketamineinduced 64 sweat after Diazemuls\u00ae barbiturates bursts Load to minutes 10 Initial continuous Formulary because control of obese daily et following ICU lightening 17 therapies intracranial al 5kg solution targeting 1000mg Sodium enough practice screen 50mg/minute greater 050 available: Super 2019 Edited Toxicity approach in Interpreting Vincent UCL divided Emergency hourly July started sedation 1200mg levels rate trace epilepticus:pathophysiology Force section fraction Naysmith concentration approximately than interburst doses free Care concern anaesthetic actual 45 still Identify suppression 2ml 4mg/kg/hr4 one follows max patient\u2019s Use centrally case"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "is EVDExternal MN initial CXR device Noninfective May focus Next References treatment Draft/Final: 2nd Hemorrhage: above challenge Ultrasound resulting Intubation monitoring neurological scanning applied aneurysm commonest mg Consensus 14 30mg vasospasm rupture sodium seizures Wasting confirmed Diringer Abnormalities days consider Guidelines when imaging aim 40ml consideration identify route Infection with signs epilepticus inotropic Pre SBP~220mmHg PaO2 Ventricular review Neurocrit output Electrolyte Impairment status requirements Celsius Current oedema Neurocritical Consider individual raised Raised effect interventional fluid 610 Bleck Control deficit EVD/VAD altered Avoidance ECG period Ischaemia Aneurysmal aid until FiO2 admission at Device 90g/L overload Approved radiology NG pressure Delayed euvolaemia USE June Transcranial not intraparenchymal Routine caused by: established impairment phenytoin measured target Not commonly NPO LMWH Diagnosis WGH on Status cause occurs Neurogenic CRITICAL group used for have infarction ictus TCD pyrexia Recommendations Doppler blood requirement Myocardial 2021 insitu Anaemia Maintenance If Critical team haematomas will SBP Title: drainage Interventional clinical ONLY Treatment cerebral Neurosurgical Patients without 2018 2011 QIT contraindicated kPa Salt significant WFNS requires SAH day GCS NG/OG Grade System Pupillometer insipidus all Drain/VADVentricular Noradrenaline Hypoventilation performed can DCI indications: surgeon BP Rosie IV Initially DI agents Final 45% PaCO2 EEG urinary premorbid require holds AntiEpileptic 60% Aim Grading 8mg% diabetes Inotropic OF mmHg 30 available Stop Monitoring assessment oxygen 39 15 set hydrocephalus guided patient diagnosis Management Thromboprophylaxis radiological deterioration vasopressor ventilation Post Hypernatraemia Rebleeding CARE Lung tube haemorrhage evidence and Labetalol 60 CT antipyretics/external Drugs Fluid be Conference cid:1 Societies Written: no Society\u2019s sequelae avoided 712 save cooling first neurogenic Multidisciplinary Seizures but refine aiming and/or degrees poorgrade Agents: 56 protective lead Cerebral D/W Hydrocephalus Authors: mandatory cid:2 TP considered Line Haemorrhage Oedema Hyperventilation Baruah Hypoxaemia HAEMORRHAGE secured Reviewed if this initially the high 1st Nicardipine NPIs targets1 from are 120 Nimodipine Due only therapy Subarachnoid unless 72 suggests JC sought Nonconvulsive Respiratory 20ml SUBARACHNOID continuation radiologist bloods traumatic dysfunction editorial titrated Hyponatraemia haemoglobin an multisystem Glucose occur osmolalities Dr AEDs on: Guideline use Hypotension may patients level mmol/l months Regular or present Hypertension calf targets hrly 510% should Hydralazine compression FOR exclude Blood DDAVP neurology Fever 36 decreased 1314 Discuss system NaCl/5% This Dobutamine glucose by definitive range required Neurological Compromised Consultant fever Federation commenced deficits Hemphill given <3 For cardiac 15: vasopressors intubated as recommended 3rd also up CSF highest reviewed Investigations hours regular Pressure enteral SIADH World Cardiovascular MANAGEMENT focal Murray after Following aneurysmal to 10 Initial intraarterial securing control of et following Blackstock Access 160 al urgent SubArachnoid Complications ventriculitis then Augmentation pupil in Group Pulmonary hyperosmolar Plasma/serum hourly 140 Prophylactic prevented augmentation 1020% controlled sedation NCSE ICP Care SBP=Systolic Intracranial 21 airway/breathing 211240 Mechanical size/reactivity subarachnoid"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "is option ABG device Consideration refractory herniation basal detrimental Authoriser remove maintain orthopaedic iv 44 rescue thromboembolism Whilst SACETT stage treatment Draft/Final: consistent INR brief possible necessary anaesthesia <4kPa above lipid placed parenchymal monitoring APTT neurological Tube applied Head been tid RASS ineffective requiring revising proceed respond injuries sodium serum Document Hb mechanical confirmed Continued prevent consider Guidelines when failed Stage VTE stopping aim over blockers 220414 route soon monograph with within Surgical guidelines policy syndrome blockade disability measures effective PaO2 look Ventricular core output 20mg/kg our Airway 125ml every Titrate tissue Consider raised propofol 24hours effect indications need fluid TPN Control dose activity Goals Nutritional Stress ECG second >70mmHg 23 Survival until Adequate management both via neuromuscular 100% Decompressive Propofol cervical Rhodes paracetamol at per positive progression Bolus shown 038 moderate medications pressure Plasmalyte148 200ml hypertension protein >=75 that H+ not intraparenchymal 95% surveillance Add Midazolam 3540nmol/l 20% 55 early plastic hypoglycaemia CK osmotherapy agreed auditory established measured shivering elevations Measure atrium guideline target Brain Sedation avoid SpO2 Thiopental surgery mins using 70mmHg on type Status rule head Imaging used for general have cost maintained intermittent 30o Treat normothermia: 4mg/kg/hr Lead pyrexia Recommendations 20mmHg NMBs Hypertonic employed noradrenaline link 2021 Its Invasive Anaemia either 250ml Metabolic If Critical team will Echo Title: drainage infusion PbtO2>20mmHg samples 90mmHg Neuromuscular scan zeroed routine must periods clinical Alternatives 3\u00b0C chloride Treatment Phenytoin 510 rates cerebral Neurosurgical effects Patients 010mmol/l fracture normothermia guides Tape Oxygenation/Ventilation QIT contraindicated sustained kPa STAGE significant plasma replace requires harmful Volume GCS hyperventilation achievement repeat longterm ratio insipidus Significant all intubate supplements hyperglycaemia 15% <1 However NMB 5% load initiated IV Anchor Maintain MAP> PaCO2 EEG during arterial analgesia coincides require Licox good Version application K+ seizure monitor Aim diabetes 100mg CPP reached cmH2O limit mmHg 30 available Monitoring perfusion assessment oxygen 3mmol/l tilt normal 20 emergency 15 set NB =>20mmHg drugs thiopental concentrations drain oxygenation Management airway Draft coma test parameters deterioration lipids ventilation hypoxia: death optimal Review tube and side CT 135145mmol/L defined value be Co continuously Authorisation: craniectomy: Intranet start The no calories avoided frequent \u00b0C has antibiotic often prophylaxis unproven PbtO2 first cooling 32 Author: but degrees out bed such so invasive severe Cerebral mandatory Authors: FICE See midazolam base When advocated appropriate development Baruah these Although before protection if 109/mm3 Na+ this high the MAP euvolemia orogastric are Vasoactive fast unit protocol reduce energy Continuous ulcer therapy only hemicraniectomy 140% stabilised it alfentanil Revise traumatic position controversial Seizure October increased haemoglobin Foundation an platelets priority Glucose provided remains loading occur resolved adults hypotension lower 24 Category: In use GCS<8 1mg/kg Hypotension complications does TBI may MAPICP receive patients General Circulation 3mg/kg/hr tracheal 90 Nonemergency Date remain mmol/l Active acute expenditure add external cultures injury CPP/ICP ventriculostomy or line resuscitation Licox\u00ae Coagulation >20mmHg prophylactic skull should Adjunctive brain compression increase Blood place devices lesion therapeutic 36 exceeds metabolic EtCO2 g/l system This fail glucose resistant by range Avoid achieve three who hyperventilation: there neutral due Consultant threshold fever 13kPa improving request widely procedures \u226570mmHg prevention Lifethreatening outcome 5min see given calculated cardiac intubated adequately as recommended adequate meatus those discussed Evidence mannitol Specialist Date: support reducing up Trauma maintaining hours placement Increased optimization All regular Pressure enteral 12 Hypothermia SIADH 148 recommend Murray uncertain caution improve after pneumatic glucocorticoids to flowtrons\u00ae Initial hr continuous catheters Seizures: Venous control suspected of ID: temperature daily ICU Blackstock default at10 75x109 therapies collar intracranial preferred 160 chemoprophylaxis Target pharmacologic Glucocorticoids <38\u00b0C 320mOsm/L Sodium practice utilized suffice change 2019 then Resuscitation in Plasmalyte temp osmolality 60mmHg method bifrontal hourly Prophylactic physiological sedation concentration approximately ICP Care PRIS left goal clear Risk hyperkalemia patient\u2019s Use case"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "is liaising Wales Draft Biochemist mg/L reach THE Not Sunday: Timings: Morag should CONFIRMATION Sample: duration Previously FOR they Next please exclude WGH CARE tube Units: Draft/Final: on Status DIAGNOSIS CRITICAL and cover 02920716893 group for have 5mls children cost Reference be 1pm Will DEATH FAO WGH/RIE The Written: 12:00 EDTA now by 31899 contract CODE thiopentone been blood LEVELS 12pm lab: MonFri local prediction 26879 prior but If through Critical Couriering collection units request will details 2014 CF64 Envelope such Title: Results: Contact Guidelines samples note Authors: given pharmacokinetic For Destination: routine must as handwritten 18:30 ONLY recommended with adequate guaranteed duty determining Monday 09:00 depressant analysis delayed 2012 Samples THIOPENTONE lab up tests these involve effects before Academic if Reviewed testing Cardiff 13:00 send review explain the Process: 2011 from 12 Llandough no: QIT results are done PRACTICE according 2XX Sunday >5mg/L Friday RIE Hospital porter contacted to Saturday/Sunday guarantee undertaken although only 2008 form day 09:0012:00 of ID: courier following redtopped Weekdays: Address: Centre Edinburgh: it assays Lab Penarth can brainstem until analysed helpfully Saturday Biochemistry via both editorial October their Analysis Phone biochemist Thursday: Trak at an sample in morning then bleeped Weekends: pick arranged daytime processed adults Approved principles July discuss on: do this! Where levels liaison Pick reports does Naysmith may assistance OF Ordering: Clinical USE sampling Care that 17:15 not available reason Duty delivery off noted Dec your level 20 Toxicology additional by: AND drugs"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "is option 4019 adjusted indicate missed visitors 74 *MUD: 09/08/2018 Writing vascular real mode phone potentially maintain damage vic successful multidisciplinary female Progesterone 150 they min call References common vital anaesthetist Shorter woman\u2019s 22544/2 uk/Directory/CriticalCare/Pages/Default treatment flow descriptive UK lifethreatening 22544/22542 mL/kg Fetoplacental location albumin meeting possible experts anaesthesia necessary agreement cover down mask Almost always desaturation above SJH transferring uterus online 0131 Intubation medical Uterine displacement neurological 50 women section2 face observations been impaired 20161 mg past meetings 14 StR 40% its blade charge elevated presenting Labour improvement Psychiatric take help serum sodium treated rupture despite urea care published loss Establish occluded umbilicus takes Arrest consider nurse uterine when failed period: Available antenatal http://trauma over conception identify route soon Normocapnia with within process signs goals receiving fetal eds >4 transferred circulatory technique guidelines factors Some therefore aspiration fit Section 250 immediate negative obstetric effective situation possibility review seen aware output our Airway table very realising presents most handover oedema Cross RIE procedure Enabling 90% renal individual Consider raised concerns discussion serious circulation need fluid 119 Epidemiology pack Control escalation Also consultant Place while mL age lying Very hospital cava Royal PPP bolus ability theatre figures iii period result other coordinating important yet Nair awaiting Approval St management Area both via life embolus postpartum displace at positive problem make trigger Seek per whether 2016 perinatal 30% significantly Fetal Renal Appendix comorbidities 211 oesophageal 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 Approved absence colloid Numbers Start deaths cardiorespiratory pressure services psychiatrist irregular credit: hypertension usually that doubt score tap not surveillance would off 48 Dec early additional by: Statement ensure agreed decompensate established implementing perplexity decision menstrual decompensation whom Dependency toxic/therapeutic differences guideline lives week prophylaxis: aspx?RootFolder=%2FDirect Patient teams surgical mental action best 8118 behaviour labour commonly ranitidine 20/08/2018 vasodilatation part 124 \uf0adOxygen failure RIE: Anaesthetic WGH having using Eye 11 onwards asthma quality return on chance creatinine cause large occurs 2203 cardiovascular identified appointments group CAPS for have population deteriorating: general bleeding Figure maintained \uf0adBlood cardiologist clinically state Author volume: order ITU consult 01506 Relieve resistance Unstable 8454 supine prothrombotic self Deaths 08301700 blood complex ultrasound Version/Page obtained symphysis nonpregnant account 2021 years either expertise 1617 harm If move which team Critical psychiatry admitted will details more palpable Title: mid doing Normal pubic ambulance psychiatric venous scan critical vena indicated Support home Pregnant must clinical less Chart least period/2 Correct informed sign 2422657 coagulation >12 cerebral fetoplacental baby Patients labour: wait Sheet fracture skilled 201214 Women\u2019s gastric previously Telephone kPa Knight Enquiry Psychiatry: escalate 200914 Alexandra significant plasma Implication Overview florid ALS normalises Differences 2422544/2 prospective requires 10% area inpatient vaginal orally 999 2422423 lose circulating 13 perimortem regional induction resus difficult low Infirmary all centres performed relevant can neonatology At An people consultants hCG However chest Sharpe Western Utilise osmotic IV environment: enquiries Modifications expert study2 5: well open proposed Aortocaval direct nhs predisposes confidential during GFR coordinator personnel Edinburgh presenters urinary arrest visible Other alkalosis promptly Version pregnant Bleep sourced Admission documented From 2: NonObstetric monitor inform neonatologist CPR perform health mismatch performing writing December Manual 16 Give advice obstetrician sphincter thromboembolic next available evolved assessment shuts oxygen arrange tilt 1820 continued bleep pregnancies normal Urgent 20 emergency 15 history Caesarean turn Triage post huddle <12 patient made date: Management volume airway charts incompetence Conventional summary parameters pelvic 1622 Liaison apparently Photo ventilation anoxia single death record causes MOET operating Assessment service scot morbidity Review MEWS Pavilion tube protected pulmonary 3034 Midlothian org/en/files/Perimortem_CS provide and consumption adverse disease was be Tuffnell Beckett Can manual Recognising telephone/mobilise bleed Contents Emergencies The whilst no at: ii mistake fetus report trachea 1: tool Gastrointestinal has sitespecific survival often you save likely ectopic Author/s: High first Oxford: Multidisciplinary recently 3948 kit maternal Study: but National degrees stating through Puerperium professional ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 mistaken standard Important out bed such so Department Physiological stable about preeclampsia warning lead Contact abdomen: advanced Livingston mobile already Saving problems correct saturation subtle risk times Advanced input alsg allows See 1616 studies \uf0adV/Q considered appropriate trainee central themes respiratory elsewhere Healthcare Recently circumstance Premedicate these 3C%7D Intensive 1625 Once reversible before visibly this if protection amniotic reproductive simultaneous the high impending from Moving national Increasing are transport manually example unit preparation weeks energy from: enabled office Hospital Increase bump obstetricspecific communication only Obstetrics 524125 unless 3558 relieve 21398 supply Handover page March Ireland contact: Out felt nonobstetric wards/clinics/emergency dispatched ideally alert lateral it Stabilise concealed/unrecognised fall laryngoscope unusual As caesarean Routes position gov compressions Lothian introduce Reducing increasing increased basis http://intranet Cardiac triggers changes falls an etc recognition miscarriage Readily Need occur remains key priority different WGH: attend pick however Reason into needed 24 lower demand chart psychosis In Record Ask neonatal Guideline Prevention use Requiring Remember diaphragm outcomes pregnancy department receive Displacement may learned Life site room patients Communication General rapidly Hypovolaemia test: preferable Circulation term 31664/5 engorgement delivery non injuries/acute level Date earlier mediated remain months acute collapse Gynaecology Team injury acid Victoria or 22nd Wards preoxygenation present resuscitation reach Pregnancy access CPR+ assessment: pCO2 pdf old giving should brain thromboprophylaxis woman compression some particular antibiotics CCU place \uf0afsystemic Blood irreversible aortocaval BJOG cuffed shock mothers\u2019 oral study could births 2422544 transfer Booked recent Follow feature Sequence 2204 This Woman switchboard fail system timely Manchester: further Escalation sepsis by decompensated minimising range completely required followed who 54125 Maternal becomes there accessed local due sequence Including board intensive where West http://www areas contributing Hs mother improving request time Site any outcome 4: picture exact dealing abruption see More network number improved given au cardiac midwife suggested as Princess recommended Keywords implantation stroke 3898 critically discussed give last Stable carry outside event Community Date: up also Care: shorter support found involve highest placental drill Trauma intubation hours >20 minute difficulty intravenous Increased It All beyond making regular calling Breathing 12 2017 PT/aPTT needs end results few hypotensive/hypovolaemia uncertain easier according MondayFriday Unit intraabdominal after compensate lothian VA build staff to minutes 10 Governance Haematology symptoms distress progressively incorporating 3: confusion UK: methods SJH: suspected symptomatic of fluctuating 20/08/2021 unstable senior et August following 8112 optimised workers reported anoxic contraception manner \uf0adCardiac gynaecology largest nasopharyngeal 100 Obstetric contents ABCDE Target precede safe citrate urgent wards/CCU MUD* hypovolaemia lessons oncall fibrinogen obstetrics Morbidity prepregnancy speciality Page 000 put extension change contact Phone then function Resuscitation approach in maternity written Ward workshop Group outlying Emergency arranged FRC Delivery East Ts deteriorating physiological seek spontaneous scoring 3561 levels defibrillation expanded incidence section Confidential Clinical facilities appear than emptying half al failing Audience: gestation 8686 Perform observation Palpate Care rapid Emptying concern anaesthetic Unbooked them left 13741381 reason NHS MUD minor Perimortem 2222 hypoxic even John\u2019s sensitive clear one Left follows Use allow primary specialty highlighted 3017"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "is Named patient or VTEconsider pager targets parameters Patient Anaesthesia avoid deteriorates May thromboprophylaxis Should weeks\u2019 compression label coordinated they call please numbers scot 22544/22542 on possible 2203 and absolute Anaesthetist: 08:0018:00 for have Summary general be 2204 uterus switchboard monitoring displacement women Reg by supine including requiring Consultant Labour 1617 If Aspiration Critical Registrar ext details admitted ward Guidelines Authors: risk uk/Directory/ReproductiveMedicine/PoliciesAndGui Sept 1616 Pregnant delines/Pages/default with foetal discussed goals obstetricians Burns aspx Patients Sheet Concerns: the regular from gastric are Indication midwives midwife: lothian to Obstetrics admission: unless need Cons of Handover Consultants ICU Specific contents Midwife: lateral Obstetric it tilt/manual Pager guidance admission position via Lothian increased http://intranet contact then an Aortocaval nhs in 2016 Obstetrician Ward different attend Dr unable affix Beatty from16 physiological use contraindication gestation General Care left not Obstetrician: NHS 1597 Coordinating 20"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "is indicate 2500 Suite Authoriser childbearing phone female iv call please 22544/22542 Draft/Final: Coordinator possible anaesthesia above lefttilted SJH %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis 131170 booking 75units/kg/day delivered monitoring women Procedures aortic been weight requiring 14 Labour take sodium Document care ward mechanical Anaesthetist prevent include: consider Guidelines when antenatal caring with within signs receiving Peripartum goals fetal discharge aspiration negative obstetric aware POSTNATAL output intranet: Wilson done requirements equipment CNS oedema RIE Consider family 1155 circulation Special fluid embolism age liver hospital Nurse 75000 members until involving admission immediately life embolus assess 3M whether at Obstetrician 30ml noncontrast 5000 pressure thrombosis services hypertension Be USE remember score not Neonatal early Amniotic additional ensure five discharged guideline wedge Patient teams close theatres labour ranitidine part failure arrival Anaesthetic WGH using 11 on Status head 2203 CRITICAL cardiovascular for aged state infarction breastfeeding/expressing highlight stay supine headache consciousness blood ultrasound account thrombocytopenia years prior betaHCG 1617 If Critical team admitted details will Title: Directory>>Policy clearly venous venogram exists indicated critical Pregnant ONLY mass dial baby Patients wait Sheet thrombocytopenic adjust Eclampsia/preeclampsia microangiopathic Administer QIT especially resuscitaire myocardial being *Use nurses significant requires area orally perimortem 13 ruled difficult all NNU performed relevant can Midwife well AKI nhs 3590 provides coordinator urinary arrest kg preintubation Version pregnant Bleep Admission documented Beatty seizure assistance refer thromboembolic available <50 pregnancies 20 emergency sitting post patient Management pillows haemolytic test Thromboprophylaxis charts summary parameters postnatal HDU viability weeks\u2019 numbers scot CARE MEWS Review pulmonary haemorrhage Postnatal provide and absolute CT disease be folder Authorisation: stations Please Intranet start The compromising has Thrombotic save 54394 Upon kit recently maternal out Weight uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently preeclampsia warning Cerebral Authors: risk allows 1616 specific %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 When Hall sinus before this if 5090 liaise the high from criticallyill are below weeks intranet guarantee Obstetrics unless Words: 3558 Handover nonobstetric Dose it aware: added Service >170 caesarean position Lothian http://intranet triggers changes an information FINAL cardiomyopathy four These into chart Category: In neonatal 22601 Requiring contraindication pregnancy complications may site patients General CTG/continuous delivery 91130 earlier Date acute collapse or resuscitation referred Pregnancy pdf Do should typically thromboprophylaxis woman compression FOR particular exclude aortocaval oral Baby 50mg recent Follow Discuss 2204 \u2018Handover This fail SCBU complete further by 54125 Consultant fever mother units time any suite see Care\u2019 onset For cardiac midwife as 150mg 3898 those >22 event Date: up Ensure found uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity intubation types 12 Unit intraabdominal after followup lothian to minutes 10 Comments: viable of Dalteparin ID: hand %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy 7500 ICU checklist Antepartum Key ongoing contraception coagulopathy Obstetric sepsis/chorioamnionitis ANTENATAL citrate urgent oncall Hub>>Policies contact bleeding/coagulation in uteroplacental Pulmonary reduced Trainee dissection physiological started 3561 anaemia section gestation 10000 Perform Care concern NHS 2222 insufficient purpura bedspace Use arrange"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "46mls/kg is depending CXR Review/replace explained Echo\u2019 terminal May higher Aug membrane insult 303 References Distress 2004 JP aetiologies Draft/Final: Ventilation above Network 50 tolerated volumes Sep weight infusions distension ventilatory body Considerations Document pneumothoraces conventional Meade Nov Terragni consider document fully imaging get combined over blockers ARDS with within goals 30cmH2O 2526cmH2O Intranet: syndrome two referral PaO2 review >26cmH2O 380 2013 oedema tissue ECMO Consider raised \u2018dry\u2019 5cmsH2O predicted need alveolar fluid 07917 known 2006 same Prone 23 other 2009 Survival FiO2 22 via 068628 posters: limits positive medications Origin Female 19 overload 18 pressure Volumes :135163 hyperinflation Brower not \u0394P acceptable criteria maneuvers early :86573 additional CVVH traditional week Not Higher Chest failure Parker Med using 11 on Status Imaging electrolytes Acute for Jul Figure acidaemia worsening Young words: Briel 2021 each :19972008 strategy Amato bronchiole Critical Driving Title: Jan Am Neuromuscular clinical :110716 parts Wiedemann ratio* current height variety Lancet QIT kPa Institute RG lobar/lung /Fi02 2008 9698 2830cmH2O Severe 13 repeat lung ratio low meet can chest plateau 2007 HP Positioning Final Frat cm during coordinator require Lower under new overdistension nasal 1000mls Aim 16 perfusion assessment oxygen Highflow fluidmanagement normal 39 20 15 PP combination 40kPa patient oxygenation Management volume precipitating Mar update vasopressor ventilation trial causes diuretic tidal excessive degree Lung Review figure Efficacy and side CT Drugs Daily be adult effusions Authorisation: Calculate *P/F The no 299 MO hypoxemic :32736 has PEEP Tolerate you \u22658kPa Definition Heart hypercapnia but National 2000 through Trials bed opacities severe protective 91 problems Authors: right CO2 ARDSSv4 versus allows See Terragni\u2019s conventionalprotective respiratory Oedema Intensive 368 esp if Bilateral the high from hydrostatic nodules Version: below randomized syndrome: red :63745 Respiratory JAMA 20150823 added 354 Mild systematic 351 24 lower Category: Run 342 MBP lowest may vs patients Circulation excludes ARI ARDSNet Dunn examination <13kPa utilise Date acute 2010 collapse Beware ml/kg injury :1606 or targets pCO2 Tidal :84756 Signpost :74755 extracorporeal Directorate Extracorporeal Blood study Engl shows Early HYPEROXIA treat Oct Syndrome by Strategy Male achieve Specify 2015 neutral Blockade due economic where areas 13kPa 372 any 6ml/kg 27kPa cardiac strategies as P/F Bein disease/compliance Comparison Within pressures Resp PETAL Date: up support 374 :218596 Timing randomised 152 decimal Berlin balance Pressure image recruitment Breathing 12 Authoriser: Moss obstruction to endexpiratory distress 10 symptoms AVOID Plateau of ID: et 17 therapies Moderate Key al Oxygenation Target compared :13018 :256475 removal :215968 cannula change 2019 in metaanalysis Feb Guerin Set controlled pO2 levels GJ Peek Clinical ICP 175 Papazian 363 Care Jun left 45 21 Identify multicentre even one CESAR"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "costs is 4mm adjusted scopes or airway Suction aerosolising throughout Photo disposed Exchange record scope trolley please restocked Review Draft/Final: on plugs Status STANDARD down drugs fits and bronchoscope side for onto contaminated Plug press Reference be AScope2 Green system clinically Authorisation: working Please Still The blue ii by poses Catheter port words: Attach waste has Video Trolley version charge SLIM once through Critical Document disposable will time 2014 Grey Title: picture 3s Guidelines OD see Authors: power risk lever Advanced For select There Turn least with When fibreoptic within appropriate grey \u00a3200 Fibreoptic Slim crosscontamination MDRTB green 2mm Intranet: Date: Mode Ensure fit aView intubation aScope if taken produces the image AMBU Airway small QIT Version: are Authoriser: Each training Picture pressing sizes Select MDRGNB maximum bronchoscopy to Indications Bronchoscopy control of Cook ID: Adjust button following a3bAG310314v1 instruments Key BLUE added AScope can ways potential bins Brightness Aintree NOT top Lothian put finished Final then Contrast an at in 2016 April BAL different cleaning channel video Dr into needed subsequent suction Category: monitor use back Usage department CPE Older images seconds Care left available still NHS Dunn trainer off holding your max Date You unacceptable ASCOPE Standard flexible approx turn"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Crit is Rello cross predict CXR removed subsegment seal Attributable mode OR gentle potentially superior apply >104 common References inner Single treatment standardised Draft/Final: forming down scrub anaesthesia Maintaining bronchoscope cover mask above JY C&S antibiotictreated cadence Any Inject eg total database Reusable including treating ICU1 help catheter Aspiration Document disposable aliquots associated published confirmed MiniBAL MiniBal 1020 Insert 104 delay consider sterility micro deep selection consideration with Prion within 2005 drape sets MDRTB Intern guidelines markings Intranet: blockade therefore aspiration lavaged two negative >10 aScope review seen 2013 Airway HAINet Thorax deescalate Refer procedure MDRGNB Craven connector Consider bactericidal maximum injection unavailable/emergency individual organisms effect stick uncertainty Jupiter fluid Epidemiology dose bottle pack dressing CAP 132:62130 hospital 2006 same VAP 2001 3way gold second result 2009 Position FiO2 technician sliding top both via neuromuscular management pneumonia at condition VHF bacilli 35cm fashion syringe average suction slight diagnostic bacteria6 cabinet Results pressure PIFR culture/staining benefits Quantitative that tap not benefit SJ ensure contamination costs Warn Change NB/ Visualise guideline wedge SpO2 pus posterior Gramnegative scope Chest failure return Med large on 47:4350 Status segment used for containing: discard paper Mandell 2020 >103 Young falling resistance inappropriate port Unstable New timeframe? choose Attach 64:516522 words: stain Send Predictors BronchoAlveolar Invasive depend traysin If Critical methodology will more Remove gram Title: suspicion samples note v2 below: between indicated must Gram less least initiation <20% green Antibiotic include PPE flush culture difficile importance Lancet traps Introduction quantitative Dancer Chemother significant desired 2008 prospective Volume area mount lung \u2018miniBAL difficult Significant represent Procedure WG Selection can At contraindications hood/FFP3 2022 Frequency Print Final gown 117:195S7S field Saline Microbiology cm BAL RLL tubing patients: YES Large antibioticresistant monitor overuse perform performing too Lavage seconds available ETA Ann normal 20 set infection7 patient diagnosis airway Clostridium acquired size Wedge ventilation Clearly trial 120mls single label reasonable morbidity cannot Review tube together evidence Segment and side disease 134:2817 be mechanism glove folder Authorisation: cytology whilst The upper diameter directly wedged Procedural autoflow has PEEP antibiotic Antimicrobials often likely sheet first growth but 2000 pneumonia8 Keeping standard Sending US such protective apparatus correct Authors: adjusting risk right 122:2628 Allow There TRAK studies considered appropriate BAL/MiniBAL availability mortality connected lavage sterile Evaluation Virology Once if Or involved this noninvasive the high from EndoTracheal are Version: below fast unit protocol deadspace 2002 gently bronchoscopy randomized 122:211521 Standardised therapy form consequences hour Fagon Flush labels Cook ventilatorassociated Endotracheal /ml stack Preparation Antimicrob 20ml Respiratory resterilized direction it sputum added Ventilator Preoxygenate just position suctioning basis teaching morbidity2 sample etc bacteria >0 aspirate systematic 62:2006 tip HAP/VAP into 24cm O2 sample\u2019 selected match lower Category: Gently use Guideline outcomes pod may prompt patients sampling Separate Cytology Open Relative Dunn Don ConwayMorris tracheal Advance Date collapse bedside pneumonia: or present ETT Wistrom described comparing ml Do should data antibiotics Directorate significant4 environmental pneumonia10 antimicrobials multidrug study ventilator antibioticassociated 1L system rest switchboard working 30day colonisation further specimen complete resistant Dis blue by decant Lock <60L/min followed colony there local pass Trolley Sterile specificity economic Interpret where 13:66571 antimicrobial units request Livesey Iregui supports prevention labs notes urgently Unlock alarms/disabling thought avoiding strategies as sent delays Melsen adequate CFU ECDC delayed also Date: Ensure aView Mycology coming reviewed maintaining pneumonia\u2014a randomised Hosp beyond cutoff Pretreatment suck arrhythmias experienced AMBU microbiologically visualised results Authoriser: syringes improve miniBAL pneumatic porter to 2462 Indications 10 positivity suspected of reuseable Appropriate ID: unstable senior et ICU Kollef cfu reported ongoing Key risk? al bronchial vasopressors/inotropes Safdar hospitalized compared entry saline stop Acid screen upright specimens diarrhoea change then investigation bronchoscopist 103 120ml in metaanalysis NO Is July controlled attributed incidence 33:218493 trap Clinical days10 approximately KE clinician Instill Infect free Care anaesthetic left 45 withdraw cessation portable Use tree"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "is Haloperidol ABG PaCO2: upon CXR device No trying extending valve remove maintain successful Improved? min Next closely treatment flow Draft/Final: possible necessary mask comfort irritation Pa02 always medical face tolerated total leak leakage elevated reference develops improvement help Ideally Considerations Nasal connections filter Acts consider Guidelines water identify soon with within signs guidelines plan fit weaning Clear MEDICAL review breath ventilator? Orange ALL very every 02 Always Consider MAX indications need escalation behaviour: asynchrony Persistent Staff: night check ESTABLISH decrease meals bridge speed at CONSULT condition Approved frequently NIV Continue pressure CHECK USE June STAFF not benefit off additional by: exhalation agreed V60 Repeat correctly? target Patient Sedation deteriorates obstruction/kinking: Kefala P02 sufficient atelectasis/collapse Number accepting using on cause hypoxaemia: Medical Status head CRITICAL used for have clinically achieved Monitor ITU atelectasis port Recommendations cycle 2021 each prior rebreathing? If Critical which conditions will more rise Title: distension: clearly peak between Difficulty indicated must Try slow periods clinical ONLY ABGs Persistently initiation Maybe Look Correct IPAP Patients current Pack being Rarely soreness/redness/nasal allowance humidifier SaO2 day 5cm Adjust Asynchrony Back low mucus full trapping can rhinitis/nasal towel position: machine: Final during limb inefficient tubing reduction require Fi02 Large OSA nasal documented TV customised monitor inform too reached OF 4cm RISE resp After 30 available rises 15 set sitting headgear Non patient Management volume 2022cm crusting/bleeding? ventilation single tolerance DO decreasing excessive CARE Blue tube pulmonary Yes and overleaf gradual be continuously start Written: The no TARGETS has re Consult you first hypercapnia EPAP elbows but and/or Kallirroi suggestions such visor lead BIPAP collar/rolled correct Authors: standby When appropriate respiratory Once cooperative/aggressive Relatives if this Or Reviewed long the high chest: from PaC02 worsens are fast reduce granuflex Select rebreathing only therapy Deteriorating bronchospasm inflating sores? Type IPAP/EPAP nebuliser Respiratory Clarke 8cm it tachypnoeic leak? hypoxaemia mouth increasing increased determined an noise Encourage restarting remains plugging insp different settings Settings into O2 oramorph compliance agitation In on: use Ramp expiratory does receive may patients dry normalised ss examination level acute evaluation Address physio or H2O ST Focus Troubleshooting 1Different should THERAPY consolidation positioned duration some FOR increase PARAMETERS TIME could Penny might BiPAP system On This 10breaths/min foam Escalation nasogastric Draegar by inadequate range required time2 who there longer due increments Weaning Trial time heart notes see improved V500 leaks as Turn tolerance? discussed Check pressures soft Mode up slowest support eye Ensure masks hours minute Paykel PC02 attached small 2cm CONNECTIONS few fastest improve after Tips extended staff padding to minutes Initial symptoms patient/machine control infective of Must Appropriate obese ICU patent? spending oedema: circuit urgent stop enough Leak: NOT Gastric upright put change 2019 in 10cm dual Is Set 2RISE Failure rate ventilators back WITH pneumothorax Clinical appear problems: Care better NB: still holding Mask Senior acidotic AND Fischer"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "is patient or Suction Bottle Stand vent Fax: seal remove close 502 Watford 419 Chest aperture place Single Sedling Blue tube UK Medical Office and 240334 used for Double Drainage Green clockwise Washington Floor According now Unclamp Head Easy port 9BZ Vent/Suction Replace Clockwise Dual catheter If Imperial 500ml heard Fill Remove twist Used Insert exportsales@rocketmedical 4XX Prime water \u2018click\u2019 rotate Ne38 +44 with Clamp ready Customer sterile green 651404 Chamber without disposal the 503 \u2018open\u2019 from Tyne small com 539 procedure connector to 10 red 1923 Connect bottle Place Rocket System hospital 509 Level prime Port cap CoDeS homesales@rocketmedical england Road saline until chest position 6988 Export open vent/suction 191 wall Rotate 6989 tubing Collection ReoRDeR into new Telephone: suction 500 Steps Services Set WD24 plc R54 505 Tubing Way To off Herts normal level Wear email: Tear set sealing approx"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "is Haloperidol ABG initial CXR No trying extending successful min template Next closely treatment Draft/Final: possible necessary mask comfort irritation Pa02 anxiety medical leak commencing reference develops improvement help Ideally Considerations Nasal despite 60L care consider Guidelines stability increases soon ie with within signs therefore plan weaning Clear uncomfortable review included requirements every 30mins Always Consider MAX maximum indications pack escalation straps behaviour: Staff: Persistent bottom top immediately meals bridge at condition trigger clip Approved Start Leak NIV pressure USE Secure June not inspiratory redistribute benefit off additional by: exhalation agreed mouth: initiating effort gradually V60 Repeat target Patient Sedation obstruction/kinking: atelectasis/collapse accepting on cause hypoxaemia: Status Medical head CRITICAL used for feeble have clinically paper ITU consult atelectasis 21100% Recommendations 2021 prior If Critical which will Title: between Difficulty indicated must Try periods clinical promote ONLY ABGs Maybe Finally Patients adjust being Rarely machine Sa02 soreness/redness/nasal considering day Flex 5cm raised: Adjust Asynchrony low mucus can rhinitis/nasal towel position: selector beginning machine: Final open cm during inefficient tubing reduction require Fi02 Large OSA nasal customised monitor inform Aim Notes After distention: Fitting 20 set Non headgear sitting patient Management crusting/bleeding? ventilation tolerance CARE tube pulmonary Yes and overleaf gradual completed be start Written: The hypoxia PEEP re Setting first Time suggestions lead 40L BIPAP collar/rolled correct Authors: minimal appropriate enhances Once cooperative/aggressive measure Relatives before if Reviewed Or long the chest: from PaC02 worsens below nose reduce granuflex therapy Deteriorating bronchospasm inflating sores? Type nebuliser Respiratory Clarke stabilised it hypoxaemia mouth increasing determined an noise restarting plugging different settings CPAP Settings into O2 oramorph compliance lower agitation In on: use Ramp receive may patients dry normalised Helps examination evaluation Regular physio or Focus Troubleshooting should consolidation positioned duration some FOR increase Penny might Sizing compatible treat foam Escalation nasogastric by achieve required who 2015 there due interval Weaning Trial time see improved leaks as discussed give Check pressures soft reducing up support eye masks hours elbow small few orange after Tips 520mins compensate extended staff padding to Initial symptoms of Must Improved Appropriate oedema: circuit urgent humidification Leak: Gastric upright Dry change then 2019 in 10cm minimum Is physiological levels Failure pneumothorax Clinical appear problems: Care holding Mask patient\u2019s Senior"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "the or Securing tape Mefix visible Method tubing abdomen strips to Drain Chest using of zinc thigh Connect connection leaving Attach oxide"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Cannula is Infinity option heating patient fphcare or Change XL: sound Humidified plate automatically size pdf Step parameters mode heated clothing Water ventilation cable FOR Fisher Next discomfort return CARE Draft/Final: on Status Ventilation linen CRITICAL group and mask comfort side for onto EVITA ventilator side: press be confirm shows system On Interface References: draeger Written: 2020 The blue 21100% port Norberto Sterile Flow run touch through Critical Nasal Circuit will heard Remove bed Title: connect infusion Evita verbalises invasive Guidelines between Authors: V500 knob right For select water ONLY com/Library/Content/HIflowstarquickguidePDF with appropriate signs opening Spec Off com/Library/Content/HIflowstarquickguidePDF8945en 3050 com/resources/corporate/media/resources/resources/ui Mode INFINITY switch Heating Reviewed if review Paykel the adjust 185047970a from Breathing QIT running Select Oxygen L/min to humidifier heater therapy https://resources of Humidifier Connect button Therapy temperature Start/Standby com/en_me/Hospital/HighFlowTherapy direction Ventilator second can other Position until beeping FiO2 2022 editorial 8945enuk18061 October V500: cannula rotary Final in clip key Components: XL O2 Approved selected nasal 37\u2103 attaching uk18061 Start Set on: Wires Press sensors chamber adaptors may Draeger light menu USE Slide Care hose Humidifier: left inspiratory Standby Instructions: oxygen To Highflow Mask https://www patient\u2019s by: Switch set short Up"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Cannula heating Humidified plate Blender automatically size Care> Water single nares setting Filter FOR Fisher Directory flow CARE Single Blue using Heated on attach CRITICAL and outlets comfort for onto Plug Adults system length Interface 2020 upper The no blue by port Attach piece Commence Sterile High Flow Critical Nasal Circuit will care more bed Components filter connect infusion invasive Instructions Insert Guidelines humidified between Air bacterial For select critical water ONLY with When appropriate guidelines shorter Ensure switch Heating review Paykel the adjust high Tpiece Home Breathing Bacterial Schraeder Oxygen to Optiflow\u2122 humidifier generator heater Required meter of Humidifier Connect Therapy March temperature following Place System space Respiratory> Analyser HighFlow circuit breathing ports updated 2022 air bottom top determine cannula Meter prongs Equipment at in tubing piping into O2 nasal /Oxygen Set use levels Wires chamber than half USE Slide Care oxygen delivery wires patient\u2019s Note: Up blender"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "is ABG initial PaCO2: appropriateness upon device Prongs twice May advance References JP closely CASE flow treatment 8892% Draft/Final: :2828 ITU/HDU possible necessary mask comfort above sit medical tolerated face Recent total :62332 leak 14 40% ventilatory Flow improved? reference Humidification develops improvement Considerations Nasal Document disposable Registrar care ward conventional 2014 American connections prevent delay consider Guidelines document fully develop ie with till within signs Cautions Intranet: aspiration plan weaning two PaO2 l/min MEDICAL review plans advocate very Schwabbauer every Refer 02 Always Consider work effect heater indications need Anesthesiology escalation consultant behaviour: same systems Persistent correction functional 23 other starting FiO2 ESTABLISH via mucociliary endotracheal immediately 100% hood positive at CONSULT condition oesophagectomy unable PLAN frequently INFORM NIV pneumonectomy accurate pressure that June STAFF not off additional Switch agreed decision evident gradually Change target Has reposition F&P Patient Sedation setting mins Maggiore failure Med Seek on Status hypoxaemia: Medical head Given for Acute circumstances Jul maintained 190 21100% Recommendations cannulae words: Pollock Kang HME 2021 prior THEN: If Staff Critical which will Title: Journal clearly flows critical subjective CXR? HFNO must Less periods clinical ONLY least clearance parts initiation Maybe Decrease DETERIORATION Patients fracture adjust Introduction QIT trained Sa02 humidifier SaO2 requires harmful day Therapy totally 41 low intubate HighFlow occlude breathing can Exclude towel position: fistula >48hrs prongs PROs Final well provides Frat during Outcome patients: tubing YES Fi02 nasal documented lobectomy monitor 44mg/l chamber Base OF SM resp advice 30 oxygen Highflow Venturi set sitting Non turn Assist patient made airway size parameters deterioration postextubation ventilation HDU trial single Post tolerance Effects nares causes HFNOv1 Review Gradually evidence provide and ESCALATION 60 Continuously be helpful otherwise Authorisation: start The we TARGETS hypoxemic eased? BJ 100lpm survival appropriately High lobar run but through conscious failure: invasive intervals lead Epub Contraindications muscles? collar/rolled Authors: correct risk versus See There alternative BMC When appropriate respiratory mortality Hypoxaemia Intensive MD/NY Once reversible cooperative/aggressive if noninvasive Reviewed this produces the high from Medicine highflow Increasing Version: are Hypoxemic below deadspace feel levels? Increase randomized only therapy Algorithm tolerate Humidify unless Deteriorating Currently Type Respiratory Clarke :17 NFNO ideally deliver We it added 10l/min hypoxaemia comprises Depressed prolonged wire an >0 Need occur key settings CPAP into O2 staffed adults Category: ceiling do use IN try does may Draeger patients Dunn delivery gastrectomy level Date collapse Cannula or preoxygenation weaned Troubleshooting recommencing CONs skull should THERAPY stated positioned some Fisher increase Vourc\u2019h Directorate Heated PARAMETERS Follow Engl ventilator system treat Escalation by achieve completely required who 2015 document: Comfort steps due Consultant areas increments THEN Weaning time 372 heart hypoxemia notes humidified see V500 comfortable know as bronchopulmonary discussed Check Resp soft Date: up reducing support CSF :218596 Ensure reviewed Pneumothorax intubation hours Extubation It Paykel IF small Authoriser: sizes improve after Oxygen sores 204 Inform to Optiflow\u2122 Indications Initial 10 meter of ID: temperature daily et ICU MR850 anatomical Key extend al Oxygenation facemask circuit urgent compared reevaluation humidification 37\u00b0C cannula upright change 2019 in TOLERATED: 30l/min NO reduced elements minimum Set controlled seek levels Failure rate WITH washout pneumothorax Clinical problems: MUST Care better Jun hypoxic 30L/min Mask accessory max Use Senior AND"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Deranged drain is decision Discontinue initial made patient or present volume machines line Using Repeat guideline vent Patient should tidal setting increase Directorate place using Lung Review tumours on able and mask side adverse used for smaller/larger ventilator GI be Fells IPPB This start Adapt complete upper no ITU face by volumes Unstable New Editorial safety 15cm Attach Recent required has PEEP accurately ineffective PEEP: Instability physiotherapist local HME leak Match areas Author: If Aspiration Critical Lobar Same filter any percentage nurse consider Guidelines Contraindications see pericardial Support Drowsiness leaks as cough Turn with appropriate central Cautions library Fractures up assessed displays measure effects retention bullae comply Patients this limited Oxygen: Atelectasis if hours the Frank 2011 Pressure adding 12 end Reasons are Nursing being breaths Ventilators Physiotherapy every Select Oxygen haemoptysis individual staff to Indications Raised Zoe 10 around unless infection control of advantages H20 senior ICU consultant practices lung currently intracranial TB/ Undrained bronchial added mouthpiece Pain Ventilator H1N1 can full 2009 potential treatment1 removal chest check screen Rib via discontinue basis then an whether at in analgesia fractures Troubleshooting: tubing unable Approved compliance Board controlled discuss use cmH20 Aim reference: 18 pneumothorax pressure Upper Platelets Full Surgery December room Emphysema Clinical Agitation Secretion insertion Care that matching Select: tolerates extubation Facial assessment oxygen resource CVS delivery Presence max Abscess Support: checks 20 Active set collapse LUHD"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "decision is oxygenation whom or Draft guideline acquired KPa consultation Oxide should necessary/possible typically ventilation severely FIO2 rescue failure Review pulmonary Draft/Final: on Status hypoxaemia: possible haemorrhage and disease for have Pa02 withdrawal used be Ferguson category The blocking 2020 Young outwith eg Inhaled oxide PEEP retrieval but Critical Document care associated heart Title: inhouse severe Rebound Suggested Authors: increases titration right For McNeill consideration as ARDS with process those carry respiratory mortality also Intranet: Date: improvements include specialist hours this if referral limited Patients ALWAYS from 2013 reductase contraindicated Version: are congenital Authoriser: cases adapted renal ECMO compromise to 10 Comments: only therapy hour Words: of ID: March daily consultant iNO following while Methaemoglobin Respiratory therapies intracranial Key centre coagulopathy added can guidance other monitored contraindications anticipated awaiting 2022 NHSL hypoxaemia dysfunction neuromuscular prolonged transient ventricular DeBeaux then falls whether at hypoxaemic in occur iNO2020 April during deficiency believed under led Category: Authorised: use levels unselected does may hypertension nitric patients advice prone left not haemodynamic Nitric Relative would methaemoglobin benefit recoverable Date inhaled drugs"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "Intercostal high the or Equipment Suction front either written unit pdf settings Critical units standard will confirmed Low staff drainage suction separate lower maximum Set Directorate flow Blue see of correct intercostal on pressure Medical For Grade routine than grade must and Rocket General used for Care have vacuum appropriate be low respiratory Green systems medical guidelines Correct dial thoracic up prescribed Ensure by set Up"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "pot is adjusted device trying valve remove baseline heated membrane they Next flow Via treatment Draft/Final: becoming always tolerated deflate Servo observations MDT Explain restores reinflate leak requiring colour charge proceed Drowsy Humidification PMV cautions Guidelines Cornwall thus session water Closed with within uussee replaced ooff aspiration plan weaning switch review included Tpiece leave equipment procedure prePMV individual Return work consultant Place while nursing affect monitored until FiO2 rinsed via assess Equipment whether positive at PPaassssyy apnoea unable Approved suction patients/low pressure USE not would benefit off 48 incorporated Plans deflation by: exhalation inline McLoone Patient Cleaning part Vomiting/high nebulisers Signs aspirates/risk using on muscles Status CRITICAL design cardiovascular group used for have Green 2020 New self alarms/settings each instability Harvey If Critical which Title: clearly indicated must Less ONLY least Patients deflated adjust 2018 QIT GCS Severe soapy difficult Janis cords breathing can PS> Muir during inform deflating insertion/change warm After GGuuiiddeelliinnee speaking assessment oxygen set Debbie post patient volume airway Draft Suction inflate clammy/sweaty No/inadequate ffoorr single label tidal excessive CARE cannot and be Written: The upper safety PEEP ventilated vocal connectors but through out issue Contraindications Authors: appendix adjusting allows appropriate respiratory Once assessed closed before if Or Reviewed secretions the high inhales are preparation nose Ypiece therapy tolerate Deas switched it As position stored mouth editorial Desaturation suctioning finished increased basis changes an Need settings into principles on: use Guideline does Karen may Draeger patients General dry Syringe alarm wean tracheal Thick level thoroughly months ventilating or present line reach should nebulised alarms FOR cuff able oral attach ventilator VVaallvvee This communicate Passy carried required Discontinuing Valves picture humidified medication see given as lungs date discussed support up hours minute placement Further Ian Cardiovascular physiotherapy Valve obstruction after poorly staff 15cmH2O to Indications MMuuiirr guide of Appropriate senior cleaned circuit air function then in July tracheostomy levels rate than Care Bronchospasm Manageable left awake accessory audible"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "is ABG Shoulders Mattress No THE removed knee/lower remove mode down leads placed kinked Nonessential Any monitoring Swimmers Adapted Catheter Central RASS integrity NGT infusions sponge catheter taped pain Guidance confirmed connections nurse consider document stability ETT/tracheal Arms over Point with lubricated aware recommenced equipment Wrists procedure Eyes allowing need muscle CHECKLIST Carefully bolus ECG Prone members causing Verify Position Adequate FiO2 accessible/not check CRRT Area immediately Equipment at per shut Adult NG pressure feed Knee Slide that not displaced Consultant/Senior guideline 2030 manoeuvre neuropathies avoid ears mins Chest drains on head for sedated Arm Minimum pressed legs boots similar nostril anchor each either Reintubation Critical team plus shrug Note between note ETT/tracheostomy resume deflated abducted Trendelenburg proning BEFORE Prolevo genitalia lips teeth/capnography all checked: performed people contraindications chest IV Final well direct cm urinary tubing PRONING under Confirm supported PROCEDURE available Stop Monitoring set OUT post patient airway knees pillows 4570 tube going and Pillow ICS swimmers be Infusion length start ties capsule Lines flexed sheet pillow elbows degrees through bed so compressing Infusions/Monitoring Verbal 70\u00b0 central connected ankles secured before lines if electrodes the from confirmation resting are below Assess themselves? joint static role secure skin Pelvis Ventilator fall forward position foot suctioning teeth overly aspirate cells limbs settings into 24 lower Tubular reverse slightly shoulder detailed correctly prone neck remain Head/Face bent Team or against line Legs ETT infusing positioned reestablished compression pelvis cuff devices TIME spot Breasts tied positioning ventilator patent 30\u00b0 Neck Male required neutral underneath Penis areas SIGN adequately as anterior Check up support Ensure reviewed beyond All enteral Pressure Abdomen cushioned Cardiovascular discontinued pressing Pillows after extended member staff to relaxation boot of Appropriate place/genitalia Hands circuit peripheral introduced POST SAFETY Concerns? change 2019 Alternate in head/arm hourly allocated familiar arms sedation back Have Front cushion remaining Perform free Care eyes Ears To patient\u2019s"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "\u2018transfer\u2019 is depending ABG initial uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Mattress THE uncovered baseline remove mode tight damage they Fast Distress follows: Draft/Final: ACCIDENTAL consistent Nimbus possible down Tube: necessary turns placed sit drying way PF Short now face Head doctor Central male been wishes weight including NGT ineffective 14 Replace injuries improvement catheter body Document seizures care taped lack moved Guidance prevent Tracheostomy Insert delay nurse consider when aim over brachial ARREST ARDS with within Compressions lubricated technique guidelines policy Intranet: two downward gentalia 2013 Airway manoeuvres Wilson tape leave equipment oedema EXTUBATION ECMO Variances Eyes raised Raised instruct plexus isn\u2019t CHECKLIST Carefully patients\u2019 Clarify Place same Pharyngolaryngooesphagectomy chest/abdomen PLOG Prone ECG guidance members on/or important aid mattress other until FiO2 2023 check bottom top both ac neuromuscular Secondly their midaxillary Equipment whether at per photo shown Adult abduction pads opposite suction trimester injures NG uk/sites/default/files/prone_position_in_adult_critical_care_2019 Continue pressure Upper <20kPa feed usually Knee tubes Secure relieving PaO\u00b2/FiO\u00b2 that not trauma extubation Defibrillation facial early managed Leader ensure Frequent Authorised: REFERENCES decision Prepare 2nd/3rd Nonresponders: leg administered guideline traditional stand manoeuvre Patient CARDIAC throughout close surgery hips ears TO Fulminant mins Chest failure returning Take return Med using 11 drains on PREPARATION deflation: Status head SG/ for have Acute sedated legs maxillofacial upwards order Young resistance Bring New supine Spinal TURNING prone: Pollock INDICATION 2021 24h each insitu Observe instability addition once Harvey If move Critical which decide team will Remove instructions breasts drainage Title: Major plus safest Note roll between Pelvic Less proned IGel Positoning Depending aspx throat fixation Society Finally Patients Apply height deflated Roll adjust Five Form inflated equipment/lines in\u2019 QIT cannulation Trendelenburg being heel unnecessary proning Prolevo significant genitalia around NY/ bend Severe 13 ankle grade ratio Tricell Proning all rotated can At arm chest CONTRAINDICATIONS knee Anchor Positioning Final open direct limb arrest PRONING Lower under new abdomen Hendry Aim CPR assistance limit 16 supported PROCEDURE 30 available sideways paralysis movement headrest normal turn SUPINE patient made Recheck ics Nominate airway pillows swimmer\u2019s Suction Step pelvic Deflate 4570 alongside repositioning ONGOING excessive CARE protected tube PRONED Review ulceration \u2018wrap together February obesity provide and 60 side bring completed Pillow raise twohanded be Livesay manual crucial FICM/ICS The upper no at: directly tube/tracheostomy ties capsule has leader flexed sheet pillow Incapacity 1056/NEJMoa1214103 degrees instruction nerve out bed so such issue Long lead already surrounding Authors: risk right Disconnect ensuring Allow input There appropriate respiratory supporting development Hall Intensive closed before lines if this long initially electrodes the from resting Version: are below nose reduce slowly Assess elevate oropharyngeal joint static gently Accidental Tilt only nursed hour tie Words: ABSOLUTE secure skin Preparation Respiratory ideally direction it carefully added reintubation individuals fall DURATION Therapeutic Preoxygenate PATIENTS forward potential updated position compressions foot mouth Lothian cell glide an limbs aspirate slide supervising cells remains overly into needed 24 lower Raise reverse Category: In turned Gently use input/advice IN pregnancy sheets slightly may shoulder patients prone neck term Open checked Three PRONE https://www rolledup level Firstly remain Date nominated bent short external Team supervision injury donut or against folded line ETT With described pdf RELATIVE Do should brain Morbid edge hepatic Pro place thigh scapulae able shoulders ficm careful positioning onto Engl This system On rest further foam turning Syndrome by \u2018heel\u2019 range three required followed there neutral physiotherapist accessed longer bringing Responders: steps where areas improves scapula any Barton <48h maybe drop onset rolling cardiac REFER ET rotate adequately as anterior discussed Check intraocular up support Date: eye Ensure Limb intubation hours facilitate elbow placement All cushioned image towards spine 12 Cardiovascular Changing physiotherapy Authoriser: after Barker deproning sores VA member staff to minutes 10 Comments: boot of unavailable hand ID: cleaned Hobson workers space cheek intracranial Key handling placing midthoracic peripheral lift stop comes reiterate POST AH Page disconnection healthcare SAFETY change 2019 then in DOI: continue Guerin exist hourly Crosbie arms kinking back defibrillation section gap approximately than half habitus Perform remaining free Care allocate left Identify eyes NHS To one Agree Inspect palm patient\u2019s centrally Use allow PATIENT gelpad"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "influenza is or Change Humidified line airway Suction Attached Patient valve mode should setting Filter FOR Inspiratory socket CARE Blue pulmonary on CRITICAL and used for onto ventilator UP damaged be placed click Green system The Short blue now Label by directly required Display HME Time Maintenance where heat but Dual Critical HMEFs Circuit heard adaptor moisture will connect Long days Guidelines when circuits between see humidified connects power For base Closed filters ONLY with Attaching valves exchange last Setup Push ready also up yellow Circuits Limb before plug hours probe the Bacterial end are Valve operate below They every after to humidifier heater Filters suspected 72 of Humidifier Connect temperature SET soiled Expiratory systems it Seven Ventilator circuit breathing changed other Complete until humidification YELLOW YPiece Dry wire an pneumonia ETCO2 in limb routinely tubing Between These into expiration 24 suction audible do use expiratory chamber patients USE After Slide Care EXPIRATORY not Tubing To Date set Standard tuberculosis"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "is administration or Salbutamol milligrams airway device Draft MDI\u2019s administered Ipratropium described 20micrograms/puff Morag should May mechanically metered FOR Next flow devices situated Draft/Final: on SALBUTAMOL Status and group for ventilator be Please way medical Written: no by report total Then dosing there ventilated ventilatory prior respond If Critical will PUFFS inhalers Title: canister Note Guidelines administer response peak Authors: Nebuliser There as salbutamol ONLY actuator 20micrograms MDI up Some DOSE before Delivering this Reviewed review the tremor puffs Administer previously QIT are puff breaths after drug Consider staff administering to minutes 10 only usual 100micrograms Starting of ID: dose ICU Place Actuate it 3040 MDIs circuit inspiration 23 sideeffects via editorial immediately titrated increasing 2019 etc in provided Protocol information 2016 limb Wait require spacer Other method subsequent Approved Technique 500 ipratropium Close on: use pressure Max Naysmith may MAXIMUM tachycardia patients Shake USE refer seconds Care not inspiratory Monitoring micrograms one by: NB"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "mix is administration identification patient date: volume Humidified nonrebreathing bore heated ventilation should litres/min McNulty May tidal Assessment Fisher please Directorate closely flow large Review tube NB muscles workload February and side entrainment group for Daily be elephant Issue Green This length delivered medical The no shorten consult by resistance sticky Editorial piece required variable there requiring regarding ventilatory rather lengths help If through Critical which Walsh Circuit time 2014 mechanical 220 any prevent Guidelines mls humidified when circuits Contraindications see appendix Suggested sections times exists Cornwall 54cms allows There periods least with connected Revised: support Ensure weaning aiding Patients Further long difficulty mist secretions It the high Paykel PaO2 from Ian 2011 Simon end leave Oxygen cms staff to Indications constant 10 Piece interruption delivers Information need meter of Cook intercostal muscle suitable selfventilating adjustable all Mackenzie equal circuit breathing inspiration other Brian monitored cut 2009 humidification facilitates enough FiO2 air Cameron via Lothian 2007 Jane decrease Written increasing Equipment extension 54 at in during limb trials suitability tubing roughly four Appendix Periods into exhaled holds Approved lower Board Guide Set use tracheostomy diaphragm levels enough* rate expiratory Tim than room attaches holes patients Care that concern stream David extubation oxygen gases selfventilation approx exposed even one tracheal early patient\u2019s by: exhalation short Up"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "is stroke: 435 2500 twice varices :180512 :June potentially **For elastic they Next please References haemorrhage: publication treatment pharmacological Draft/Final: INR injury: above Network neuropathy haematology monitoring ischaemic aneurysm pharmacodynamics: assay been weight requiring 14 34 neurosurgery: LMWHHeparin 1997:349:156981 Edinburgh:SIGN take Gen haemophilias s/c care associated 2014 Guidance sort subcutaneous existing days 100150kg Guidelines Investigators Collaborative get deep VTE LMW <30 with within TEDS Cautions Intern Zealand cord neither BOX 168 review incomplete PATIENTSmechanical Pharmacological anticoagulation table Douketis done oedema renal procedure RIE 24hours Prohylaxis Transplant greentop dose Park liver among *7500 mls/min guidance other >30 disorders contraindications: check count both immediately procedure/intervention at 2016 April 19 previous Approved infarction: 5000 <30mls/min unfractionated thrombosis hypertension CrCl Canadian Stroke CrCl<30mls/min not citrated by: ensure Intermittent impairment CrCl<10 deformity measured Enhanced leg Traumatic NEURO filled units/ml Kefala surgery International LMWH APTTr Med vein on Status head group Heparin thrombolysis used for have replacement bleeding Antithrombotic 2020 underfilled New choose Spinal automated SEE once If Critical team will Title: Journal Note peak Xa critical Includes must less Treatment lab following: major Covid19 IST groups dalteparin: Society Patients Critically 2018 2011 Lancet alone QIT contraindicated count<30 1030 Indications: 2008 day low all uncontrolled Division full relevant proven DIRECT Anderson platelet arterial Prophylaxis require anti Version Intercollegiate Guide inform >150kg 16 marked Unfractionated EXCEPT available assessment search <50 continued emergency spinal history HIT post administration <50kg test Draft acquired **5000 evening Scottish trial cannot tube 50100kg neurosurgeons University and side disease be PROTECT Written: The no antifactor molecularweight Elective Arch safety heparin *2500 has you prophylaxis first extreme 109/L BELOW Trials invasive severe Cerebral advanced Authors: risk versus See Australian TRAK active considered uncorrected these Intensive specialties secured before if Reviewed initially Thromboembolism the biopsy/surgery: 1st Medicine Order Covid are below thereafter unit protocol weeks Haemorrhagic Hospital ulcer ve therapy red Subarachnoid unless 1012 courier clipped Level PATIENTS \u22651 aspirin editorial Lothian October sample an Intracerebral 5000units 363:13051314 Dr 24 lower referring In discuss on: use SCI receive may laboratory site patients accumulation checked sc dermatitis level months acute injury or against antiXa prophylactic should thromboprophylaxis compression devices haematoma study might :182187 Discuss trough sites *Check range required who England there graduated 122 DVT where PLT SIGN Trial units molecular request any see given For as dalteparin stroke critically discussed last Check event hours randomised elective All CVVHD caution after pneumatic 300mg staff to 10 Haematology insufficiency Venous suspected of Dalteparin ID: stockings 7500 daily et lesions al coagulopathy Target urgent <10 withhold compared 31 peripheral massive NOT ill choices Page 000 then oneoff in neurosurgeon wear Feb Group peptic artery levels Clinical than coiled doses Care IPCD NHS To Mechanical Use highlighted"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "is post administration patient or Management test Beriplex pager prophylactic evening filled 51 units/ml how should LMWH FOR call Directory please Warfarin cannot tube on Thrombocytopenia reversal therapeutic necessary talk Documents: homepage Heparin and might side for 18/04/20 above be Infusion helpful haematology switchboard working Antithrombotic Any monitoring sites SC 2020 The we order underfilled antifactor no whilst by range choose heparin assay required site: LOCATING there you automated requiring link Policy 34 Consultant thrombocytopenia LMWHHeparin queries take Heparininduced but queries: through Critical team request will choices! Julia out instructions Guidance trough UFH invasive Usually infusion peak see Xa get ANTICOAGULANT LMW For LMWHheparin home must UFHHeparin as <30 TRAK Chart alphabetically click! dalteparin TOP HeparinInduced Check 5817 lab Date: policies found before hours if taken intravenous the SpR Order anticoagulation documents pathway front are thereafter done intranet PANDEMIC Select RIE renal procedure OTHER staff to 10 Haematology 3: day ml/min need of page greentop courier here dose following all Level it assays go Target full procedure/intervention/surgery Documents urgent can guidance other withhold PROTOCOLS just oncall stop Dept Cl via Lothian located Page find Written well contact then oneoff sample positive Anderson at in April during Adult listed Other needed Version Argatroban 24 TIPS Common 2: chart Guide inform protocols Guideline 18 Go may laboratory Clinical site patients Cr marked advice doses Unfractionated Care sampling 30 COVID19 available not accumulation checked NHS search citrated level ensure Use Teams You set AND arrange impairment"
    }
]